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1S1. Functional ovarian genomics: A tale of oocytic citizens.
EY Adashi1, M Tanaka2, JD Hennebold3, M Kihara1,
B Meczekalski4 & GJ King1. 1University of Utah, Department of
Obstetrics and Gynecology, Utah, US; 2Department of Obstetrics
and Gynecology, Keio University School of Medicine, Tokyo,
Japan; 3Division of Reproductive Sciences, Oregon National
Primate Research Center, Oregon Health and Sciences University,
Oregon, US; 4Department of Gynecological Endocrinology,
University of Medical Sciences in Poznan, Poznan, Poland.
Oocytes and early embryos of multiple (non-mammalian) species
lack the somatic form of the linker histone H1. We have uncovered
the cDNA in question in the course of a diffential screening
(suppression subtractive hybridization (SSH))project. The
significance of this pre-embryonic H1, one of only a few known
oocyte-specific proteins, draws on its substantial orthologous
conservation, singular structural attributes, highly
circumscribed/relatively short-lived expression pattern, marking
of the germ as distinct from the soma cell lineage and apparent
predominance amongst germ cell H1s. Herein, we report that the
intronic, single copy, five exon H1fo gene (greater than or equal
5301bp), maps to chromosome 6 rather than to the well-
characterized cluster of somatic H1 genes on chromosome 13.
The corresponding primary H1fo transcript gave rise to two
alternatively spliced, likely polyadenylated NMD (Non-sense
Mediated RNA Degradation)-impervious RNA species differing
only by an ‘intronic’ frame-shifting GTAG insert [H1fo-alpha
(1,120bp; 304 residues) and H1fo-beta (1,124bp; 246 residues)].
In situ hybridization confirmed the H1fo gene to be oocyte-
specific and coupled to primordial follicle recruitment and thus
to the onset of oocytic growth. Both protein isoforms, both
NLS-endowed but NES-free, localized to peri-nucleolar,
peripheral and possibly centromeric heterochromatin in the
oocytic GV. Intense investigation will be required to define the
putative functional role of the H1FO protein in the ordering of
the genetic and epigenetic programs of the chromatin of early
mammalian development as well as in defining the attendant
developmental agenda during the primordial-to-primary follicular
transition.
S2. Embryonic steps towards stem cell medicine.
RA Pedersen. Department of Surgery, Addenbrooke’s Hospital,
Hills Road, University of Cambridge, Cambridge, UK.
Embryonic stem (ES) cells provide a promising means for
generating many or perhaps all of the ~ 200 specialised cell
types of the body. With the availability of surplus early human
embryos as a consequence of in vitro fertilisation as a therapy
for infertility, it has become possible to undertake other studies
of such early embryos. A number of human ES (hES) cell lines
have been derived from human blastocysts, however, no lines
yet exist that can meet transplant quality standards. Thus, there
is a need to derive and characterise additional hES cell lines that
could be distributed widely and used in future clinical
applications. Recent studies on ES cells have shown that they
can form a number of cell types, including ectodermal,
mesodermal and endodermal cell types. For example, studies
have shown that pancreatic islet-like cells can be generated
from both mouse and human ES cells. Thus, the aims of our
research are to use state-of-the-art technologies to address
fundamental questions related to ES cell differentiation, and to
further the clinical application of these unique cells by deriving
additional lines and by studying their differentiation into specific
cell types. There is a particular interest in the generation of
haematopoietic stem cells (HSCs) from cultured hES cells, in
view of the broad utility of HSC not only in treating diseases of
the blood but also in potentially inducing tolerance to other
tissues derived from the same genetic source.
Supported by the Medical Research Council.
S3. Energy production by the mouse blastocyst and isolated
inner cell mass.
FD Houghton. Department of Biology (Area 3), University of
York, York, UK.
Introduction: The blastocyst comprises two distinct cell
lineages; the inner cell mass (ICM), from which the embryo
proper is derived and the trophectoderm (TE), the first epithelium
of development which gives rise to extra embryonic structures.
However, the biochemical properties of these cell lineages are
not well characterised. Blastocoel formation is associated with
an increase in energy metabolism which may be estimated by
measuring oxygen consumption and glycolysis (lactate
formation).
Methods: Immunosurgery was used to isolate the ICM from day
4 blastocysts derived by in vitro culture from zygotes. Oxygen
consumption by 20-22 ICMs and 10 blastocysts was determined
in modified KSOM medium. The spent medium was used to
determine lactate production using an ultramicrofluorescence
technique. Blastocyst cell number was obtained using
bisbenzimide staining.
Results and Discussion: Oxygen consumption of mouse intact
blastocysts (0.4nl/blastocyst/h) was significantly greater than
the ICM (0.06nl/ICM/h) P=0.006. When the value for the ICM
was subtracted from the total blastocyst oxygen consumption,
the TE consumed 11.3±1.7pl/cell/h compared to 4.65±0.18pl/cell/
h; P=0.028 for the ICM. There was no significant difference
between lactate production by the blastocyst and isolated ICM.
Together, these data suggest that the TE produces approximately
80% of the ATP generated at the blastocyst stage with the ICM
contributing 20%. The major energy consumer is likely to be the
Na+, K+, ATPase (sodium pump enzyme) located on the TE
basolateral membrane.
Supported by the Wellcome Trust.
S4. Fetal origins of male reproductive disorders: From
environment to mechanisms.
RM Sharpe. MRC Human Reproductive Sciences Unit, Centre
for Reproductive Biology, Edinburgh,UK.
Disorders of the male reproductive system are remarkably
common. They manifest either at birth, in the form of the two
commonest congenital malformations (cryptorchidism,
hypospadias) or in adulthood in the form of low sperm counts
or as testicular germ cell cancer. These disorders share
pregnancy-related risk factors and are risk factors for each other.
This has led to the hypothesis that these disorders form a
syndrome - the testicular dysgenesis syndrome (TDS) - which
2has its origins in fetal life centred on abnormal development of
the Sertoli and Leydig cells. This talk will review the evidence
for TDS and its changing incidence, describe the associated
testicular/cellular changes and outline the hormonal events of
sexual differentiation that underlie it. The contribution of
‘endocrine disruptors’ or lifestyle factors to TDS will be outlined,
but resolution of causal factors requires identification of the
cellular mechanisms involved, and is impossible to do in the
human fetus.
A possible animal model for TDS will be described, based on
exposure of the rat fetus to high (non-toxic) doses of phthalate
esters during the period of sexual differentiation. This treatment
induces a high rate of (mainly unilateral) cryptorchidism,
hypospadias and infertility in male offspring, as well as focal or
more widespread occurrence of Sertoli cell-only areas in the
testes. These changes are associated in perinatal life with
suppression of fetal testosterone levels and focal testicular
dysgenesis (malformation of seminiferous cords), together with
focal Leydig cell hyperplasia, intratubular Leydig cells and
abnormal development of fetal germ cells. Evidence will be
presented that the abnormal testicular changes are associated
with failure of Sertoli cells to undergo terminal differentiation/
maturation as the result of abnormal development in fetal life.
The biochemical pathways that might account for these changes
will be described. Elucidation of these pathways in the rat should
help to identify potential causes of TDS and aid assessment of
whether phthalate exposure in the human could cause TDS.
S5. The ageing ovary: Achilles heel of reproduction.
RG Gosden. The Jones Institute for Reproductive Medicine,
Eastern Virginia Medical School, Norfolk, US.
At mid-life, the human ovary is already senescent - not only is
the store of primordial follicles depleted, halting the capacity for
ovulatory cycles, but fewer oocytes in the premenopausal
decade are competent to produce viable embryos. The ovarian
lifespan is determined by the programmed formation, utilization
and cell death of follicles and, while follicular progression
appears highly ordered, stochastic factors hold sway at key
stages in development and atresia. Since the store of small
follicles is the zeitgeber of the ovarian lifespan, knowledge of
their biology, pathology and dynamics may lead to non-hormonal
markers of ovarian age for forecasting menopause, and perhaps
even to methods for controlling the primary follicular recruitment
and menopausal age. What is more, if oocyte quality is not
independent of the follicle store size, as some data imply, even
age-specific infertility may not be totally unyielding. In an era
when more women are deferring fertility to later reproductive
ages, ovarian age and oocyte quality have become dominant
factors affecting the chances of genetic parenthood and are
stimulating a demand for oocytes from younger donors. At
present, cryopreservation appears to offer prospects for
preserving women’s own fertility but, further ahead, biological
control of follicular dynamics and oocyte quality in vivo may be
feasible.
S6. Evolutionary genomics of reproductive ligand and receptor
genes.
AJ Hsueh, SY Hsu, K Nakabayashi, S Mazerbourg, S Sudo,
U Vitt & I Ben-Shlomo. Division of Reproductive Biology,
Department of Obstetrics and Gynecology, Stanford University
School of Medicine, Stanford, US.
Recent publication of genomic sequences for human and
multiple model organisms allows the elucidation of the
evolutionary origin of all human genes. For reproductive
biologists, this breakthrough facilitates the analysis of
reproductive genes by tracing their phylogenetic roots based
on the comparison of homologs from human and lower species.
Using GenBank searches, we identified new polypeptide
hormones and receptors based on an evolutionary tracing
approach. Because of the co-evolution of ligands and their
cogent receptors, analysis of human genomic sequences allows
one to predict the pairing of these elements. We have identified
novel human paralogs for glycoprotein hormone subunits (alpha
2 and beta 5), relaxin/insulin-like factors, and CRH-related
polypeptides. In addition, we isolated a group of five orphan
LGRs (leucine-rich repeat-containing, G protein-coupled
receptors) homologous to LH, FSH and TSH receptors. The
matching of polypeptide hormones and receptors led to the
finding of a new heterodimeric glycoprotein hormone
thyrostimulin (alpha 2/beta 5) as an agonistic ligand for the TSH
receptor (J Clin Invest. 109:1445 2002) and two selective ligands
for the type 2 CRH receptor (stresscopin and stresscopin-related
peptide; Nature Med, 7:605 2000). In addition, the elusive
receptors for the classic hormone relaxin were identified as LGR7
and LGR8 (Science, 295: 671 2002) whereas the INSL3 and relaxin
3 were found as specific ligands for LGR8 and LGR7, respectively
(J Biol Chem 277:31283 2002). Based on the evolutionary genomic
approach, we also identified the known BMPRII as the receptor
for GDF-9 (Biol Reprod. 67:473 2002).
Genomic analysis of the evolution of polypeptide ligand and
receptor gene families provides a functional genomic paradigm
for the future identification of novel ligands and receptors as
well as their matching. This approach should be applicable to
the understanding of the physiological and pathophysiological
roles of diverse reproductive genes.
S7. Identifying differentially expressed genes in the developing
gonad.
M Clinton. Department of Gene Expression and Development,
Roslin Institute, Midlothian, UK.
The developmental pathway that leads to gonadal differentiation
in vertebrates involves a sequence of well-characterised
morphological stages which in recent years have been correlated
with the expression of a set of specific genes. Gonadal
development can be considered to be under the control of two
genetic programmes; an underlying gene cascade regulates the
differentiation of the precursor cells of the genital ridge into the
specialised cells of the testis and ovary, and superimposed on
this programme is the sex-determining mechanism that controls
the biological decision to follow the pathway of testicular or
ovarian development. The programme of gene expression during
gonadal differentiation appears to be fairly well conserved across
vertebrates but the mechanism that directs the choice between
3male or female gonad is surprisingly variable. Sex is usually
determined via heteromorphic sex chromosomes; for example,
in mammals the Y chromosome carries the SRY gene, the
expression of which is sufficient to direct the indifferent gonadal
ridge toward the formation of testes. Other possible models
exist, but it is currently uncertain which, if any, of the established
models of sex determination apply to birds.
Carinate birds, which include chickens, contain a pair of
heteromorphic sex chromosomes designated Z and W, with
females ZW and males ZZ and we have recently demonstrated
that Z-chromosome genes undergo dosage compensation,
equalising expression levels in males and females. In terms of
gonadal differentiation, there are many similarities between
mammals and birds in the profile and pattern of genes regulating
this developmental process, however, there is no direct avian
homologue to the Sry gene. So far only approximately twenty
genes have been localised to the Z-chromosome and only four
W-chromosome genes identified, although potential candidate
genes for both a W-chromosome switch mechanism and a Z-
chromosome dosage mechanism have been proposed. i.e. ASW/
wPKCI and DMRT1.
We have adopted a transcriptional approach (Differential Display
RT-PCR) in an attempt to identify potential avian sex-determining
genes. We have examined the expression profile of over ten
thousand transcripts at multiple timepoints during gonadal
development in male and female chick embryos. We have
identified numerous transcripts displaying either sexually-
dimorphic or sex-specific patterns of expression, and here we
report the isolation and characterisation of three such candidates.
S8. Cell surface proteins of the human egg, embryo and
embryonic stem cells.
HDM Moore1, R Harun1, L Ruban1, CH Wong1, JS Draper2 &
PW Andrews2. 1Reproductive and Developmental Medicine,
University of Sheffield, Sheffield, UK; 2Biomedical Sciences,
University of Sheffield, Sheffield, UK.
Introduction: As well as having an intrinsic function in the
plasma membrane, cell surface antigens provide valuable tools
for the identification of cell types and in the analysis of
differentiation. In particular, stage-specific embryonic antigens
that are developmentally regulated during early embryogenesis
are widely used as markers to monitor the stages and cell types
of the pre-implantation embryo and to monitor the differentiation
of mouse and human embryonic stem (ES) cells, embryonic germ
(EG) cells and their malignant counterparts, embryonic carcinoma
(EC) cells.
Methods: We have used a variety of antigen localisation studies
using microscopic immunofluorescence and FACS analysis (in
conjunction with RT-PCR) to determine expression patterns of
stage - specific antigen markers in germ cells, embryos and
embryonic stem cells in culture. Recently we have begun to use
a proteomics approach to identify novel antigens involved in
differentiation signalling pathways.
Results and Discussion: On the rodent and human egg
membrane, antigens such as the tetraspanins CD9 and CD81
play an important role in the gamete fusion process and show
many similarities. However, in the early embryo, there are notable
differences in the expression patterns between stage-specific
antigens, SSEA 1-4, Tra-1-60 and Tra-1-81 in the mouse and
human. ES and EC cells express antigen profiles corresponding
to the species. These results indicate that the human inner cell
mass (ICM) and cultured ES cells share a common antigen
phenotype that also resembles human EC cells but is distinct
from that of murine ICM. The antigenic profile of EG cells is
similar but not exactly the same as ES cells in culture. The
relationship between antigen profiles and cellular differentiation
will be discussed along with the role of some membrane antigens
during development.
S9. Is there altered gene expression in the endometrium of
infertile women?
AM Sharkey1, R Teirney2, ML Hull1, AE Evans1, S Saidi2 &
SK Smith2. 1Department of Pathology, University of Cambridge,
Cambridge, UK; 2Department of Obstetrics and Gynaecology,
University of Cambridge, Rosie Maternity Hospital, Cambridge,
UK.
Introduction: A major obstacle to reproductive success is our
inability to diagnose or treat the non-receptive endometrium.
The endometrium becomes receptive for a limited period,
characterised by expression of particular genes which allow the
endometrium to respond to the embryo. Recently, several
molecules have been reported whose function is essential for
uterine receptivity in rodents and primates. Altered expression
of some of these molecules has been reported in women with
subfertility. However the high degree of variation between
patients means none of these markers have yet proven clinically
useful. High throughput techniques such as microarrays and
proteomics methods to investigate gene expression in the
endometrium provide a novel approach to defining receptivity
at the molecular level.
Methods: We have used human cDNA and oligonucleotide
microarrays to compare the transcriptome of endometrium from
women with unexplained infertility and normal fertile controls.
Timed endometrial biopsies were obtained between LH+6 and
LH+9. Total RNA was isolated and hybridised to the arrays to
obtain the endometrial gene expression profile for each patient
during this time window.
Results and Discussion: This data set is being interrogated to
identify individual genes whose expression differs between the
fertile and infertile patient groups using conventional t-tests.
We have also developed Independent Component Analysis to
analyse the whole gene expression profile to identify groups of
genes which contribute significantly to features within the data.
These groups of genes (components) may differ significantly
between the two patient groups even when individual genes
within the component do not. ICA provides a powerful new
approach to extracting clinically useful information from
microarray data. We have recently shown that this method can
successfully differentiate different forms of endometrial cancer.
If ICA can identify differences between endometrium from fertile
and infertile women this would provide a new approach to the
diagnosis and treatment of infertility. The potential impact of
these tools on clinical practice will be discussed.
4S10. Measuring sperm function: What our methods tell us.
WV Holt. Reproductive Biology, Institute of Zoology, London,
UK.
While evolutionary pressures have shaped a basic sperm design
that is recognisable across many genera, the peculiarities of
reproduction within a species have refined the details. However,
the same pressures that led to species divergence in sperm shape
and size are still operational today, acting through selective and
adaptive mechanisms. Attempting to understand some of these
selective pressures may provide insights to help in the
development of techniques for assessing sperm quality. Today,
there are multiple methods for the objective assessment of semen
parameters, but their interpretation remains a problem. Intuitively
we understand that a successful spermatozoon is the one that
reached the oocyte, fertilised it and whose genome was
sufficiently defect-free to support embryonic development. In
fact, this successful spermatozoon must be fully competent in a
variety of functions that include motility, metabolism, ability to
undergo the acrosome reaction, and all the signalling systems
needed to modulate the interaction with their environment.
Clearly, not all spermatozoa exhibit this level of competence and
some may be completely dysfunctional. However, while
spermatozoa may be perfectly capable of supporting fertilisation
and embryonic development, they may be unable to compete
with spermatozoa that have superior ability to colonise the female
tract and reach the oocyte. If the competing spermatozoa are
from a different male, as happens frequently in nature, the
outcome will tend to skew the genetics of the next generation,
possibly towards the production of even more highly effective
spermatozoa. Female reproductive systems in many taxa select
the best spermatozoa in an ejaculate, store them for later use
and discard the rest, thereby gaining genetic benefits for the
next generation. If they can do it, it should be possible to integrate
all of our laboratory techniques and eventually work out how to
do it ourselves.
S11. Early embryo origins of fetal programming and postnatal
physiology.
TP Fleming. School of Biological Sciences, University of
Southampton, Southampton, UK.
Introduction: A growing body of evidence indicates that the
environment of the egg and early embryo may impact not only
on short-term morphogenetic processes but also on long-term
postimplantation or postnatal growth and physiology. These
aspects of early development provide a legacy with implications
for human healthcare. Thus, for example in our own work,
maternal protein undernutrition applied exclusively during the
preimplantation period of rodent development led to down-
regulation of blastocyst inner cell mass and trophectoderm cell
numbers, low birth weight, abnormal postnatal growth and
hypertension in a gender-specific manner (Kwong et al., 2000).
Our current studies are focused on determining underlying
mechanisms of programming involving genetic, cellular and
physiological processes.
Methods: Semi-quantitative RT-PCR; PCR embryo sexing;
immunoblotting; radiolabel uptake; in vitro culture and embryo
transfer; plethysmography.
Results and Discussion: Maternal protein undernutrition during
the preimplantation period may alter the pattern of growth factor,
amino acid and glucose composition within the uterus or uterine
fluid during blastocyst formation which may contribute to
induction of programming. The level of expression of imprinted
genes within blastocysts changes in response to maternal diet
in a gender-specific way. Later in development, maternal protein
undernutrition can induce down-regulation of visceral yolk sac
endocytic nutritional support for gestation. We have also
developed an in vitro culture and embryo transfer model for
programming; data using this model indicate postnatal growth
and systolic blood pressure are sensitive to preimplantation
environmental conditions. Collectively, these studies indicate
that programming may result from the interaction of diverse
mechanisms operating at molecular, cellular and physiological
levels.
This work is funded by MRC.
S12. Endocrine mechanisms of intrauterine programming.
AL Fowden. Department of Physiology, University of Cambridge,
UK.
Epidemiological observations in man and experimental studies
in other species have shown that impaired intrauterine growth
alters postnatal tissue function (1). In part, this prenatal
programming of tissues may be due to changes in the endocrine
environment in utero. Hormones, such as cortisol, insulin,
thyroid hormones and the insulin-like growth factors, have been
shown to regulate fetal growth and are responsive to nutritional
and other conditions known to programme tissues in utero (2).
The programming effects of these hormonal changes depend
on the route, duration and timing of fetal hormone exposure.
Early in gestation, hormone changes largely of maternal or
placental origin may affect tissue development either directly at
critical stages during organogenesis or indirectly by altering
the size, structure and/or function of the placenta with
consequences for the placental supply of nutrients and/or
hormones later in gestation. During late gestation, the fetal
endocrine glands are functional and responsive to nutritional
and other stimuli. Hence, hormonal changes of fetal origin can
also directly alter the pattern of growth and development in
utero by regulated tissue uptake and utilization of the nutrients
provided by the placenta. The glucocorticoids, in particular,
have an important role controlling the balance between tissue
accretion and differentiation during late gestation (3). Fetal
glucocorticoid overexposure of either fetal, placental or maternal
origin can, therefore, lead to inappropriate changes in the cell
cycle for the stage of development with adverse sequelae for
tissue function much later in life (3). Indeed, increased exposure
to glucocorticoids may be the common mechanism by which
adverse environmental conditions programme tissues in utero.
1. Bertram C & Hanson MA 2001. BMB 60 103-121.
2. Fowden AL & Forhead AJ 2001. Lung Biology in Health &
Disease 151 199-228.
3. Fowden AL et al., (1998). Proc. Soc. Nutri. 57 113-122
5S13. Role of imprinted genes in function of the placenta.
M Constancia4, A Fowden1, A Ferguson-Smith2, K Mitsuya4,
F Santos4, W Dean4, C Sibley3 & W Reik4. 1Department of
Physiology, University of Cambridge, UK; 2Department of
Anatomy, University of Cambridge, UK; 3University of
Manchester, UK; 4The Babraham Institute, Cambridge, UK.
Imprinted genes in mammals have important roles in the control
of fetal growth and many are expressed in the placenta. We
have begun to ask questions about the role of imprinted genes
in the placenta. We have knocked out the placenta specific
transcript of Igf2 in the mouse and found that this results in
growth deficiency of the placenta from shortly after mid gestation
followed by fetal growth restriction late in gestation. Mutant
pups are born approximately with 70% of normal birthweight,
and show catch-up growth later on. The passive diffusion
capacity of the mutant placenta is reduced, but active amino
acid transport is initially upregulated, presumably to compensate
for reduced passive diffusion. Later in gestation this
compensatory upregulation fails and growth restriction ensues.
We have interpreted these findings as suggesting a ‘fetal demand
signal’ (which could be fetal Igf2 itself) which can regulate
‘placental supply’ of amino acids. We are interested in
understanding these signals at the molecular level.
The placenta is also of interest in terms of the mechanisms of
imprinting and epigenetic gene regulation. We have found that
cloned embryos generally have elevated levels of DNA
methylation and histone modifications in extraembryonic tissues
(whose development is often most adversely affected in clones),
and that some imprinting marks appear to be independent of
DNA methylation. Thus epigenetic regulation in extraembryonic
tissues may differ uniquely from that in somatic tissues.
S14. Novel transcriptional mediators of angiogenesis and
vascular development.
P Oettgen. Harvard Institute of Medicine, Boston, US.
Vascular development is a highly organized sequence of events
that requires the correct spatial and temporal expression of
specific sets of genes leading to the development of a primary
vascular network. The first step in this process is the
differentiation of pluripotent stem cells into endothelial cells.
This is followed by endothelial proliferation, migration, and
eventual formation of endothelial tubes. Maturation of these
primitive tubes into fully developed blood vessels requires the
recruitment of surrounding pericytes and their differentiation
into vascular smooth muscle cells. Additional growth factors
and receptors are required for the formation of arteries and veins.
Many of the events that occur during vasculogenesis are
recapitulated during angiogenesis. Transcription factors have
been shown to serve as master switches for regulating a number
of developmental processes. The purpose of this talk is to
provide an update on the progress that has been made in our
understanding of the transcriptional regulation of vascular
development and to review some of the approaches that are
being used to identify novel factors.
S15. Fetal systolic load and oxygen affect life-long heart health.
KL Thornburg, MD Reller, GD Giraud, MJ Morton, CW Pinson,
N Sundgren & L Davis. Heart Research Center, Oregon Health
& Science University, Portland, US.
Introduction: It is well known that the risk for ischemic cardiac
disease in adult life is related to inadequate fetal growth. The
roles of hemodynamic forces and hypoxemia in regulating cell
maturation and cardiac chamber growth during fetal and adult
life have not been studied. We performed a series of studies
designed to assess the degrees to which systolic pressure load
and hypoxemia alter heart myocytes growth and coronary flow.
Methods: For pressure load studies, we placed an inflatable
occluder on the pulmonary artery of fetal sheep at about 130d
gestation (150d term). The occluder was inflated to generate a
20 mm Hg systolic pressure load to the right ventricle for 10
days. For coronary flow studies we induced fetal anemia by
removing red cells and decreasing hematocrit by 50% for about
7 days after which we replaced RBCs. We allowed treated and
untreated lambs to deliver. They were studied as adults at six
months of age.
Results and Discussion: Loaded right ventricles were thicker
and heavier than control ventricles. Loaded myocytes had
undergone hyperplasia, hypertrophy and increased
binucleation. Binucleated cells cannot divide but are able to
enlarge. We conclude that loading increases the number of cells
that are terminally differentiated and can no longer divide.
Coronary conductance was two times higher in anemic fetuses
compared to controls. At 6 mo., coronary conductance remained
two times normal. We conclude that a short window of fetal
anemia leads to increased coronary conductance for life.
S16. Breaking bad news at any age.
MM Barnett. Centre for Primary Health Care Studies, University
of Warwick, Coventry, UK; University Hospitals of Coventry &
Warwickshire NHS Trust, Coventry, UK.
Introduction: In this paper I shall look at the impact of breaking
of bad news (BBN), both from the clinicians and patient
perspectives, focusing particularly on the Breaking Bad News
Project, carried out at Warwick University. We examined patient
experiences, and previous training and current day to day
experience described by consultants.
Subsequently we implemented and evaluated three approaches
aimed at improving skills and attitudes. Training comprised 1-
day workshop (skills), 2-day workshop (experiential) or self-
directed learning.
We measured participants self rated evaluation of quality of
training and its effect on their confidence and practice. We also
used objective outcome measures to evaluate effectiveness of
training.
Methods: 285 consultants representing 30 specialties received
a postal questionnaire and invitation to participate in Breaking
Bad News Training. Questions included: frequency and
description of BBN situations. Outcome measures: McMichael-
Barnett patient-centredness (P-C Score) and WERD-Score
(emotional comfort). Skills assessment used video-ratings of
simulated consultations (BAS).
Results and Discussion: 1) Questionnaire: 154/285 (54%)
6response. 49% of respondents had not undertaken any formal
training relating to bbn, yet the majority (52%) performed this
task frequently (>1-2/week). BBN situations included: cancer
diagnosis, cardiac failure, visual loss, and intra-uterine death.
Attitude measures showed that a substantial proportion lacked
a patient-centred approach and were emotionally uncomfortable
when faced with this task.
2) Training: 121 consultants agreed to participate, 71 participated
within the study period: 27 1-day, 25 2-day, 19 self-directed.
Participants rated all three interventions highly, and self-ratings
of confidence increased significantly. Objective measures of
performance showed a training effect on behaviour, although
no significant differences were demonstrated between
approaches.
Breaking bad news is a frequent task for hospital consultants,
but many are not comfortable or patient-centred when faced
with this task. This suggests that training in breaking bad news
is both relevant and necessary for consultants in all clinical
specialties. Brief workshop training is effective in improving
confidence and skill.
S17. To feel or not to feel? - Emotions: An invisible 3rd
dimension in fertility and reproduction work.
CJ Hill. Centre for Professional and Organisational Development,
School of Health and Social Care, Sheffield Hallam University,
Sheffield, UK.
The most obvious resources that professionals bring to
reproductive and fertility care are their scientific knowledge and
their mastery of technology. Conferences such as this one
support professionals in developing their understanding on
these areas.
The field, at the level of patient experience, is, however, one that
is frequently suffused with intense emotions of many kinds.
Professionals working in the field are working continually with
and amongst these emotions.
This session focuses on the emotional skills and the emotional
energy that professionals bring to their professional practice:
- Over the past 10 years ‘emotional work’ has been treated
seriously enough to have become the subject of research. See
for example : Wharton & Erikson (1993). Managing emotions on
the job and at home: Understanding the consequences of
multiple emotional roles. Academy of Management Review,
18,457-486.
- Increasingly it is realised that emotional intelligence is
something that is required by effective professionals. See for
example: Goleman, D. (1996) Emotional Intelligence : Why it can
matter more than IQ. Bloomsbury.
- Emotional strain is understood to impact on both professional
performance and personal wellbeing. See for example : Borrill,C.S.,
et al. (1998) Stress among staff in N.H.S. Trusts. Final Report.
Institute of Work Psychology, University of Sheffield; and
Health and Safety Commission, (1999). Managing Stress at Work.
A discussion document. HSE Books.
The session will have an interactive format and will aim to
engage the audience in examining the nature of their own
emotional work and reflecting on its impact, both on individual
professionals and on the performance of clinical teams.
S18. Ethnographic focus on holistic care in fertility nursing.
HT Allan1 & D Barber2. 1European Institute of Health and Medical
Sciences, Guildford, UK; 2Fertility Unit ,John Radcliffe Hospital,
Oxford, UK.
Introduction: This paper presents early data analysis of a mini
ethnography of higher levels of nursing roles in fertility care.
Methods: It is based on a mini ethnography of a fertility unit in
the UK. 3 months of data collection were undertaken using
participant observation and individual qualitative interviews with
the nursing and medical staff on the unit.
Ethical approval was obtained from the relevant LREC.
Interviews lasted 60 minutes and were audiotaped and transcribed
verbatim.
Thematic analysis was used and themes constructed from the
transcripts. A conceptual map and emerged on which this paper
is based.
The findings were shared with the participants and feedback on
the conceptual map included in the final analysis and report.
Results and Discussion: These themes focus on the context of
the developing levels of practice within fertility nursing and the
attributes of such roles. This paper presents a conceptual map
for nurses to begin exploring the factors which lead them to
develop higher levels of practice, the rationale for these changes
and the attributes which distinguish such nursing practice from
other forms of professional practice.
The themes which formed the context of nursing role
development in this study were:
the nature of the task
inside culture of the unit
emotional preparation of self
availability of support
availability of training
acceptability of changes within profession.
The Attributes of higher levels of practice are:
knowing
caring
working practices.
S19. Psychological distress in infertility: A qualitative study
of the areas of couples’ lives affected by infertility and its
investigation and treatment.
GA Farmer, R Shaw-Smith, E McVeigh & PJ Magill. Nuffield
Department of Obstetrics and Gynaecology, University of Oxford,
Oxford, UK.
Introduction: The distress caused by infertility is not well
captured by generic measures. Three fertility specific measures
have been identified, but also appear to have limitations. The
aim of this study was to investigate infertility couples’
perceptions of the areas of their lives principally affected to
assist in the valid investigation of distress in a longitudinal
study.
Methods: Thirteen couples at different stages of investigation,
treatment or disengagement from infertility were recruited to a
qualitative study. Informed consent was obtained and the work
7approved by the Oxford Psychological Research Ethics
Committee. Audio taped, semi-structured interviews were
conducted with each partner separately. The tapes were
transcribed verbatim, coded and analysed using constant
comparison. Interviews continued until data saturation was
reached.
Results and Discussion: Couples reported that the ‘whole of
their lives’ were affected, with infertility becoming their main
focus over many months or years. Analysis identified three
broad themes.
1/ Effects of infertility on self: role failure, reduction in self-
esteem, self-blame, guilt and regret, emotional highs and lows
and the direct effects of treatment and procedures.
2/ Effects on life plans: re-evaluation of previous assumptions
about becoming a parent, putting life on hold, balancing work
and treatment, use of money, loss of control, and facing the
future.
3/ Effects on relationships: those with partners were most
prominently affected, followed by friends, family and work
colleagues. Deterioration was commonly reported but
improvement was also observed. Relationships with health
professionals were important.
Infertility associated distress has wide ranging effects that are
predictable in populations but not cogently explained in
individual couples. Existing measures do not encompass all
aspects of couples’ distress and argue for further work on a
new fertility related stress adaptation questionnaire.
The study was supported by grants from Serono
Pharmaceuticals Ltd and the Oxford Medical Research Fund.
S20. Conducting and publishing research.
MJ Renfrew. Mother and Infant Research Unit, University of
Leeds, Leeds, UK.
Getting started in research is challenging. Any research study
needs:
A good research question
Research skills
An environment in which you will be supported
Involvement of the team
Funding
Stamina to complete the study
Writing and publishing skills
For nurses, this is especially difficult; nurses do not always
have the research training, they may not be supported to do
research, and funding is especially difficult to obtain. But in the
field of fertility and reproduction, there are many research
questions that nurses are best placed to address, and nurses in
many fields have shown the tenacity and skill needed to develop
research that makes a difference to care.
This session will examine the need to develop research in nursing
in this field, and will, through interaction with the audience,
identify some of the major barriers to research development,
and some ways forward. A plan will be developed to address
the barriers and develop real solutions. Information will be given
about good resources to support research development and
writing skills.
S21. The menopause: An evolutionary accident?
DT Baird. Centre for Reproductive Biology, University of
Edinburgh, Edinburgh, UK.
The ovary is no exception to the ravages of ageing. The
menopause marks the time when the store of oocytes laid down
in fetal life is finally exhausted. In contrast to somatic cells the
germ-line (oogonia and spermatogenia) are potentially immortal
with a minority being passed on to the next generation. After
fetal life oocytes are arrested in the dictyate stage of first meiosis
and hence might be expected to be protected from the deleterious
effects associated with repeated cell divisions. However the
striking rise in the incidence of miscarriages and births associated
with chromosome abnormalities in older mothers, points to the
fact that oocytes do age. Studies involving ovum donation
clearly demonstrates that the oocyte rather than the uterus is
the main cause of the marked reduction in fertility with age.
Women are almost unique amongst female mammals in that they
can live for several decades after reproductive potential has
ceased. It has been suggested that because children are
dependent on their parents for several years after birth, there
could be an evolutionary advantage in having mothers (and
grandmothers) to assist in rearing. However it is hard to imagine
what would be the advantage of breeding later in life when
childbearing is more hazardous and the chances of abnormal
offspring greater.
An alternative hypothesis is that the menopause is an
evolutionary accident which occurred only exceptionally until
the last few hundred years. Even in 1900 the majority of women
in the UK died before the age of 50 years. The occurrence of the
menopause in the majority of women in modern society is a
consequence of the striking extension of life expectancy due to
improved nutrition, reduction in disease and ravages of
childbearing. Some animals (monkeys, sheep, rats) reared under
protected conditions in captivity will survive beyond the time
when the ovary fails.
S22. Pituitary-testis function throughout life.
IT Huhtaniemi. Institute of Reproductive and Developmental
Biology, Imperial College London, London, UK.
The male is exposed to testicular androgens throughout his
entire life span, from the turn of the first trimesters of pregnancy
until old age. The most conspicuous effect of fetal androgens is
to stabilize the Wolffian ducts and induce their development
into the internal male sex organs. The other fetal testicular
hormones are the Sertoli cell product, anti-Muellerian hormone,
bringing about involution of the Muellerian ducts, and insulin-
like factor 3, responsible for the transabdominal testicular
descent. Testosterone is also converted to the more potent
androgen, 5a-dihydrotestosterone that masculinizes the fetal
external sex organs. Fetal androgens also masculinise certain
nuclei of the central nervous system. The androgen levels stay
low for the latter half of gestation, and the second increase
occurs during the first 3-6 postnatal months with a clear peak in
circulating gonadotrophins and testosterone. The function of
these hormones remains unknown and they may only represent
adaptation to postnatal life after elimination of placental steroid
hormones. The neonatal period is followed by a sedentary phase
of hypothalamic-pituitary-gonadal activity, which is interrupter
8by reawakening at puberty. This process is initiated by increased
amplitude of episodic night-time gonadotrophin discharges,
which gradually start occurring also in day time with persistent
elevation of testicular androgen production. Pituitary LH is
responsible for Leydig cell testosterone production and FSH
stimulates the pubertal proliferation of Sertoli cells and initiation
of spermatogenesis. However, FSH may be not be absolutely
necessary for the initiation of spermatogenesis, because men
with inactivating FSH receptor mutation have only variable
suppression of spermatogenesis. Testicular androgen
production continues in theory unaltered for the rest of life, but
in practice it declines with advancing age. Whether this
represents a physiological phenomenon, analogous to female
menopause (hence the term ‘andropause’) or whether it is
caused by increased frequency of systemic diseases with ageing
remains contentious.
S23. Human reproductive aging: Insights into mechanisms
from an animal (rat) model
BR Zirkin. Division of Reproductive Biology, Department of
Biochemistry and Molecular Biology, John Hopkins University,
Bloomberg School of Public Health, Baltimore, US.
With aging, there are progressive reductions in the ability of
Leydig cells to produce testosterone. Using the Brown Norway
rat model, we have found that this results from changes in
individual Leydig cells, not in loss of these cells. Our major
objectives have been to understand why old Leydig cells
produce less testosterone, and what causes them to do so. We
have shown that, with aging, serum levels of luteinizing hormone
(LH) do not change, but LH receptor numbers on the Leydig cell
plasma membrane are reduced; and within the Leydig cell, that
there are reductions in: intracellular cAMP formation;
steroidogenic acute regulatory protein (StAR) and peripheral
benzodiazapine receptor (PBR), both involved in the
translocation of cholesterol to the inner mitochondrial
membrane; the conversion of cholesterol to pregnenolone within
the mitochondria, catalyzed by P450 side-chain cleavage enzyme
(P450scc); the conversion of pregnenolone to progesterone in
the smooth endoplasmic reticulum, catalyzed by the 3ß-HSD/
D5-4-isomerase enzyme (3ß-HSD); the subsequent conversion
of progesterone to 17a-hydroxyprogesterone and then
androstenedione, catalyzed by 17a-hydroxylase/C17-20 lyase
(P45017?); and finally the conversion of androstenedione to
testosterone (T) by 17b-hydroxysteroid dehydrogenase (17b-
HSD). We have found that culture of isolated Leydig cells with
LH maintains high levels of testosterone production by young
cells, but does not restore old cells to high levels. In contrast,
dbcAMP is able to do so, suggesting that the major problem
with old Leydig cells is its signal transduction mechanisms
between the LH receptor and cAMP production. We have found
that experimental, long-term suppression of steroidogenesis,
accomplished by administering exogenous testosterone to
middle-aged rats, prevents the steroidogenic aging of the cells.
This suggests that steroidogenesis itself ultimately causes age-
related reductions in steroidogenesis. As measured with
lucigenin, reactive oxygen production by old Leydig cells was
found to be significantly greater than by young Leydig cells.
We have shown by microarray and Northern blot analysis that
the expression of genes for SOD1, SOD2, catalase and
glutathione peroxidase, the products of which protect Leydig
cells from oxidative stress, are reduced as these cells age, as are
the activities and protein levels of these scavenging enzymes.
Taken together, our data suggest, but do not prove, that reactive
oxygen damage might cause the changes in Leydig cells that
result in reduced testosterone production. It seems possible
that the reactive oxygen derives, at least in part, from
steroidogenesis itself.
S24. Why is competency so important?
K Manley. Royal College of Nursing, London, UK.
The need to demonstrate individual competency is greater than
ever before. However competencies need to be linked to a
common vision about nursing within the specialism as well as
integrated within the career framework if practitioners are to be
influential as a body in furthering the direction of their specialism
and positively influencing healthcare.
The main benefactors of an UK-wide integrated career and
competency framework are patients and users who can be
assured the same standards whereever they access care across
the UK. For practitioners there are also benefits over and above
benefiting patients - the transferability of one’s skills to any
where in the UK, and, formal accreditation /recognition for
competencies through professional accreditation which assists
in career progression, particularly in light of Agenda for Change.
The recognition of expertise in practice (Manley & Garbett 2000)
and the impact this has on patients (RCN 2002), in addition to
the links between practice development, competence
development, and work-based learning enables practitioners to
really demonstrate their impact within the spirit of life-long
learning. Career progression is made easier as it is known to all
the competencies to be achieved.
The RCN Accreditation unit is currently preparing to
professionally accredit practitioners who can demonstrate their
impact on practice, whether it is in the form of demonstrating
their expertise, or their competence against competency
standards at different stages of the career framework, or their
facilitation skills, or the practice development they have
achieved through work-based learning support and facilitation.
Developing UK-wide competency frameworks for the specialism
is therefore the first step but the challenge is to keep focused on
those competencies that are specialism specific than those that
are generic to all nursing specialisms. Generalist competencies
are currently being brought together to integrate the changing
healthcare context in which we work (e.g. The Knowledge and
Skills framework, Higher Level Practice) - such adaptability and
flexibility is a core attribute of effective individuals, teams and
cultures (Manly 2001).
Manley K; Garbett Rob (2000) Paying Peter and Paul: reconciling
concepts of expertise with competency for a clinical career
structure Journal of Clinical Nursing 9: 360-368
RCN (2002) Expertise in Practice Project Launch of findings RCN
Congress 2002 Harrogate
Manley K 2001 Consultant nurse: concept, processes outcome.
PhD Thesis University of Manchester/RCN London
9S25. Are we as good as we think we are?
P O’Donnell & BT Podsiadly. SIVF Newcastle Pty Ltd,
Newcastle, Australia.
Introduction: Assessment tools to measure the quality of a
service such as a Fertility Centre are diverse. The philosophy
that must be accepted of any centre, which has an aim to be
‘good’, or ‘better’, is that the pregnancy results alone are not an
absolute measure. That is, being ‘good’ is not about reaching
or surpassing established pregnancy rates, it is about
incorporating a system and a culture within the clinic that leads
to an optimal outcome for the customer. The philosophy of the
centre must also include the provision of resources to implement
the type of service it aims for. The implementation of an
international standard of assessment is a starting point. ISO
9001 is an excellent accreditation tool and very good at
benchmarking processes occurring within a clinic.
There are additional parameters, such as clinic presentation and
public perception of a good service, which can also be used to
enhance a ‘good’ clinic.
Methods: Aim
To outline the benefits of ISO 9001
Illustrate patient surveys as an assessment tool.
Outline communication issues in the fertility centre.
Examples of education programs for staff and patients.
Illustrate pregnancy results over time
Give examples of outside influences directing treatment
Results and Discussion: Implementation of ISO 9001, in
particular the use of the internal audits, focuses on maintaining
a standard that is consistent and reproducible.
195 patient questionnaires, each with 47 questions, were collated
over a 6-month period for the SIVF group. The results overall
give the service provider an indication on the consumer’s views,
and the areas that need change.
The preferred number of embryos transferred has been reduced
to ‘one’ as a result of the impact multiple birth has had on
community resources.
Conclusion: Providing a ‘good’ clinic requires ongoing
assessment of the service in terms of pregnancy rates, staff and
patient satisfaction and incorporation of outside influences. It
is important to appreciate that IVF is not a stationary process; it
requires constant reevaluation to ensure a high standard is
maintained.
S26. Decision making in in-vitro fertilisation (DEMI): How
couples view the end of treatment.
V Peddie1, E van Teijlingen2 & S Bhattacharya1. 1Department of
Obstetrics & Gynaecology, University of Aberdeen, UK;
2Department of Public Health, Aberdeen, UK.
Introduction: The decision not to continue in-vitro fertilisation
after one or more unsuccessful attempts is an important one for
nearly all couples. Relatively little is known about couples’
perception of this process. This study was undertaken to assess
patient’s satisfaction with the decision-making process at the
final consultation in the IVF Unit as well as the decision made.
Methods: This study used both quantitative and qualitative
methods. Couples who had decided to end treatment after
unsuccessful IVF within the last 24 months were invited to
participate in a questionnaire study. A sub-set were interviewed.
Quantitative and qualitative methods were used to analyse data.
Interviews were tape-recorded, transcribed and analysed using
the open coding technique.
Results and Discussion: Out of a total of 139 couples contacted,
71 (51%) returned valid questionnaires. Six (4%) were returned
undelivered and 5 (4%) decided to have further treatment. The
mean (SD) age range of the women who responded was 37 (4.5)
years. Each had a mean (SD) of 2.7 (1.4) fresh IVF cycles and 1.5
(1.5) frozen embryo transfers. Thirty four women (47%) had
previous failed pregnancies. At the time of decision making, 27
(38%) couples were certain that they wished to stop treatment,
11 (15%) wanted to continue and 7 (10%) had not thought about
this issue. Fifty eight couples (81%) felt involved with the
decision making process, however only 8 (11%) strongly agreed
that the doctor had given them sufficient information to
understand the decision. Overall, 42 (58%) were satisfied with
the decision made. The following concerns were raised during
interview: insufficient information about the reasons for
treatment failure; unfamiliarity with the doctor who undertook
the final consultation and lack of support from the IVF Unit
afterwards. Many couples expressed that they were unprepared
for the final decision to stop IVF treatment, therefore, prior
counselling about the possibility of failed treatment may be
beneficial.
S27. Active ageing for men: The European male ageing study.
FCW Wu. Andrology Research Unit, Department of
Endocrinology, University of Manchester, UK.
Senescence is a multi-faceted multi-system condition, which is
amenable to individual and population modifications. Preventing
or deferring the disabilities and morbidities associated with
ageing has become a particularly relevant healthcare target with
the relentless global demographic shifts towards an increasingly
elderly population in the 21st century.
In men, one aspect amongst many of these ageing-related
changes is the gradual and variable decline of circulating
testosterone into the low normal (rather than the truly
hypogonadal) range. Evidence suggests that, at least in part,
the testosterone decline may be a sentinel for general co-
morbidity implying that it is potentially modifiable and to some
extent reversible if the risk factors are identified. Causal
relationships between the various well recognised ageing-
associated functional decline and decreased testosterone, and
thus a rational basis for a ‘clinical syndrome of androgen
insufficiency ‘ in elderly men, has not been established. Further
observational studies in the general population are required to
investigate the predisposing variables (genetic and acquired)
underlying hormonal dysregulation, their relationships to health
status, to define thresholds at which and identify individuals in
whom various interventions including hormone replacement may
prevent disabilities and improve quality of life. These objectives
are currently being addressed in the multi-national, multi-
disciplinary prospective cohort European Male Ageing Study
(EMAS) involving 8 countries and 3,400 men aged 40 - 79 yr.
Short-term interventional trials (in highly selected clinic
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populations) with testosterone have shown that hormone
supplementation can increase sexual interest, lean body mass
and possibly bone density and decrease fat mass (mostly
surrogate endpoints). But, as yet, significant improvements in
function (including fracture incidence), muscle strength and
performance, activities of daily living and quality of life have
not been demonstrated. So far, the limited studies are not powered
to assess longer-term risks of testosterone treatment. They
include exacerbation of occult prostate cancer, polycythaemia,
sleep apnoea, fluid retention. Accurate risk-benefit assessment
of hormone replacement in ageing men is currently not possible.
Large-scale prospective randomised placebo-controlled trials,
along the lines of those conducted for female hormone
replacement, are required. A European consortium of urologists,
endocrinologists, psychistrists, epidemiologists and basic
scientists is being established with the aim of organising such
trials.
Currently, there is insufficient data to support the routine practice
of hormone replacement for elderly men without a clear diagnosis
of hypogonadism. Emphasis should also be placed on active
prevention from earlier years to achieve healthy ageing.
S28. Is there a male menopause? The answer lies in the data.
JB McKinlay. New England Research Institutes, Watertown,
US.
Introduction: Some pseudoscientists recently claim to have
discovered a new syndrome, male andropause. But the notion
of a male menopause, mid-life crisis or andropause has been
discussed for several decades. Worldwide male aging is
generating public interest and also, incidentally, a lucrative
market. Pharmaceutical involvement is producing new treatments
(Testosterone Replacement) in search of a disease. Several
authors have written nonscientific books on male menopause:
they self-select and misrepresent scientific data in support of
preconceived notions.
Methods: With some facts on male hormone changes with aging
this paper explodes the myth of andropause. Data for this paper
come from the milestone Massachusetts Male Aging study
(MMAS), the largest randomly sampled male endocrine database
presently available.
Results and Discussion: We show that: *Unlike hormone
changes in mid-aged women (who experience a rapid decline)
male hormones decline quite gradually with age (testosterone
at approximately 1%/year) and there is simply no empirical
support for a syndrome; *Depending on the cutoffs used (Total
Testosterone < 250 ng/dl is common), a small proportion of men
(approximately 5%) do evidence hypogonadism (which is a
distinct clinical entity not to be confused with andropause);
*Comorbidities (like diabetes, coronary heart disease, and
depression) appear to contribute to hormone declines over the
above aging.
*Adverse life styles (smoking, alcohol consumption and physical
inactivity) appear to also contribute to declines in hormones
and sexual functioning. *There is evidence that weight gain
with aging may contribute more to declines in testosterone than
aging itself. US male testosterone levels appear to be on the
decline possibly due to weight gain and secular changes in
smoking *Using the defining characteristics (mainly
psychological) advanced by the proponents of andropause,
there is no epidemiologic support for the new claims being made.
S29. A retrospective study of key factors influencing
enrollment in the expectant management vs. IVF (EMVI) trial.
L Burville1, V Wilkie2 & EG Hughes1. 1Department of Obstetrics
& Gynaecology, McMaster University, Hamilton, US;
2University of Ottawa, Ottawa, Canada.
Introduction: To estimate the relevant importance of key factors
influencing acceptance or rejection of an invitation to enroll in
the Expectant Management vs IVF (EMVI) Trial. Design: A
qualitative and quantitative retrospective survey. Population:
All patients eligible for inclusion in the EMVI trial were
approached. Inclusion criteria are as follows:
Methods: Between May 1999 and April 2002, 139 couples were
enrolled in five Canadian IVF programs, based on the following
criteria: duration of sub-fertility of >2 years; female age of 18-39;
patency of at least one fallopian tube; adequate ejaculated sperm
for IVF or ICSI; cycle day 3 FSH < 15 IU/l; and no previous IVF
treatment. Many declined. Couples were randomly assigned
using numbered sealed envelopes, to IVF within 90 days or an
observation period of 90 days with no fertility treatment.
Allocation was blocked and stratified by centre, female age and
sperm quality. Follow-up at four, six, nine and 12 months assessed
multiple outcomes, including live birth and associated morbidity.
A questionnaire was developed including key factors identified
in a previous literature review of elements influencing patient
enrollment. An analog score was used to measure patients’
agreement with positive statements. Key factors include: timing
of treatment, interest in research and cost saving.
Results and Discussion: These will be tabulated for presentation
at the National meeting.
A high proportion of subjects declined enrollment into this
important trial. This survey will explain and quantify key
elements responsible for this problem. Understanding these
factors is of enormous importance for future trial design, ensuring
an ethical, comfortable and effective approach to enrollment.
Acknowledgements: The authors gratefully acknowledge the
involvement of the other physicians and research team members
including, ML Beecroft1, P Claman2, I Tummon3, E Greenblatt4,
M Fluker5, L. Watson3, D Davies4, and H McDonald5, University
of Western Ontario3, London, University of Toronto4, Toronto,
Ontario and Genesis Fertility Center Incorporated 5, Vancouver,
British Columbia.
S30. Health and development of ICSI children is normal at five
years.
GI Leslie1,2, F Gibson2, C MacMahon3, J Cohen3, D Saunders1 &
C Tennant3. 1Department of Obstetrics & Gynaecology,
University of Sydney Northern Clinical School, St Leonards,
Australia; 2Department of Neonatology, Royal North Shore
Hospital, St Leonards, Australia; 3Department of Psychological
Medicine, University of Sydney Northern Clinical School,
Australia.
Introduction: Early studies of health and development of ICSI
children raised concerns, which are biologically plausible, that
they may be at increased risk of adverse long-term outcomes.
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The aim of this study was thus to determine health and
developmental outcomes at 5 years of age for children conceived
using ICSI, compared with groups conceived naturally or using
IVF.
Methods: At 5 years we reassessed the health and development
of ICSI, IVF and naturally conceived control children whom we
had previously assessed at 1 year. We also assessed additional
ICSI and control children to provide the study with 97% power
to confirm the difference in risk for delayed development
observed at 1 year. Details concerning child health were obtained
from the parents. Cognitive development was assessed using
the intelligence quotient (IQ) obtained from the Wechsler
Preschool and Primary Scales of Intelligence. Statistical analyses
were controlled for demographic factors.
Results and Discussion: We assessed 97 ICSI, 80 IVF and 110
control children. During the first 5 years ICSI children had a
similar number of illnesses (difference = -0.7; 95% C.I. = -1.7, 0.4;
P = 0.21) and visits to a doctor (difference = 1.2; 95% C.I. = -3.0,
5.4; P = 0.57) compared with IVF and naturally conceived
children. ICSI children were also not more likely to require
hospitalisation (odds ratio = 1.1; 95% C.I. = 0.7, 1.8; P = 0.80).
There was no significant between group difference for mean
full-scale IQ (ICSI 110 ± 18, IVF 111 ± 13, Control 114 ± 13; P =
0.21). ICSI children were not more likely to have delayed cognitive
development (ICSI 5.2%, IVF 2.5%, Control 0.9%; P = 0.18).
These findings suggest that mode of conception is less
important than genetic and environmental factors in determining
long-term child health and development for children conceived
using ICSI.
O1. Proteomic approaches to study human spermatozoa in
fertile and infertile men.
KL Pixton1, ED Deeks1, FM Flesch1, CLR Barratt1, 2 & IA Brewis1,2.
1The Reproductive Biology and Genetics Group, Division of
Medical Sciences, University of Birmingham, UK; 2The Assisted
Conception Unit, Birmingham Women’s Hospital, Birmingham,
UK.
Introduction:  Proteomics is the systematic unbiased
identification of proteins and is presently the subject of much
interest. However it is particularly complex and much technical
development is required. We have investigated the human sperm
proteome in normozoospermic donors in detail and in particular
have addressed the concern of variability. Such validation is
critical in order to investigate differences in patients who have
failed or reduced fertility.
Methods: Extensive development of existing techniques has
been carried out by investigating differences in sample
preparation and optimising the reproducibility of the two-
dimensional electrophoresis (2DE). The silver staining and
trypsin digestion protocols have also been developed to achieve
the best possible data for mass spectrometry (MS). Using Q-
Tof tandem MS analysis we can now identify moderately sized
silver-stained protein spots (down to 2.5 fmol of material).
Results and Discussion: We now achieve a high level of
reproducibility on 2D gels with duplicate samples from the same
ejaculate. Two ‘maps’ of the human sperm proteome have been
built using Phoretix Evolution software. These enable us to
clearly determine protein differences between a) different
ejaculates from a single donor of proven fertility and b) different
normozoospermic donors. Many relatively abundant proteins
and also minor proteins from these samples have been identified
and variation between different ejaculates from same donor
appears to be due to seminal plasma protein contamination. The
‘different donor’ studies are ongoing, and we are now addressing
two types of male infertility: globozoospermia (severe
teratozoospermia with round-headed sperm) and sperm from
patients who have experienced fertilisation failure (FF) during
IVF. We have identified approximately 60 proteins absent in
globozoospermia and 5-10 absent in the FF patients. Presently
we are identifying these protein in order to further understand
these conditions.
O2. Disruption of in-vitro fetal human testis steroidogenesis,
LH receptor expression and protein profile by a weakly
oestrogenic pesticide, dieldrin.
PA Fowler1, T Murray2, DR Abramovich1, N Haites3 & RG Lea4.
1Department of Obstetrics & Gynaecology, University of
Aberdeen, Aberdeen, UK; 2Boston University School of Public
Health, Boston, US; 3Department of Medical Genetics, University
of Aberdeen, Aberdeen, UK; 4Rowett Research Institute,
Aberdeen, UK.
Introduction: We have previously demonstrated that short-term
exposure (<24 hrs) to the endocrine disrupting chemical (EDC)
dieldrin halves LH-induced, but not constitutive testosterone
secretion from the fetal human testis in-vitro. Our aim was to
establish whether these effects were due to changes in
steroidogenic enzymes, LH receptor (LHR) or other mechanisms.
Methods: Testes were collected from 11-19 week old male fetuses
following medical termination for social reasons. Full informed
consent was given and only morphologically normal fetuses
were used. The testes were cut into <1 mm thick slices and
cultured for 2 hours in medium containing 10% adult human
male serum. The media was collected and replaced with medium
containing LH (0-1,000 IU/L), dieldrin (1 & 1,000 pmol) and LH +
dieldrin for 18 hours. The medium was collected and assayed
for testosterone while the slices were split between snap-freezing
for 1-D and 2-D gel electrophoresis and Boiuns fixation for
immunohistochemistry.
Results and Discussion: As previously reported, LH-induced
testosterone secretion was halved by dieldrin treatment.
Western blotting of 1-D gels showed that Steroid-acute
regulatory protein (StAR) and LHR were increased 40% and
60% respectively by LH, but this was reversed by the co-
administration of dieldrin. StAR immunostaining in the fetal
Leydig cells showed a similar trend. Proteomic analysis of the 2-
D gels revealed that LH treatment altered the expression of 81
testis proteins, including CD63 and zinc finger protein 33A.
However, the co-administration of dieldrin with LH resulted in
changes in expression of up to 95 proteins, including the WNT-
2B precursor WNT-13, cytoskeletal tropomyosin and imidazoline
receptor antiserum selected protein. We conclude that even
short-term fetal exposure to low EDC concentrations may be
sufficient to perturb normal fetal testis function and, by affecting
proteins such as WNT-2, disrupt normal development.
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O3. Frozen assets? Semen cryostorage service for men with
malignant disease in the North of Scotland.
EM Mathers, A McTavish, M Hamilton, G Nicoll, T McKay &
S Bhattacharya. Aberdeen Fertility Centre, Aberdeen, Scotland,
UK.
Introduction: Semen cryostorage is used as a means of
preserving the fertility of men about to undergo chemotherapy
or radiotherapy for a malignant disease. Many men retain their
fertility after treatment but others seek assisted reproduction
using their cryopreserved samples in the presence of
azoospermia or impaired semen quality. The Aberdeen Fertility
Centre has offered a semen cryostorage facility to men in the
North of Scotland since 1981. The objectives of this study were
to develop a profile of the patient groups, to assess the use of
stored samples and to determine the incidence of spontaneous
conception for these men.
Methods: Data were extracted from the Andrology database to
determine the demographic profiles, geographical location,
tumour type and survival rate of patients with stored samples.
Information regarding post-treatment fertility assessments and
use of stored samples was collated. A questionnaire has been
complied and will be sent to all surviving patients to collect
information about reasons for discarding samples and the
incidence of spontaneous pregnancies post-treatment.
Results and Discussion: Between 1981 and 2000, semen samples
from 193 patients were cryopreserved. Of these, 77% were from
Grampian Region, 14% from Highland, 3% from Orkney and 7%
from Shetland. The number of referrals each year has increased
from 1 in 1981 to 36 in 2002. The types of malignancies
encountered included testicular n=86 (45%), Hodgkin’s disease
n=32 (17%), Lymphoma n=18 (9%), Leukaemia n=21 (11%) and
others n=26 (14%). Post treatment, 81 (32%) men have discarded
their samples without use, and 112 (58%) are still storing their
samples. Twenty men (10%) have used their samples and 11
(55%) have achieved a pregnancy. From the present study we
conclude that sperm storage is a beneficial service for all tumour
types. We are uncertain as to why nearly a third of these men
have discarded their samples.
O4. Glutathione peroxidase 4 activity but not expression is
lower in infertile males than normal fertile controls.
M Meseguer1, N Garrido1, C Simon1, 2, A Pellicer1, 2, 3 & J Remohi1,2.
1Andrology Laboratory and Semen Bank, Valencia, Spain;
2Department of Paediatrics, Obstetrics and Gynaecology,
University of Valencia, School of Medicine, Valencia, Spain;
3Hospital Dr. Peset, Valencia, Spain.
Introduction: Oxidative stress is defined as the imbalance
between pro and anti-oxidative systems, favouring the former,
thus causing a toxic and damaging presence of free radicals. A
strong body of evidence suggests that oxidative stress status
can discriminate between fertile and infertile males
independently of the results of the classical studies of the sperm.
Then, our aim was to determine the relevance of concrete
components of the glutathione system (GS), specifically
glutathione peroxidases-1 and -4 (GPX-1,-4), glutathione
reductase (GR) and glutathione (GS), both activities and mRNA
expression on male fertility.
Methods: Semen samples of proven fertility donors (n=42), and
from infertile males undergoing assisted reproduction (n= 43),
were obtained after 3-5 days of sexual abstinence together with
previous signed consent. All samples were studied according
with WHO statements for volume, concentration and motility in
the routine semen analysis by two different observers (MM
and NG). We measured gene expression of GPx and GR by
fluorescent quantitative PCR. Intracellular glutathione (GSH)
concentrations and GPx and GR activities were measured by
spectrophotometry under controlled biochemical reactions, and
the results normalized by quantifying total protein in the sperm
samples by Bradford’s method. T test was employed to detect
differences between groups of fertile and infertile regarding the
expression and activity of the (GS) components.
Results and Discussion: GPX4 enzymatic activity was
significantly higher in infertile patients than in fertile donors
(0.20 IU/mg of protein vs 2.34 IU/ mg, p=0.02). Inversely, GPX4
gene expression was comparable between both groups. No other
difference was found in GPX1, GR expression and activity, and
GSH concentrations depending on the fertility status of the
male.
Conclusions: GPX4 activity is somehow differentially regulated
in infertile males when compared with fertile donors. However,
the concrete contribution leading to sub-fertility remains to be
elucidated.
O5. Inbreeding effects on DNA content and integrity in
spermatozoa of endangered ungulates.
R Carballada1, ERS Roldan1, J Garde2, G Espeso3 & M Gomendio1.
1Museo Nacional de Ciencias Naturales (CSIC), Madrid, Spain;
2Depto. Ciencia y Tecnologia Agroforestal, Universidad de
Castilla-La Mancha, Albacete, Spain; 3Estacion Experimental de
Zonas Aridas, Almeria, Spain.
Introduction: Inbreeding has well known negative effects on
litter size, and on newborn and juvenile survival, but little is
known about its influence on male reproductive function. Here
we examine the effects of male inbreeding on sperm DNA
characteristics in three endangered gazelle species (Gazella
cuvieri, G. dama mhorr, G.dorcas neglecta).
Methods: By using flow cytometry we estimated DNA content,
staining with propidium iodide (indicative of DNA aneuploidy/
diploidy), and assessed DNA integrity by means of the Sperm
Chromatin Structure Assay (SCSA). The SCSA method takes
advantage of the metachromatic properties of acridine orange.
This dye fluoresces in the green band when combined with the
intact double DNA helix, and in the red band when combined
with RNA or denatured DNA. 10,000 cells per sample were
analysed and the percentages of sperm with abnormal DNA
content and with damaged DNA were calculated for each animal.
Inbreeding Coefficients were calculated from pedigrees.
Results and Discussion: Comparative analysis between species
revealed that the average % aneuploid/diploid spermatozoa in
each species was related to its average level of inbreeding. On
the other hand, there was no correlation for the % spermatozoa
with fragmented nuclei and inbreeding. This suggests that
inbreeding could have negative effects on sperm DNA, but that
DNA content and integrity are effects to be examined separately
and may not correlate. The examination of DNA characteristics
in the semen of animals with high levels of inbreeding should be
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considered in animal conservation programmes and in the
establishment of genetic resource banks.
[MCYT REN2000-1470]
O6. Semen quality of British men.
AA Pacey, HS Baillie & HD Moore. Academic Unit of
Reproductive and Developmental Medicine, University of
Sheffield, Sheffield, UK.
Introduction: Recent concerns about the possible influence of
occupation and environmental exposure on semen quality led
to this multi-centre study which was performed in twelve UK
fertility clinics.
Methods: In each centre, the male partners of couples attending
for their first consultation for infertility investigations were
recruited. Each participant filled out questionnaires relating to
their occupation and lifestyle and then produced a semen sample
for analysis. Measures of semen volume, pH and sperm
concentration were made locally and morphology smears were
prepared and fixed. Standardisation of semen analysis was
achieved by: (1) videotaping of samples using a specially
designed computer controlled outstation for further analysis
by CASA in Sheffield; (2) fixing aliquots of semen from each
patient for further central analysis by FACS or manual counting;
(3) staining morphology smears in Sheffield by Papanicolaou
and analysing them using a single CASA system. Ethical
approval for the study was granted by the North West MREC
and the local Ethics Committee for each participating centre.
Results and Discussion: Complete data from 2,449 participants
recruited from February 1999 to January 2002 was analysed.
According to WHO (1999) criteria, 76.9% of men were
normozoospermic, with 19.5% and 3.6% being oligozoospermic
and azoospermic respectively. Semen volume ranged from 0.1 to
10 ml (median 3.0 ml), sperm concentration from 0 to 805 x106 per
ml (median 50 x106 per ml) and median sperm motility (WHO
grades a + b) was 39 % (range 0 to 100%). These parameters are
similar to those reported for men in other European countries,
but the value of this study will be the ability to subsequently
relate semen quality to occupational and environmental factors.
This work is ongoing and will be reported separately.
This study was funded by the Department of Health and CEFIC
and the results are presented on behalf of CHAPS-UK.
O7. 11ß-Hydroxysteroid dehydrogenase (11ßHSD) expression
and activities in the developing ovarian follicle at defined phases
of the bovine oestrus cycle.
LM Thurston1, AE Michael1,2, K Jonas1,2 & DRE Abayasekara1.
1Reproduction & Development Group, Department of Veterinary
Basic Sciences, Royal Veterinary College, London, UK;
2Department of Biochemistry & Molecular Biology, Royal Free
& University College Medical School, University College
London, London, UK.
Introduction: Cortisol-cortisone inter-conversion is catalysed
by isoforms of 11BHSD. While 11BHSD1 is a bi-directional,
NADP(H)-dependent enzyme, 11BHSD2 is an NAD-dependent,
dehydrogenase. Human and rat granulosa cells have been shown
to express 11BHSD2 mRNA, switching to 11BHSD1 mRNA
expression as luteinisation occurs. The objectives of this study
were to establish whether (i) 11BHSD protein expression changes
during follicular development, and (ii) 11B-dehydrogenase (11β-
DH) and 11-ketosteroid reductase (11-KSR) activities vary during
the bovine oestrus cycle.
Methods: Ovaries were obtained from slaughterhouse material
(requiring no ethical consent) from 5 animals in each phase of
the ovarian cycle. Granulosa cells were isolated from follicles
<4mm, 4-8mm or >8mm in diameter in the follicular or luteal
phases. Granulosa cells and whole corpora lutea (CL) were
homogenised for either Western blotting (using commercial
11BHSD antibodies) or incubated for 1 hour with cofactors
(NADP/NADPH/NAD) plus 100nM 3H-cortisol or 3H-cortisone
to assay 11B-DH and 11-KSR activities, respectively. Steroids
were resolved by TLC and quantified using a
radiochromatogramme scanner.
Results and Discussion: In Western Blots, the 11BHSD1
antibody recognised bands of 34kDa and 68kDa, while the
11BHSD2 antibody recognised bands of 48kDa and 50kDa.
Expression of both 11BHSD1 and 11BHSD2 proteins increased
with follicular diameter. Large antral follicles expressed
predominantly 11BHSD2 while CL expressed predominantly
11BHSD1. NADP(H)-dependent 11B-DH and 11-KSR activities
in cell homogenates increased with follicle diameter, as did NAD-
dependent 11B-DH activities. In granulosa cells from dominant
follicles in the follicular phase, NADP-dependent 11B-DH
activities were significantly lower than NAD-dependent 11B-
DH activities (3.4±0.6 vs 13.3±2.3 pmoles cortisone/hr,
respectively; P<0.05). However, in CL, NADP-dependent 11B-
DH activities exceeded NAD-dependent 11B-DH activities
(8.3±1.2 vs 6.9±0.6 pmoles cortisone/hr, respectively; P<0.05).
We conclude that in bovine follicular granulosa cells, the
oxidative 11BHSD2 isoform predominates, whereas in the CL,
the reductive 11BHSD1 enzyme is the dominant isoform.
Supported by BBSRC project grant 48/S15850.
O8. 11ß-Hydroxysteroid dehydrogenase (11ßHSD) activities
in aT3-1 AND LBT2 gonadotroph cell lines: Acute effects of
GnRH AND cAMP.
LM Thurston1, RC Fowkes2, JM Burrin2 & AE Michael1,3
1Veterinary Basic Science, Royal Veterinary College, London,
UK; 2Department of Endocrinology, St.Bartholomew’s & the
Royal London School of Medicine & Dentistry, London, UK;
3Department of Biochemistry & Molecular Biology, Royal Free
& University College Medical School, University College
London, London, UK.
Introduction: Glucocorticoids generally suppress endocrine
activity in anterior pituitary cells. In these cells, 11BHSD enzymes
can catalyse oxidation of cortisol to inert cortisone (via their
11β-dehydrogenase activity) or generate active glucocorticoids
(via their 11-ketosteroid reductase activity). Hence, the objectives
of this study were to establish (i) whether pituitary cell lines
catalyse cortisol-cortisone interconversion, and (ii) whether the
dehydrogenase and reductase activities of immortalised
gonadotrophs can be influenced by regulators of gonadotrophin
secretion.
Methods: Corticotroph (AtT20), somatotroph (GH3) and
gonadotroph (aT3-1 and LBT2) cell lines were incubated (in
standard media) for 4 hours with either 100nM 3H-cortisol or
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3H-cortisone. After resolving steroids by TLC, enzyme activities
were quantified using a radiochromatogramme scanner. In
subsequent experiments, enzyme activities were assessed in
aT3-1 and LBT2 cells treated for 4 hours with 1mM cAMP or
100nM gonadotrophin-releasing hormone (GnRH). All data are
mean±SEM values for 3 independent experiments.
Results and Discussion:  Dehydrogenase and reductase
activities were 3-fold higher (P<0.01) in gonadotroph cell lines
than in AtT20 and GH3 cells, indicating a potential role for
11BHSD in modulating the control of gonadotrophs by
glucocorticoids. While dehydrogenase activities were identical
in aT3-1 and LBT2 cells (3.0±0.2 versus 3.5±0.5 pmol cortisone/
4h, respectively), reductase activities were higher in LBT2 cells
(6.3±0.5 versus 3.6±0.2 pmol cortisol/4h, respectively; P<0.01).
Furthermore, within LBT2 cells, reductase activities were 1.8-
fold higher than dehydrogenase activities (P<0.05). This
predominance of reductase activity could serve to maximise
glucocorticoid actions in LBT2 gonadotrophs. Finally, the
dehydrogenase and reductase activities of aT3-1 cells were both
stimulated by GnRH (41.4±11.8% and 56.1±19.5%, respectively;
P<0.05), whereas cAMP exerted no significant effects. In LBT2
cells, dehydrogenase activities were increased by cAMP
(52.6±13.0%; P<0.05), but were unaffected by GnRH. Moreover,
neither treatment affected reductase activities in LBT2 cells.
We conclude that cAMP and GnRH exert differential effects on
11BHSD activities in aT3-1 versus LBT2 cells.
O9. Effects of lactation on ovarian activity and secretion of
metabolic and reproductive hormones in the horse.
C Aurich1, B Heidler1, H Sauerwein2, RM Bruckmaier3,
U Heintges2 & N Parvizi4. 1Clinic for Obstetrics, Gynecology
and Andrology, University of Veterinary Sciences, Vienna,
Austria; 2Institure for Anatomy and Physiology of Domestic
Animals, University of Bonn, Bonn, Germany; 3Institute for
Physiology, Technical University of Munich, Freising-
Weihenstephan, Germany; 4Institute for Animal Science,
Neustadt-Mariensee, Germany.
Introduction: Via influences on metabolic hormones such as
IGF-1 and leptin, lactation has marked effects on ovarian activity.
In humans, pigs and beef cattle, this regularly leads to lactational
anoestrus, a condition uncommon in the horse. Therefore,
interactions between bodyweight and different metabolic and
reproductive parameters in lactating mares were investigated in
this study.
Methods: Weight, ovarian activity, plasma glucose
concentrations, growth hormone (GH), insulin-like growth factor
1 (IGF-1), leptin and luteinising hormone (LH) were analysed in
mares from late pregnancy throughout lactation (group 1, n=46)
and in non lactating mares (group 2, n=11).
Results and Discussion: In group 1, no major weight loss could
be detected during lactation, however, plasma glucose
concentrations were constantly lower than in group 2 (p<0.01).
Plasma GH concentrations in group 1 were lower than in mares
of group 2 (p<0.05). Highest IGF-1 levels were found in lactating
mares in the week of foaling. IGF-1 concentrations decreased
continuously thereafter. Plasma leptin concentrations decreased
after foaling and, for 4 weeks, were lower in lactating than in non
lactating mares (p<0.05). Plasma LH concentrations in group 1
before foaling were lower than at corresponding times in group
2 (p<0.05). In group 1, LH concentrations then increased, did no
longer differ from group 2 until week two postpartum, but
subsequently decreased again (p<0.05 vs. group 2).
In lactating mares, reduced leptin concentrations may promote
feed intake and allow to avoid an energy deficit. Increased IGF-
1 concentrations early postpartum might contribute to ovarian
stimulation resulting in early resumption of ovarian activity.
Changes in somatotrophic hormones at least in part, could explain
a more pronounced stimulation of ovarian function early
postpartum than during the following months of lactation in the
mare.
This study was supported by the Mehl-Muelhens-Foundation.
O10. Metformin for polycystic ovary syndrome: A meta-analysis
and cochrane review.
JM Lord1, I Flight2 & R Norman3. 1South West Centre for
Reproductive Medicine, Derriford Hospital, Plymouth, UK;
2Consumer Science Program, CSIRO Health Sciences and
Nutrition, Adelaide, Australia; 3Reproductive Medicine Unit,
Department of Obstetrics and Gynaecology, University of
Adelaide, The Queen Elizabeth Hospital, Australia.
Introduction: Polycystic ovary syndrome (PCOS) is
characterised by anovulation, hyperandrogenaemia and insulin
resistance. Hyperinsulinaemia is known to be associated with
an increase in cardiovascular risk and the development of
diabetes mellitus. If the insulin sensitising drug metformin is
effective in treating features of PCOS, then it could have wider
health benefits than just treating the symptoms of the syndrome.
Methods: MEDLINE, EMBASE and the Cochrane central register
of controlled trials (CENTRAL) were searched up to and including
December 2002 to find suitable randomised controlled trials using
standard cochrane methodology. Twelve trials were suitable for
inclusion involving 453 participants. Meta-analysis was
performed using odds ratios (dichotomous outcomes) and
weighted mean differences (WMD) (continuous outcomes).
Results and Discussion: Meta-analysis showed that metformin
is effective in achieving ovulation in women with PCOS with
odds ratios of 4.12 (p<0.00001) for metformin versus placebo
and 6.72 (p<0.00001) for metformin and clomifene versus
clomifene alone. An analysis of pregnancy rates suggests a
significant treatment effect (odds ratio 4.58, p=0.00003).
Metformin was associated with a significantly higher incidence
of nausea and vomiting (odds ratio 3.91) and other
gastrointestinal disturbance (odds ratio 4.62), but no serious
adverse effects were reported.
Metformin is an effective treatment in women with PCOS.
Ovulation rates are higher when combined with clomifene (76%
compared to 46% when used alone), but there is no evidence to
indicate whether there is an increased multiple pregnancy rate
with this combination. Its use as a first line agent in women with
PCOS appears justified, although there is no data as to its safety
in long term use in young women. Other groups have reported
greater ovulation rates by using lifestyle changes. Therefore
metformin should be used as an adjuvant to general lifestyle
improvements, and not as a replacement for increased exercise
and improved diet. This abstract is a summary of a full cochrane
review due for electronic publication in July 2003 with parallel
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publication in a peer-reviewed journal.
The cochrane collaboration requires that copyright for the review
is maintained by them, although the abstract submitted here is
an edited (and therefore changed) version of that submitted to
the cochrane group.
O11. Establishing the psychometric properties of the polycystic
ovary syndrome questionnaire.
GL Jones1, WL Ledger2, H Lashen2, KE Shepherd2,
VH Wilkinson2, TL Clark2, MG Holder2, TJ Haynes2, A Balen3 &
M Singh3. 1Institute of General Practice & Primary Care,
University of Sheffield, Sheffield, UK; 2Section of Reproductive
& Developmental Medicine, University of Sheffield, Sheffield,
UK; 3The University Department of Obstetrics & Gynaecology,
University of Leeds, Leeds, UK.
Introduction: At present no validated health outcome measure
exists to measure the quality of life of women with polycystic
ovary syndrome (PCOS). The Polycystic Ovary Syndrome
Questionnaire (PCOSQ) was developed to investigate the
subjective impact of PCOS. However, it’s psychometric properties
have not been established, thereby limiting it’s use in clinical
practice. The objective of this study is to evaluate whether the
PCOSQ is a reliable and valid instrument for measuring the quality
of life of women with PCOS.
Methods: To assess internal reliability and test-retest reliability,
185 women diagnosed with PCOS were sent two copies of the
PCOSQ and the Short Form-36 (SF-36) to be completed at time 1
and time 2. Twelve patients were interviewed to assess face and
content validity. Construct validity was assessed by correlating
the PCOSQ with the relevant scales on the SF-36.
Results and Discussion: All five PCOSQ dimensions proved to
be internally reliable with Cronbach alpha values ranging from
0.73-0.97. The intra-class correlation co-efficients to evaluate
the test-retest reliability were high (0.88-098, p<0.001). Face
validity and content validity were not demonstrated. The PCOSQ
appears to be a reliable instrument for measuring the quality of
life of women with PCOS. However, the face and content validity
of the instrument would be improved with a dimension on acne
being incorporated into the questionnaire.
O12. Factors in the assessment of ‘ovarian reserve’ and the
outcome of IVF-ET treatment cycles.
GM Lockwood. Midland Fertility Services, Aldridge, UK.
Introduction: The prediction of oocyte yield is central to the
success and safety of ART. Many factors such as age, basal
FSH, primordial follicle count and ovarian volume have been
promoted as indicators of ovarian response.
Methods: Pre-treatment serum samples were taken from 450
women on cycle day 4-6 undergoing a first IVF or ICSI cycle and
frozen for subsequent analysis for inhibin B. Gonadotrophin
dose was determined by age, FSH level, BMI, smoking history
and presence of endometriosis and/or PCOS. Patients with FSH
<8 and FSH:LH ratios <2 undertake a long protocol, down-
regulated cycle with GnRH agonist and ovarian stimulation is
with 150-225 IU HMG or FSH. Patients with raised FSH levels
undertake short protocol, agonist ‘flare-up’ cycles with GnRH
antagonist administration to prevent premature luteinisation.
The samples were retrospectively analysed for inhibin B by
dimeric ELISA and aliquots were also assayed for FSH and LH.
Results and Discussion: Inhibin B and FSH show a highly
significant negative correlation (-0.76, p<0.001) which is absent
in women with ‘unexplained’ infertility.There was no significant
correlation between age and FSH, but a significant negative
correlation (-0.64, p<0.01)between age and follicle number (but
not oocyte yield). Inter-cycle fluctuation of FSH for women aged
>35 years was significant with 22% of patients having raised
FSH levels in one of the two samples, whereas inhbin B levels
showed a high degree of inter-cycle consistency. We conclude
that inhbin B and FSH are equally good indicators of ‘ovarian
reserve’ for women aged <35 years with normal BMI and normal
FSH levels. Inhibin B ia a more accurate predictor than FSH for
women aged >35, with a raised FSH and/or a diagnosis of
‘unexplained’ infertility. Information on inhibin B levels may be
used to counsel women with objective risk factors for poor
response about their chances of achieving ET.
O13. IVF with PGD for sex selection.
J Catt, K de Boer & R Jansen. Sydney IVF, Sydney, Australia.
Introduction: IVF and PGD for determination of blastomere sex
chromosome number is the most effective method known for
choosing the sex of a future baby. With such certainty comes
ethical controversy, including the argument (Chalmers, 1999)
that in a liberal society there is no prevailing reason for
prohibition, especially if there is no compromise to recipients of
IVF/PGD for medical indications and no community subsidy.
Nonetheless with such a social innovation there is a duty to
determine the characteristics of, and outcomes for, couples
electing sex selection.
Methods: Summary data are reviewed for 155 couples proceeding
to 238 IVF cycles. Based on initial experience, a specific
questionnaire was introduced in April 2002 to more specifically
query motivation; 75 have been completed to date. Counselling
has been compulsory during this time.
Results and Discussion: Of the total cohort of 155 couples, the
preferred sex was 60% for females (C2 = 4.9, compared with
population sex ratio) and the clinical pregnancy rate among
different ages comprised: 24-37y, 41%; 38-39y, 24%; 40+y, 30%;
pregnant.
Among the recent cohort of 75, 7% gave specific reasons for
attempting sex selections , for example, 3 couples were attempting
to have a child of the sex of a deceased child or stillbirth; 3 (4 %)
cited ‘external family pressure’; 49 (65%) were couples balancing
their family (median previous children = 2, range: 1-5); and an
additional 19 (24%) were mother-led quests for a daughter after
1, 2, 3 and 4 previous sons. Overall the desire for a sex-selected
child was rated as more father-led in 2 cases (4%, for a boy),
more mother-led in 22 (29%, 10 for a girl, 1 for a boy) and equal
in 51 (67%).
Experience with clinically effective sex selection reveals a mild
but significant excess of couples attempting a daughter. Women
were more likely than men to regard themselves as the driving
partner seeking sex selection, usually for a daughter after a series
of sons.
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O14. Predictors of IVF outcome by three-dimensional
ultrasound.
TJ Child1,2, C Sylvestre2, SJ Phillips2 & SL Tan2. 1Oxford Fertility
Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK;
2McGill Reproductive Center, McGill University, Montreal,
Canada.
Introduction:  Three-dimensional (3D) power Doppler
sonography of the endometrium on the first day of ovarian
stimulation is predictive of IVF pregnancy rate (Schild 2000).
Furthermore, 2D ovarian Doppler ultrasound is predictive of
ovarian follicular response (Engmann 1999). The current
prospective study aims to confirm the first reports findings and
to extend those of the second to examine whether 3D power
Doppler measurement of ovarian blood flow is predictive of IVF
outcome.
Methods: Women on the first day of ovarian stimulation for IVF
underwent ultrasonography using 3D power Doppler equipment
(Medison 530D, Medison, CA, USA). In part I of the study
(n=70) the ovarian volume, antral follicle count (AFC), and ‘total’
ovarian blood flow were measured with 3D power Doppler. In
part II (n=94) the 3D ‘total’ blood flow within the endometrial
and subendometrial area was measured. Three blood flow
indices were derived: (vascularization index (VI), flow index (FI)
and vascularization-flow index (VFI)). Measurements were
compared with subsequent outcome using linear (for numbers
of oocytes retrieved) and logistic (for pregnancy outcome)
regression analysis. Patient age, FSH concentration, and FSH
ampoules used were included.
Results and Discussion: Part I. On univariate analysis the AFC
(P < 0.001, r= 0.56), average ovarian volume (P = 0.019, r= 0.33)
and total ampoules FSH used (P<0.001, r= -0.36) were
significantly associated with number of oocytes retrieved.
Following adjustment for other model variables, AFC remained
the only significant factor (P<0.001). Blood flow measurement
was of no value. Part II. None of the 3D Doppler derived indices
of endometrial blood flow were predictive of pregnancy on
logistic regression analysis. We have shown that 3D
measurement of the AFC on the first day of stimulation is
significantly predictive of the number of oocytes retrieved.
However, 3D power Doppler measurement of ovarian and
endometrial blood flow on the first day of ovarian stimulation is
not predictive of IVF outcome.
O15. Assisted conception in HIV positive women: Risk of mother
to embryo viral transmission.
LCG Frodsham, AD Cox, PA Almeida, G Rozis & C Gilling-Smith.
Assisted Conception Unit, Chelsea and Westminster Hospital,
London, UK.
Introduction: Demand for assisted conception in HIV infected
couples is increasing in parallel to the rise in prevalence of HIV
in the heterosexual population. Increased efficacy of
antiretroviral drugs (increased life expectancy) and reduced
vertical transmission risk have led many women to consider
childbearing. Retrospective data from HIV positive women in
Africa indicate reduced fertility and many positive women may
need IVF. Whilst sperm washing is a validated method of
reducing viral transmission risk in HIV positive men, little is
known about the safety of invasive IVF procedures in positive
women and their potential to increase the rate of mother to
embryo transmission of HIV.
Methods: Four HIV positive women underwent four cycles of
IVF or ICSI. Routine stimulation was with injectable
gonadotrophins and eggs were collected under transvaginal
ultrasound guidance and serum viral load measured. Follicular
fluid from initial aspiration and subsequent flushing (which can
liberate blood from the follicular wall) at the time of egg collection
was tested for HIV viral load by Chiron assay. Validation of the
Chiron assay was performed using follicular fluid from HIV
negative controls.
Results and Discussion: Detectable virus was found in follicular
fluid in all four patients (2/27, 9/46, 15/39 and 18/29). Follicular
viral load varied from 50-642 copies/mL. Serum viral load ranged
from 101 to 3071 copies/mL. Virus was detected in not only the
follicles where flushing was used but also in the initial aspiration
samples. Levels appear to be correlated with serum viral load.
As demand for IVF increases it is essential that safety is
assessed. This study demonstrates that HIV is detectable in the
follicular fluid from egg collections performed in the routine
manner and raises concerns about the potential infection of the
egg and embryo with HIV.
O16. Implementation of a single embryo transfer programme.
J Catt, M Henman, T Wood & R Jansen. Sydney IVF, Sydney,
Australia.
Introduction: The obvious solution to excessive ART twins is
to only transfer one embryo. We have initiated comprehensive
culture to day 5 and examined the clinical impact of transferring
a single embryo.
Methods: Clinical data was used to test the efficacy of day 5
culture. Cumulative pregnancy rate was defined as the number
of pregnancies derived from a single stimulated cycle.
Implantation rate was defined as the number of fetal hearts per
embryo transferred for a stimulated cycle or per embryo thawed
for a frozen cycle.
For the single embryo transfer (SET) trial, patients were restricted
to being less than 38 with 3 or more blastocysts available for
transfer.
Clinical acceptance of SET was monitored during 2002.
Results and Discussion: Out of 854 patient cycles 778 (91%)
elected to attempt a day 5 transfer and 38 (4.8%) of these did not
produce a blastocyst suitable for transfer.
Of the 4702 zygotes observed, 3009 produced blastocysts (64%)
and 84% of these formed by day 5. From the 3009 blastocysts,
2484 were used for embryo transfer or cryopreservation (53% of
zygotes or 83% of the blastocysts produced
For patients less than 38 the clinical pregnancy rate was 52%
(225/435) with an implantation rate of 40% (289/727) per embryo
transferred. The twinning rate was 28% per pregnancy. The
corresponding figures for patients over the age of 38 were 30%
clinical pregnancy rate (91/305) with an implantation rate of 18%
(110/299) per embryo transferred.
Patients having SET achieved a cumulative pregnancy rate of
58% (64/111). The corresponding figures for having two embryos
transferred were 60% (152/254) with a twinning rate of 40%.
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Since this study, over 70% of patients in the good prognosis
group have elected for SET, with an ongoing pregnancy rate of
38%.
SET allows twinning rate to be controlled without compromising
the chance of a patient having a baby. SET has been accepted
by the majority of suitable patients
O17. Should epidermal growth factor contamination influence
the choice of human chorionic gonadotropin preparation?
JM Jenkins1, SJ Yarram2, C Tasman2, JR Sandy2 & JP Mansell2.
1Centre for Reproductive Medicine, University of Bristol, Bristol,
UK; 2Department of Oral & Dental Science, University of Bristol,
Bristol, UK.
Introduction: A chance finding revealed that certain urinary
human chorionic gonadotropin (HCG) preparations were able
to stimulate cultured human osteoblasts whereas recombinant
HCG was without effect. This prompted us to search for the
urinary contaminant responsible and to ascertain which of the
different commercially available HCG preparations harboured
the contaminant.
Methods: Suspicion that the contaminant might be epidermal
growth factor (EGF) was strengthened by blocking the urinary
HCG induced response in osteoblasts with AG1478, an inhibitor
of the EGF receptor (Erb1). To confirm these initial findings an
EGF ELISA (R&D Systems) was used to quantify EGF
concentrations in the three preparations of urinary HCG currently
licensed for use in the UK, namely Choragon (Ferring), Profasi
(Serono) and Pregnyl (Organon). All batches (5000IU per
ampoule) tested were reconstituted in 1ml PBS and diluted 2,500
fold prior to assay by ELISA as instructed by the manufacturer.
Results and Discussion: EGF was detected in all three
preparations tested but varied substantially in amount: Profasi
contained the least EGF (<10ng per ampoule in 2 batches tested),
Choragon was contaminated with high levels of EGF (150 ng per
ampoule in 1 batch tested) and Pregnyl contained the most EGF
(181-204ng per ampoule in three batches tested). These findings
provide compelling evidence for substantial EGF contamination
in certain preparations of urinary hCG.
Although the clinical implications of EGF contamination of
urinary HCG preparations are unclear, they should be discussed
as they may influence prescribing practice. Beyond the obvious
issue of skin reactions at the injection site theoretical influences
on the oocyte or increased risk of ovarian hyperstimulation
syndrome should be considered.
O18. Embryo stage at 25-27h post insemination, embryo
development and clinical IVF treatment cycle outcome: The
Manchester experience.
HR Hunter, N Thomas, JD Critchlow, G Horne, MAK Hooper,
RE Arnesen & DR Brison. Regional IVF Unit, Department of
Reproductive Medicine, St Mary’s Hospital, Manchester, UK.
Introduction: Choosing embryos for replacement in human IVF
is based on cell number and morphological appearance. Some
studies have indicated that developmental stage 16 hours earlier
on day 1 can help select the best embryo(s).
Aim: to determine whether embryo stage at 25-27 hours post
insemination (cleavage check) has a prognostic value greater
than selection on day 2.
Methods: 455 patients who underwent 521 cycles of IVF/ICSI
between January 2001 and December 2002 were included. A
control group of patients without the cleavage check (260 cycles)
was also analysed. All patients were treated using standard
laboratory and clinical protocols. Fertilised zygotes in the test
group were assessed 25-27 hours after insemination and graded
as EC (cleaved to 2 cells), 0PN (syngamy) or 2PN (pronuclei
visible). Selection of embryos for replacement was using
established methods, if 2 embryos were of equal grade the ‘best’
at EC check was selected for replacement.
Results and Discussion: Of 1792 embryos in the test group,
18% reached EC, 25% were 0PN and 57% at 2PN. Clinical
pregnancy rates per embryo transfer (CPR) were highest when
only EC embryos (21%) or only 0PN embryos (21%) were replaced
(embryo implantation rates [IR] 15.1% and 14.2% respectively).
An 11.5% CPR (IR 8%) was seen when only 2PN embryos were
replaced. In mixed replacements, a CPR of 23% (IR 12.9%) was
observed when at least 1 EC embryo was replaced, compared to
14% (IR 7.7%) if the best embryo was 0PN. The control group
had a CPR of 22.7% (IR 13.9%).
The Manchester experience is that embryo stage at 25-27 hours
post insemination has limited value in selecting embryos for
replacement.
O19. The temporal expression, localisation and signalling of
the prostacyclin receptor in the human endometrium across
the menstrual cycle.
S Battersby & HN Jabbour. MRC Human Reproductive Sciences
Unit, Edinburgh, UK.
Introduction: Prostacyclin (PGI2) is the main prostanoid
synthesised by vascular endothelium and is postulated to be
involved in menstruation. However, little information is available
as to its function in the human uterus. The objective of the
present investigation was to study the expression of PGI
synthase (PGIS), the specific synthase enzyme for prostacyclin,
and PGI2 receptor (IP) during the menstrual cycle in the non-
pregnant human uterus. In addition, the effect of the PGI2
analogue iloprost on cAMP generation in endometrial tissue
was assessed.
Methods: Endometrial tissue was obtained from women with
regular menstrual cycles. Ethical approval was obtained from
Lothian Research Ethics Committee and written informed
consent was obtained from all subjects. Expression of PGIS and
IP in the endometrium were studied by quantitative RT-PCR and
immunohistochemistry. Cyclic AMP generation in reponse to
iloprost was assessed by ELISA assay.
Results and Discussion: PGIS and IP mRNA expression in the
human endometrium were significantly higher in the early
proliferative phase of the menstrual cycle. PGIS and IP were
localised by immunohistochemistry to glandular epithelium and
stromal cells in the endometrium and also detected in endothelial
cells in blood vessels throughout the uterus and in smooth
muscle cells in the myometrium. Cyclic AMP generation in
response to the prostacyclin analogue iloprost was significantly
higher (p<0.05) in endometrial tissue obtained during the
proliferative phase of the menstrual cycle (4.83±0.74; n=4)
compared with the secretory phase (2.07±.39; n=4).
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The increase in PGIS and IP expression in the uterus during the
early proliferative phase of the menstrual cycle is consistent
with a proposed role for prostacyclin in menstruation.
Furthermore, the rise in cAMP generation in response to iloprost
at this phase suggests PGI2 signalling via stimulation of the
protein kinase A pathway in the human endometrium.
O20. IL-15 in the decidualised endometrium.
CL Dunn1, RW Kelly1 & HOD Critchley2. 1MRC Human
Reproductive Sciences Unit, Centre for Reproductive Biology,
University of Edinburgh, Edinburgh, UK; 2Obstetrics and
Gynaecology, Centre for Reproductive Biology, University of
Edinburgh, Edinburgh, UK.
Introduction:  In humans, endometrial preparation via
decidualisation is required for successful implantation. The
stromal compartment experiences morphological and
biochemical changes during decidualisation although the
controlling components and mechanisms have yet to be fully
clarified. If pregnancy is established progesterone (P) is
maintained at a high level in the late secretory phase and
throughout gestation. P is also believed to be important to
stromal decidualisation in vivo. The cytokine IL-15 is important
to uterine Natural Killer cell function (Verma et al 2000) and has
been linked to P-induced decidualisation in humans (Okada et
al 2000). The aim of this study was to explore the role of P in IL-
15 production and endometrial stromal cell (ESC) decidualisation.
Methods: Immunocytochemistry for IL-15 was performed in
human endometrium. Ethical approval was granted by Lothian
Research Ethics Committee. The control group was mid-luteal
phase endometrium (LH+8-10). The treatment group were given
injections of hCG from day LH+8 for 14 days in order to extend
the lifespan of the corpus luteum, mimicking early pregnancy
(n=5). ESCs were decidualised in vitro for 4, 8 and 12 days (n=4)
using a selection of treatments and their decidualised-status
confirmed by Q RT-PCR for prolactin and IGFBP-1 and by
prolactin ELISAs. IL-15 mRNA expression by these decidualised
ESCs was examined by Q RT PCR.
Results and Discussion: Immunocytochemistry for IL-15
demonstrated upregulation of this cytokine in the glands (P <
0.05) and stroma in women treated with hCG compared to
controls. Q RT-PCR confirmed an upregulation of IL-15 mRNA
expression in decidualised ESCs compared with controls (P <
0.03). IL-15 expression in vivo appears to be controlled by the
ovary, the major product of which being progesterone. However,
experiments in vitro demonstrate the involvement of factors
other than progesterone and that the process of decidualisation
and IL-15 expression are related.
O21. COX-2 reduces the cleavage of plasminogen to the potent
antiangiogenic factor angiostatin.
GB Perchick & HN Jabbour. MRC Human Reproductive Sciences
Unit, Centre for Reproductive Biology, University of Edinburgh,
Edinburgh, UK.
Introduction: Prostaglandin E2 (PGE) is synthesised in cells by
the action of cyclooxygenase (COX) enzymes including COX-2
and is known to be a potent regulator of vascular function.
COX-2 and PGE are elevated in endometrium of women with
excessive menstrual bleeding, endometriosis or endometrial
cancer. Using an endometrial epithelial cell line (Ishikawa) stably
transfected with the COX-2 cDNA in the sense or antisense
directions, we conducted studies to identify differential
expression of genes that may be involved in vascular function.
Methods: Identification of differentially expressed genes was
carried out using cDNA array analysis and Western blotting.
To investigate the generation of angiostatin in the sense and
antisense clones, 350 000 cells of COX-2 sense, COX-2 antisense
and Ishikawa wild type cells were serum starved overnight and
100ul aliquots of serum starved conditioned media were then
incubated at 37°C in the presence of plasminogen (25ug per ml)
for 0, 4, 8 and 24 hours (n=3 independent experiments). A total
of 20ul of media was then analysed by Western blotting using
an antibody to recombinant plasminogen.
Results and Discussion: Cathepsin D RNA was shown to be
6.7 fold upregulated in the COX-2 antisense compared with
sense cells. Similarly cathepsin D protein expression was
2.12±0.23 (n=4) fold higher in the antisense compared with the
sense cells. Cathepsin D is known to cleave plasminogen to the
anti-angiogenic factor angiostatin. Generation of angiostatin
Kringle 1-3 (32 kDa in size) from plasminogen was visibly
inhibited in a time dependant manner in the media from COX-2
sense cells compared with the COX-2 antisense and wildtype
cells. These data demonstrate suppression of expression of
cathepsin D by COX-2, which in turn may result in the reduced
generation of angiostatin. In conclusion, this model system
outlines a novel role for COX-2 in regulation of vascular function
through inhibition of formation of antiangiogenic factors.
O22. Effects of polychlorinated biphenyls (PCB) on telomerase-
immortalized human endometrial epithelial cells (hTERT-EEC).
S Hombach-Klonisch, M Peich & T Klonisch. Department of
Anatomy and Cell Biology, Medical Faculty, Martin-Luther-
University Halle-Wittenberg, Halle/ Saale, Germany.
Introduction: Polychlorinated biphenyls (PCB) are lipophilic
environmental pollutants that bioaccumulate and have
substantial impact on human health. Coplanar PCB activate the
arylhydrocarbon receptor (AhR; dioxin receptor) promoting
transcription of AhR target genes such as members of the
cytochrome p450 family (CYP 1A1, 1A2 and 1B1). These enzymes
interfere with endocrine signaling by affecting metabolism of
steroid hormones.
Methods: Human endometrial epithelial cells were immortalized
by stable transfection with a hTERT vector construct.
Functionality of the AhR/ARNT, estrogen receptor alpha (Era),
and progesterone receptor PR were determined by reporter
assays and differential gene analysis. The molecular effect of
the coplanar PCB congener mixture PCBs 77, 126, 169 on the
hTERT-EEC was determined by PCR, Westernblot and 2D-gel
electrophoresis.
Results and Discussion: The hTERT-EEC cell line expressed
functional AhR/ARNT, ERa and PR. 17b-estradiol (E2) induced
known estrogen target genes as VEGF and PR. Incubation with
progesteron of E2-primed hTERT-EEC up-regulated Muc-1
expression. The coplanar PCB mixture caused a time- and
concentration-dependent induction of the AhR target gene CYP
1A1. Of the three coplanar PCB congeners employed in the
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mixture, PCB 126 was the most potent inducer of CYP 1A1 gene
activity. 2D-gel electrophoresis revealed differential expression
of protein spots in extracts of hTERT-EEC exposed to the PCB
mixture or PCB126. In conclusion, the hTERT-EEC is a suitable
novel hormonally responsive cellular system to study the effects
of xenobiotics on the human endometrial epithelium.
O23. The semi-quantification of sub-endometrial blood flow
during the menstrual cycle in women with unexplained sub-
fertility using three dimensional power Doppler angiography
(3D-PDA) and shell-imaging.
NJ Raine-Fleming, BK Campbell, JS Cleves, NR Kendall &
IR Johnson. School of Human Development, University of
Nottingham, Nottingham, UK.
Introduction: Studies using two-dimensional Doppler ultrasound
have suggested impaired uterine blood supply in a cohort of
women with unexplained infertility. 3D-PDA is potentially a more
powerful method to examine this question as it permits the semi-
quantification of the power Doppler signal throughout the whole
sub-endometrium rather than a two-dimensional plane. The
objective of this study was to define the changes in sub-
endometrial blood flow (SEBF) that occur during the menstrual
cycle in patients with unexplained sub-fertility (USF).
Methods: 3D-PDA was performed on alternate days from day 3
of the cycle until ovulation and then every four days until
menses, in 29 women with USF and 27 normal women not using
hormonal contraception. Virtual Organ Computer-aided
AnaLysis and Shell-imaging were used to quantify the Doppler
signal within the sub-endometrium to derive the Vascular Index
(VI; ratio of colour to grey information) and Flow Index (FI;
intensity Doppler signal). Data were analysed using repeated
measures ANOVA.
Results and Discussion: In controls the sub-endometrial VI
increased (p<0.001) during the follicular phase, peaking 3 days
prior to ovulation before decreasing to a nadir 5 days later
(p<0.001). Thereafter the VI gradually increased during the
transition from early to mid-luteal phase. The FI showed a similar
pattern but with a longer nadir post-ovulation. Women with
USF demonstrated similar trends in SEBF but with a significantly
lower VI during the follicular phase (p<0.05) and early luteal
phase (p<0.05) with a blunted pre-ovulatory peak. Oestradiol
and progesterone concentrations did not differ between the
groups. It is concluded that SEBF varies markedly during the
normal menstrual cycle, reaching its lowest level during the early
luteal phase around the time of implantation. Further, sub-fertile
women have reduced SEBF during the follicular phase. These
results are contrary to previously published work and require
further research to elucidate a physiological explanation.
O24. Endometriosis disturbs the pattern of endometrial cell
protein profile changes between proliferative and secretory
phases.
PA Fowler1, S Sparks1, N Aslam1 & RG Lea2. 1Department of
Obstetrics & Gynaecology, University of Aberdeen, Aberdeen,
UK; 2Rowett Research Institute, Aberdeen, UK.
Introduction:  A number of studies have demonstrated
significant changes in endometrial gene expression patterns
between the proliferative and secretory phases. Using the
proteomic technique, we have found that some of the products
of these genes are differentially expressed in the secretory phase
endometrium of women with endometriosis. It is thought that
there might be subtle impairment of endometrial receptivity in
women with endometriosis. Therefore we carried out a pilot study
to investigate differences in protein expression profile changes
between proliferative and secretory phases of women with and
without endometriosis.
Methods: Endometrial tissue was collected from women with
and without endometriosis during the proliferative (days 8-10
after menses) and secretory (days 20-24 after menses) phases.
The women gave informed consent and were not undergoing
any hormonal treatment or using oral contraceptives. Protein
expression profiles in pooled (6 women/pool) and individual
tissue samples were visualised by 2-D gel electrophoresis (pH
4-7, 10-250 kDa minigels) and analysed using Phoretix-2D
Software. Proteins of interest were excised from the gels and
identified by mass spectroscopic peptide mass mapping.
Results and Discussion: In the first instance we compared
proliferative with secretory phase protein profiles. Based on the
pooled endometrial tissue samples, 22 & 11 proteins were down-
regulated >3-fold and 35 & 26 proteins were up-regulated >3-
fold in women with and without endometriosis respectively,
Further comparisons of protein profiles from individual women
showed higher Trx 1 (Thioredoxin peroxidase 1/Peroxirdoxin 2)
expression in the proliferative phase in women without, but not
with endometriosis. Trx is associated with pinopodes and is
thought to play a role in resistance of cell to apoptosis. In
addition, Trx mRNA levels are highest early in the secretory
phase endometrium. Therefore, our findings suggest that
differences in Trx protein expression in the endometrium may be
associated with reduced implantation in women with
endometriosis.
O25. The effect of anticardiolipin antibody on extravillous
trophoblast, a possible mechanism for pregnancy loss?
AJ Drakeley1, S Mountfield2, L Chamley3, CR Kingsland1,
RG Farquharson1, G Vince2 & S Quenby2. 1Liverpool Women’s
Hospital, Liverpool, UK; 2Liverpool University, Liverpool, UK;
3Auckland University, New Zealand.
Introduction: The role of the antiphospholipid antibody
syndrome (APS) as being strongly associated with recurrent
pregnancy loss is well established. Proposed theories on
mechanism include placental microthromboses and infarction,
which are not universally found on histological examination.
We wished to test the hypothesis that extravillous trophoblast
(EVT) differentiation is impaired in women with APS versus a
control group.
Methods: Blood was taken from women with recurrent
miscarriages and APS with anticardiolipin (aCL) IgG >20 IU/L
was subjected to affinity purification to extract the IgG fraction.
IgG was also purified from an APS negative multiparous control
group. Primary EVT was isolated from term placentae by enzyme
digestion of chorionic strips and cultured with the aCL from
affected women and an equivalent total IgG from controls, then
stained using immunohistochemistry with cytokeratin 7.
Trophoblast differentiation was measured by counting
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multinucleate giant cell formation.
Results and Discussion: There was significant inhibition of
extravillous trophoblast differentiation (p<0.0001) with the APS
patients but not the control women. This was demonstrated
from 50mcg/ml of anticardiolipin and was maximal at 48 hour cell
culture. We conclude that affinity purified aCL caused inhibition
of trophoblast differentiation in our in vitro model. aCL may
contribute to pregnancy loss by inhibiting EVT biology at the
time of early placentation.
O26. Activin A is an oogonial autocrine survival/proliferation
factor in the developing human ovary.
SJ Martins da Silva, RAL Bayne, N Cambray, PS Hartley,
AS McNeilly & RA Anderson. MRC Human Reproductive
Sciences Unit, Edinburgh, UK.
Introduction:  Oogonia undergo rapid proliferation and
maturation immediately preceding primordial follicle formation,
but the factors regulating these processes remain largely
unidentified. We have recently demonstrated the expression of
activin subunits and their receptors by oogonia in the human
fetal ovary. Here we investigated changes in activin expression
leading up to primordial follicle formation and the effect of activin
on oogonial proliferation.
Methods: Human fetal ovaries were obtained following mid-
trimester medical termination of pregnancy with approval from
the Research Ethics Committee. Changes in activin BA subunit
mRNA expression was investigated across a range of gestations
by quantitative RT-PCR. Immunohistochemistry was used to
localise the BA subunit and determine changes in its expression
associated with oogonial maturation. Fragments of 6 ovaries
(14-17 wk gestation) were cultured with 100ng/ml recombinant
activin A for 17h, and germ cell proliferation quantified by BrdU
immunostaining using stereology.
Results and Discussion: Activin BA subunit mRNA and protein
were detected across the mid-trimester. There was an
approximately 2-fold increase in BA subunit mRNA expression
between 14 and 19 weeks gestation. Small clusters of intensely
BA immunopositive oogonia were identified at later gestations,
compared to only weaker immunoreactivity at earlier stages.
The immunopositive cells, constituting approximately 15% of
the total number of oogonia, were larger than oogonia not
expressing BA (nuclear diameter 11.2±0.2 vs 9.8±0.1mm,
p<0.0001). Oocytes within primordial follicles showed only weak
or no BA immunoreactivity however. Activin A treatment
resulted in a mean increase of 26% in the total number of germ
cells (56±4 vs 45±4) and of 50% in the number of proliferating
germ cells (9.2±1.0 vs 6.4±0.8) per unit area (both p<0.01). We
conclude that activin A is a regulatory factor in fetal germ cell
proliferation and survival, and may be of particular importance
during a relatively short period of development immediately
preceding primordial follicle formation.
O27. Prediction of outcome of conservative management of
miscarriage.
J Elson1,2, R Salim2, A Lawrence2, P Cassik2 & D Jurkovic2.
1Department of Reproductive Medicine, Saint Marys Hospital,
Manchester, UK; 2Early Pregnancy and Gynaecology
Assessment Unit, Kings College Hospital, London , UK.
Introduction: With better access to early pregnancy assessment
units, diagnosis of early pregnancy failure is often made in
women with mild or minimal clinical symptoms. In this case
expectant management is a very attractive option to both
clinicians and patients and offers better use of available
resources. Its effectiveness however varies between 25 and 80%.
The success rate depends mainly on the selection criteria. The
aim of the study was to examine the value clinical, ultrasound
and biochemical parameters for the prediction of final pregnancy
outcome in women with miscarriages managed expectantly.
Methods: This was a prospective observational study set in a
dedicated early pregnancy assessment unit in an inner city
teaching hospital. Clinically stable women with an ultrasound
diagnosis of miscarriage were offered expectant management.
In all cases the gestational age, size of products of conception,
serum human chorionic gonadotrophin (B - hCG) , progesterone,
17 OH progesterone, insulin growth factor binding protein 1
(IGFBP-1) , inhibin A and inhibin pro a C RI levels were recorded.
Follow up continued until resolution of the pregnancy, with
surgery indicated for failure of pregnancy resolution after one
week, or worsening clinical symptoms. Clinical data, ultrasound
findings, and biochemical markers were analysed using
univariate analysis.
Results and Discussion: 54 women underwent expectant
management of miscarriage. 37 (69%) had successful expectant
management and 17 (31%) required surgery. The mean time to
pregnancy resolution was 8.5 days. The size of the products,
serum B-hCG, progesterone, inhibin A, and inhibin pro a C RI
were all significantly different in those pregnancies that resolved
spontaneously (p< 0.05). Serum hCG was the best predictor of
outcome.
This study shows that it is possible to use a combination of
ultrasound and biochemical markers to predict the likelihood of
successful expectant management of miscarriage.
O28. An investigation of parental attitudes concerning mode
of conception and informing the in-vitro fertilisation (IVF)
conceived child.
C Peters, X Chrysostomou, P Edwards & AG Sutcliffe.
Department of Child Health, University College London, London,
UK.
Introduction: We wished to investigate in an established cohort
of IVF families with five year old children, parental intention to
reveal conception status and factors influencing that decision
Methods: 352 families who had conceived with IVF or
Intracytoplasmic Sperm Injection (IVF-ICSI) were sent a
questionnaire to be completed by each parent. This established
conception status of all children in the family; who was informed
(eg child, relatives, others); if not informed, did they plan to tell
and at what age?;what information would make telling easier?
Results and Discussion: 178 (50%) families responded there
21
were 140 couples and 38 single responses. Of the 318 individual
parent responders, 149 were IVF parents 169 ICSI parents. The
responders were of similar parental age and social class to non-
responders. Mothers were more likely to complete the
questionnair(mother : father ratio was 1.2 : 1).25% of families
had informed their child in some manner. 71% stated an intention
to inform their child, although only 28% had decided at what
age to do so. Of those who had revealed conception status,
levels of secrecy varied. 5 parents stated that they definitely
never intended to inform their child, 49 remained undecided.
The reason(s) given for non-revelation included: too young
(76%), parents unable to agree on decision (15%), do not want
child to feel different from peer group (37%), fear that child will
tell others (19%), concern about acceptance of child within family
culture (9%), unsure how to approach subject (41%).
The child born as a result of IVF has unmet needs concerning
their right to know how they were conceived with important
implications for their future health and fertility. Parental attitudes
towards informing their children of their mode of conception
vary and the discussion of this issue is a challenge to many of
them. Parents need help and advice in breaking the news.
O29. The effect of metformin on the metabolic syndrome in
women with polycystic ovary syndrome: A randomised, double-
blind, placebo controlled trial.
JM Lord1, N O’Neill1, U Acharya1 & T Wilkin2. 1South West
Centre for Reproductive Medicine, Derriford Hospital, Plymouth,
UK; 2Department of Endocrinology and Metabolism, Peninsula
Medical School, Plymouth, UK.
Introduction:  Polycystic ovary syndrome (PCOS) is
characterised by insulin resistance and altered fat distribution.
Similar metabolic changes are seen in patients with the metabolic
syndrome, and these patients are known to be at high risk of
developing diabetes and cardiovascular disease. Metformin has
been described as an effective agent in inducing ovulation. If it
were also to have beneficial effects on the metabolic indices of
women with PCOS, then it would have advantages over other
ovulation inducers, and may also reduce the potential burden
of vascular disease and diabetes mellitus in later life.
Methods: Women with PCOS and anovulation who were seeking
ovulation induction were recruited (n=40). PCOS was defined
as hyperandrogenism and anovulation. The women were
randomised to receive either metformin 500mg tds or placebo in
a double-blind design. Insulin resistance was calculated by
homeostasis model assessment (HOMA). Visceral and
subcutaneous fat were measured by computerised tomography
scan (CT). Cholesterol, lipoprotein fractions and triglyceride
levels were determined on fasting serum. Measurements were
repeated after 3 months of either metformin therapy or placebo.
Ovulation was determined using weekly progesterone
measurements. Data were analysed using independent-samples
t test.
Results and Discussion: Both the metformin and placebo
groups had similar mean baseline characteristics. After three
months of treatment, the metformin group had significantly lower
total cholesterol (p=0.04), LDL-cholesterol (p=0.03) and systolic
blood pressure (p=0.003). There were no significant differences
in androgens, insulin resistance, weight or fat distribution. There
was no significant effect on ovulation, although overall 48%
ovulated during the three months of follow-up.
Metformin appeared to have beneficial effects on some aspects
of the metabolic syndrome in women with PCOS. Although
metformin is primarily used for ovulation induction, these
findings suggest that it may also have other advantages in
women with PCOS comparable to those already described in
patients with the metabolic syndrome.
O30. Maternal age rather than time since vasectomy remains
the principal determinant of ICSI success in men with
azoospermia following vasectomy.
JDM Nicopoullos1, C Gilling-Smith1, PA Almeida1 &
JWA Ramsay1,2. 1Assisted Conception Unit, Chelsea &
Westminster Hospital, London, UK; 2Charing Cross Hospital,
London, UK.
Introduction: Following vasectomy, 6% of men request reversal
and this group of patients make up a large percentage of men
with obstructive azoospermia. Previous reports have suggested
an association between the time since vasectomy and chances
of natural conception as well as the outcome of ICSI with
surgically retrieved sperm. The aim of our paper is to (i) report
our findings in this group of patients and (ii) assess the effect of
maternal age on outcome.
Methods: 37 couples underwent 56 cycles of ICSI in our centre
using sperm surgically retrieved at the time of vasectomy reversal.
The ICSI cycles were analysed in four groups according to years
since vasectomy (<10 years, 11-15 years, 16-20 years and >20
years). The same cycles were reanalysed in three groups
according to maternal age (<32, 32-37, >38). Statistical analysis
was performed using Fisher’s exact test and logistic regression.
Results and Discussion: No significant trend in fertilisation
rate (FR), implantation rate (IR) or live birth rate (LBR) was seen
according to time since vasectomy. The highest FR and LBR
were in fact found in the group with the longest time interval
(57% and 44% respectively). These findings could not be
explained by differences in either patient characteristics or
stimulation regimes.
When reanalysed by maternal age, there was an improvement in
IR and LBR with decreasing maternal age. Live birth rates of
38.5%, 22.7% and 11.8% were achieved for maternal ages of <32,
32-37 and >38 respectively. Logistic regression confirmed a
statistically significant effect on outcome of maternal age
(p=0.038) but not time since vasectomy (p-0.127). Our data
suggests that maternal age, and not interval since vasectomy,
remains the principal determinant of ICSI success in men with
obstructive azoospermia following vasectomy.
O31. Effects of human chorionic gonadotropin (hCG) and leptin
on trophoblastic vascular endothelial growth factor (VEGF) and
matrix metalloproteinase-9 (MMP-9).
D Islami, P Bischof & D Chardonnens. Department of Obstetrics
& Gynaecology, University of Geneva, Geneva, Switzerland.
Introduction: Vascular endothelial growth factor (VEGF) has
been identified as an endothelium specific mitogen and inducer
of angiogenesis and endothelial cell survival. Leptin and human
chorionic gonadotropin (hCG) have also been suggested as
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possible regulators of angiogenesis in various models.
Moreover, MMP-9 is a key regulator of angiogenesis and is
also involved in intra-uterine tissue remodelling during the
establishment of pregnancy. Secretion of hCG is timely related
to trophoblastic invasion during pregnancy. In vivo and in vitro
assays revealed that leptin has an angiogenic activity and that
the vascular endothelium is a target for leptin. Thus, we raised
the hypothesis that products of cytotrophoblastic cells may
play a role in placental angiogenesis and therefore investigated
the effects of leptin and hCG on cytotrophoblast VEGF and
MMP-9 secretion.
Methods: The study was approved by Ethics Commitee of the
University Hospital of Geneva. Immunopurified
cytotrophoblastic cells (CTB), obtained from normal first trimester
pregnancies, were incubated in triplicates with or without
different concentrations of rhLept (0 - 4 pg/ml), or profasi (hCG,
0 - 30.000 IU/ml). After 4 hours of incubation media were collected.
Each experiment was repeated 3 times. VEGF, MMP-9, hCG and
leptin were measured by ELISA.
Results and Discussion: RhLept stimulated hCG (p = 0.0045)
and MMP-9, but decreased VEGF release (p = 0.0008) by CTB in
a concentration-dependent manner. On the other hand,
increasing concentrations of hCG (0 - 30000 IU/ml), induced a
significant inhibition on leptin secretion (p = 0.0028) and a marked
dose-dependent stimulation in VEGF165 (p < 0.0001) and MMP-
9 secretion (p < 0.0001). We conclude that trophoblastic products
such as hCG and leptin are probably involved in the control of
VEGF and MMP-9 secretion at the maternal-foetal interface.
Leptin and hCG are important endocrine/paracrine modulators
of trophoblast invasion and angiogenesis.
O32. An investigation into the internalization mechanism of
the human oxytocin receptor expressed in HEK cells.
VJ Ayad1, EP Kelly2 & A López-Bernal1. 1Division of Obstetrics
& Gynaecology, University of Bristol, Bristol, UK; 2Department
of Pharmacology, University of Bristol, Bristol,UK.
Introduction: Understanding the mechanisms involved in
oxytocin receptor (OTR) internalization may be important in
developing novel strategies to manage labour .
This study was carried out with the aim of determining the
mechanism of OTR internalization.
Methods: OTR tagged with HA was transfected into HEK-293
cells and 48 h later experiments were performed. OTR
internalization at 37°C was quantified using an ELISA to
determine loss of HA-immunoreactivity from the cell surface.
The localization of HA was detected using immunofluorescence.
Results and Discussion: Loss of cell surface OTR in response
to OT was rapid (within 5 min) and time- and dose- dependent,
with doses between 10pmol/l and 100nmol/l effective (maximal
response (75% loss)with 100nmol/l OT, 30 min). The punctate
pattern of HA immunoreactivity within cells following the
application of OT suggested that OTR was internalized to
vesicles. OTR agonists affected OTR internalization with a
potency equal to that of OT while OTR specific antagonists
inhibited OT-induced internalization. [Arg8]-vasopressin
(100nmol/l for 30 min) caused 80% of the response of a similar
dose of OT.
Co-transfection of a dynamin dominant negative mutant (DNM)
significantly reduced OT induced internalization (70% cell
surface receptor internalized (30 min, 100nmol/l OT) vs. 28%
when DNM co-transfected; P<0.01), while co-transfection with
an arrestin-2 DNM only caused a small (~ 10%) reduction. Protein
kinase C (PKC) inhibition caused a small (<10%) reduction in
OT induced internalization, whereas inhibition of Ca2+
calmodulin-dependent kinase II had no effect.
We conclude that (i) OTR is rapidly internalised by a dynamin
dependent pathway; (ii) PKC and arrestin-2 play a relatively
minor role in OTR internalization and (iii) HEK cells expressing
OTR provide a useful model in which to study the dynamics
and regulation of OTR internalization/recycling.
Supported by Wellbeing.
O33. The effect of a diet high in n-6 polyunsaturated fatty acids
(PUFAs) on precursor availability for prostaglandin production
in the placenta of late gestational ewes.
M Elmes1, P Tew2, SE Kirkup1, Z Cheng1, GC Burdge2,
DRE Abayasekara1, PC Calder2, MA Hanson2 & DC Wathes1.
1Department of Veterinary Basic Science, Royal Veterinary Collge,
Hatfield, UK; 2Centre for FOAD, University of Southampton,
UK.
Introduction: With 40% of the UK population dying annually
from cardiovascular disease, intakes of saturated fat have
declined in favour of unsaturated fat in vegetable oils. These
oils are enriched in the n-6 PUFA linoleic acid (LA), which is
converted by desaturase and elongase enzymes to arachidonic
acid (AA). These fatty acids are important structural components
of the cell membrane phospholipids phosphatidylcholine (PC)
and phosphatidylethanolamine (PE). AA is the parent compound
for the production of 2 series prostaglandins PGF2-aand PGE2.
This study investigated the effect of increased n-6 PUFA
consumption on the LA and AA content of placental tissues
and plasma of late gestational ewes.
Methods: Reproductive tracts were removed on d 135 from ewes
fed throughout late gestation either a control (n=9) or n-6 PUFA-
enriched (n=10) isoenergetic diet containing SoyPreme. Maternal
and fetal blood plasma, fetal allantochorion and maternal
caruncular and intercaruncular endometrium were collected at
slaughter. The fatty acid compositions of tissue and plasma
phospholipids were measured by GC-FID. Data were analysed
by ANOVA.
Results and Discussion: The high n-6 diet increased
concentrations of LA and AA in both maternal and fetal plasma
approximately 2 fold. LA concentrations were consistently higher
in all uterine and placental tissues, although significance was
only achieved in the PE fraction of maternal caruncle (P<0.05).
This was accompanied by a significant 2 fold increase in the
AA concentration of both the PC and PE lipid fractions of the
caruncular endometrium and allantochorion (eg caruncle PC:
Control 204 ± 25, n-6 supplemented 451 ± 96 nmol/g, P<0.05).
These results show that a high maternal n-6 diet elevates AA
concentrations in placental tissues and suggest that such a diet
is likely to alter prostaglandin production during parturition.
Funded by BBSRC.
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O34. A role for prostaglandin (PG)F2a in endometrial
tumorigenesis via the phospholipase C (PLC) and MAPK
pathways.
KJ Sales1, SA Milne2, RA Anderson1 & HN Jabbour1. 1MRC
Human Reproductive Sciences Unit, Edinburgh, UK;
2Department of Neuroscience, The University of Edinburgh,
Edinburgh, UK.
Introduction: Elevated synthesis of PG’s has been shown to
potentiate malignant change by promoting angiogenesis,
inhibiting apoptosis and enhancing proliferation. PGF2a is
biosynthesized by cyclooxygenase (COX) and mediates its
biological activity via the heptahelical Gq coupled FP receptor.
PGF2a is a major metabolite of COX in human endometrium and,
as well as being present in menstrual fluid, is released by human
endometrial explants in culture. In this study we investigated
the expression, localization and signalling of PGF2a in
adenocarcinoma of the endometrium.
Methods: Human adenocarcinoma biopsies were obtained in
accordance with Lothian Research Ethics Committee guidance
with informed patient consent. Expression of the FP receptor
was determined by real-time RT-PCR and Western blot analysis
and localization of receptor expression was determined by in
situ hybridization and immunohistochemistry. Intracellular
signalling in carcinoma tissues was determined by
radioimmunoassay and Western blot analysis following
incubation of carcinoma biopsy explants with 100nM PGF2α.
Results and Discussion:  FP receptor expression was
significantly increased in uterine adenocarcinoma samples
compared to normal endometrium (116.3 ± 63.7 vs 0.15 ± 0.04;
p<0.05), and localized specifically in the neoplastic epithelial
cells with no discernible change in pattern between poor,
moderately or well differentiated samples. Treatment of uterine
adenocarcinoma biopsy explants with 100nM PGF2a resulted in
accumulation of inositol trisphosphates and activation of MAPK
signalling and CREB. Treatment of biopsy explants with U73122
(an inhibitor of PLC) and PD98059 (an inhibitor of MAPK)
abolished activation of MAPK and CREB. Moreover, treatment
of carcinoma biopsy explants with AG1478, an inhibitor of EGF
receptor activation, also abolished the activation of MAPK
signalling and activation of CREB. These data suggest that PGF2a
plays a role in endometrial adenocarcinomas via the PLC and
MAPK pathways and activation of CREB. This activation may
involve transactivation of the EGF receptor by PGF2a.
O35. Progesterone receptor isoforms AB and B in human
oviduct mucosal cells.
CM Briton-Jones1, CK Cheung1, IH Lok2, TTY Chiu2, LP Cheung2
& CJ Haines1. 1The Department of Obstetrics and Gynaecology,
The Chinese University of Hong Kong, Hong Kong; 2The
Department of Obstetrics and Gynaecology, The Hospital
Authority of Hong Kong, Hong Kong.
Introduction: The relative expression of progesterone receptor
(PR) isoforms AB and B may determine the tissue response to
circulating progesterone (P). Little is known about the regulation
of PRAB and PRB in the oviduct. The objective of this study
was to determine the relative ratio of PRAB to PRB expression
in human oviduct mucosal cells throughout the ovulatory cycle
and in different regions of the oviduct.
Methods: Oviducts (N=15) were obtained from women
undergoing surgery for benign gynaecological conditions. The
cycle phase was determined by last menstrual period (LMP)
and appropriate concentrations of oestradiol, luteinizing
hormone and progesterone. mRNA was isolated from oviduct
mucosal cells and a semi-quantitative reverse transcriptase-
polymerase chain reaction (RT-PCR) performed. Primers for
PRAB and PRB isoforms were co-amplified with the control
primers for B-actin and a ratio for each product was obtained by
densitometry. The results were verified by immunohistochemistry
for both PR isoforms. This study was approved by the Clinical
Research Ethics Committee of the Chinese University of Hong
Kong.
Results and Discussion: PRAB and PRB were expressed in the
fimbrial and ampullary regions but were absent or lowly
expressed in the isthmic region in early and late follicular phases.
PRAB or PRB were absent or lowly expressed in the luteal phase
in all regions. The ratio of PRAB:PRB mRNA expression was
significantly higher in fimbrial mucosal cells compared to
ampullary mucosal cells, P<0.01. These results show that there
is relatively more expression of the active PRB isoform in the
ampullary region of the oviduct. This being the site of
fertilization and embryo cleavage suggests that this receptor
may play a role in these early reproductive events.
O36. High oestradiol content of bovine uterine endometrium.
GE Mann & DV Scholey. School of Biosciences, University of
Nottingham, Sutton Bonington, UK.
Introduction: High tissue concentrations of oestradiol have been
reported in ovine endometrium (Challis et al., 1976, Journal of
Endocrinology 69, 451-2). To determine if this is also the case in
the cow, we have investigated the oestradiol content of bovine
endometrium and related this to circulating plasma oestradiol
concentrations.
Methods: In Study 1, uteri and a single peripheral plasma sample
were collected following slaughter from 9 heifers and oestradiol
content/concentration determined. Tissue was then chopped
into pieces of <1mm3, washed twice and 180mg aliquots cultured
(6 replicates per animal per time point) on lens cleaning tissue
on stainless steel grids at the air:media interface in supplemented
MEM at 37°C in a humidified atmosphere of 95% air: 5% CO2.
Media was changed at 24h intervals and media and tissue
harvested at 24h, 48h and 72h of culture. In Study 2, endometrium
from 4 heifers was cultured in media with or without 5ng/ml
testosterone for 72h with media changed every 24h.
Results and Discussion: In Study 1, the mean ± sem plasma
oestradiol concentration was 0.64 ± 0.25pg/ml while the mean ±
sem endometrial oestradiol content was 43.0 ± 14.7pg/g tissue.
There was a close relationship between plasma and tissue
oestradiol levels (R2 = 0.81; P < 0.001). During culture there was
a progressive decline (P<0.005) in oestradiol content to 19.4 ±
6.7 pg/ml by 72h. This was accompanied by a similar decline in
media oestradiol concentration (24h 5.0 ± 1.8pg/well; 48h 3.3 ±
0.7 pg/well; 72h 2.1 ± 0.4 pg/well). In Study 2, supplementation
with testosterone did not result in any increase in oestradiol
release at any time point. These results confirm high tissue
concentrations of oestradiol in bovine endometrium while
providing no evidence for oestradiol synthesis by this tissue.
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The presence of such high concentrations of oestradiol in
endometrial tissues has implications for examining the role of
oestradiol in the control of uterine function in this species.
O37. Prepubertal changes in bovine testicular LH and FSH
receptors (LH-R and FSH-R) and serum concentrations of LH
and FSH.
ET Bagu, CL Gratton, DMW Barrett, R Duggavathi,
PM Bartlewski & NC Rawlings. Department of Veterinary
Biomedical Sciences, University of Saskatchewan, Saskatoon,
Canada.
Introduction: The objective of this study was to follow changes
in testicular LH-R and FSH-R concentrations and affinity
constant (K
a
) during sexual maturation in bull calves.
Methods: Separate groups of 6 Hereford x Charolais bull calves
were castrated every 4 wks from 5 to 33 wks of age, a week prior
to castration blood samples were taken every 15 min for 10h.
Gonadotropin receptors were assessed by a radio-receptor
assay using iodinated bovine LH (USDA-bLH-I1) and FSH
(NIDDK-AFP5332B).
Results and Discussion: LH pulse frequency and mean serum
LH concentration increased (P<0.01) from 4 wks of age (2.7±0.5
peaks/10h and 0.5±0.2ng/ml, respectively) to 12wks of age
(8.2±1.1 peaks/10h and 1.7±0.2ng/ml, respectively) and then
declined (P<0.01) to a nadir at 24 wks of age (1.00±0.45 peaks/
10h and 0.40±0.1ng/ml, respectively). Mean serum FSH
concentrations were transiently elevated at 12wks of age
(1.6±0.5ng/ml; P<0.01). Concentrations of LH-R declined from
4.27±0.95pM/mg of protein at 13 wks of age to 1.52±0.22pM/mg
of protein at 21 wks of age (P<0.01). The LH-RK
a
 increased from
17 wks of age (1.32±0.09 x 1010 M-1) to 29 wks of age(2.21±0.17 x
1010M-1); P<0.001). Mean FSH-R concentrations declined from 5
wks of age (7.46±0.90pM/mg of protein) to 25wks of age
(4.30±0.41pM/mg of protein) and then susequently increased at
33 wks of age (7.43±0.61pM/mg of protein; P<0.05). The FSH-
RK
a
 did not change with age (P>0.05). LH-R concentrations were
correlated with mean serum FSH concentration (r value 0.83;
P<0.05). FSH-R concentrations were correlated to LH pulse
amplitude (r value -0.74; P<0.01).
High concentrations of gonadotropins in serum and
gonadotropin receptors in the testis during the early postnatal
period in bull calves, maybe critical to initiate rapid testis growth;
however, increased LH-RK
a
 and FSH-R concentrations later in
testes development, may also be important for regulating testes
growth.
O38. Genetic control of the Leydig cell responsiveness during
the postnatal development in mice.
AV Osadchuk, LG Ahmerova & KV Svechnikov. Institute of
Cytology and Genetics, Novosibirsk, Russia.
Introduction:  Previously we discovered strain-related
differences in the Leydig cell responsiveness (LCR) between
four inbred mouse strains during the postnatal developmental
(Osadchuk et al., 2001). However, inheritance of the strain-related
LCR peculiarities has not been still clear. To elucidate the problem
we studied the developmental pattern of the LCR in these four
strains (CBA/Lac, A/He, BALB/c, PT) and all their 12 reciprocal
F1 hybrids.
Methods: The LCR was estimated by the testosterone production
by crude Leydig cell suspension in response to submaximal
concentrations of hCG, d,b-cAMP and pregnenolone on days
20, 35, 60 and 100 of the postnatal life in all 16 crosses.
Testosterone was determined by RIA.
Results and Discussion: We revealed three main properties of
the heritable LCR pattern. First, the coordinated and significant
between-cross differences in every parameter of the LCR for
each point of the postnatal development were observed. Second,
the highly significant genotype-age interaction effects on the
LCR were demonstrated. It means that the between-cross LCR
differences are modified from point to point of the postnatal
development. Specifically, the negative between-cross
correlations between the LCR on days 20 and 35 were observed.
On the contrary, the positive correlations between the LCR on
days 60 and 100 were obtained. No correlations between the
LCR in the prepubertal and pubertal periods were found. Third,
the heritable LCR postnatal pattern was polygenic since it was
accounted for the simplest 3-locus segregation genetic model
we developed. We conclude that in every point of the postnatal
development the LCR is under the coordinated and polygenic
control that is subjected to dramatic postnatal modifications.
The adult LCR heritable pattern is formed at the end of the
pubertal period and can be associated with formation of the
adult Leydig cell population.
The work was supported by the grant RFBR N 01-04-49523.
O39. Effect of cannabinoids on the adult mouse testis.
K Wilson1, RF Thomson1, RG Pertwee2 & PA Fowler1.
1Department of Obstetrics & Gynaecology, University of
Aberdeen, Aberdeen, UK; 2Department of Biomedical Sciences,
University of Aberdeen, Aberdeen, UK.
Introduction: There is evidence of cannabinoid receptor (CB1)
expression in the testis. For instance, delta-9-
tetrahydrocannabinol interferes with FSH receptors of the Sertoli
cell and cannabinoids accumulate in the testis following toxic
challenge. The effects of the CB1 agonist WIN55 212-2 and CB1
antagonist SR141716A on testosterone production were
investigated.
Methods: Testes were harvested from 10-12 week old mice and
(a) tissue was sliced and cultured for 0.5, 1, 2 & 5 hours or (b)
cells were dispersed enzymatically and cultured at 25,000 cells
per well for 5 hours: in SFDM + 1% BSA. Treatments were
SR141716A, WIN55 212-2 (0, 0.001, 0.1, 1 ÁM) and LH (0 - 1 ug/
ml). Samples were collected after each time interval and assayed
for testosterone. Data was analysed using the Mann-Whitney
test.
Results and Discussion: In both culture systems, WIN55
stimulated basal testosterone production (41% of control,
p=0.0016 in slice culture) and suppressed LH-induced
testosterone production (45% of control, p<0.0001 in slice
culture). SR141716A alone moderately suppressed basal
testosterone production and significantly suppressed LH-
induced testosterone production in a dose dependant manner
(47% of control, p=0.0004 in slice culture & 56% of control, p
=0.0066 in cell culture). SR141716A antagonised the stimulatory
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effects of WIN55 on basal testosterone production in cell culture.
In slice culture, WIN55 and SR141716A together greatly
increased LH-induced testosterone production (246% of control,
p<0.0001), however in cell culture SR141716A with WIN55
caused further suppression of LH-induced testosterone
production (51% of control, p=0.0415). These results suggest
CB1 receptor activation affects testosterone production,
although other receptors/post receptor mechanisms may be
involved. It is also possible that since CB1 activation reduces
adenylate cyclase activity, this counteracts the intracellular
cAMP levels that are raised via LH receptor activation.
Elucidating the mechanism(s) involved may be complicated by
testicular production of endocannabinoids such as anandamide.
O40. Expression of inhibin, activin and follistatin in human
male fetal reproductive tract.
AO Bahathiq & W Ledger. Section of Reproductive and
Developmental Medicine, University of Sheffield, Sheffield, UK.
Introduction: In humans, differentiation of the testis is evident
from week 8 of gestation, when the testis comprises cords
containing Sertoli cells surrounded by an interstitium that
includes Leydig cells.There is early evidence that inhibin and
activin participate in gonadal development, but the present study
is the first to study the expression of inhibin/activin and
follistatin in human fetal reproductive tract as early as 8 weeks
of gestation.
Methods: Immunohistochemical localisation of the a, bA and
bB subunits was carried out in different regions of the human
fetal reproductive tract tissues using specific antisera generated
against inhibin subunits (Oxford Bio-innovation, Oxford, UK)
and follistatin (R&D Systems, UK). This study was approved
by the South Sheffield Research Ethics Committee.
Results and Discussion: At 8 weeks of gestation, inhibin a  and
bB-subunit were expressed on the mesonephros only, while the
inhibin betaA-subunit and follistatin were expressed on both
the mesonephros and genital ridge with different intensities.
With further testicular development at 10 and 12 weeks of
gestation, gonocytes mainly expressed the betaB subunit, but
no positive reactions were observed with other inhibin subunits
or follistatin. In contrast, tubular or Sertoli cells expressed both
a and bB subunits. Interstitial cells (pre-Leydig cells) showed
positive reaction with different intensity to all inhibin subunits
and follistatin. The presence of the a and bB subunits indicates
that fetal Sertoli cells may produce inhibin B, consistent with
the presence of inhibin B in the fetal circulation. Testicular
production of inhibin may participate in the regulation of FSH
secretion at this stage in development, which in turn may
contribute to Sertoli cell and gonocyte proliferation. Leydig cells
expressed all three inhibin/activin subunits, in broad agreement
with previous studies. Thus, inhibin and activins may also
participate in the autocrine or paracrine regulation of fetal Leydig
cell steroidogenesis and proliferation.
O41. Plasma inhibin B is not useful in the management of the
infertile man with impaired spermatogenesis.
C Gearon, HA Abdalla & JP Pryor. Assisted Conception Unit,
Lister Hospital, London, UK.
Introduction: The correlation between testicular size, FSH level
and testicular histology was the basis for managing infertile
men with azoospermia/severe oligozoospermia. The ability to
collect sperm from men with sertoli cell only syndrome has led
to the suggestion that plasma inhibinB level might be a better
prognostic test. This study was performed to see if it were
clinically useful.
Methods: 30 azoospermic/severely oligozoospermic men referred
for possible sperm retrieval were assessed including testicular
size and plasma gonadotphin hormone and inhibinB levels before
undergoing testicular sperm retrieval and testicular biopsy.
Results and Discussion: Eight men opted not to proceed to
sperm retrieval due to a poor prospect of success and semen
quality improved in 3 so that operation was unnecessary.
InhibinB levels were normal(>100pg/ml) in 7 but spermatozoa
were not obtained in 2 men and the histology confirmed the
total absence of spermatozoa.
InhibinB levels were low in 9 men and spermatozoa were not
extracted in 6 although spermatozoa were present in the biopsies
of 2 of these - in 3.5% and 4% of seminiferous tubules. Sperm
were obtained in one man even though none were present in the
biopsy.
InhibinB levels were <15pg/ml in 6 men and sperm were extracted
in 2 of these men even though there was no histological evidence
of spermatogenesis in all 6 men, including 1 with Klinefelter's
syndrome whose wife conceived.
InhibinB is not clinically useful in the management of the man
with impaired spermatogenesis and there is an incomplete
correlation between the ability to collect spermatozoa and
testicular histology.
O42. Evidence of local immune reaction in primary obstructive
infertility and its correlation with abnormal sperm morphology.
SA Bhalla, AK Sarda, D Pandey & G Gautam. Department of
General Surgery, Maulana Azad Medical College, New Delhi,
India.
Introduction: Obstruction to the outflow of the sperms is an
important cause of primary infertility in males. The commonest
site of obstruction in patients of primary obstructive infertility
is the epididymis or the proximal part of vas deferens. The
reported spontaneous pregnancy rate is low (13% to 56%) even
after a technically successful and patent vasoepididymostomy
which implies that certain factors lead to a morphological or
functional damage to spermatozoa in these patients with resultant
failure of impregnation. In case of obstructive azoospermia,
spermatozoal degradation occurs proximal to the site of
obstruction in the epididymis with the possibility of leakage of
sperm antigens and production of antibodies. The objective of
the study was to find evidence of a local immune reaction in the
epididymis proximal to the site of obstruction in the form of
presence of antisperm antibodies in epididymal fluid. A positive
evidence of immune reaction was then correlated with presence
of morphologically abnormal sperms in epididymal fluid.
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Methods: The study included forty patients of primary
obstructive infertility who underwent a vasoepididymostomy.
Epididymal fluid was aspirated peroperatively. ELISA test was
used to detect antisperm antibodies in the fluid. Scanning
electron microscopy was used to study the sperm morphology.
The study was approved by local ethical committee.
Results and Discussion: A direct evidence of local immune
response was found in the form of a positive ELISA for antisperm
antibodies in the epididymal fluid in 22/40 (55%) of patients.
There was a significant association between the presence of
morphologically abnormal sperms in the epididymis and
antisperm antibodies in the epididymal fluid (P<0.05). In
conclusion, the damage to spermatozoa in primary obstructive
infertility may be immunologically mediated.
O43. Comparison of follicular fluid antioxidant capacities
between fertile and sub-fertile women.
OA Oyawoye1, A Abdel Gadir2, A Garner3, C Perrett1 &
P Hardiman1. 1Department of Obstetrics and Gynaecology, Royal
Free Campus, Royal Free and University College Medical School,
London, UK; 2London Female and Male Fertility Centre, London,
UK; 3Department of Biological Sciences, Brunel University,
Brunel, UK.
Introduction: Reactive oxygen species (ROS) have been widely
implicated in male sub-fertility but only few studies in women
exist. These studies largely concentrated on measurement of
specific antioxidants, such as superoxide dismutase (SOD) and
glutathione peroxidase, as an indirect evaluation of ROS
activities. This prospective study was designed to assess the
effect of ROS in reproduction by comparing follicular total
antioxidant capacity (TAC) and antioxidant consumption
between fertile and sub-fertile women.
Methods: Follicular fluid was aspirated from fourteen pre-
ovulatory women during laparoscopy performed either as part
of evaluation for sub-fertility (n=9) or for sterilisation (n=5).
TAC was measured using the ferric reducing/antioxidant power
(FRAP) assay and the levels were compared between the two
groups. Ethical approval was obtained from the research ethics
committee of Enfield and Haringey Health Authority.
Results and Discussion: For all the patients, the mean follicular
TAC was 0.93 ± 0.26 mmol/L. The mean follicular TAC among
the sub-fertile women (0.90 ± 0.25 mmol/L) was less than that of
the fertile women (1.00 ± 0.30 mmol/L). However, the numbers
were too few to demonstrate statistical significance. Follicular
antioxidant levels, an indicator of the innate potential of the
fluid and the oocytes contained to withstand oxidative stress,
may be slightly higher in fertile women compared to the sub-
fertile women. Further studies are indicated to evaluate the role
of follicular antioxidants and ROS in female reproduction.
O44. An examination of the presence of follicular dominance
in cyclic sheep by injection of a physiological dose of oFSH
during the first follicular wave of the estrous cycle.
R Duggavathi, PM Bartlewski, DMW Barrett, KL Davies,
ET Bagu & NC Rawlings. Department of Veterinary Biomedical
Sciences, Western College of Veterinary Medicine, University
of Saskatchewan, Saskatoon, Canada.
Introduction: In sheep, the existence of follicular dominance or
the suppression of follicle wave emergence by the large follicles
of successive waves is still controversial. The objective of this
study was to see if a physiological dose of FSH would induce a
follicle wave if injected during the growth phase of the first
follicular wave of the ovine estrous cycle.
Methods: Five Western White Face ewes were given ovine FSH
(oFSH; NIDDK-oFSH-18; 0.5 ug kg-1 s.c. in 0.05% bovine serum
albumin and 50% polyvinylpyrrolidone) 12 h after follicle(s) in
the first wave of the estrous cycle attained 4 mm in diameter;
based on twice daily transrectal ovarian ultrasonography. A
second injection was given 8 h later. Six control ewes received
vehicle.
Results and Discussion: In treated ewes, serum FSH
concentrations reached a peak (P<0.05) by 0.5 d after first
injection (d 0). This induced FSH peak (3.3±0.3 ng ml-1) did not
differ (P>0.05) from the endogenous FSH peaks of both treated
and control ewes detected on d -1 before (3.9±0.3 and 3.7±0.3 ng
ml-1, respectively) and d 4 after (3.5±0.3 and 3.4±0.3 ng ml-1,
respectively) treatment. In both treated and control ewes the
inter-wave interval between the first and second waves of the
cycle was 4.8±0.2 and 5.1±0.3 d, respectively (P>0.05). However,
in treated ewes, an additional follicle wave emerged 0.5±0.0 d
after oFSH treatment and 1.8±0.1 d after the emergence of first
wave of the cycle. Follicle waves in both groups of ewes did not
differ (P>0.05) in terms of growth characteristics and serum
estradiol concentrations, following their emergence. The
induction of an extra follicle wave by injected oFSH, during the
growth phase of the first follicle wave of the cycle, and the lack
of disruption of follicle wave rhythmicity, suggest that follicular
dominance is not present early in the ovine estrous cycle.
O45. Suppression of follicle wave emergence in cyclic western
white face (WWF) ewes by supra-physiological concentrations
of oestradiol-17B and induction with a physiological dose of
exogenous ovine FSH (oFSH)
DMW Barrett, PM Bartlewski, R Duggavathi, KL Davies,
SJ Cook, ET Bagu & NC Rawlings. Department of Veterinary
Biomedical Sciences, University of Saskatchewan, Saskatoon,
Canada.
Introduction: Regular waves of antral follicle growth are preceded
by a peak in serum concentrations of FSH in the ewe. The
purpose of the present study was to see if treatment with
oestradiol implants would block FSH peaks to create a model in
which the effect of the timing and mode of FSH peaks could be
studied by injection of oFSH.
Methods: On d 4 post-ovulation, 5 WWF ewes received silastic
rubber implants containing 10% oestradiol-17B (oestradiol
implants)(s.c.) and 5 ewes received implants without oestradiol-
17B Implants were left in for 10 d. Blood samples were taken
every 12 min for 6 h on d 5 after treatment. In a second experiment,
12 WWF ewes received oestradiol implants on d 4 post-
ovulation. On d 5 after implant insertion, 6 out of 12 ewes were
injected  with  oFSH  twice,  8 h  apart  (NIDDK-oFSH-18;  0.5 ug
kg-1, s.c.). In both studies, transrectal ovarian ultrasonography
and blood sampling were done daily.
Results and Discussion: In the first study, mean serum
oestradiol concentrations were higher (10.4±0.7 vs 3.9±0.7 pg
mL-1; P<0.001) and the amplitude of FSH peaks were lower
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(0.66±0.11 vs 1.08±0.16 ng mL-1; P<0.05) in ewes with oestradiol
implants compared to control ewes. Mean serum FSH
concentrations were unaffected by treatment. Between d 0 to 8
after implant insertion, no follicular waves emerged. On d 5 of
treatment, LH pulse frequency did not differ between the
treatment groups (P>0.05). When FSH was injected, a new
follicle wave emerged 1.5±0.5 d post-injection; however, in
control ewes a follicle wave emerged 4.8±0.8 d post-injection
(P<0.01). We concluded that truncation of peaks in serum
concentrations of FSH by oestradiol implant treatment prevented
emergence of follicle waves, but injection of physiological
concentrations of oFSH reinitiated follicle emergence.
O46. Lupins modulate folliculogenesis directly by an FSH-
independent mechanism.
NR Kendall1, 2, RJ Scaramuzzi2, DT Baird3 & BK Campbell1. 1School
of Human Development, University of Nottingham, Nottingham,
UK; 2Veterinary Basic Sciences, Royal Veterinary College,
London, UK; 3Centre for Reproductive Biology, University of
Edinburgh, Edinburgh, UK.
Introduction: Lupins are a leguminous grain used as a high
energy (13MJ ME/kgDM), high protein (320g CP/kgDM)
supplement. Short-term lupin feeding increases ovulation rate
in ewes by an unknown mechanism. The aims were to determine
if lupins increased follicular sensitivity to FSH and if this effect
was due to their high nutrient value.
Methods: Hypogonadotrophic-hypogonadism was induced in
18 ewes with ovarian autotransplants by a 3-week pre-treatment
with GnRH antagonist (1.3mg/3-4 days; Cetrorelix, Serono) and
progestagen sponges. From sponge withdrawal (SW; 0h), ewes
received FSH (5ug oFSH-S17/ h) for 72h followed by hCG (500
IU). All sheep were fed a maintenance diet starting 1 week prior
to treatment. From 18h before SW one group (n=6) were fed
lupins (Lupinus angustifolius) 500-600 g/day for 90h (-18-72h).
A positive control group (n=6) were similarly fed an isocaloric,
isonitrogenous diet. The control sheep (n=6) remained on the
maintenance diet. The autotransplanted ovary was scanned by
ultrasound daily.
Results and Discussion: Lupins increased the number of large
follicles at 72h and ovulation rate. Respectively, the lupin group
had mean (±SE) follicles and ovulation rates of 5.8 ± 0.7 and 3.6
± 0.4, compared to controls 2.3 ± 0.6 and 1.3 ± 0.3 (P<0.05) and
isocaloric positive controls 2.5 ± 0.5 and 1.2 ± 0.3 (P< 0.05). The
control groups did not differ.
These results suggest that lupins increase follicular sensitivity
to FSH and that this effect is due to a specific component of
lupin grain. We conclude that a factor(s) in lupins acts acutely
and directly on the ovary to enhance gonadotrophin-dependent
follicle development.
O47. The effect of insulin-like growth factor on health and
morphology of bovine antral follicles in vitro.
K Walters1, DG Armstrong2 & EE Telfer1. 1Institute of Cell and
Molecular Biology, University of Edinburgh, Edinburgh, UK;
2Roslin Institute, Edinburgh, UK.
Introduction: IGFBP-2 mRNA has been detected in the oocyte
of preantral and antral bovine follicles. Previous work has shown
that direct access of IGF to preantral follicles has a negative
effect on oocyte size. The aim of this study was to investigate
further the hypothesis that the bioavailability of IGF is strictly
regulated according to developmental stage. This was
determined by studying the effects of IGF on bovine antral follicle
development in vitro.
Methods: Bovine antral follicles (165-215m and 216-280um) were
dissected out and cultured for 4 days in either control media or
in control media supplemented with either 10ng/ml or 1ug/ml
human recombinant IGF-I (IGF-Ir), which binds to IGF-binding
proteins, or 5ng/ml Long R3 IGF-I (LR3 IGF-I), which does not
bind to IGF-binding proteins. Half the medium was replaced
every day and the conditioned media was analysed for oestradiol
production by hormone assay. At the end of the culture period
the follicles were fixed and processed for histology.
Results and Discussion: There was significant follicle growth
over 4 days in all groups (P<0.01). Follicle growth significantly
increased at day 4 in follicles (165-215µm) cultured in media
supplemented with 1ug/ml IGF-Ir (P<0.05). At the end of the
culture period, follicles (165-215um) cultured with 5ng/ml LR3
IGF-I or 1ug/ml IGF-Ir, had significantly reduced oocyte:follicle
diameter ratios compared to control and day 0 groups (p<0.05).
In conclusion, a high dose of IGF had a stimualtory effect on
follicles (165-215um) but was associated with a deleterious effect
on oocyte growth. In contrast, the follicles (216-280um) did not
show the significant increase in follicle growth and deleterious
effect on oocyte growth. IGF may therefore be overstimulating
the early antral follicles (165-215um), when the regulation of IGF
by the IGFBPs is not functioning, and causing deleterious effects
on the oocyte.
This work is supported by the BBSRC.
O48. Regulation of LH receptor (LHR) production in bovine
granulosa (GC) and theca cells (TC).
P Marsters, NR Kendall & BK Campbell. School of Human
Development, University of Nottingham, Nottingham, UK.
Introduction: The development of functional LHR by the GC of
large follicles is critical to the process of follicle selection. The
identification of an LHR mRNA binding protein (LRBP; Nair et
al 2002 JBC) that inhibits LHR translation suggests that LHR
production is regulated post-transcription. This study examined
the regulation of LHR mRNA translation in cultured bovine GC
and TC induced to differentiate in vitro.
Methods: GC and TC were isolated from small (3-5mm) bovine
follicles and cultured serum-free under conditions known to
induce differentiation (Campbell et al 1996, 1998 JRF). At 0, 16,
24, 48, 96, 144 and 192 h of culture LHR mRNA was analysed
from GC and TC by semi-quantitative RT-PCR using primer sets
which either targeted a region adjacent to the 5' LHR translation
start site or a region found in all LHR mRNA isoforms.
Results and Discussion: The common LHR mRNA sequence
could be identified in freshly isolated GC and TC (0h) indicating
similar levels of transcription in both cell types. After 16 to 24 h
of culture both TC and GC showed a marked reduction in LHR
mRNA expression, which revived by 48 to 96 h. This increase
paralleled induction of steroidogenesis by both GC and TC.
However, in marked contrast, the translation start site region
was amplified in TC but not in GC, suggesting that translation
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was repressed in this cell type. These results support the
hypothesis that LHR production in GC is regulated by post-
transcription mechanisms and confirm our previous report (SRF
2002) that gene activity transiently falls in cultured cells following
dispersion prior to recovery after re-establishment of cell-cell
communication.
O49. Abstract Withdrawn
O50. Inhibition of oxytocin receptor and oestrogen receptor-
alpha gene expression in the myometrium of late pregnant
relaxin knockout mice.
AL Siebel1,2 & LJ Parry1,2. 1Howard Florey Institute, University
of Melbourne, Melbourne, Australia; 2Department of Zoology,
University of Melbourne, Melbourne, Australia.
Introduction: An important contractile-associated protein,
highly upregulated in the myometrium at term, is the oxytocin
receptor (OTR). In rodents, the increase in myometrial OTRs is
influenced by oestrogen. However, another mediator of OTRs
may be the ovarian peptide relaxin (Rlx). Recent evidence
suggests that the uterotrophic effects of Rlx are mediated by
activation of oestrogen receptors (ERs) (Pillai et al.
Endocrinology 1999; 140:2426). Activation of ERs by Rlx in the
myometrium could potentially facilitate an upregulation in OTRs.
The main objective of this study was to use a relaxin gene
knockout mouse (Rlx-/-) developed by Zhao et al.
(Endocrinology 1999; 140:445) to investigate the influence of
Rlx on myometrial OTR and ER-alpha gene expression in late
pregnancy.
Methods: Myometrium was collected from C57/Blk6J Rlx+/+ and
Rlx-/- mice on d7.5, d10.5, d14.5, d17.5, and d18.5 post coitum
(n=5-6/stage) with Institute AEEC approval. Quantitative
measurement of OTR and ER-alpha mRNA concentrations was
performed using real-time PCR, with Taqman probes. Expression
of both genes was examined in the myometrium of Rlx+/+ mice
throughout gestation and comparisons were then made with
Rlx-/- mice at d14.5 and d18.5 pc.
Results and Discussion:  Myometrial ER-alpha mRNA
concentrations in Rlx+/+ mice increased significantly (p<0.05;
ANOVA) on d14.5 pc, with expression remaining high throughout
gestation. This upregulation was not observed in Rlx-/- mice at
the two stages of gestation examined. Similarly, OTR mRNA
concentrations increased significantly (p<0.03) in the
myometrium of Rlx+/+ mice, but only on d18.5 pc. However,
there was no significant increase in OTR mRNA concentrations
in relaxin-deficient mice. These data demonstrate an inhibition
of both OTR and ER-alpha mRNA expression in the myometrium
of late pregnant Rlx-/- mice. This suggests a potential regulatory
role for the peptide Rlx on these two receptors in the myometrium.
Funded by the Australian Research Council.
O51. Endoplasmic reticulum reorganisation during mouse
oocyte maturation.
G FitzHarris1, JJ Eppig2 & J Carroll1. 1Department of Obstetrics
and Gynaecology, Assisted Conception Unit, University
College London, London, UK; 2The Jackson Laboratory, Bar
Harbour, Maine, US.
Introduction: Oocyte maturation is accompanied by
modifications in Ca2+ homeostasis that prepare for the
generation of sperm-induced Ca2+ oscillations at fertilization.
The modifications include an increase in the sensitivity of Ca2+
release and a reorganization of the endoplasmic reticulum into a
network of cortical clusters in mature oocytes. The aim of the
present study is to establish the time-course, mechanism and
role of ER reorganisation during oocyte maturation.
Methods: Oocytes from MF1 mice were recovered at various
times after administration of hCG, microinjected with the
lipophilic marker DiI, and the ER examined using confocal
microscopy. Chromosomes were labelled with Hoechst 33342.
To compare the sensitivity of InsP3 mediated Ca2+ release in
groups of oocytes, [Ca2+]i was monitored with fura red following
photolysis of ‘caged’ InsP3 by UV exposure.
Results and Discussion: Following germinal vesicle breakdown
a dense ring of ER becomes evident in the interior of the oocyte,
the formation of which is inhibited by the microtubule-
depolymerising agent nocodazole. Co-labelling with Hoechst
33342 reveals that this ER ring closely envelops the
chromosomes during centro-cortical migration. Cortical clusters
of ER are formed late in maturation, close to the time of first
polar body (Pb1) extrusion. Pb1 is not a prerequisite of cluster
formation however, since ER clusters are present in oocytes of
mouse strain LTXBO which exhibit premature arrest at MI.
Finally, the sensitivity of Ca2+ release in response to inositol
1,4,5-trisphosphate, is upregulated over a similar timecourse as
the generation of ER clusters (fura ratio change after 100ms UV
exposure 9h post hCG 0.42±0.03r.u.; 14h post hCG 0.56±0.02r.u.,
P<0.01). These experiments suggest that ER reorganisation is
microtubule-dependent, and is associated with an increase in
the sensitivity of Ca2+ release.
O52. Chicken gonadotrophin inhibitory peptide inhibits
gonadotrophin subunit mRNAs.
N Ciccone1, K Tsutsui2, S Lumineau3, IC Dunn1 & T Boswell1.
1Roslin Institute, Roslin, Midlothian, UK; 2Faculty of Integrated
Arts and Sciences, Hiroshima University, Higashi-Hiroshima,
Japan; 3CNRS Universite de Rennes 1, Campus de Beaulieu,
France.
Introduction: A 12 amino-acid peptide isolated from quail brain,
gonadotrophin inhibiting hormone (GnIH), inhibits LH, but not
prolactin release from the quail pituitary. The objective of this
study was to obtain evidence for the functional significance of
GnIH in the domestic chicken by i) determining whether GnIH
inhibits gonadotrophin subunit mRNAs in vitro and, ii)
determining whether GnIH is present in neurons in the
hypothalamus.
Methods: Competitive PCR assays were validated for the
measurement of chicken common gonadotrophin, LHB and FSHB
subunit mRNAs (Ciccone et al. 2002. SRF Leeds, 22: 49). An
antibody raised against GnIH was validated for
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immunocytochemistry. Diced pituitaries from cockerels were pre-
incubated for 90min in DMEM then incubated with medium alone
or three concentrations of GnIH (n=6 /treatment) for 120min.
RNA from the pituitary fragments were then assayed for
gonadotrophin subunits mRNAs. Brain sections through the
hypothalamus from three laying hens were immunolabelled for
GnIH.
Results and Discussion: The amounts of gonadotrophin subunit
mRNAs / ribosomal RNA (x 10-17 moles cDNA equivalents)
observed after incubation with 0 (control), 105,106 and 107moles
GnIH were:-
Common alpha subunit: 25.74±11.36, 10.54±5.44, 3.42±1.43, and
2.88±0.7.
FSHB subunit: 19.62±6.4, 5.92±1.06, 10.73±2.3, and 12.77±4.4.
LHB subunit: 5.70±1.2, 4.04±1.2, 3.96±1.4, and 3.51±1.0.
Although all doses of GnIH suppressed gonadotrophin subunit
mRNAs, regression analysis of log10gonadotrophin subunit
mRNA vs doses of GnIH were non significant for common
subunit (P= 0.4) and LHB (P=0.4) and significant for FSHB
(P=0.01). Immunocytochemical analysis revealed GnIH cells
bodies in the paraventricular nucleus with a heavy innervation
of the external layer of the median eminence. These findings
strengthen the view that GnIH may be a functionally significant
in the chicken. It suppresses FSHB mRNA and may have a
similar effect on the other gonadotrophin subunits, and is
localized appropriately in the median eminence to regulate
anterior pituitary function.
CN is supported by a CASE BBSRC studentship.
O53. Comparison of fertiloscopy vs. laparoscopy in - results of
an international multicentric prospective trial. The ‘ FLY ‘
(Fertiloscopy-LaparoscopY) Study.
A Watrelot & C Racinet. St Bartholomew’s and the London
Hospital, London, UK
Introduction: The aim of this prospective multi-centre study
was to compare two endoscopic techniques, laparoscopy and
fertiloscopy, in the routine evaluation of the pelvis in infertile
women.
Methods: For that purpose 92 women were selected in 14
University Hospitals to undergo fertiloscopy followed by
transabdominal laparoscopy by a team of two surgeons in each
hospital.
Results and Discussion: We observed a high degree of
concordance between these two techniques in that if
fertiloscopy did not detect any abnormalities this was also
confirmed by laparoscopy. Discordance was observed in a similar
number of cases 8 in laparoscopy and 9 in fertiloscopy. The
diagnostic index for both methods was calculated, sensitivity
and negative predictive value being similar for fertiloscopy and
laparoscopy (86% and 87% respectively for sensitivity and 64%
and 67% for negative predictive value). The kappa index was
also calculated for each of the six sites and concordance was
considered to be almost complete, being between 0.78 and 0.91.
These results confirm that fertiloscopy is a minimally invasive
safe procedure which can be considered to be an alternative to
diagnostic laparoscopy in the routine assessment of women
without clinical or ultrasound evidence of pelvic disease. Due
to the additional advantages of fertiloscopy, namely
salpingoscopy or microsalpingoscopy, we consider that
fertiloscopy can replace laparoscopy as a routine procedure in
such women.
O54. An amniocyte cell culture model to assess the impact of
adhesion prevention fluids in-vitro.
RL Knight1, T Davis2 & P Wardle1. 1Fertility Clinic, Southmead
Hospital, Bristol, UK; 2Department of Cytogenetics, Southmead
Hospital, Bristol, UK.
Introduction: Pelvic surgery is associated with a significant
incidence of post-operative adhesions. Re-admission rates of
up to 6% have been reported. Infertility complicates pelvic
adhesions in 15-20% of patients.
A number of liquid barriers are now available to reduce the
incidence of post-operative peritoneal adhesion. The majority
of efficacy studies to date involve a second look laparoscopy
which is an invasive form of assessment. We report the findings
of a cell-culture model we have used to assess and compare the
impact of adhesion prevention fluids in-vitro. The cells used
were amniocytes which are easily cultured and have similar
properties to peritoneal mesothelial cells.
Methods: The cultures were prepared using equal quantities of
thawed, pooled amniocytes. The cells were cultured with differing
concentrations of each adhesion prevention fluid for 7 days. At
the end of the culture time the cell colonies were stained and
counted according to standard laboratory techniques. Each
culture assay was performed in duplicate.
Results and Discussion: Colony counts were significantly lower
in the cultures where adhesion prevention fluid was added to
the amniocyte cell culture. Greater inhibition was seen with higher
concentrations of adhesion prevention fluid. There was wide
variation in the degree of inhibition with different fluids. A
solution of 2% Icodextran resulted in significantly fewer colonies
following incubation compared with Hartman’s crystalloid
solution, p<0.001, and a 2% Icodextrin solution inhibited cell
culture significantly more than a 0.4% solution, p<0.001.
This is the first report of a cell culture method to assess the
effect of adhesion prevention fluids in-vitro. We found that
amniocyte cultures demonstrated a dose related inhibition when
adhesion prevent fluid was added to the culture medium. This
suggests that some adhesion prevention fluids are cytotoxic
and that their liberal use should await the results of randomised
controlled trials.
O55. An ectopic pregnancy team: Is there an improvement in
patient management?
B Cloke, S Lavery, C Ng, R Margara & G Trew. Department of
Reproductive Medicine, Hammersmith Hospital, London, UK.
Introduction: Ectopic pregnancy remains a significant cause of
pregnancy related deaths in the UK. Although laparoscopic
treatment is increasingly accepted as the surgical gold standard,
many patients still undergo laparotomy. We initiated a dedicated
ectopic team with the aim of improving the management of the
haemodynamically stable patients as well as providing a source
of laparoscopic training for junior doctors.
Methods: A retrospective audit of the management of ectopic
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pregnancy was performed for the year prior to the introduction
of the ectopic pregnancy team, and then data was collected
prospectively for one year. All patients with a differential
diagnosis of an extrauterine pregnancy were included. Referral
criteria included a haemodynamically stable patient with an
imaging result and positive pregnancy test. Prospective data
was therefore divided into two arms; non-referred and referred.
Results and Discussion: A total of 96 and 114 cases were
analysed in the retrospective and prospective arms respectively.
49 prospective cases were accepted by the ectopic team. The
remaining 65 cases were managed by the admitting team. A
comparison between the retrospective and prospective years
revealed that the initial laparoscopy rates were similar (81.7% vs
89.8%), however the conversion rate to laparotomy was different
(65.3% vs 24.5% p=0.001). The numbers of operative
laparoscopies were significantly increased (20.4% vs 56.6%
p<0.001) and more cases were managed medically with
methotrexate (1.5% vs 11.3% p=0.01). Furthermore, comparison
between the non-referred and referred arms of the prospective
cases revealed that more patients were treated conservatively
(0% vs 12.1% p=0.02) and the negative laparoscopy rate was
also significantly less (29% vs 4.5% p=0.001). Ten trainees were
taught skills in laparoscopic ectopic surgery. In conclusion, a
dedicated ectopic team results in a statistically significant
reduction in the laparotomy rate, post operative stay as well as
negative laparoscopy rate, and provides a training opportunity
for junior doctors.
O56. A prospective analysis of intra-abdominal adhesions in
patients undergoing Palmer’s point entry laparoscopy based
on previous surgical history.
TZ Jacobson & CJ Davis. Department of Obstetrics and
Gynaecology, Barts and the Royal London Hospitals, London,
UK.
Introduction: Complications secondary to Veress needle or trocar
insertion at initial portal entry is a rare but serious complication
of laparoscopic surgery. Bowel and vascular complications are
reported to occur in 0.1-0.5% of laparoscopic procedures. A
study of over 900 cases(1) using a 2.1mm microlaparoscope at
Palmer’s Point showed an overall rate of umbilical adhesions of
9.7%. Of those with a previous Pfannensteil incision the rate
was 21.3% and if they had a previous midline incision the rate of
peri-umbilical adhesions was 53%. The rate of severe adhesions
with a potential risk of damage at blind trocar insertion in the
previous midline scar group was 31.25%.
Methods: We report a series of Palmer’s point laparoscopic
procedures in women undergoing laparoscopy in whom it was
felt prudent to perform a Palmer’s point trocar insertion or in
whom initial entry at the sub-umbilical site was difficult. The
number and degree of peri-umbilical adhesions identified was
prospectively recorded and is analysed in relation to their
previous surgical history.
Results and Discussion: We have collected data on 32 patients
undergoing Palmer’s point entry. 15 had undergone a previous
Pfannensteil laparotomy and of these 40% had omental
adhesions and 27% had bowel adhesions in the sub-umbilical
site. Of thos with a previous midline incision, 50% had omental
adhesions and 17% had bowel adhesions.
There were no complications with the procedures but in one
patient with a previous cholecystectomy there were adhesions
near to Palmer’s point. Upper abdominal surgery is a relative
contraindication to the use of Palmer’s point.
Conclusion: There is a high rate of peri-umbilical adhesions
following pelvic or abdominal surgery. Palmer’s point is a safe
technique that should considered as the standard entry
technique in the presence of previous surgery. Experience in its
use should be a standard part of training for all gynaecological
laparoscopists.
1) Audebert AJM. The role of microlaparoscopy for safer wall
entry : incidence of umbilical adhesions according to past surgical
history. Gynaecological Endoscopy 1999;8:363-367.
O57. Routine use of multiple Filshie clips for female
sterilization: Indications and consequences.
S Allahdin1 & V Kay2. 1Department of Obstetric and
Gynaecology, Forth Park Hospital, Kirkcaldy, Fife, UK;
2]Department of Obstetrics and Gynaecology, Forth Park Hospital,
Kirkcaldy, Fife, UK.
Introduction: Single application of the Filshie clip to each
fallopian tube is adequate for effective female sterilization.
Multiple applications of the clips can lead to hydrosalpinx
formation, resulting in chronic pelvic pain from non-infarctive
torsion of the tube.
Methods: This is a 5-year retrospective study of 211 women
sterilized between September 1997 to September 2002 by one
Consultant at a District General Hospital. The aim of the study
was to determine the failure rate in 106 patients with single clip
application and incidence of hydrosalpinx in 105 patients in
whom two clips were routinely applied.
Results and Discussion: 106 patients had single clip application
with 1(0.9%) failure. 105 patients had two clips applied routinely
with 2(1.8%) cases of hydrosalpinx. Both patients presented
repeatedly with chronic abdominal pain and required a
laproscopy and salpingectomy for the hydrosalpinx.
DISCUSSION:
Multiple clips are applied when there is a difficulty occluding
the tubes, especially at postpartum sterilization. Increased
litigation claims for failed sterilization following an English Court
of Appeal judgment in 1985, has resulted in an increased
tendency for routine application of two Filshie clips on each
tube for reassurance.
Multiple clip application incurs an extra cost of £300 (cost of
Filshie clips) for each patient and increases the incidence of
hydrosalpinx formation requiring salpingectomy.
The Crest study shows that 2 and 2.7 percent of the over 7500
women expressed regret at 1 and 2 years postoperatively
respectively. The Filshie clip causes minimal degree of tubal
destruction, thus allowing for maximum reversibility. The
application of multiple clips would reduce the minimal functional
length required for successful reversal and hydrosalpinx
followed by salpingectomy would make this task almost
impossible.
Patients are counselled for failure rate prior to sterilization.
Provided that the incidence of failure is within the national
average, there is no indication for multiple clips routinely.
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O58. Monitoring and improving the management of ectopic
pregnancy in Scotland.
MJ Cameron1, GC Penney1 & GP Cumming2. 1Scottish Programme
for Clinical Effectiveness in Reproductive Health, Aberdeen
Maternity Hospital, Aberdeen, UK; 2Department of Obstetrics
and Gynaecology, Dr Gray’s Hospital, Elgin, UK.
Introduction: Ectopic pregnancy accounts for 12% of all direct
deaths reported in the Confidential Enquiry into Maternal Deaths
in the United Kingdom (1997-1999) with 62% of deaths
associated with substandard care.
In an effort to lower the rate of repeat ectopic pregnancy and
preserve subsequent fertility, management has changed rapidly
during the past decade. New health technologies, including
medical treatment and laparoscopic surgical techniques, were
introduced. Salpingectomy, rather than traditional salpingotomy,
has been shown to be the preferred surgical treatment when the
contra-lateral tube is healthy.
Due to perceived variations in clinical practice the Royal College
of Obstetricians and Gynaecologists published a guideline
document, The Management of Tubal Pregnancies, in 1999.
This study’s objectives were to assess the extent to which these
guidelines have been incorporated into the working practice of
gynaecologists in Scotland; and, by feedback of the findings,
to promote improvements in care.
Methods: A retrospective case note review of ectopic pregnancy
management in Scotland for the period 1st August 2001 to 31st
July 2002 was conducted. Case ascertainment was through local
hospital ward and theatre registers. Trained audit assistants at
each hospital extracted data from case records using a
standardised data extraction form.
Results and Discussion: Fifteen representative and typical
obstetric and gynaecology services in Scotland participated in
this study. Within the 15 services, 337 patient records were
reviewed. Comparative performance on key performance
indicators for ectopic pregnancy management suggests variation
among services in the proportion of women being offered medical
versus surgical treatment, and in the method of definitive surgical
management. In conclusion, clinical audit against standards
developed from a national guideline has revealed variations and
deficiencies in clinical care. Feedback of the audit findings will
incorporate strategies tailored to overcome identified barriers
to adoption of the guideline. Subsequent re-audit will monitor
any resulting improvements.
O59. Trophoblast stem cells generated from human embryonic
stem cells.
R Harun1, L Ruban1, C Wong1, PW Andrews2 & HDM Moore1.
1Reproductive and Developmental Medicine, University of
Sheffield, Sheffield, UK; 2Department of Biomedical Sciences,
University of Sheffield, Sheffield, UK.
Introduction: Embryonic stem (ES) cells are pluripotent and have
the capacity to differentiate into most cell types in vitro. An
exception was thought to be trophectoderm. In the mouse, ES
cells fail to generate trophoblast either in vitro or in vivo,
although trophoblast stem cells can be derived from
trophectoderm in the presence of fibroblast growth factor-4
(FGF4) and heparin in conditioned medium (TS). Human ES cells
often display early expression of chorionic gonadotropin (hCG),
indicating the possibility that trophoblast cells might be formed.
Here, we describe the generation of trophoblast-like stem cells
(under HFEA License) from human embryoid bodies (EBs).
Methods: Human ES cells were proliferated in serum-free hES
medium on mouse fibroblast feeders, recovered with collagenase
IV and cultured to EBs in the presence of FGF4 in Petri dishes.
After 5-8 days, EBs were transferred singly to 96-well plates and
hCG secretion measured by immunoassay. Those EBs (3.8%)
producing high levels of hCG (>500 mIU/ml) were cultured further
in TS conditioned medium with FGF4 and heparin.
Results and Discussion: High proportions of cells from these
cultures displayed a variety of trophoblast markers, were positive
for hCG-β and formed syncytia. Three cell lines were generated
initially but only one showed sustained propagation in the
absence of feeder cells. Proteome analysis is in progress to
characterise this trophoblast cell line. Recently hES cells have
been shown to differentiate directly to trophoblast cells in the
presence of BMP4. However, the culture through the EB stage
may be more amenable to propagation of trophoblast stem cells.
The functional ability of the cell line to interact with human
endometrium in vitro is being investigated. A trophoblastic cell
line with normal karyotype would be an excellent model for
human in vitro implantation studies.
O60. CRH and CRH R1 Expression in mouse pre-implantation
embryos and fallopian tubes: A possible autocrine/paracrine
role for early embryo development.
LN Lim1,2, YQ Yao1,2, F Rashid-Doubell1, IL Sargent1,2,
JE McVeigh1,2, DH Barlow1,2 & EA Linton1,2. 1Nuffield Department
of Obstetrics and Gynaecology, University of Oxford, Oxford,
UK; 2Oxford Fertility Unit, John Radcliffe Hospital, Oxford, UK.
Introduction: Studies in rodents have shown that the
hypothalamic stress hormone, Corticotrophin Releasing
Hormone (CRH), is produced in the endometrium, with highest
levels expressed at implantation sites. In humans, the peptide is
thought to promote blastocyst implantation and maintenance
of early pregnancy by killing activated T cells at the implantation
site. The aim of this study was to determine whether CRH and
its R1 receptor were expressed in mouse pre-implantation
embryos and whether the mouse fallopian tube also produced
the peptide.
Methods: Unfertilised oocytes, embryos at various stages of
development and fallopian tubes were obtained from hormonally
superovulated CBAB6 F1 mice. All embryos were flushed from
the fallopian tubes which were then carefully dissected from the
adjacent ovary and uterus and stored at -20°C until use.
Expression studies to explore CRH peptide and its CRH R1
receptor protein in the embryos were carried out using specific
antibodies and indirect fluorescence immunocytochemistry.
Reverse transcription nested polymerase chain reactions (PCR)
were performed on blastocysts to examine the gene expression
of CRH and CRH R1. Western blotting and radioimmunoassay
for CRH measurement and PCR for CRH gene expression were
performed on the fallopian tubes. Gene sequencing was carried-
out on the PCR products so produced.
Results and Discussion: The presence of both CRH peptide
and CRH R1 protein was detected in mouse oocytes, 2, 4 and 6-
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8 cell embryos and in blastocysts (N = minimum of 2 at each
stage). The transcription of CRH and CRH R1 genes was
successfully detected in mouse blastocysts, with confirmation
of cDNA products by gene sequencing. Fallopian tube CRH
content averaged 358pg, with Western blotting revealing a
19kDa band corresponding to pro-CRH. Sequencing confirmed
the presence of the CRH gene in fallopian tubes. These novel
findings suggest that CRH may be involved in early mouse
embryo development in an autocrine and/or paracrine manner.
O61. In vivo injection of vascular endothelial growth factor
(VEGF) gene promotes follicular development and the resultant
ovulation in immature female rats.
T Shimizu, K Iijima, Y Ogawa, H Sasada & E Sato. Laboratory of
Animal Reproduction, Tohoku University, Sendai, Japan.
Introduction: Ovarian follicular angiogenesis initiates early
during follicular development and continues throughout
follicular growth. Based on our previous finding (Shimizu et al.,
2002) that VEGF plays a major role in the thecal angiogenesis,
we performed in vivo injection of VEGF gene to enhance the
thecal angiogenesis associated with follicular development.
Methods: Wister-Imamichi immature female rats were used and
divided into two groups. The animals were received with no
injection (control) or in situ injection of VEGF gene fragments (4
µg DNA/ovary) into both ovaries at age of 21 days, followed by
administration i.p. with 20 IU of eCG at age of 26 days. The
ovaries were removed before and 48 h after eCG injection to
subject for histological examination of follicular population. In
addition, 48 h after eCG injection, the animals were given i.p.
with 20 IU of hCG and the ovulated oocytes in both groups
were recovered from the oviducts at the following day.
Results and Discussion: Histological examination indicated that
the percentage of atretic follicles decreased and that total number
of follicles per ovary increased in the VEGF injection group
compared with the control group. The number of the oocytes
ovulated significantly increased in the VEGF injection group
than in the control. The oocytes collected in the VEGF-treated
ovaries showed normal figures similar to the control. From the
present study, we conclude that VEGF gene treatment in
combination with hormonal treatment has significant benefit to
obtain more follicles with healthy oocytes by reflection of
decrease of the atretic follicles, suggesting that these results
may offer an innovate protocol to develop one of novel therapies
for prevention and treatment of infertility associated with ovarian
dysfunction.
O62. Bax and Bcl2 in ejaculated sperm.
CM McVicar1, K Williamson2, N McClure1, P Maxwell2, P Casey1,
L McCaffrey1 & SEM Lewis1. 1Department of Obstetrics and
Gynaecology, Queens University Belfast, Belfast, Northern
Ireland, UK; 2Pathology, Queens University Belfast, Belfast,
Northern Ireland, UK.
Introduction: Apoptosis plays an important role in controlling
germ cell number and eliminating defective germ cells during
testicular development and spermatogenesis. Bcl2 family
members are key regulators of apoptosis. They may either
support cell survival (eg. Bcl2) or promote cell death (eg. Bax).
The Bcl2 to Bax ratio predetermines the cell’s susceptibility to a
given apoptotic stimulus. The aim of this study was to assess
the incidence and intensity of these apoptotic markers in
ejaculated sperm from infertile men.
Methods: Semen samples (n=13) were obtained from men,
attending an infertility clinic, following 2-5 days’ sexual
abstinence.
Bax: Sperm were fixed with an intra-prep fixation reagent followed
by primary antibody and IgG2b isotype. The cells were then
incubated with secondary R-phycoerythrin-conjugated
antibody.
Bcl2: Sperm were fixed in ethanol. Primary antibody and IgG1b
isotype were added. The sperm were washed and incubated
with secondary R-phycoerythrin-conjugated antibody and
analysed using a flow cytometer.
Percentage of cells positive and the intensity were assessed.
Pearson’s correlation was used to assess the differences between
the Bax/Bcl2 positive sperm, their intensities and the abnormal
sperm parameters.
Results and Discussion: Both Bax and Bcl2 were present in
ejaculated sperm. Bcl2 was found in the samples which displayed
normal morphology by Kruger Criteria (i.e.>13% normal forms).
There was a positive relationship between the intensity of Bax
and percentage normal morphology (r=0.55, p=0.05) and motility
(r=0.56, p=0.05). There was an inverse relationship between the
percentage of sperm Bcl2 positive and percentage normal
morphology (r=-0.51, p=0.09) and between the intensity of Bcl2
staining and percentage normal morphology (r=-0.64, p=0.02).
Bcl2 is known to have a role in inhibiting apoptosis. It is possible
that Bcl2 over-expression in sperm with poor morphology and
under-expression of Bax is associated with an increased
percentage of abnormal sperm escaping apoptotic death.
O63. Expression of mRNAs encoding IGFs and IGF binding
proteins in equine follicles during spring transition and the
breeding season.
S-E Bae1, M Steele1, R Thomassen1, CO Hogg2, S Thomson1,
DG Armstrong2 & ED Watson1. 1Department of Veterinary Clinical
Studies, University of Edinburgh, Easter Bush, Roslin,
Midlothian, UK; 2Division of Integrative Biology, Roslin
Institute, Midlothian, UK.
Introduction: In mares, the period of vernal transition is
characterized by a resurgence of follicular activity, irregular
exhibition of oestrous behaviour and growth and regression of
large follicles without ovulation. The insulin-like growth factor
(IGF) system, plays an essential role in modulating the response
of follicles to gonadotrophins, controlling follicular growth,
development, and steroidogenesis. The IGFs stimulate granulosa
cell proliferation and interact with FSH to control oestradiol
production by granulosa cells. IGFBPs are involved in regulating
this process by influencing IGF bioavailability.
Methods: Ovaries were obtained from 14 mares on the day after
detection of an actively growing 30 mm follicle in spring
transition, and also at the second oestrus of the breeding season.
In situ hybridization was performed on frozen sections using
35S-labelled riboprobes for IGF-I, and -II, and IGFBP-2, -3, and -
4. Level of expression was quantified by image analysis and
analysed by ANOVA.
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Results and Discussion: IGF-I mRNA was present in both theca
and granulosa cells, but was greater (P<0.01) in granulosa cells.
IGF-II mRNA was detected only in theca cells. There was
significantly lower expression of mRNAs for IGF-I and IGF-II
(P<0.05) in transitional follicles than in preovulatory follicles.
IGFBP-2 mRNA was detected in both granulosa and theca cells,
but IGFBP-3 and -4 mRNAs were detected only in theca cells.
There was a significantly lower level (P<0.001) of IGFBP-2 mRNA
expression in theca cells of transitional follicles than in
preovulatory follicles, however, there was no significant
difference in IGFBP-2 mRNA expression in granulosa cells. There
was no significant difference in mRNA expression of IGFBP-3
and IGFBP-4 between transitional and preovulatory follicles.
In conclusion, large equine follicles during spring transition
have low levels of mRNA encoding IGF-I and IGF-II, which will
contribute to the steroidogenic incompetence of dominant
follicles during spring transition and their subsequent
regression.
O64. The role of a tumor suppressor gene BARD1 and its
spliced variant in spermatogenesis.
A Feki1,2, CE Jefford1, P Durand3, H Lucas2, D Chardonnens2,
KH Krause1 & I Irminger1. 1Biology of Aging Laboratory,
Department of Geriatrics, Geneva, Switzerland; 2Department of
Gynecology and Obstetrics, Geneva, Switzerland; 3INSERM-
INRA U 418, Hôpital Debrousse, Lyon, France.
Introduction: BARD1 is a protein interacting with the RING
domain of BRCA1. It is structurally homologous to BRCA1 .
Co-localization of BARD1 with BRCA1 and other repair proteins
indicates a function in DNA repair. As reported for BRCA1,
BARD1 expression is maximal in testis and spleen. BRCA1 mRNA
level is highly expressed in germ cells and not somatic cells. The
highest level of expression was found in meiotic cells and their
downstream post meiotic products which are undergoing
differentiation. In contrast, premeiotic germ cells expressed little
or no BRCA1. However, neither the specific localization nor the
function of BARD1 have been elucidated during
spermatogenesis. Exogenous expression or stress induced up-
regulation of BARD1 led to apoptosis in vitro and in vivo. Since
apoptosis is an important mechanism for homeostasis of germ
cells, we hypothesized that BARD1 could function in apoptosis
induction and selection in spermatogenesis.
Methods: The presence of BARD1 in rat testis by immuno-
histochemistry and biochemical procedure. RT-PCR was
performed in a rat testis. The new BARD1 isoform was sequenced
and cloned in an expression vector.
Results and Discussion: BARD1 is expressed in mitotic
spermatogonia and pachytene spermatocytes, but unlike BRCA1
it is also expressed in secondary spermatocytes and early round
spermatids of adult rats. Two isoforms of BARD1 were identified.
RT-PCR on purified cells from rat testes, led to the identification
of a new testis specific BARD1 splice variant that retains
apoptotic capacity. Our data suggest that only the full length
BARD1 acts in concert with BRCA1 in the pachytene
spermatocytes. We showed that the full length BARD1 and its
isoform are associated with apoptosis in spermatogenesis.
Survival of male germ cells is determined by a complex network
of signals, including paracrine signals as well as endocrine
signals. A model, how BARD1 can be integrated into these
known signaling networks, will be proposed.
O65. Obstetric outcome following subfertility: A review of 4157
women.
F Thomson, S Shanbhag, S Bhattacharya & A Templeton.
Department of Obstetrics and Gynaecology, Aberdeen Maternity
Hospital, Aberdeen University, Aberdeen, UK.
Introduction: It has been suggested that subfertility is
associated with increased obstetric and perinatal risks.
Confirmation of these findings could inform appropriate planning
of obstetric services. The co-existence of Aberdeen Maternity
and Neonatal Databank (AMND) and the Aberdeen Fertility
Clinic Database (AFCD) provide a unique opportunity to study
obstetric outcomes in large cohorts of subfertile women. We
aimed to examine the obstetric and perinatal outcomes of
singleton pregnancies in couples with subfertility.
Methods: This was a retrospective cohort study. Women with
subfertility attending Aberdeen Fertility Clinic between 1989
and 1999 were identified from AFCD. Their unit numbers and
dates of birth were matched against the AMND (which records
all deliveries in Aberdeen) to extract obstetric records of women
with subsequent singleton pregnancy outcomes. The remaining
obstetric population over the same time period served as the
control group. Maternal characteristics, pregnancy outcomes,
maternal complications, labour and delivery events and neonatal
variables were compared.
Results and Discussion: The 4157 eligible subfertile women
were followed-up for a median (IQR) duration of 4 (2-6) years. Of
these, 1437 (35%) women, with a singleton delivery, were
compared to a control population of 32,969 women. Subfertile
women were older [mean (SD) age years: 31 (4.7) versus 28 (5.3),
p < 0.001] and more likely to be primiparous [70% versus 47%, p
< 0.001], than control women. No increased risks of neonatal
complications were detected for subfertile women. After
adjusting for age and parity, subfertile women were at increased
risk [OR (95% CI)] of pre-eclampsia [6.4 (4.9 to 8.5)], APH [3.0
(1.8 to 5.1)], Caesarean Section [2.0 (1.7 to 2.2)], instrumental
delivery [2.0 (1.6 to 2.3)] and induction of labour [1.4 (1.2 to 2.6)],
in comparison with the general population. The odds of CS
remained significantly high [1.8 (1.6 to 2.0)] after adjusting for
induction, pre-eclampsia and ante-partum haemorrhage.
Subfertile women appear to be at increased risk of obstetric
complications, which persist after adjusting for age and parity.
O66. The effect of increased endometrial thickness on the
outcome in hormone replacement frozen embryo transfer cycles.
N Hammadieh1, M Afnan2, K Sharif2, S Basu1, G Jose1 & S Laren1.
1Cardiff Assisted Reproduction Unit, University Hospital of
Wales, Cardiff, UK; 2Assisted Conception Unit, Birmingham
Women’s Hospital, Birmingham, UK.
Introduction: Recent reports claimed that increased endometrial
thickness is associated with poor outcome in assisted
conception due to endometrial trauma during embryo transfer
(ET). Our objective was to assess if increased endometrial
thickness (> 14 mm), as measured with transvaginal ultrasound
(TVS) 3 days before ET, had any effect on the outcome of
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hormone replacement frozen embryo transfer (FET) cycles. A
retrospective review of all FET cycles initiated between January
1998 and December 2000.
Methods: A total of 641 frozen cycles in 410 patients, were
divided into two groups based on endometrial thickness. Their
mean age was 33.9 + 4.7 (years). Group 1 consisted of 568 cycles
(88.6%) cycles with endometrial thickness between 8-13.9 mm,
and group 2 included 73 (11.4) cycles, in which endometrial
thickness was >14 mm. Oral oestradiol valerate (E2) 12 mg/day
was taken for 9 days then endometrial thickness was measured
by TVS. The cut off point was set at >8 mm before ET. If the
endometrial thickness was still <8 mm, we increased E2 dose
until the criteria were met. A maximum of three embryos were
transferred (median = 2).
Results and Discussion: All groups were comparable in terms
of age, aetiology of infertility, number and quality of embryos
transferred. Overall comparison of outcome was made and there
were statistically no significant difference on clinical pregnancy
(20.6 vs 23.3%), early pregnancy loss (including biochemical
pregnancy) (20.4 vs 26.1%), multiple pregnancy (20.5 vs 29.4%),
and implantation rate (11.1 vs 12.7%) between group 1 and group
2 respectively.
In conclusion, endometrial thickness >14 mm did not seem to
influence the outcome in hormone replacement FET cycles.
O67. WT1 modulates differentiation of fertile human
endometrium.
N Brook1, E-N Lalani2, R Margara1 & J White1. 1Institute of
Reproductive & Developmental Biology, Wolfson & Weston
Centre for Family Health, Hammersmith Hospital Campus, Imperial
College, London, UK; 2Department of Histopathology,
Hammersmith Hospital Campus, Imperial College, London, UK.
Introduction: The Wilms’ Tumour gene (WT1) is a transcription
factor found in the urogenital system and is expressed in human
endometrium. We have investigated the temporal and spatial
pattern of expression of WT1 in the endometrium of fertile and
infertile patient groups (ovulatory polycystic ovarian disease).
The biological activity of WT1 is influenced by its association
with PAR-4, which consequently affects expression/function of
DAX-1 and SF-1. The co-presence of these transcription factors
with WT1 in endometrium would suggest the potential for
functional interaction. Their expression has therefore also been
investigated
Methods: 50 endometrial samples from fertile and infertile women
were taken at timed intervals throughout the menstrual cycle.
The expression of WT1, DAX-1, PAR-4 and SF-1 was determined
in these formalin-fixed specimens by immunohistochemistry.
Results and Discussion: In fertile endometrium the expression
of WT1 was restricted to stromal cells being localised in the
nuclear and cytoplasmic compartments. At the start of the cycle
WT1 was not expressed but expression increased dramatically
to reach a peak in the mid-secretory phase before decreasing
towards the end of the menstrual cycle. PAR 4, DAX-1 and SF-
1 expression was heterogeneous in both the stromal and
glandular compartments throughout the cycle. Expression of
WT1 in infertile endometrium was also restricted to the stromal
compartment but was localised predominantly in the nucleus of
mid-secretory endometrium.
WT1 expression in fertile human endometrium is restricted to
stromal cells and is regulated throughout the menstrual cycle
being highest in the mid secretory phase. In infertile women
there is a dramatic change in its subcellular distribution with
WT1 expression in the mid secretory phase predominantly
localising to the nuclei but not cytoplasm of stromal cells.
Expression of DAX-1, PAR-4 and SF-1 throughout the cycle
suggests the potential for their interaction with WT1 in a
temporal and spatially restricted manner.
O68. Does the duration of hormone stimulation affect clinical
outcome in hormone replacement frozen embryo transfer
cycles?
N Hammadieh1, M Afnan2, K Sharif2, S Basu1, G Jose1 & S Laren1.
1Cardiff Assisted Reproduction Unit, University Hospital of
Wales, Cardiff, UK; 2Assisted Conception Unit, Birmingham
Women’s Hospital, Birmingham, UK.
Introduction: To determine whether the duration of hormone
stimulation using oestradiol valeriate (E2) has effect on the
outcome in frozen embryo transfer cycle (FET).
Methods: A total of six hundred and thirty-two frozen cycles
were included in this study (18 cycles were excluded due to
cancellation and lack of recorded information) were divided into
three groups based on the duration of stimulation. Group I
consisted of 45 (7.1%) cycles with stimulation duration 9-10
days, group II included 498 (78.8%) cycles in which the
stimulation duration was 11-12 days, and group III consisted of
89 (14.1%) cycles where the stimulation duration > 12 days (range
13-25 days). Oral E2 (12 mg/day) was taken for 9 days at least
and then endometrial thickness was measured by transvaginal
ultrasound. The cut off point was set at > 8mm before embryo
transfer (ET) if the endometrial thickness was still <8 mm, we
increased E2 dose to 18 mg/day until the criteria were met. A
maximum of three embryos were transferred (median = 2). The
study is a cohort clinical trial. The data were analysed using
Chi-square test.
Results and Discussion: All groups are comparable in terms of
mean age, aetiology of infertility, number and quality of embryos
transferred. Overall comparison of FET cycles outcome was made
and there were statistically no significant difference in
implantation (9, 11,11%) clinical pregnancy (15.6, 20.9, 23.6%)
and pregnancy loss (41.7, 25.4, 8.7%) rates between the different
stimulation duration groups (I, II, III respectively).
To best of our knowledge we believe this is the first report
assessing the relation between stimulation duration and the
clinical outcome in hormone replacement FET cycles. In
conclusion, the duration of stimulation did not seem to influence
the outcome in hormone replacement FET cycles.
O69. Can the measurement of chlamydial antibodies alone or
in combination with medical history and/or transvaginal
ultrasound, predict tubal disease in subfertile women?
S Logan1, R Gazvani1, H McKenzie2, A Templeton1 &
S Bhattacharya1. 1Department of Obstetrics & Gynaecology,
Aberdeen Maternity Hospital, Foresterhill, Aberdeen, UK;
2Department of Medical Microbiology, University of Aberdeen,
Foresterhill, Aberdeen, UK.
Introduction: Neither laparoscopy nor hysterosalpingogram are
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entirely satisfactory in determining tubal status in subfertile
women. The association between chlamydial antibody (Ab) titres
and TFI is recognised, yet its predictive value is poor. Both
medical history and transvaginal ultrasound (TVUSS) are readily
available, but little is known about their performance in identifying
tubal pathology. This study’s aim was to determine whether the
measurement of chlamydial Ab titres, medical history and/or
TVUSS could predict tubal disease.
Methods: Consecutive subfertile women were recruited prior to
tubal evaluation. Relevant medical history was recorded, a
transvaginal ultrasound performed, and serum C. trachomatis -
specific IgG antibodies measured by an enzyme immunoassay
(EIA). Following laparoscopy and dye hydrotubation, estimates
of sensitivity, specificity, predictive values, likelihood ratios,
and accuracy were calculated for each test or combination.
Results and Discussion: Thirty percent (63/207) of the women
were diagnosed with TFI. Those with TFI were more likely to
have positive/equivocal IgG antibodies (p<0.0001). In pragmatic
terms, the performances of each test or combination were either
poor or identified too few women. Screening using clinical
feature(s), TVUSS appearances, and C. trachomatis IgG Ab
testing by EIA, alone, or in combination, failed to accurately
predict the presence of tubal disease in subfertile women.
O70. The effect of dalmazin (PGF) on luteal cysts and
dalmerelin (GnRH analogue) on follicular cysts in Sahiwal
cows.
TH Khan1, M Rafique2 & AM Amer2. 1Institute of Biology,
Zakariya University, Multan, Pakistan; 2Livestock Production
Research Institute, Bahadurnagar, Okara, Pakistan.
Introduction: In livestock, there are so many different conditions
which affect their fertility and reproductive performance. Luteal
and follicular cysts are important among those. It was suggested
that these conditions are difficult to treat and consequently
result in lengthening of service period and calving interval and
may result into permanent infertility and thereby, huge loss to
the breeders.
Methods: The present investigation has been conducted on
Sahiwal cows maintained at Livestock Experimental Station,
Bahadurnagar, Okara (Pakistan). The cows, after 70-90 days post-
partum, were examined per rectum to check the condition of
genitalia for luteal and follicular cysts. The cows (n=24: body
weight, 399.5 ± 4.5 kg) were treated with 2 ml of Dalmazin (i.m) on
the same day whereas other cows (n=28: body weight, 401.5 ±
4.1 kg) were treated with Dalmerelin (i.m).
Results and Discussion: It was found that as a result of Dalmazin
(Fatro Pharmaceutical) treatment, 66.66% (16/24) of the animals
became pregnant whereas 33.34% (08/24) did not show any
response. In case of Dalmerelin (Fatro Pharmaceutical) 64.3%
(18/28) of the cows were pregnant, 25% (07/28) were cycling
regularly whereas 10.7% (03/28) did not responded to the
treatment. In conclusion, the treatment of Sahiwal cows, which
were suffering from luteal and follicular cysts, with Dalmazin
and Dalmerelin may correct these conditions.
O71. Expression analysis of the transcription factor Figa in
human fetal ovary.
RAL Bayne & RA Anderson. MRC Human Reproductive
Sciences Unit, Edinburgh, UK.
Introduction: During ovarian development there is a relatively
sudden transition from germ cell proliferation to primordial follicle
formation with arrest in the prophase of meiosis I. In the human
this occurs during the second trimester of pregnancy. We have
previously identified a number of factors which are expressed in
the fetal ovary at this time and are interested in what may be
controlling their expression. Gene knockout analysis in the
mouse has shown that Figa, a transcription factor specifically
expressed in germ cells, is essential for primordial follicle
formation. It has been shown recently by others that Figa, which
is also involved in the expression of zona pellucida genes, is
expressed in adult human oocytes. Our objective was to
investigate whether a putative human homologue present in
the genome database could play a similar role in early human
ovary development.
Methods: Mid-gestation human fetal ovaries were obtained
following medical termination of pregnancy. Women gave
consent according to national guidelines and the study was
approved by the local Ethics Sub-Committee. Conventional and
real-time RT-PCR analysis of RNA extracted from human fetal
ovaries was used to demonstrate the expression of the human
homologue of mouse Figa in the ovary.
Results and Discussion: RT-PCR demonstrated that the human
Figa gene is expressed throughout mid-gestation in the fetal
ovary. Real-time quantitative RT-PCR also demonstrated that
Figa expression rises 40-fold at approximately 19 weeks
gestation, around the time of primordial follicle formation,
compared to expression at 14 weeks, a time of oogonial
proliferation. Analysis of RNA from other fetal tissues, including
testis, indicated that Figa expression is confined to the ovary.
We conclude that the expression pattern of Figa is consistent
with it playing a role in controlling the formation of primordial
follicles in the human ovary.
O72. Abstract  Withdrawn
O73. Meiotic maturation in vitro of mouse oocytes induced by
follicle stimulating hormone (FSH), epidermal growth factor
(EGF) and follicular fluid meiosis-activating sterol (FF-MAS).
G Coticchio1, S Cecconi2, A Borini1, C Grøndahl3, G Rossi2,
G Macchiarelli4, AM Griffin5 & SD Fleming5. 1Tecnobios
Procreazione, Bologna, Italy; 2Department of Biomedical Sciences
and Technologies, University of L’Aquila, Italy; 3Novo Nordisk
A/S, Copenhagen, Denmark; 4Department of Experimental
Medicine, University of L’Aquila, Italy; 5Department of
Obstetrics & Gynaecology, University of Sydney, Sydney,
Australia.
Introduction: In vitro, isolated preovulatory germinal vesicle
(GV) stage oocytes reinitiate meiosis spontaneously, following
a decrease in intracellular cAMP, or in response to FSH, EGF or
FF-MAS, a follicle cell-derived sterol, under conditions that
prevent spontaneous meiotic maturation. Here, we compared
the ability of FSH, EGF and FF-MAS to induce meiotic
resumption and polar body emission.
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Methods: Cumulus-enclosed oocytes (CEOs), retrieved from
PMSG-primed mice, were cultured in a-MEM medium under the
following conditions: A) control; B) 0.3 mM dibutyryl cAMP
(dbcAMP) ± FSH (150 mIU/ml), EGF (10 ng/ml) or FF-MAS (10
µM); C) 4 mM hypoxanthine ± FFMAS or EGF; D) 8.5 µM
cilostamide, a specific type 3 phosphodiesterase (PDE) inhibitor,
± FSH, EGF or FF-MAS. After 20 hours, the proportion of oocytes
that had undergone germinal vesicle breakdown (GVBD) and, in
some groups, polar body emission was estimated.
Results and Discussion: Spontaneous GVBD occurred in 96%
of control CEOs, while this process was largely inhibited in the
presence of either dbcAMP, hypoxanthine or cilostamide (9%,
20%, and 11% GVBD, respectively). FSH and EGF, but not FF-
MAS, were able to override the inhibitory influence of dbcAMP
(97%, 78%, and 4% GVBD). In the presence of hypoxanthine,
both FF-MAS and EGF were able to promote GVBD (77% and
87%), but polar body extrusion rate was higher in the presence
of EGF (11% and 48%). Finally, neither FSH, EGF or FF-MAS
caused significant increase in meiotic resumption in cilostamide-
treated oocytes (12%, 20% and 22% GVBD). These results
suggest that I) FF-MAS has a limited ability to promote GVBD,
being unable to overcome the meiotic block imposed by a high
dbcAMP level; II) polar body extrusion is positively influenced
by EGF; III) inhibition of oocyte type 3 PDE imposes a meiotic
arrest that cannot be overriden by agents that stimulate meiotic
resumption.
O74. Effect of increasing cAMP in somatic cells or the oocyte
on in vitro mouse follicle maturation.
F Marshall, RJ Webb, G FitzHarris, P Marangos & J Carroll.
Department of Physiology, Univeristy College London, London,
UK.
Introduction: Intercellular communication of the second
messenger cAMP between the oocyte and somatic cells is
thought to be important for follicle development and maturation.
Here we investigate the effect of increasing cAMP in the somatic
cells, the oocyte, or both, on in vitro follicle culture and
maturation. cAMP was increased in the somatic cells using
rolipram, a type IV phosphodisaterase (PDE) inhibitor and follicle
stimulating hormone (FSH), in the oocyte using milrinone, a
type III PDE inhibitor, or in both using IBMX, a non-specific
PDE inhibitor.
Methods: Pre-antral follicles were dissected from 14 day old
MF1 mice and microinjected with the cAMP indictor FlCRhR
which was excited at 488 nm and fluorescence monitored at 520
and >580 nm. A second group was cultured for 12 days in alpha-
MEM with insulin, transferrin, selenium and 5% FCS,
supplemented with either IBMX (200uM), milrinone (100uM),
rolipram (100uM), or FSH (100mIU/mL). On Day 12 hCG was
added to induce maturation, after which the oocytes were scored
for GVBD and polar body formation.
Results and Discussion: IBMX and milrinone caused a maximal
sustained increase in cAMP accumulation, with a change in
ratio of 0.22 ± 0.02 and 0.23 ± 0.03 ratio units respectively. While,
FSH and rolipram caused small transient increases in cAMP of
0.04 ± 0.01 and 0.07 ± 0.01 ratio units, respectively. In culture
none of the agents resulted in the formation of follicular antrums
with the exception of FSH. hCG had no effect on cultures
containing IBMX or milrinone, however GVBD was stimulated
in 4/9 cultures with rolipram and 10/17 with FSH, 7 of which
formed polar bodies. These data provide evidence for cAMP-
mediated signaling between the somatic cells and the oocyte in
growing follicles and suggest conditions that sustain elevated
cAMP in the oocyte are not compatible with hormone-induced
maturation.
O75. Intra and inter individual variations in ATP and mtDNA
contents on bovine oocytes.
M Tamassia1, P May-Panloup2, P Reynier2, M Stojkovic3,
E Wolf3, Y Heyman4 & S Chastant-Maillard1. 1Biologie du
Développement et de la Reproduction, Ecole Nationale
Vétérinaire d’Alfort, Maisons Alfort, France; 2Laboratoire de
Biochimie et Biologie Moléculaire, CHU d’Angers, Angers,
France; 3Department of Molecular Animal Breeding and
Biotechnology, University of Munich, Oberschleisshein,
Germany; 4INRA, Jouy en Josas, France.
Introduction: Mitochondria supply most of the cell energy in
the form of ATP. Oocytes contain large numbers of mitochondria
that accumulates during maturation, each containing several
copies of mtDNA. Low ATP content in the oocyte might be
responsible for implantation failure in apparently normal
embryos.
The objective of the present study is to measure the quantity of
ATP and mtDNA present in the bovine oocyte and to look at
stock variation between animals and between the oocytes of
the same female.
Methods: Oocyte collection was performed by ultrasound guided
follicular aspiration (OPU), twice a week for 16 weeks on six
cows. Good quality oocytes had their cumulus cells stripped
from them before freezing. Slaughterhouse oocytes were used
as control.
Oocyte ATP content was measured using the Bioluminescent
Somatic Cell Assay-kit FL-ASC (Sigma).
Oocyte DNA was extracted using the High Pure PCR Template
Preparation Kit (Roche Diagnostics). To determine the mtDNA
copy number a quantitative real time PCR was performed in a
Roche LightCycler using LightCycler-Faststart DNA master
SYBR Green 1 kit (Roche).
Results and Discussion: In 256 oocytes measured, mean ATP
content was of 2.47±0.05 pmol/oocyte with a small intra-animal
variation (CV of 6.2%) but a significant variation between animals
(from 2.12±0.08 to 3.12±0.06 pmol/oocyte; p<0.05).
Slaughterhouse oocytes had significantly less ATP (1.49±0.07
pmol/oocyte) than OPU oocytes. Each oocyte contained a mean
of 377327±14014 copies of mtDNA (n = 331) varying significantly
between animals (from 311607 to 536878 mtDNA copies/oocyte).
Within the same female, a large intra-oocyte variation of mtDNA
is observed (CV from 46.5% to 76.3%).
OPU oocytes had higher basal ATP levels than slaughterhouse
oocytes probably because they did not consume the ATP
reserves, as did slaughterhouse oocytes during the 3-4 hours
of transit to the laboratory. While the quantity of ATP/oocyte
varies significantly between animals with a small intra-animal
variation, mtDNA is highly variable in both aspects.
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O76. In-vitro development of sheep oocytes from primordial
and primary follicles.
W Muruvi1, HM Picton2, RG Rodway1 & IM Joyce1. 1School of
Biology, University of Leeds, Leeds, UK; 2Department of
Obstetrics and Gynaecology, University of Leeds, Leeds, UK.
Introduction: In large animal species there is no technology for
producing embryogenically competent oocytes from early
follicles in vitro. The objective of this project was therefore to
develop a culture system for sheep oocytes from primordial and
primary follicles.
Methods: 20, 50 and 100 primordial follicles (less than 45µm
diameter) were cultured per well in Waymouth medium
containing 3mg/ml BSA and 1% ITS in 384 well plates coated
with fibronectin.
Results and Discussion: After 2 days, cultures were composed
of denuded oocytes resting on a monolayer of somatic cells. In
the three treatment groups approximately 17% of the oocytes
survived to Day 28, with most losses (47%) during the first 2
days. At densities of 50 and 100 follicles per well median oocyte
diameter on Day 28 was higher than on Day 7 (27.6um vs 31.4um;
28.9 um vs 35.0um, respectively; P< 0.05). Inclusion of rhActivin
A (0ng/ml; 10ng/ml; 30ng/ml and 100ng/ml) in the culture media
had no significant effect on primordial development and oocyte
survival. However, an increase in the median oocyte diameter at
the end of the culture was only observed in the control group.
The next series of experiments examined the in vitro development
of primary follicles (50 to 60um diameter). After 2 days, cultures
were again composed of denuded oocytes resting on a monolayer
of granulosa cells. However, within 21 days oocytes were
enveloped within at least one layer of granulosa cells. Oocytes
within these ‘follicular’ structures survived in culture for at least
90 days and increased from circa 48um to 87um in diameter during
this time. In summary, under the long-term culture conditions
described, nearly 20% of oocytes from primordial follicles
survived, but oocyte growth was minimal. On the other hand,
oocytes from primary follicles reorganized a three-dimensional
granulosa cell architecture and showed considerable growth.
O77. Fertility ability: A pilot study to evaluate teaching
secondary school pupils about infertility and assisted
conception.
CR Fertleman, E Rosenberg & J Tizzard. Progress Educational
Trust, London, UK.
Introduction: Although the experience of infertility is common,
patients undergoing assisted conception have a weak knowledge
of basic fertility. By raising awareness of this in schools everyone
will have access to this information. Basic fertility facts are
covered in science with the emphasis on promoting
contraception. The National Curriculum incorporates four
themes; literacy, numeracy, information and communication
technology and citizenship. Accordingly an effective strategy
for raising infertility taps into these themes.
Methods: A pilot study was set up to evaluate a workshop on
assisted conception. Educational materials were produced,
schools contacted and the IVF worksheet and accompanying
information delivered to the classroom. Pupils were assessed in
terms of their knowledge about infertility before and after the
workshop (test-score; maximum 20). Pupils provided personal
demographic data and evaluated the project as did their teachers.
The data was analysed using SPSS (V11).
Results and Discussion: The educational material produced
contained a worksheet, glossary and teacher’s notes. The
worksheet covered the process of IVF using text, diagrams,
graphs, cartoons and articles. Questions in the worksheet
addressed three themes in the National Curriculum.
The workshop was piloted in four schools in January 2001.
Information was collected from 115 pupils. They had a mean age
of 15.6 years, 78 were girls, most had siblings and 99 pupils
wanted to have children. Pupils cited 39 negative emotions that
people facing infertility felt. The mean test-score increase was
2.8. The pupils felt that the workshop was useful but difficult
and that the materials provided were good. The teachers felt the
same, and that the workshop was relevant to the themes of
literacy, numeracy and citizenship.
In conclusion, this pilot study was successful in teaching
children about the facts of IVF and was felt to be useful and
relevant by both pupils and their teachers.
This work was supported by Department of Health.
O78. ‘It’s not about the money. It’s about becoming parents and
trying to help other people as well’: Experiences of an ‘egg
sharing’ programme in the UK.
ED Blyth. School of Human and Health Sciences, University of
Huddersfield, UK.
Introduction: The HFEA has authorised egg sharing since 1998;
however it remains a controversial service. This paper reports
on the first empirical study in the UK of the experiences of
women who have considered egg sharing and their partners.
Methods: Retrospective semi-structured interviews with 20
female patients - and 18 husbands/partners - attending one UK
licensed treatment centre, all of whom had received counselling
with a view to participating in the centre’s egg sharing
programme.
Results and Discussion: After counselling, 12 women proceeded
with egg sharing (seven of whom were successful with their
own treatment and five remained unsuccessful at the time of
interview). Six women decided to proceed with egg sharing but
did not produce enough oocytes to enable egg sharing to take
place; two women decided not to proceed.
Interview data included: (in)fertility history and motivation for
egg sharing; treatment experiences; attitudes regarding
recipients of donated oocytes, towards receiving information
about outcomes of recipients’ treatment and regarding any
children born following egg sharing; information management
within their own family and social networks and responses of
others within family and social networks.
Egg sharing was supported as an acceptable means of family
creation for involuntarily childless people with limited options.
No participant regretted undertaking egg sharing. The majority
of respondents distinguished egg sharing from remunerated
donation, citing both altruism and self-interest as significant
motivating factors. Almost all participants thought donor
information should be updated periodically, in particular any
new medical information. Participants were evenly divided
whether they would wish to learn the outcome of a recipient’s
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treatment. Two thirds believed any child born following egg
sharing should be told about their origins and half thought that
the child should be able to learn the donor’s identity. A majority
would continue to donate if they were identifiable to any child.
O79. Who donates? Why donate? An exploration of the
characteristics and motivations of known egg donors: The
Victoria, Australia example.
JR Blood & NL Warren. Melbourne IVF/Reproductive Services,
Melbourne, Australia.
Introduction: Since its inception in the early 1980s, numerous
scientific and clinical trials have focused on egg donation yet
relatively few studies have focused on the psychosocial aspects
of donation. Furthermore, studies have tended to explore
recipients’ experiences of egg donation, and no studies have
looked at roles of donors’ partners and significant family
members in decision-making about egg donation. The lack of
studies looking at psychosocial considerations of egg donors
has meant a limited understanding of issues within clinical
practice when dealing with donors. This study seeks to explore
the characteristics of women who donate eggs, their motivation
and the role of their partners and families in their donation
decision.
Methods: Invitations to participate were mailed to all known
donors and their partners who had donated eggs between 1997
and 2000 in Melbourne, Australia.
Results and Discussion: 27 donors and 14 partners returned
questionnaires. The median age at donation was 33 years. 89%
of donors had children of their own, most (72%) had completed
their families at the time of donation, and 78% had two or more
children. 59% had histories of reproductive loss. 44% of donors
indicated that their family experience influenced their decision
to donate, yet 70% felt no pressure to donate from their families.
Partners tended to be involved in the donation decision, usually
in a supportive role. The decision to donate was often made
quickly and based on little information, yet donors indicated
they were satisfied with their decision to donate. Known donors
had concerns which were primarily health-related or focused on
their own children or the donor-conceived offspring.
The decision to donate is a complex and multi-faceted process
which is influenced by their partner and other family members.
Family, in particular, is an important theme.
O80. The development and validation of a screening instrument
to identify women and their partners at risk post-miscarriage
of developing psychological morbidity and problems of
adjustment.
GP Cumming1, DA Alexander2, S Klein2 & J Bell3. 1Department of
Obstetrics and Gynaecology, Aberdeen, UK; 2Aberdeen Centre
for Trauma Research, University of Aberdeen, UK; 3Dugald Baird
Centre for Research on Women’s Health, Aberdeen, UK.
Introduction: Miscarriage is the commonest complication of
pregnancy and is a signal obstetric event that carries a risk of
psychopathology and problems of adjustment. There is
currently no standardised measure to identify those most at
risk. The objective of this research is to design an instrument to
identify those at risk of developing psychological morbidity
following miscarriage, enabling researchers and clinicians to
target limited resources at those most likely to require them.
Methods: A 30 month prospective study of 700 women and
their partners attending Early Pregnancy Assessment Units at
three maternity hospitals in Scotland. This research has been
approved by the Grampian Research Ethics Committee and the
Lanarkshire Ethics of Research Committee. The initial assessment
was conducted by means of a questionnaire booklet comprising
five standardised measures (Perinatal Grief Scale; Golombok Rust
Inventory of Marital State; Fetal Health Locus of Control Scale;
Perinatal Event Scale; Hospital Anxiety and Depression Scale)
and a semi-structured interview to obtain quantitative and
qualitative data. Outcome at 6 months post-miscarriage was
assessed using the Hospital Anxiety and Depression Scale.
Results and Discussion: Preliminary data on approximately 400
participants were subjected to a multivariate logistic regression
analysis to determine how the predictor variables in question
contributed multiplicatively to the risk (or odds) of developing
anxiety and/or depression post-miscarriage. The data from this
study will contribute to the development and validation of a
predictive index enabling researchers and clinicians to target
limited resources at those most likely to require them.
O81. Fate of sperm ejaculated from male Syrian hamster with
all accessory sex glands removed during fertilization.
H Chen1, MPL Cheung1, PH Chow2, ALM Cheung1 & WS O1.
1Department of Anatomy, The University of Hong Kong, Hong
Kong, China; 2Department of Anatomy, The Chinese University
of Hong Kong, Shatin, Hong Kong, China.
Introduction: Previous studies in our laboratory showed that
sperm not exposed to male accessory sex gland (ASG) secretions
presented higher incidence of single-strand (ss) and double-
strand (ds) DNA damage and more extensive ssDNA damage.
Male ASG secretions afford protection to uterine sperm DNA
from damage after NADPH treatment, indicating that male ASG
secretions might have a role in preserving sperm genomic
integrity in the female genital tract. In the present study, we
trace the fate of sperm not exposed to ASG secretions after
fertilizing normal oocytes in vivo by alkaline and neutral single
cell gel electrophoresis (or comet assay).
Methods: Two experimental groups of male golden hamsters
were used: TX (all major ASG removed) and SH (sham-operated
control). Five hours after mating with individual experimental
male hamster, zygotes were collected from oviducts with TALP-
BSA free medium. Cumulus cells were removed with 1%
hyaluronidase. These zona-intact zygotes were washed with
fresh TALP medium and then 1x PBS/PVP and subjected to DNA
integrity assessment by alkaline and neutral comet assays.
Results and Discussion: At five hours post coitum, zygotes
clearly showed female pronuclei, decondensed sperm and two
polar bodies. After comet analysis, the incidence of ssDNA
damage of sperm not exposed to ASG secretions was
significantly higher compared with control (TX=7.0% (4/57);
SH=0% (0/80); P<0.05). The incidence of dsDNA damage of
sperm not exposed to ASG secretions was also significantly
higher compared with control (TX=5.1% (5/99); SH=0% (0/101);
P<0.05). Nearly all polar body II showed DNA damage. These
results indicated that sperm with ssDNA and dsDNA damage
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could fertilize normal oocytes. Whether these zygotes with
damaged sperm DNA can repair the breakage and develop further
require advance studies.
Supported by grants from RGC/HK 10203218/03678/20200/
324.
O82. Improving semen cryopreservation protocols for the
establishment of a genetic resource bank of endangered Mohor
gazelle (G. dama mhorr).
J Garde1, A del Olmo2, AJ Soler1, G Espeso3, M Gomendio2 &
ERS Roldan2. 1Depto. Ciencia y Tecnologia Agroforestal,
Universidad de Castilla-La Mancha, Albacete, Spain; 2Museo
Nacional de Ciencias Naturales (CSIC), Madrid, Spain; 3Estacion
Experimental de Zonas Aridas, Almeria, Spain.
Introduction: Semen cryopreservation is a valuable tool for
genetic management of endangered populations. Earlier work
achieved semen cryopreservation in the Mohor gazelle although
cryosurvival was low. Here we seek to improve freezing protocols
by modifications of a Tes-Tris (TEST) diluent, or the use of skim
milk- or raffinose-based cryodiluents.
Methods: Electroejaculates repeatedly obtained from 15 males
were used in 3 experimental series examining: (1) egg yolk (EY)
concentration: TEST with 5% or 20%EY and 6% glycerol (G)
(N=6); (2) effect of sugars: TEST with 5%EY-6%G, without or
with addition of fructose (F) (N=9), lactose (L) (N=6), or raffinose
(R) (N=7); (3) other cryodiluents: TEST 5%EY-6%G, skimmilk-
6%G, 13.5% raffinose-20% egg yolk-7% glycerol (REYG) (N=7).
Diluted semen samples were loaded into 0.25 ml straws, cooled
slowly to 5°C during 1.5 h, equilibrated at 5°C for 2 h, frozen in
nitrogen vapours and plunged into liquid nitrogen. Straws were
thawed at 37°C for 30 s. The following were examined in fresh
samples, after equilibration, and after thawing: % motility (M),
quality (Q, scale 0-5), and % intact acrosomes (normal apical
ridges, NAR). Sperm motility index (SMI) was calculated:
[(%M)+(Qx20)]/2.
Results and Discussion: Fresh semen values were not different
between experimental series: 85-90%M; 94-96%NAR. Both
motility and acrosome integrity decreased upon thawing in all
experimental series. In series (1) no differences were seen upon
thawing between TEST diluents with different EY concentrations
(5%EY: 36±11%M, SMI 46±6, 44±5%NAR; 20%EY: 31±11%M,
SMI 41±7, 42±7%NAR). In series (2) addition of sugars to TEST-
5%EY-6%G resulted in no improvement (lactose), or in a decrease
in cryosurvival (fructose, raffinose). In series (3) results upon
thawing revealed that skim-milk-6%G (12±8%M, 22±8 SMI,
57±8%NAR) was worse than TEST-5%EY-6%G (32+/-9%M, SMI
41±5, 52±6%NAR) and that REYG (52±5%M, SMI 52±3,
60±6%NAR) was significantly better (P<0.02). These results
demonstrate an improvement in cryopreservation protocols for
this endangered gazelle.
MCYT REN2000-1470.
O83. Effect of medium on the kinematics of frozen-thawed ram
sperm.
ST Mortimer. Department of Veterinary Science, Sydney
University, Australia; Genesis Fertility Centre, Vancouver,
Canada.
Introduction: Cervically-inseminated cryopreserved ram sperm
have reduced fertility due to poor mucus-penetrating ability.
This effect, due to altered sperm kinematics, is ameliorated by
adding 20% seminal plasma (SP) to the PBS thawing medium.
The aim of this study was to determine whether the SP-induced
alterations in sperm kinematics were due to SP increasing its
viscosity or the medium’s components by including a
comparison with Artificial Seminal Plasma (ASP: O’Donnell, JRF,
19:207, 1969), a medium that supports motility but not
capacitation.
Methods: Pooled semen from 7 mature rams was diluted 1+4
with temperature-equilibrated Tris-citrate-egg-yolk-glycerol
medium, cooled to 5°C over 2 h, frozen as 200ul pellets on dry
ice, and stored in liquid nitrogen. Thawed semen was layered
under 1ml of either PBS, PBS+SP or ASP and motile sperm
allowed to swim-up (37°C, 30 min). Upper regions of the overlays
were harvested and sperm movement was videotaped in 300um
chambers for both CASA assessment (Hamilton-Thorne IVOS
v10.6), and manual flagellar curvature analysis. For flagellar
analysis, 30 sperm per treatment were selected solely upon
flagellar image clarity and lack of collision with other sperm,
regardless of their movement pattern. The influences of media
upon flagellar beating and sperm kinematics were determined
using the Kruskal-Wallis test and analysis of variance.
Results and Discussion: Sperm in ASP medium had significantly
larger diameter proximal flagellar bends than those in either PBS
or PBS+SP (P<0.0001 and P <0.003, respectively), with PBS
inducing greater curvature than PBS+SP (P<0.05). CASA
analysis of 2099 sperm tracks revealed that sperm had
significantly more complex trajectories in PBS than either PBS+SP
or ASP (P<0.0001), and that the latter groups showed very similar
kinematics. These results indicated that increased viscosity was
not the reason for the different kinematics observed when SP
was added to PBS since ASP has a similar viscosity to PBS.
O84. In-vitro fertilizing capacity of bovine sperm after 6 days
of cooled storage in three different diluents.
S Verberckmoes, I De Pauw, A Van Soom, J Dewulf & A de Kruif.
Department of Reproduction, Obstetrics and Herd Health,
Faculty of Veterinary Medicine, Ghent University, Merelbeke,
Belgium.
Introduction: A new diluent based on the composition of Cauda
Epididymal Plasma (CEP diluent) has been developed in our
laboratory. In this study, the in vitro fertilizing (IVF) capacity of
fresh bovine sperm after prolonged preservation in the CEP
diluent, was compared to that of fresh semen stored in Caprogen
and Triladyl diluent.
Methods: Semen of a bull with good sperm quality was used.
Spermatozoa were stored at a concentration of 10 x 106
spermazoa/mL in either CEP, Caprogen, or Triladyl diluent at
5°C in airtight glass tubes. In the Caprogen diluent spermatozoa
were stored under N2 gas, whereas in CEP and Triladyl they
were stored under aerobic conditions.
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After 6 days of storage, oocytes were inseminated with a final
sperm concentration of 1 x 106 spermatozoa/mL in 500µl of
fertilization medium. As control, 1 group of oocytes was
inseminated with frozen-thawed semen of a bull with proven
IVF rates. Per group 197 ±14 oocytes were used. The zygotes
were stained with Hoechst 33342, mounted in 100% glycerol
and evaluated by means of a Leica DMR fluorescence
microscope for fertilization and polyspermy (3 replicates).
Results and Discussion: The fertilization and polyspermy rate
of fresh bovine semen after 6 days of storage at 5°C were 50.0%
and 11.5% in the CEP diluent, 51.7% and 14.7% in the Caprogen,
and 21.7% and 2.9% in the Triladyl diluent. In the control group
the fertilization and polyspermy rate were 57.7% and 17.0%.
No difference in fertilization and polyspermy rates was observed
between fresh semen stored in CEP and Caprogen diluent, and
frozen-thawed semen. However, the fertilization rate of semen
stored in Triladyl diluent was decreased (P<0.01).
In conclusion, the in vitro fertilisation capacity of spermatozoa
stored for 6 days at 5°C in the new CEP diluent is comparable to
that of spermatozoa stored in the Caprogen diluent.
O85. Reducing the dose of buserelin decreases cancellation
rates: Comparison of 250 against 500 ug with day 21 long
protocol IVF.
Kamel Mohamed1 & EA Lenton2. 1CARE at the three Shires
Hospital, Northampton, UK; 2Sheffield Fertility Centre (CARE),
Sheffield, UK.
Introduction: Poor response to ovarian stimulation has been
linked to over suppression of the pituitary with a consequent
reduction in LH. This could be associated with too high a dose
of buserelin. The aim of this study was to look at the cancellation
rates and pregnancy outcomes in IVF patients given 250 ug
instead of the conventional 500 ug buserelin daily
Methods: 140 first IVF treatment long protocol (day 21) buserelin
cycles were started in women aged < 38 years.Seventy patients
were given the standard 500 ug buserelin daily (group 1) and
seventy were given 250 ug (group 2).The mean ages in both
groups were similar. All patients had regular menstrual cycles
and a basal FSH < 10 IU/L. In all other respects their treatment
was completely conventional.
Results and Discussion: There was no significant difference
between Group 1 and Group 2 in the number of days required for
down regulation or the duration of ovarian stimulation. There
was no significant differences in the number of oocytes retrieved
or fertilisation rates. Embryos were not transferred (freeze all or
failed fertilisation) in 3 cycles from each group. Similarly there
was no significant difference in implantation rate, clinical
pregnancy rate /ET (40.4% versus 45.6%) or live birth rate/cycle
(22.8% versus 35.7%) although there was a trend towards lower
birth rates in Group1. This was due in part to a higher clinical
pregnancy loss rate in Group 1 (15.8% versus 3.8%) and partly
to significantly (p<0.05) lower cycle cancellation rates for poor
response in Group 2 (14.3% versus 28.6%).
CONCLUSION: The 250ug dose was effective in reducing
cancellation rates for poor response. There was no adverse effect
on  clinical  outcome  or  the  risk  of  OHSS  (2/70  compared  with
1/70). The study was too small to show a beneficial association
between a reduction in buserelin and significantly improved
outcomes. Despite this there are economic benefits from a
reduction in buserelin.
O86. Clinical and laboratory parameters of pregnant and non
pregnant women during coasting in cases at risk of severe
ovarian hyperstimulation syndrome.
A Al-Habib1, E Immarrone2, A Tozer1, A Zosmer1, K Shehata1,
C Gillot1, I Ferrare2, R Balet2, T Al-Shawaf1 &
JG Grudzinskas1,2.1The Centre for Reproductive Medicine, St.
Bartholomew’s Hospital, London, UK; 2The Bridge Centre,
London, UK.
Introduction: Withholding gonadotrophin stimulation (coasting)
while continuing down regulation in IVF/ICSI programmes will
permit continuing treatment whilst reducing the risk of severe
OHSS.
In this retrospective study we attempt to identify differences
between conception and non-conception cycles in those who
underwent coasting.
Methods: Over the period January 1998 to May 2002, 5637
women underwent IVF/ICSI Cycles, 337(6.7%) women had been
coasted because of risk of severe OHSS.
Gonadotrophin injections were withheld when ultrasound
showed more than a total of 20 follicles, >20% of the follicles
had a diameter of >15 mm and serum oestradiol level more than
13,200 pmol/l. Human chorionic gonadotrophin was administered
when at least three follicles had a diameter of >18 mm and serum
oestradiol concentration was <10,000pmol/l. 299 women (88.7%)
reached the stage of embryo transfer.
Results and Discussion: One hundred and sixty women
underwent IVF and 139 had ICSI treatment cycles. There were
108 clinical pregnancies (32.1% per coasted cycle and 36.1% per
ET). There were no statistical differences seen between those
conceived and those who did not, with relation to mean age,
body mass index (BMI), early follicular phase FSH and LH,
starting and total doses of gonadotrophin, serum oestradiol
levels on the day of hCG trigger, no. of oocytes retrieved, no. of
2 PN, total no. of embryos and no. of embryos transferred in
uterus. The period of stimulation and the duration of coasting
in days 3.3±1.4 ( 2-8 ) and 3.7±1.65 ( 2-9 ) for pregnant and non
pregnant women respectively}were also not significantly
different. The clinical pregnancy rate was 33.8% after IVF and
28.3% after ICSI. There were four cases of severe OHSS (1.2%
per coasted cycle) needed hospital admission, of whom three
developed late onset OHSS as they were pregnant
Conclusion:
We were unable to identify any parameters that could identify
women who would not conceive following coasting. Coasting
strategy appears to be effective and safe in maintaining
pregnancy rate and reducing severe OHSS markedly.
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O87. GnRH antagonist treatment for the poor responders -
Does it work?: Experience in a tertiary infertility referral
centre.
S Basu1, J Evans1, B Nix2 & G Jose1. 1Cardiff Assisted
Reproduction Unit, University Hospital of Wales, Cardiff, Wales,
UK; 2Department of Epidemiology, University of Wales College
of Medicine, Cardiff, Wales, UK.
Introduction: Five to ten percent of all stimulated IVF cycles are
cancelled due to poor follicular response. These patients require
higher dose of Gonadotropin and better stimulation protocol.
This study was carried out to evaluate the effect of GnRH
antagonist on poor responders regarding follicular response,
oocyte retrieval, embryo development and pregnancy outcome.
Methods: Twenty-four patients were identified through our
database and data were entered on SPSS programme.
Out of these twenty-four patients, twenty-one had step up
stimulation along with long down regulation in the past and
were diagnosed as poor responders. In the current cycle
Gonadotropin were started on day 2/ 3 of the cycle and GnRH
antagonist (Cetrorelix 0.25 mg/day) were started when leading
follicle reached size of 11 mm. HCG were administered when
leading follicle reached the size of 18mm.The follicular
monitoring, oocyte retrieval, embryo transfer & luteal phase
support were carried out according to our unit protocol
Results and Discussion: Twenty-four patients had thirty cycles
of antagonist treatments in total. Patient’s age varied from 31
years to 46 years with mean age 37.6 years. . The antagonist
group were compared to their immediate past treatment cycle
and no statistically significant difference was found regarding
follicular response (P = 0.133), oocyte retrieval (P = 0.14) or
development of embryos (P = 0.27). There was a visual tendency
of more pregnancy in the antagonist group but when statistical
test were applied (Fisher’s exact test), the difference was not
significant (P = 0.25)
Different infertility units have adopted different stimulation
regime for poor responders. So far our clinic experience using
GnRH antagonist for this group is disappointing. Slightly better
follicular response or development of embryos does not
necessarily mean better pregnancy outcome.
O88. Moderate or severe OHSS following a modified ‘coasting’
protocol in IVF ± ICSI cycles.
A Zosmer, A Al-Habib, K Shehata, A Tozer, C Gillott, T Al-
Shawaf & JG Grudzinskas. Centre for Reproductive Medicine,
St. Bartholomew’s Hospital, West Smithfield, London, UK.
Introduction: A modified coasting protocol for the prevention
of OHSS in IVF ± ICSI has been implemented in our unit in the
last 5 years. We analysed the characteristics of cycles where
moderate/severe OHSS did develop.
Methods: We retrospectively reviewed all IVF ± ICSI cycles of
women who subsequently developed moderate/severe OHSS
with respect to patients’ characteristics, cycle data and outcome
of treatment. Monitoring and coasting were implemented as
previously described (Al-Shawaf et al., Hum Reprod 16;24-
30:2001).
Results and Discussion: Between March 1998 and December
2002, coasting was initiated in 7.8% out of 3065 cycles of IVF ±
ICSI. In one cycle HCG trigger was withheld because of
symptoms of OHSS. Nineteen women (age 31.9±4.2 years)
developed moderate [12 (0.39%)] or severe [7 (0.22%] OHSS.
Polycystic ovaries (PCO) were identified in 63% of these cases.
Early OHSS [diagnosed up to 7 days after oocyte retrieval (OR)]
developed in 10 cases (4 had all embryos cryopreserved; of the
remaining 6 cases two conceived). Late OHSS (diagnosed >7
days after OR) occurred in 9 cases (all conceived). Overall, eight
pregnancies ended in a live delivery or are on going (42.1% per
retrieval) (twins - 87.5% per delivery/on going).
Only one woman who was considered to be at low risk developed
OHSS (severe). In four cases the coasting protocol was violated
(HCG was administered when E2 >13,200pmol/l). Nine cases were
not coasted (in accordance with the protocol) (in 6 cases pre-
HCG E2 was 9,000-13,200pmol/l; in 3 cases E2 was <9,000pmol/l).
We conclude that our protocol is sensitive and effective. Patients
who develop OHSS are usually young, have PCO, conceive
with more than one foetus and the outcome their pregnancy is
very good. Adherence to the coasting protocol, a lower threshold
of E2 for starting coasting and replacing only one embryo in
such patients may further reduce the incidence of moderate/
severe OHSS.
O89. The relationship of maternal body mass, insulin sensitivity
and cause of infertility with fetal birthweight after ovulation
induction.
M Gaudoin1, IT Cameron2, RWS Yates1 & R Fleming1. ]Department
of Obstetrics & Gynaecology, Royal Infirmary, Glasgow, UK;
2Obstetrics and Gynaecology, Princess Anne Hospital,
Southampton, UK
Introduction: We have previously demonstrated that singleton
pregnancies following ovulation induction and intrauterine
insemination in sub-fertile women are more likely to result in
clinically low birthweight babies compared with their national
cohort (1). Maternal factors, which may influence birthweight,
have been examined with respect to outcome in this cohort of
women.
Methods: We used a retrospective observational cohort design
to examine the perinatal outcomes of 119 consecutive singleton
pregnancies conceived following OI/IUI. Birthweights were
examined and related to maternal age, cause of infertility, body
mass index and insulin sensitivity. Outcomes evaluated were
fetal birthweight, gestational age at delivery and birth centile.
Results and Discussion: Neither maternal age nor cause of
infertility was related to perinatal outcome. Maternal BMI was
negatively associated with fetal birthweight (r = -0.22, p < 0.02).
Obese women (BMI > 29 Kg/2) had the shortest duration of
pregnancy and the smallest babies, which were also smaller for
gestational age than those of normal weight women (BMI < 25
Kg/m2, p < 0.02). Within each maternal BMI category, there was
an indication that insulin sensitive women (represented by pre-
pregnancy SHBG concentration > 35 nmol/l) delivered smaller
babies than insulin resistant women. Linear regression analysis
showed no relationship between maternal body mass and
birthweight amongst the insulin resistant women. However, there
was a strong negative linear regression between birthweight
and maternal BMI in the insulin sensitive group (r squared =0.14,
p=0.002).
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Decreasing fetal birthweight was associated with increasing
maternal BMI and increasing insulin sensitivity in infertile
women, irrespective of the cause of infertility. Increasing insulin
resistance (associated with elevated circulating insulin
concentrations and lower SHBG) tended to counter the negative
effect of increasing maternal BMI. These findings suggest areas
where further research into factors affecting fetal growth may
be fruitful.
1. M.R. Gaudoin, R. Dobbie, J. Chalmers, I.T. Cameron and R.
Fleming. Am. J. Obstet. Gynecol. In press.
O90. Interleukin-1 receptor antagonist and interleukin-1 beta
polymorphisms in women with recurrent miscarriage.
SA Linjawi1, TC Li2, AIF Blakemore3 & SM Laird1,2. 1Biomedical
Research Centre, Sheffield Hallam University, Sheffield, UK;
2Biomedical Research Unit, Jessop Hospital for Women,
Sheffield, UK; 3Department of Medical and Community Genetics,
Imperial College, London, UK.
Introduction: The aetiology of recurrent miscarriage (RM) in
50% of cases is unknown. The IL1 family of cytokines are
important in the control of embryo implantation and it is possible
that abnormalities in their expression could cause RM. In this
study we have typed the IL-1B-511C/T and the IL-1ra tandem
repeat polymorphism in 206 RM women with various known
causes of RM and compared their distribution with that for
normal fertile women.
Methods: DNA was prepared from blood samples collected with
patients consent. Ethical committee approval was obtained for
the study. PCR using primers specific for IL1ra and IL-1B were
used to amplify the alleles. For the IL-1ra polymorphism this
results in production of different sized products (240bp or 410bp).
The IL-1B PCR product was digested by Ava1 to give three
different sized products (316bp,178bp and 100bp). IL-1B
concentrations in plasma obtained from the same women were
measured by ELISA.
Results and Discussion: Chi2 analysis showed no significant
differences between the distributions of either the IL-1B alleles
or the IL-1ra alleles in either the RM group as a whole (IL-1ra
genotypes; 2,2 6%, 4,2 38%, 4,4 56%, IL-1B genotypes; TT 9%,
CT 58%,CC 33%), or when divided according to the cause of
recurrent miscarriage compared to normal fertile women (IL-1ra
genotypes; 2,2 7%, 4,2 35%, 4,4 58%: IL-B genotypes; TT 13%,
CT 49%, CC 38%). Haplotype analysis showed that there was
no association between expression of different alleles of the IL-
1ra and IL-1B gene, except in the PCO group. There was no
correlation between IL-1B plasma levels and either IL-1B or IL-
1ra genotype. These results suggest that IL-1ra and IL-1B genes
individually do not play a role in preventing miscarriage.
O91. Uterine dendritic cells (DC) in murine pregnancy.
S Blois1,2, R Pliet1, BF Klapp1, RA Margni2 & PC Arck1. 1Charité,
Humboldt University of Berlin, Berlin, Germany; 2IDEHU,
University of Buenos Aires, Buenos Aires, Argentina.
Introduction: DC have been described at the feto-maternal
interface of human deciduas, predominantly located at the basal
layer of the decidua. Further, intimate endometrial gland contacts
of DC indicate an active immune response during gestation.
Recent data suggests that HLA-G inhibits the functions of murine
DC, however, the exact physiological role and phenotype of
decidual DC still remains unclear. The objective of the present
study was to investigate the kinetics and phenotype of DC in
the decidua during murine pregnancy.
Methods: After overnight cohabitation of CBA/J females with
DBA/2J, females with vaginal plugs were segregated and
sacrificed on days 1.5, 3.5, 5.5, 8.5, 11.5, 13.5, 15.5 of gestation.
Frequency of uterine CD11c+ DC, phenotype (surface expression
CD8a) and cytokine expression (interleukin (IL)-12, IL-10) were
evaluated by flow cytometry
Results and Discussion: We observed an increased percentage
of CD11c+ uterus cells starting on day 8.5, reaching a plateau
from day 9.5 until day 15.5 of gestation. High expression of
uterine myeloid CD11c+ DC, as identified by their negativity for
CD8a, was detectable throughout gestation. The percentage
lymphoid CD11c+ DC, as delineated by their positivity for CD8a,
decreased on day 8.5. The frequency of uterine CD11c+/IL-10+
DC was higher than CD11c+/IL-12+ during pregnancy.
Our data suggest that lymphoid DC play an important role rather
during the peri-implatation period of murine pregnancy. The
high expression of myeloid DC at gestation day 8.5, unopposed
by lymphoid DC, indicate a protective role in preventing fetal
rejection in after implantation has occurred. In addition, the high
frequency of CD11c+/IL-10+ DC among uterine cells indicate a
putative pathway of inducing the Th2 milieu necessary for the
initiation and maintenance of pregnancy.
O92. Differential effect of hydrocortisone on the expression of
system a transporters ATA1 and ATA2.
HN Thomas1, CJ Ashworth1, KR Page2 & HJ McArdle3. 1Animal
Biology Division, SAC, Aberdeen, UK; 2Department of
Biomedical Sciences, University of Aberdeen, Aberdeen, UK;
3Rowett Research Institute, Aberdeen, UK.
Introduction: Glucocorticoid administration during pregnancy
reduces birth weight. Our studies of growth restricted pig fetuses
revealed an inverse relationship between fetal weight and both
plasma and allantoic fluid cortisol concentrations on day 100
and plasma cortisol concentrations on day 65.
Intrauterine growth restriction (IUGR) in humans and rats is
strongly associated with insufficiency in placental System A
amino acid transport. System A regulation by cortisol has been
investigated using MeAIB uptake, however the results differed
between studies and did not identify which System A
transporter was regulated. This study determined the effect of
different cortisol concentrations on the expression of System A
transporters ATA1 and ATA2 in the BeWo choriocarcinoma
cell line.
Methods: BeWo cells were obtained from the European
Collection of Cell Cultures and routinely maintained in Ham’s
F12 nutrient mix + 10% fetal calf serum and 2% penicillin/
streptomycin. Experimental flasks were exposed to 1uM or 2.5uM
hydrocortisone (HC) for 24 and 48 hours. RNA was isolated
using Tri-Reagent and separated by electrophoresis. Expression
was studied using Northern blotting.
Results and Discussion: Expression of ATA1 mRNA in BeWo
cells was not affected by exposure to increased HC
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concentrations. ATA2 mRNA expression increased by 20% after
exposure to 1 uM HC for 24 hours (P=<0.05) and 30% after
exposure to 2.5 uM HC for 24 hours (P=<0.01) compared to
unexposed cells. Up-regulation of ATA2 expression by 45%
occurred with prolonged exposure (48hours) to 2.5 uM HC
(P=<0.05). These results suggest that the increase in MeAIB
uptake, associated with an increase in Vmax, seen in previous
studies using fibroblasts and trophoblasts, is due to the up
regulation of the system A transporter ATA2. It is therefore
unlikely that increased cortisol levels in the IUGR fetus and
placenta are directly responsible for the insufficiency of placental
System A transporters.
Work funded by SEERAD flexible fund.
O93. Cloning and expression of the BMP and activin membrane-
bound inhibitor (BAMBI) gene in sheep.
CJH Souza1,2, DT Baird2, L Nicol3 & AS McNeilly3. 1EMBRAPA
Genetic Resource and Biotechnology, Brasilia, Brazil;
2Department of Reproductive and Developmental Sciences,
University of Edinburgh, Edinburgh, UK; 3MRC Human
Reproductive Sciences Unit, Centre for Reproductive Biology,
Edinburgh, UK.
Introduction: Ovarian follicular growth is regulated not only by
classical endocrine control but also by local ovarian growth
factors. The TGF beta superfamily of peptides is among the
main paracrine regulators of folliculogenesis. In sheep we, and
others, have recently demonstrated the continuous expression
of peptide ligands from this superfamily and the ubiquitous
location of their receptors in the ovary. However the action of
these potent growth factors have to be tightly regulated. To
explore the hypothesis that BAMBI, an inhibitor that prevents
the formation of receptor complexes, acts as a regulator of TGF
beta superfamily ligand action in the sheep ovary, we cloned
the sheep BAMBI gene and investigated its expression in tissues
of importance in the reproductive axis.
Methods: Total RNA was extracted from tissue obtained from a
slaughterhouse or from healthy ewes sacrificed for another
reasons. Ovarian cDNA was made and amplified by PCR using
primers designed based on conserved regions of the human
and mouse sequences. The PCR product was cloned and
sequenced to confirm its identity. Using the sheep clone as a
probe labelled with radioactive isotope the expression of the
BAMBI gene was investigated by Northern Blot hybridisation
in total RNA of term placenta, pituitary, adrenal and ovary.
Results and Discussion: The full sequence of the gene was
cloned from ovarian cDNA (Genbank accession AY147883) and
the deduced protein sequence of the sheep had 94.6, 93.5, 91.1
and 81.1% homology with the human, rat, mouse and Xenopus
sequences, respectively. Northern blot showed hybridisation
in all tissues examined. There was strong expression in placenta,
pituitary, adrenal, undifferentiated follicles (< 3 mm in diameter),
large follicles (>3 mm), and isolated theca and granulosa cells.
There was significant but lower expression in the mid-luteal
corpus luteum. These results suggest that the membrane bound
inhibitor BAMBI could play a role regulating the bioavailability
of ligands of the TGF beta superfamily in the ovarian follicles
and other reproductive organs of the sheep.
O94. BMPs 2, 6 and 15 are regulators of porcine granulosa
cell function in-vitro.
V Brankin, RL Quinn, C McGarr, R Webb & MG Hunter. School
of Biosciences, University of Nottingham, Sutton Bonington
Campus, Loughborough, UK.
Introduction: BMPs belong to the transforming growth factor-
B family and have important roles in fertility and ovulation rate.
BMPs 6 and 15 are oocyte specific peptides and we have
demonstrated the presence of BMP receptors on porcine
granulosa cells. The aim of this study was to determine the
effects of BMPs 2, 6 and 15 on porcine granulosa cells cultured
under serum-free conditions.
Methods: Granulosa cells were isolated from 2-6mm healthy
follicles of mature porcine ovaries and cultured under serum-
free conditions, supplemented with: 0 or 100ng/ml LR3 IGF-1,
10ng/ml insulin, 100ng/ml testosterone, 0-100ng/ml recombinant
human BMP-2, 6 or 15 and 0 or 1ng/ml FSH in a 96 well plate.
Cells were cultured for 144h, after which viable cell numbers
were determined. Medium was replaced every 48h and spent
medium analysed for steroids.
Results and Discussion: All BMPs studied suppressed
progesterone levels: BMP-2 (48h: P<0.001; 144 h: P<0.001), BMP-
6 (48h: P<0.001; 144h: P<0.001) and BMP-15 (48h: P=0.027; 144h:
P=0.036). There were significant interactions between BMP-2
(48h: P=0.024; 144h: P<0.001) and BMP-6 (48h: P<0.001; 144h:
P=0.014) with IGF-1 on progesterone inhibition.
BMPs 2, 6 and 15 stimulated oestradiol synthesis. BMP-2 (48h:
P=0.013; 144h: P=0.003) and BMP-6 (144h: P<0.001) stimulated
oestradiol synthesis in the absence of IGF-1. Oestradiol
synthesis was promoted by BMP-15 in the absence of FSH
(48h: P=0.01; 144h: P=0.08). Only BMP-2 increased (P=0.05)
viable cell numbers.
The results provide evidence for a functional BMP system in
the porcine ovary. The effects of these BMPs support the
hypothesis of oocyte secreted factors acting as luteinization
inhibitors. Since each BMP affects steroidogenesis and cell
proliferation differently, this suggests that each BMP has a
separate mechanism of action. The results also demonstrate
that BMPs interact with other intra- and extra-ovarian factors
such as IGF-1 and FSH to prevent luteinization.
Funded by BBSRC.
O95. Expression of activin receptors and demonstration of their
functional activation by exogenous activin-A in bovine oocytes
and granulosa cells.
C Glister & PG Knight. School of Animal and Microbial Sciences,
The University of Reading, Reading, UK.
Introduction: Within the ovary granulosa cells (GC) are a major
site of activin-A production. We have previously shown that
bovine GC secrete activin-A in an FSH- and IGF-responsive
manner (Glister et al, 2001 BOR 65:120-128) and that activin-A
can enhance oocyte developmental competence (Silva & Knight,
1998 BOR 58, 558-565), in a follistatin-reversible manner. The
present objectives were to: 1) confirm whether inhibin/activin
BA subunit is present in both oocytes and GC; 2) determine
which activin receptor subtypes are expressed on oocytes and
GC; 3) investigate whether exposure of oocytes and GC to
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activin-A leads to specific activation of the intracellular
signalling intermediary, Smad-2, as determined by the
accumulation of phosphorylated Smad-2 (pSmad-2); 4) determine
whether follistatin can block activin-induced phosphorylation
of Smad-2.
Methods: GC from 4-6mm follicles were cultured for 6 days in
multi-chamber slides before fixing in 4% paraformaldehyde.
Cumulus-enclosed oocytes were denuded and cultured
overnight before fixing. Antibodies against the following were
used for immunocytochemistry: BA-subunit, ActRIA, ActRIB,
ActRIIA, ActRIIB, pSmad-2, pSmad-1. Matched controls were
incubated with normal sera/IgG at the same dilution. After
incubation with fluor-labelled secondary antibodies, cells were
imaged and signal intensities quantified using a confocal
microscope.
Results and Discussion: Immunostaining for BA subunit was
detected in both oocytes and GC. Positive staining was also
seen for all 4 activin receptor subtypes in both oocytes and GC.
In addition, 4h-exposure of oocytes and GC to activin-A activated
the intracellular Smad-2 pathway as reflected by a marked increase
in phosphorylation detected using the pSmad-2 antibody
(P<0.01); activin did not activate the Smad-1 pathway. Activin-
induced Smad-2 phosphorylation was dose-dependently
suppressed by follistatin (P<0.01). Follistatin also suppressed
pSmad-2 levels in the absence of exogenous activin-A
presumably reflecting neutralization of endogenous activin.
These findings provide further evidence supporting local
autocrine/ paracrine roles for activin within bovine antral follicles.
O96. Analysis of the transcriptome of the gonadotrophin-
stimulated granulosa cell using SAGE.
RS McRae, HJ Johnstone & PJ O’Shaughnessy. Veterinary
Preclinical Studies, University of Glasgow, Glasgow, UK.
Introduction: Serial Analysis of Gene Expression (SAGE) can
be used to provide a quantative analysis of the transcriptome of
cells or tissues. The technique generates considerable amounts
of gene expression data with the potential to provide novel
insights into fundamental physiological processes without
restriction to known genes. Here we have applied this technique
to the granulosa cells of murine preovulatory follicles to produce
an mRNA expression profile of these cells.
Methods: Day 20 immature normal mice were treated with 5IU
PMSG by intraperitoneal injection and granulosa cells harvested
48hrs later. Isolated mRNA was used to create a SAGE library.
Results and Discussion: A total of 51,528 SAGE tags have been
sequenced representing 26,293 unique transcripts of which
18,149 could be matched to known genes using the NCBI SAGE
tag database. There were 8,144 unidentified transcripts of which
418 were represented by more than a single tag. A substantial
proportion of the highly expressed transcripts are associated
with mitochondrial and ribosomal genes. Also among the highly
expressed tags are the steroidogenic enzyme 3B-HSD I, Inhibin
beta-B, connexin 43, hexokinase 1, cathepsin L, clusterin, and
alpha fetoprotein. Uncharacterised EST’s account for 6 of the
top 50 transcripts and the most abundant of these we have
characterised as a non-coding mRNA species. Of the transcripts
detected at least twice 785 are unique to gonadal tissue and 459
unique to the granulosa cell when compared to other murine
SAGE libraries.
This library has generated a database of granulosa cell activity
and provides a basis for identification of differential gene
expression during granulosa cell development.
This work was supported by project grants from the Welcome
Trust.
O97. Angiogenic factors in the developing bovine corpus
luteum.
RS Robinson1, AJ Hammond1, KD Sinclair2, SJ Adamiak2,
MG Hunter1 & GE Mann1. 1School of Biosiences, University of
Nottingham, Loughborough, UK; 2Division of Animal Biology,
Scottish Agricultural College, Aberdeen, UK.
Introduction: In dairy cows, a delayed post-ovulatory rise in
progesterone has been associated with poor embryonic
development and lower conception rates. In order to produce
sufficient progesterone the corpus luteum (CL) needs to grow
rapidly, which is in turn dependent on angiogenesis. The
objective of this study was to investigate the levels of vascular
endothelial growth factor (VEGF) and fibroblast growth factor-
2 (FGF-2) during early CL development.
Methods: Twenty-two beef heifers were administered with an
intramuscular injection of prostaglandin during the mid-luteal
phase and were slaughtered 8 days later during the early luteal
phase. The work was conducted in accordance with Home Office
regulations. The CL were collected and divided into 3 groups
on a weight basis: small (0.5-1.4 g, n=6), medium (1.5-2.9 g, n=8)
and large (3.0-5.0 g, n=8). The CL concentrations of progesterone
and FGF-2 were determined by radioimmunoassay and ELISA
respectively. VEGF and VEGF receptor-1 (VEGFR-1) were
localised by immunocytochemistry.
Results and Discussion: CL size had no effect on progesterone
content, however FGF-2 concentrations were significantly
greater in the small CL (14.8 ± 2.6 ng/g CL) compared with medium
(6.9 ± 0.9 ng/g CL) and large-sized CL (7.7 ± 1.1 ng/g CL) (P<0.01).
The strongest VEGF immunostaining was observed in the large
luteal cells, but was also present at lower levels in endothelial
cells. The large luteal cell VEGF staining did not vary between
the different CL size categories. However, VEGF staining in the
luteal endothelial cells was greatest in the small and medium
sized CL groups (P<0.01). VEGFR-1 was immunolocalised to the
large luteal cells, with small CL group having the lowest levels
(P<0.05). In conclusion, FGF-2 and VEGF were most abundant
in the smallest CL and are thus likely to play a dynamic role in
early CL development in the cow.
Funded by BBSRC and DEFRA.
O98. The human corpus luteum: Luteal rescue with hCG does
not prevent the down-regulation of genomic progesterone
receptors seen in the late-luteal phase.
WC Duncan, E Gay & JA Maybin. Reproductive and
Developmental Sciences, University of Edinburgh, Edinburgh,
UK.
Introduction: The human corpus luteum (CL) expresses genomic
progesterone receptors (PR). These can be localised to the
granulosa-lutein cells and stromal fibroblasts. However, the role
of luteal PR is not known. In the endometrium, where
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progesterone has key functions, there is evidence of changing
PR expression. This study aimed to assess changes of
expression of PR in granulosa-lutein cells and fibroblasts
throughout the luteal phase and after luteal rescue with hCG
using both in vivo and in vitro model systems.
Methods: Human corpora lutea (n=17) were studied in the early
(LH+1 to LH+5), mid (LH+6 to LH+10) and late-luteal (LH+11 to
LH+14) phases and after luteal rescue with exogenous hCG
(hCGx5 to hCGx8). PR were detected by immunohistochemistry
and analysed in each cellular compartment. Luteinised granulosa
cells were obtained from stimulated IVF cycles and separated
using a Percoll gradient. They were cultured for 14 days in
medium supplemented with LDL and 1 ng/ml hCG. After 7 days
the hCG was either withdrawn or increased to 100 ng/ml. Cells
were studied at four time points, Day 3, Day 7, Day 12 (hCG) and
Day 12 (no hCG). Culture medium was analysed for progesterone
and mRNA extracted from the cells for quantitative RT-PCR for
PR.
Results and Discussion: Immunostaining of PR in the stromal
fibroblasts was consistent throughout the luteal cycle and after
luteal rescue. There was a non-significant trend to reduced PR
in granulosa-lutein cells in the late luteal phase and after luteal
rescue. The progesterone concentrations in vitro increased from
Day 3 to Day 7 to Day 12 (hCG) (P<0.05) but were lower on Day
12 (no hCG) (P<0.05). Progesterone receptor mRNA expression
was lower in Day 12 in the presence or absence of hCG (P<0.05).
These data confirm that PR are down-regulated in the mid-luteal
phase in the presence of luteolysis or luteal rescue and suggest
a limited role for progesterone in the phenotype of granulosa
lutein cells.
O99. The role of prolactin in preimplantation development of
the mouse.
K Markham1, N Horseman2 & P Kaye1. 1School of Biomedical
Sciences, University of Queensland, Brisbane, Australia;
2Department of Molecular and Cellular Physiology, University
of Cincinnati, Cincinnati, Ohio, US.
Introduction: Prolactin (PRL) has many effects, including on
preimplantation development in vitro. The presence of several
ligands for the prolactin receptor confounds studies with PRL
receptor knockout mice, but PRL-null mutant mice provide an
opportunity to examine effects due specifically to the absence
of PRL in vivo.
Methods: Mice with a non-functional PRL gene were genotyped
before mating (Horseman et al., 1997). The day of appearance of
vaginal plug was Day 1 of pregnancy. From Day 1 to Day 4
embryonic morphology in wild type mice, PRL-null mice and
PRL-null mice with progesterone implant (25% mg progesterone,
1 mg per day release rate, inserted on Day 2) was assessed.
Study approved by University of Cincinnati Animal Care and
Use Committee.
Results and Discussion: The numbers of embryos and their
developmental stage were similar until Day 3, when only 8% of
PRL-null embryos had compacted compared with 84% in wild
type (23-37 embryos from 3-4 mice in each group, chi2 = 35.3, P<
0.001). Progesterone had no effect on this retarded development
in the PRL-null mice, which persisted into Day 4. Serum
progesterone levels were similar on Day 1 and Day 3, but by
Day 4 the untreated PRL-null mice displayed lower serum
progesterone levels that were normalised by the progesterone
implant.
A conspicuous phenotype of PRL-null gene was failure of
blastocysts to attach and implant. This was attributed to the
absence of PRL luteotrophic effects on the corpus luteum,
leading to luteolysis and failure to increase maternal
progesterone levels. Analysis of preimplantation development
has revealed retarded compaction on Day 3, before any
progesterone requirement and persisting into Day 4. This may
arise from a maternal or embryonic PRL deficiency. Further studies
are required to assess the importance of this PRL requirement of
preimplantation pregnancy.
Supported by NHMRC, ARC and University of Queensland
Graduate Travel Award.
O100. Ammonium and pyruvate affect amino acid metabolism
in the bovine blastocyst in vitro.
NM Orsi1 & HJ Leese2. 1Academic Unit of Obstetrics and
Gynaecology, Leeds General Infirmary, Leeds, UK; 2Department
of Biology, University of York, York, UK.
Introduction: Amino acids improve preimplantation embryo
development in vitro, but their metabolism can compromise
development due to the accumulation of ammonium ions (NH4+).
This study examined possible ammonium disposal mechanism(s)
in the bovine embryo.
Methods: Embryos were generated by in vitro fertilisation of in
vitro matured abattoir-derived immature oocytes. Zygotes were
cultured in synthetic oviduct fluid (SOFaaBSA) at 39°C in 20µl
microdrops with a mineral oil overlay under a humidified 5%O2/
5%CO2/5%N2atmosphere. Blastocysts (n = 154) were placed
singly in 1ul SOFaaBSA incubation drops for 12h in six
experimental groups: ± 0.33mM pyruvate and ± 0, 1.25 or 2.5mM
NH4Cl. Profiles of amino acid disappearance or appearance were
determined by high performance liquid chromatography. In
parallel, early blastocysts were incubated (9 in 15ul) for 40h for
the measurement of urea (n = 9) and NH4+ (n = 7) production,
determined enzymatically. Data were compared by nested two-
way analysis of variance, with a Bonferroni post hoc test.
Results and Discussion: Alanine was the major amino acid to
appear in the medium. Removing pyruvate from the medium
significantly decreased the appearance of alanine (P<0.001),
glycine and tryptophan (P<0.05), as well as total amino acid
turnover (the sum of disappearance and appearance) (P<0.01).
NH4+ supplementation increased asparagine disappearance
(P<0.05), but decreased that of valine (P<0.001), and had no
significant dose-responsive effects on alanine appearance.
Aspartate and glutamate disappearance were affected by both
parameters: decreased by pyruvate removal, and increased by
NH4+ addition (P<0.05). Embryos produced 4.28 (± 0.36) pmol
NH4+/embryo/h, but urea formation was not detected. In
conclusion, amino nitrogen is released by early bovine embryos
as free NH4+ and/or potentially fixed as alanine. The mechanism
based on alanine disposal appears to have a limited capacity to
cope with increased external NH4+ loads.
Supported by the European Commission and the University of
York.
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O101. Stress-associated developmental arrest following in vitro
ovine embryo culture in the presence of docosahexaenoic acid
(DHA).
A Reis1,2, JA Rooke1, GJ McCallum1, M Ewen1, MA Lomax2 &
TG McEvoy1. 1Animal Biology Division, Scottish Agricultural
College, Aberdeen, UK; 2Department of Agriculture and
Forestry, University of Aberdeen, Aberdeen, UK.
Introduction: This study examined the effects on ovine embryo
development of media supplementation with either saturated
(palmitic acid) or polyunsaturated (DHA) fatty acids.
Methods: Cleaved zygotes were cultured (Days 1-3: 3 replicates;
Days 1-7: 7 replicates) in Synthetic Oviduct Fluid (SOF)
supplemented with 0.4% w/v fatty acid-free BSA (SBSA), or
with the same BSA complexed with palmitic (C16:0; SBSAP) or
docosahexaenoic acid (C22:6n-3; SBSAD). Respective fatty acid
concentrations (µg/ml; mean ± s.e.m.) in these media were 6.8 ±
0.91, 9.6 ± 1.83 and 7.9 ± 2.39 for palmitate, and 0.02 ± 0.02, 0.05
± 0.03 and 1.70 ± 0.35 for docosahexaenoic acid. All zygotes
were incubated at 38.5°C in 5% CO2, 5% O2 + 90% N2. Day 3
embryos (8-16 cells) were incubated (30 min) in 10 µM 2',7'-
dichlorodihydrofluorescein diacetate (Molecular Probes) to
detect peroxides. Mean fluorescence indices per embryo were
determined via microscopy (x250 mag.; excitation: 460nm;
emission: 535nm) and image analysis (ImageJ, Version 1.19q;
NIH, USA); data were analysed by ANOVA. Day 6+7 blastocyst
yields were recorded and these data analysed by Generalised
Linear Model (binomial distribution).
Results and Discussion: Mean (± s.e.m.) indices of peroxide
status (fluorescence intensity scale: 0 to 255) in Day 3 SBSAD
embryos (51 ± 1.7) were greater (P<0.001) than in either SBSA
(32 ± 1.6) or SBSAP (38 ± 1.5) embryos. Blastocyst yields from
SBSA and SBSAP were 32 ± 7.9% and 20 ± 8.3%, respectively
(P<0.01); no SBSAD embryos developed beyond the 8-16 cell
stage. These findings suggest that culture in the presence of
DHA generated more radicals in early stage embryos, imposing
a greater oxidative stress and thus inhibiting further
development. They also suggest that indices of peroxide status
at Day 3 may be useful predictors of the capacity of 8-16 cell
embryos to develop subsequently to the blastocyst stage.
 Funded by SEERAD; AR supported by Portuguese Ministry of
Science & Technology (Praxis XXI).
O102. Inhibition of bovine sperm-oocyte fusion by the p-
aminophenyl derivative of D-mannose.
S Tanghe1, A Van Soom1, L Duchateau2 & A de Kruif1.
1Department of Reproduction, Obstetrics and Herd Health,
Faculty of Veterinary Medicine, Merelbeke, Belgium;
2Department of Physiology, Biochemistry and Biometry, Faculty
of Veterinary Medicine, Merelbeke, Belgium.
Introduction: Preliminary results showed that inseminating
cumulus-oocyte complexes in the presence of the p-aminophenyl
derivative of D-mannose (AFMP) at a 50mM concentration
significantly inhibited the fertilization rate with 94% (P<0.05). In
this study, the fertilization step(s) at which this blocking effect
is exerted were investigated i.e. sperm penetration of the cumulus
oophorus, sperm-zona binding, acrosome reaction, sperm-
oolemma binding and/or sperm-oocyte fusion.
Methods: The following parameters were assessed: (1) total
motility and progressive motility of spermatozoa incubated in
the presence of 50mM AFMP at 0h, 1h, 4h and 6h during
incubation, (2) fertilization rate of cumulus-enclosed and
cumulus-denuded oocytes inseminated in medium
supplemented with 50mM AFMP, (3) sperm-zona binding in the
presence of 0mM, 12.5mM, 25mM and 50mM AFMP, (4)
acrosome reaction of spermatozoa incubated in medium
supplemented with 12.5mM, 25mM, 50mM AFMP and with 10ng/
mL, 1µg/mL, 100µg/mL D-mannosylated BSA, (5) sperm-oolemma
binding and (6) sperm-oocyte fusion in the presence of 50mM
AFMP. The data were statistically analysed using (generalized)
mixed models. Values were considered to be statistically
significant when P<0.05.
Results and Discussion: (1) Incubating spermatozoa in the
presence of AFMP significantly stimulated total motility and
progressive motility at any time. (2) Inseminating cumulus-
enclosed and cumulus-denuded oocytes in the presence of
AFMP significantly reduced the fertilization rate to a comparable
minimum level. (3) There was no significant linear relationship
between the number of spermatozoa bound to the zona pellucida
and the AFMP concentration, and (4) both AFMP and D-
mannosylated BSA neither suppressed nor stimulated the
acrosome reaction. (5) Inseminating zona-free oocytes in the
presence of AFMP did not influence sperm-oolemma binding,
but (6) significantly inhibited sperm-oocyte fusion with 88%.
These results show that the blocking effect of AFMP on bovine
fertilization is exerted at sperm-oocyte fusion, suggesting that
D-mannose is involved in the fusion process itself.
O103. Developmental of ovine nuclear transfer embryos
reconstructed using donor cells depleted of mitochondrial DNA
(mtDNA).
JH Lee1, R Alberio1, RE Lloyd2, JC St. John2 & KHS Campbell1.
1Division of Animal Physiology, School of Biosciences, The
University of Nottingham, Sutton Bonington Campus,
Loughborough, UK; 2Reproductive Biology and Genetics Group,
The Medical School, The University of Birmingham,
Birmingham, UK.
Introduction: Embryos produced by Nuclear Transfer (NT)
contain mitochondria derived from both the donor cell and the
recipient oocyte and are therefore heteroplasmic for mtDNAs.
The use of cell donors depleted of mtDNA would allow the
production of embryos homoplasmic for mtDNA. The aim of
this study was to compare the development of embryos
reconstructed using primary ovine fetal fibroblasts (OFFs) or
mtDNA depleted OFFs as donor cells.
Methods: Cumulus-oocyte complexes (COCs) were matured in
TCM-199 supplemented with 10% FBS, 5ug/ml FSH, 5ug/ml LH,
1ug/ml estradiol, 0.3mM sodium pyruvate and 100uM
cysteamine. Oocytes were enucleated 16-18hr after onset of
maturation in Hepes-buffered Synthetic Oviduct Fluid (HSOF)
medium plus 4mg/ml BSA and 7.5ug/ml cytochalasin B. OFFs
were depleted of mtDNA by treatment with ethidium bromide
(50ng/ml). Donor cells were cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM) containing 10% FBS and used at 60-
70% confluency. Cell fusion was induced with a single DC pulse
of 40V/cm for 20us, delivered by an Eppendorf Multiporator.
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Fused couplets were activated in HSOF containing 5ug/ml
ionomycin, cultured in SOF with 10ug/ml of cycloheximide and
7.5ug/ml cytochalasin B for 5h. and then transferred to
mSOFaaBSA medium, all at 5% CO2, 5% O2 and 90% N2 at 39°C.
On 2 day cleavage was assessed and 5% FBS was added to the
culture medium. On day 7 development to blastocyst and total
cell numbers were assessed. Statistical analysis was performed
using the Chi-square test.
Results and Discussion: The proportion of fused couplets was
greater with control than treated cells (116/134 (86.6%) vs 95/130
(73.1%)) (P<0.05). In addition the cleavage rate of control fused
embryos was significantly higher than that of embryos produced
using mtDNA depleted cells (80.6% vs 59.2%,). No significant
difference was observed in blastocyst rate (32.1 % vs 23.1%,
respectively) or cell number (94.3 vs 74.5) on 7 day (P>0.05).
O104. Analysis of levels of mitochondrial DNA (mtDNA)
transcripts in donor cells for use in somatic cell nuclear
transfer (SCNT).
RE Lloyd1, EJ Bowles1, R Alberio2, JH Lee2, KHS Campbell2 &
JC St. John1. 1Medical School, The University of Birmingham,
Birmingham, UK; 2School of Biosciences, University of
Nottingham, Sutton Bonington, Loughborough, UK.
Introduction: We have previously reported (Reproduction (2002)
Abstract Series 28, 14) the production of mtDNA depleted cells
that are potential candidates, as donor cells, for SCNT. These
cells were produced to eliminate the possible transmission of
donor cell mtDNA during SCNT. The aim of this study was to
determine whether mitochondrial mRNAs persist following
mtDNA depletion.
Methods: Caprine, ovine and bovine foetal fibroblast primary
cell cultures were depleted of their mtDNA by supplementing
their depletion medium with low concentrations of ethidium
bromide (50 ng per ml), a known inhibitor of mtDNA replication.
During the mtDNA depletion process, treated cells were
collected and then analysed using RTPCR. Total RNA was
extracted from each sample collected, and following DNase
treatment, cDNA was produced by reverse transcription of
mRNA using oligodT primers. A series of primers, specific for
the mtDNA of each species, was then used to amplify the cDNA
from each of the samples using conventional PCR.
Results and Discussion: The expression of several mitochondrial
genes encoding protein components of the electron transport
chain were analysed including; ND1 to ND3 and COXII. The
nuclear gene Beta Actin was used as a control. RTPCR revealed
either a sequential decrease or an absence of mitochondrial
mRNA levels for all the mitochondrial genes analysed
throughout ethidium bromide treatment. Eliminating donor cell
mitochondrial transcripts prior to nuclear transfer to the recipient
oocyte should facilitate the reprogramming of the donor cell
nucleus enabling it to regulate mtDNA transcription and
replication.
O105. Comparison of the anxiety factors between infertile
females and males.
EA Hadjikazemi1, A Mahmoodi2, M Mahmoodi2 & F Rahimi1.
1Iran University of Medical Sience, Health Depatment, Tehran,
Iran; 2Tehran University, Department of Health, Tehran, Iran.
Introduction: Infertility is a serious crisis in couples’ family life.
Infertile couples often experience a great deal of anxiety about
their inability to provide grandchildren for their own parents
.They may experience some marital disruption. Socializing with
family members during ‘child-oriented’ events as holidays may
be quite difficult for infertile person. The aim of this study was
determining and comparing the anxiety factors in infertile male
& female.
Methods: In this study 100 samples were selected randomly
among infertile men & women (50 men & 50 women) who were
referring for treatment to the infertility centers in Tehran. Data
collection was by questioner. The questioner had 2 parts consist
of :
1) several questions about samples characteristics.
2) questions about anxiety factors include:a) family factors,b)
socio-economic factors
Results and Discussion: The results showed 54% of women &
70% of men were 30-40 Years old.
The marriage length of 52% of women and 19% of men were
more than 10 years. 46% of women and 40% of men were
suffering from anxiety factors. Women were more anxious than
men about losing their family life.This difference was significant
(p=0.05).The greatest anxiety factors was about treatment
protocols. This  item  was  different  between  women  and  men
(p = 0.05).
Although the diagnosis and treatment of infertility is a great
medical responsibility but many infertility related problems are
clinical nursing problems too. At every step couple who is
involved in this process are likely to need information,
anticipatory, guidance and emotional support which are the
primary nursing responsibility.
O106. Donation is for now, identification is for life - the donors’
view of anonymity.
L Stewart, A McTavish & M Hamilton. Department of Obstetrics
and Gynaecology, University of Aberdeen, Aberdeen, UK.
Introduction: The object of this study was to determine how
withdrawal of anonymity might affect recruitment of gamete
donors in our unit.
Methods: An analysis of our database was performed to
determine donor (8 sperm (2000-2003) & 47 egg (1998-2002))
characteristics and motives for donation. 20 recent egg donors
were then asked to complete a questionnaire regarding their
attitudes to anonymity.
Results and Discussion: Database analysis revealed that donors
covered the full age ranges accepted. Many were in stable
relationships (38% sperm; 87% egg) with their own children
(63% sperm; 83% egg), and most were in full time or part time
employment (75% sperm; 74% egg). The vast majority (88%
sperm; 100% egg), said their motivation to donate was to help
others have children, though 12% of sperm donors said that
payment was the main reason.
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Questionnaire responses showed 31% had concerns about being
contacted in the future by offspring, 23% about the impact on
their family of their donation, and 31% said they would not have
donated if they knew they would be able to be identified in
future. Only 46% said they would be happy for identifying
information to be given to a couple undergoing treatment using
their gametes, although 62% said they would be happy for this
information to be passed to offspring.
Comments showed that donating was something they did at
one point in time, then it was past and forgotten about. The
possibility of future identification meant that they wouldn’t know
if in twenty or thirty or even fifty years time their lives might be
disrupted by contact from offspring.
No one can say what future identification will mean for donors
in the long term - and the uncertainty about how it will affect
their own lives in the future appeared to be the biggest issue.
O107. Provision of information in subfertility (POIS): a
randomised controlled trial of alternative methods of providing
information to couples undergoing in-vitro fertilisation.
S Murray, A Shetty, A Rattrau, V Taylor & S Bhattacharya.
Aberdeen Fertility Centre, Obstetrics and Gynaecology,
University of Aberdeen, UK.
Introduction: Many couples undergoing in-vitro fertilisation
(IVF) are unaware of the risks associated with twins and may
not wish to limit the number of embryos transferred. Multiple
pregnancies could be minimised by a policy of elective single
embryo transfer (SET). We evaluated the effects of alternative
methods of information provision about twin pregnancies and
SET on couples’ attitudes and decision-making.
Methods: Couples awaiting IVF were randomised into three
groups. Group A (control) received a standard information pack;
group B received an additional information sheet. Couples in
Group C received both as well as a 10 minute discussion with a
fertility nurse. The information sheet contained information
about the risks of twin pregnancies and published data about
elective SET. Couples were then asked to complete a
questionnaire. Local ethical committee approval was obtained.
Results and Discussion: To date, 171 questionnaires have been
returned (A = 57; B = 59; C = 55). Randomised groups were
comparable in terms of female age, educational status, and
duration of subfertility. Awareness of risks associated with twins
was high [A= 55 (97%); B = 58 (98%); C = 54 (98%)]. A singleton
pregnancy was the desired outcome for most [A = 36 (63%); B =
40 (68%); C = 35 (64%)]. Many would find SET unacceptable if
it lowered pregnancy rates [A = 40 (70%); B = 40 (68%); C = 35
(64%)], but not if cumulative live birth rates remained unchanged
[A = 47 (83%); B = 48 (82%); C = 48 (87%)]. Eliminating extra
charges for frozen transfers would encourage couples to opt for
SET [A = 31 (54%), B = 31 (52%), C = 34 (62%)]. Alternative
methods of information provision are unlikely to affect decision
making about SET by sub-fertile couples.
O108. Funding for fertility treatment.
C Wilson. Essex, UK.
Essay Submission.
O109. An exploration into the midwifery care support provided
for women who have conceived following in vitro fertilisation.
K Pettett. Women’s Centre, John Radcliffe Hospital, Oxford, UK.
Essay Submission.
O110. What is the impact of integrated care pathways on patient
care? A literature review.
J Bulmer. Reproductive Medicine Unit, Leeds General Infirmary,
Leeds, UK
Essay Submission.
O111. Oocyte freezing, the way forward.
H Birch. Midland Fertility Services, Aldridge, UK.
Essay Submission.
O112. Decision making at the end of in-vitro fertilisation:
Whose decision?
V Peddie. Aberdeen Fertility Centre, Aberdeen, UK.
Essay Submission.
P1. A potential new use for Gonadotrophin-releasing hormone
antagonists.
TR Aust, J Sklavounos, R Gazvani & CR Kingsland. Department
of Reproductive Medicine, Liverpool Women’s Hospital,
Liverpool, UK.
Introduction: This case reports a 37 year-old nulliparous woman
and her husband who presented for their third cycle of IVF with
intracytoplasmic sperm injection (ICSI).After nine days of
ovarian stimulation it emerged that the patient had mistakenly
omitted the buserelin from the day of starting gonadotrophins,
and so had now been without pituitary desensitisation for nine
days.
Methods: The decision was then made to administer a GnRH
antagonist to prevent a Luteinising Hormone surge which could
lead to ovulation before oocyte retrieval.
Results and Discussion: Successful oocyte retrieval was carried
out, two embryos transferred and a viable twin pregnancy
ensued.
It should be noted that this patient was well informed and had
experience of IVF, having previously undergone two complete
cycles. It should therefore be kept in mind that patients will not
necessarily know what to do at each stage of their cycle even
when they are experienced. Reiteration and written reminders of
regimens may have prevented this situation occurring.
Whilst it is accepted that this is an unusual case and that the
risk of ovulation was low, this is a potential alternative use of
the drug as a rescue agent to prevent cycle failure in these rare
circumstances.
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P2. Early luteal phase progesterone supplementation and IVF-
ET outcome.
PM Lam, LP Cheung & CJ Haines. Department of Obstetrics
and Gynaecology, The Prince of Wales Hospital, New Territories,
Hong Kong.
Introduction: The objective of this study was to examine whether
the use of early luteal phase progesterone supplementation in
addition to standard luteal phase support would improve IVF-
ET outcome. It has been suggested that increased uterine
contractility may impair endometrial receptivity. Uterine
contractility has been found to be negatively correlated with
serum progesterone concentrations.
Methods: A prospective randomized controlled trial that will
include 250 women undergoing IVF treatment. Approval granted
by the Research Ethics Committee of the Chinese University of
Hong Kong. Subjects are randomly assigned to either early
(group A) or conventional (group B) luteal phase support. In
group A, 200 mg micronized progesterone is given vaginally
three times daily from the afternoon of oocyte retrieval until the
morning of embryo transfer (9 doses). Subjects in this group
also receive standard luteal phase support in the form of HCG
2000 IU every third day for 4 doses starting on the day of oocyte
retrieval. Group B subjects receive HCG luteal phase support as
above but no additional progesterone.
Results and Discussion: Biochemical pregnancy rate: 15/50
(30%) in Group A and 15/52 (28.8%) in Group B (NS). Clinical
pregnancy rate: 10/50 (20%) in Group A and 14/50 (28%) in
Group B (NS).
Mean change in serum progesterone 288 ± 119 nmol/L in Group
A and 252 ± 97 nmol/L in Group B (NS).
Pregnancy outcome:
Group A: 5 viable intrauterine, 2 missed abortion, 2 ectopic, 1
biochemical
Group B: 13 viable intrauterine, 1 missed abortion
The preliminary data suggest that there is neither an advantage
nor a disadvantage in adding vaginal progesterone to standard
luteal phase support. Numbers are too small to draw any
conclusion about the difference in pregnancy outcome, but initial
results suggest that even if an effect is found, the magnitude of
the effect will probably not be clinically significant.
P3. New protocol for commencing the GnRH antagonist in
assisted conception treatment cycles: Elimination of the
premature LH surge with similar pregnancy rates.
A Mavrides, S Lavery & G Trew. Department of Reproductive
Medicine, Imperial College, London, UK.
Introduction: GnRH antagonists have been used with increasing
frequency over the past few years and have been associated
with quicker and more profound LH suppression and shorter
treatment cycles than conventional GnRH agonists. Usually,
these are commenced on day 6 of FSH stimulation without
allowing for patient variation in response to treatment. The study
aims to individualise this protocol to the patients’ ovarian
response.
Methods: 196 treatment cycles where commencement of GnRH
antagonist was on day 6 of FSH stimulation were reviewed and
analysed. Then a new protocol was formulated where
commencement was based on ultrasonographic findings alone
was applied to practice and 157 treatment cycles following that
were analysed.
Results and Discussion: The study group had no premature
LH surges (LH>10iu/ml) compared to the control group who
had a rate of 4.1%. There is also a higher fertilisation and clinical
pregnancy rate in the study group (p = 0.06). It is concluded
that the new individualised GnRH antagonist protocol eliminates
premature LH surges in assisted conception treatment cycles
and may improve clinical pregnancy rates compared to the
conventional protocol of ‘day 6 commencement’.
P4. Intravenous sedation in assisted conception units: A UK
survey.
NM Elkington1, J Kehoe2 & U Acharya1. 1South West Centre for
Reproductive Medicine, Derriford Hospital, Plymouth, UK;
2Department of Anaesthesia, Derriford Hospital, Plymouth, UK.
Introduction: Conscious intravenous (IV) sedation appears to
be a safe and cost-effective method of providing analgesia and
anaesthesia for trans-vaginal egg collection. However, it has
the potential to cause life-threatening complications such as
respiratory arrest, cardiac arrest, anaphylaxis and drug
interactions. Currently there is a great deal of variation in the IV
techniques practised in the UK. The aim of this audit was to
assess current practice of IV in assisted conception units in the
United Kingdom (UK).
Methods: A postal questionnaire was sent to all assisted
conception units (ACUs) in the UK that undertake in-vitro
fertilisation (IVF).
Results and Discussion: The return rate was 62/74 (84 %). The
majority of units (84%) used IV sedation for trans-vaginal egg
collection, whereas 16% used general anaesthesia. There was a
great variation in personnel present during the procedure, the
use of drugs, the degree of monitoring and the availability of
emergency drugs. Most units titrate an IV benzodiazepine and
IV opiate manually, usually midazolam and fentanyl respectively.
This audit demonstrates the wide variation in current UK practice
and highlights the need for the adoption of national guidelines
for safe use of IV sedation in ACUs. This audit was done in
conjunction with drawing up ‘Guidelines for Safe Sedation in
Assisted Conception’ at the request of the BFS. The great
variation in practice in the UK is clearly demonstrated by the
results.
P5. A national survey of the different positions used during
transvaginal scanning.
Y Sajjad, TR Aust, A Drakeley, S Curran & CR Kingsland.
Reproductive Medicine Unit, Liverpool Women’s Hospital,
Liverpool, UK.
Introduction: Transvaginal (TV) scanning is fundamental to
assisted reproductive techniques such as IVF. However there
seems to have been little work conducted on the best way to
position the patient during a TV scan. Many operators simply
place a pillow to slightly raise the lower back which would seem
to be only a slight modification of the position used for a TA
scan. Other operators favour a position closer to a modified
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lithotomy position. Currently there would seem to be no
recommendation for best practice or any knowledge of the best
position in terms of patient comfort or feelings of exposure.
There are 74 units providing IVF in the UK. The aim of the study
was to discover what position operators were using at the centres
around the UK.
Methods: A national survey of all assisted reproduction units
in the UK.
74 centres were sent questionaires, 63 responded (85.1%), giving
142 completed individual forms. They were questioned as to the
grade of the person performing the scan and the position into
which the patient was placed.
Results and Discussion: The national survey showed that
consultants, registrars and ultrasonographers had a fairly even
spread between the two positions whilst the majority of nurse
practitioners preferred supporting the legs on a chair. Overall,
85 (60%) of operators used the modified lithotomy position and
57 (40%) lay the patient up the bed usually supporting the
buttocks with a cushion.
The survey shows that different operators favour different
scanning positions and this is probably related to the position
they used during their training.
As there is no consensus as to the best position for TV scanning
it would be interesting to which position the patients prefer.
This would best be carried out in the form of a crossover in
which patients undergo a scan in each of the two positions.
P6. Which position do patients prefer during transvaginal
ultrasound scanning? A prospective randomised crossover
questionnaire study.
Y Sajjad, TR Aust, A Drakeley, S Curran & CR Kingsland.
Reproductive Medicine Unit, Liverpool Women’s Hospital,
Liverpool, UK.
Introduction: Transvaginal (TV) scanning is fundamental to
assisted reproductive techniques such as IVF. During a TV scan
many operators simply place a pillow to slightly raise the lower
back which would seem to be only a slight modification of the
position used for a transabdominal scan. Other operators favour
a position closer to a modified lithotomy position.
The aim of the study was to determine which position patients
preferred if given the choice
Methods: The design was a randomised prospective crossover
questionnaire study
Ethical approval was granted by the Liverpool Research Ethics
Committee. Women attending for IVF were asked to participate
in the study. A total of 109 women were recruited.
At the time of baseline scan each patient was randomised (using
sealed opaque envelopes) to have their scan performed in one
of the two positions described. They then filled out a brief
questionnaire stating how comfortable they found the scan.
They were scanned in the other position after 9 days of ovarian
stimulation and filled out a second questionnaire.
Results and Discussion: Of the 108 patients recruited (one
patient excluded) 61 (56.4%) stated a preference for the modified
lithotomy position, 36 (33.3%) preferred lying flat on the couch
whilst only 11 (10.3%) stated they had no preference.
Of those who preferred the modified lithotomy position 40
(65.6%) had had that scan performed at baseline and similarly in
those who preferred flat on the couch 24 (66.7%) had that scan
performed at baseline. Thus the preferences may partly be due
to the multiple ovarian follicles causing discomfort during the
second scan.
Our study suggests that patients may prefer having their legs
raised during their scan so units should consider offering this if
they do not already.
P7. Pilot study for a randomised controlled trial of ultrasound
guidance in embryo transfer.
TR Aust, G Rowley, J Sklavounos, A Drakeley, Y Sajjad, R Gazvani
& CR Kingsland. Reproductive Medicine Unit, Liverpool
Women’s Hospital, Liverpool, UK.
Introduction: We conducted a pilot study looking at ultrasound
guided embryo transfer in a UK assisted conception unit. This
was in order to evaluate whether or not a larger randomised
controlled trial would be justified.
Methods: Pilot study of 30 women undergoing trans-cervical
embryo transfer in a large IVF unit. All women had two embryos
transferred using an echogenic tip transfer catheter under trans-
abdominal ultrasound guidance.
Results and Discussion: Ten of the 30 women conceived
(biochemical pregnancy), 33% (95% confidence interval 17 to
56%). The overall unit biochemical pregnancy rate at that time
was 23%.
Ultrasound guided embryo transfer appears to improve
pregnancy rates so a randomised controlled trial is warranted.
Previous RCT’s have been underpowered or quasi-randomised.
We feel that a 5% increase in the pregnancy rate would justify
changing our practice in this busy IVF unit (1100 cycles per
year). A power calculation based on 5% alpha error and 80%
power would require 1000 women in each arm. Local research
ethics committee approval has been granted for a randomised
controlled trial and recruitment began in February 2003.
P8. The effect of difficult embryo transfer on pregnancy rates.
TR Aust, T Kiernan, Y Sajjad, A Drakeley, R Gazvani &
CR Kingsland. Reproductive Medicine Unit, Liverpool Women’s
Hospital, Liverpool, UK.
Introduction: Embryo transfer (ET) is an important step in in-
vitro fertilisation (IVF) cycles. The methods used for ET have
remained largely unchanged since IVF was first developed. We
wished to evaluate whether or not the degree of difficulty of ET
correlated with the pregnancy rate
Methods: Retrospective case note analysis. All embryo transfers
over a 6 month period were analysed and divided according to
degree of difficulty. An easy transfer was defined as one in
which the soft catheter passed directly into the uterine cavity
without any extra instruments or manipulation. The other
categories included those that required the more rigid outer
sheath to be used, those that needed a malleable inner stylet to
be employed or transfers that in which a tenaculum had to be
51
applied to the cervix. The subsequent outcome (biochemical
pregnancy rate) was then recorded.
Results and Discussion: 463 ET’s were analysed. 126 were
considered difficult. There was a stepwise reduction in the
pregnancy rate from 29.7% in the easy transfers to 9.1% when a
stylet and tenaculum were used.
Our results would suggest that degree of difficulty during ET
has an impact on success rates. One could speculate that this
may be due to increased uterine contractions caused by
increased cervical trauma and hence prostaglandin release. This
study emphasises the importance of operators attempting to
perform as atraumatic an ET as possible.
P9. The use of methotrexate for ectopic pregnancy after IVF.
TMH Tang, AJ Rutherford & AH Balen. Reproductive Medicine
Unit, Leeds General Infirmary, Leeds, UK.
Introduction: A protocol of using methotrexate (MTX) for EP
had been used in the IVF center since 2001.This audit is to
evaluate the efficacy in the management of early ectopic
pregnancy after IVF.
Methods: Twenty-eight women were diagnosed with EP after
IVF between January 2001 and December 2002. Ectopic
pregnancy was suspected when the serum B-HCG was <50IU/L
14 days after egg collection (EC) associated with slowly rising
levels over the next 14 days. All women had TVUS 28 days after
EC. A viable EP was diagnosed when an extrauterine gestational
sac with fetal heart activity was demonstrated by TVUS and
laparoscopic surgery was performed.
In cases when no gestational sac was identified, a repeat TVUS
and serum B-HCG were performed after 2 days. The diagnosis
of EP was made when TVUS was still unable to demonstrate a
sac and B-HCG levels were above 1000IU/L. If the levels were
less than 1000IU/L, the patients were re-assessed after 2 days.
EP was diagnosed when the TVUS findings remained unchanged
with an abnormal rise (<50%) of B-HCG levels. Unless the patient
was haemodynamically unstable, a single dose of methotrexate
50mg per m2 was given intramuscularly without folinic acid rescue.
The patients were monitored with weekly B-HCG.
Results and Discussion: The overall EP rate was 5.5%. The
mean (S.D.) of the day 14 B-HCG levels was 24.4 ± 15.5IU/L. 7
patients with a viable EP were admitted for laparoscopic
salpingectomy with subsequent histological confirmation. 21
women received MTX and the mean (S.D.) of pre-treatment HCG
levels was 821 ± 618IU/L which was significantly lower than the
mean of pre-surgery HCG levels of the viable EP (3099 ± 3201IU/
L), p<0.05.
One out of 21 patients required a second dose of MTX. The
MTX treatment success rate was 95% (20/21).The mean (S.D.)
time to resolution after MTX was 30 ± 13.7 days. No patient was
admitted with ruptured EP.
Methotrexate therapy offers a high success rate in selected
patients combined with a careful monitoring protocol.
P10. A prospective randomized crossover study to determine
the impact of an incubator air filtration system on IVF treatment
outcome.
G Horne, JD Critchlow, HR Hunter, N Thomas, MAK Hooper,
BA Lieberman & DR Brison. Regional IVF Unit, Department of
Reproductive Medicine, St Mary’s Hospital, Manchester, UK.
Introduction: It has been suggested that volatile organic
compounds (VOCs) are a major source of air impurities and may
have a detrimental effect on oocyte, sperm and embryo viability
in a clinical IVF programme. The objective of this study was to
determine the effect of intra-incubator chamber air filters
accompanied with gas line filters upon the fertilization, embryo
division and clinical pregnancy rate/embryo transfer (CPR/ET)
following replacement of fresh and frozen embryos.
Methods: The setting was an NHS IVF unit situated in an inner
city area with potentially high concentrations of VOCs. At egg
retrieval, patients were randomly assigned to one of two Hereaus
incubators, one of which contained both a Coda incubator
chamber and gas line filter (<genX> international, Connecticut,
USA), while the other incubator had neither. A maximum of 2
embryos were selected for replacement on day 2. After a period
of 6 months the Coda units were removed and transferred to the
previously non-filtered incubator for 6 more months. The
crossover was performed to eliminate any variables due to the
performance of specific incubator chambers.
Results and Discussion: There was no significant difference in
the fresh CPR/ET (incubator a not filtered -17.8%, incubator b
filtered -18.3%; incubator a filtered -17.9%, incubator b not filtered
-18.2%) or frozen embryo CPR/ET (7.6%,14.9%; 12.3%, 11.1%
respectively).There was no significant difference seen in the
fertilisation rate in either incubator before or after the crossover.
Conclusions: These results demonstrate there was no significant
improvement in the fertilization or CPR/ET with an incubator air
purification system despite their use in an area of potentially
high VOC concentrations. However, we cannot rule out the
possibility that these air filter systems provide a low level of
benefit, below the statistical power of our study.
P11. Evaluation of a variety of management strategies to rescue
poorly responding cycles in women undergoing assisted
reproduction.
AI Salih & EA Lenton. Sheffield Fertility Centre, Sheffield, UK.
Introduction: Some 10-20% of all young women treated by day
21 long protocol and low dose FSH will experience cancellation
in their first IVF cycle. It is difficult to identify these patients
before treatment starts so the onus is on making the best of the
current cycle by, if possible, ‘rescuing’ or maximising follicle
development. This study was designed to establish which, if
any of the strategies had sufficient potential to be worth
evaluating in a large randomised study.
Methods: 50 poorly responding patients who were identified
after five days of ovarian stimulation with rFSH (150 iu daily)
were divided into 5 groups of 10 subjects as follows: (1)
continuing FSH administration with no intervention [control],
(2) introducing alternate day low dose HCG, (3) increasing FSH
dose (225 iu daily), (4) introducing HCG in addition to increasing
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FSH dose and (5) changing from rFSH to HMG. Cancellation
rate was the main outcome measure.
Results and Discussion: Patients whose FSH dose was
increased showed higher plasma FSH but not E2 concentrations.
Patients given HCG supplements showed higher plasma E2.
Those who had HCG in addition to increased FSH showed both
higher FSH and E2. Changing from rFSH to HMG resulted in
higher FSH levels, similar to those achieved by increasing the
FSH dose. Cancellation rates were (1) 30% (2) 50% (3) 20% (4)
0% (5) 30% but encouragingly, of the cycles that continued to
egg collection and embryo transfer, clinical pregnancies were
achieved in (1) 2/7 (2) 4/5 (3) 3/8 (4) 2/10 and (5) 3/7. Overall the
eventual cancellation rate was 26% and the clinical pregnancy
rate 37% per ET (28% per cycle started). In reality it is clear that
some women will respond poorly with low oestradiol and low
follicle numbers but in spite of this they still have a reasonable
prognosis if treatment is allowed to continue.
This study was supported by the Infertility Research Trust.
P12. Isolation and proliferation of inner cell mass of horse
blastocyst.
X Li & WR Allen. Equine Fertility Unit, Suffolk, UK.
Introduction: Embryonic stem (ES) cell lines have been
successfully derived from the inner cell mass (ICM) of human
and mouse preimplantation embryos. These cells can provide
an unlimited supply of different cell types for application to
tissue replacement, drug screening and functional genomics. In
this study we attempted to isolate and proliferate in vitro, ICMs
obtained from horse blastocysts.
Methods: DMEM/nut mix F12 containing 15% FCS, 2mM L-
glutamine, 1% non-essential amino acids, 0.2 mM 2-
mercaptoethanol and 1000 units/ml LIF was used as the basic
medium for ES cell culture. Two types of cells, mouse primary
embryonic fibroblasts (mPEF) and horse fetal fibroblasts (hFF),
were used as feeder cells. Eleven day 7 or 8 horse blastocysts
were recovered by non-surgically flushing the uteri of artificially
inseminated mares. The ICM of each blastocyst was isolated by
immunodisection as described previously by Evans and
Kaufman (1981) and Thomsson et al. (1998).
Results and Discussion: Six good ICM were obtained for culture
and cell proliferation. After 6-10 days of primary culture,
expanded colonies from individual ICMs was observed on both
mPEF and hFF feeder monolayers. Following cell proliferation
during passages 1 to 5, all the cell masses separated after
passage 1 to form new colonies on both mPEF and hFF. The
cells retained their undifferentiated status, as determined by
their expression of the cell surface markers alkaline phosphatase,
TRA-1-60, TRA-1-81, SSEA-1 and SSEA-4. However,
morphological analysis of colonies grown in feeder cell-free
conditions showed differentiation of the cultured cells into a
flattened, epithelioid type of morphology by the end of passage
3-5. Single cells taken from ICMs were not able to form colonies
after 6-10 days of primary culture, either in the presence or
absence of monolayers of mPEF or hFF.
P13. Metabolic characterisation of isolated bovine inner cell
mass, trophectoderm and blastocoel fluid.
N Gopichandran & HJ Leese. Department of Biology, University
of York, York, UK.
Introduction: Blastocyst viability depends on the establishment
of an appropriate number of inner cell mass (ICM) and
trophectoderm (TE) cells but little is known about the
biochemistry of these two cell populations, nor of the
composition of blastocoel fluid which surrounds the ICM. We
have therefore measured the energy metabolism (glucose and
pyruvate uptake and lactate production) of isolated ICM and
TE from bovine blastocysts and the concentration of these
nutrients in blastocoel fluid.
Methods: Bovine embryos were produced by in vitro maturation
and fertilisation of immature oocytes from abattoir-derived
ovaries. Embryos were cultured in Synthetic Oviductal Fluid
supplemented with 18 amino acids and BSA (SOFaaBSA). ICMs
were isolated by immunosurgery; TE was obtained by freehand
biopsy. Blastocoel fluid was removed from expanded blastocysts
by micropuncture and aspiration. Intact blastocysts, ICM and
TE were cultured for 0.5-6h in SOFaaBSA and subsequently
stained with bisbenzimide to determine cell numbers. Blastocoel
fluid samples and spent culture drops were analysed
ultramicrofluorometrically.
Results and Discussion: Glucose, lactate and pyruvate
metabolism by isolated ICM and TE differed significantly. On a
per cell basis, the TE showed a higher pyruvate (P<0.001) and
lower glucose (P<0.05) consumption and increased lactate
production (P<0.05). Lactate concentration in blastocoel fluid
was significantly higher than in SOFaaBSA (P<0.05) whilst
pyruvate (P<0.05) and glucose (P<0.001) concentrations were
lower. Significant differences existed between intact and
‘composite’ blastocysts, obtained by summing the consumption/
production metabolic profiles of the ICM and TE and taking
into account their respective cell numbers. The ‘composite’
showed higher pyruvate consumption and lactate production
and decreased glucose uptake compared to the intact blastocyst.
Therefore, the sum of isolated ICM and TE metabolically did
not equal the intact blastocyst, suggesting that upon isolation
ICM and TE suffer loss of metabolic control possibly due to the
disruption of paracrine interactions and/or culture-induced
cellular stress.
P14. Fate of tetraploid cells in tetraploid - diploid chimeric
mouse blastocysts.
GE MacKay & JD West. Reproductive and Developmental
Sciences, University of Edinburgh, Edinburgh, UK.
Introduction: In mid-gestation (embryonic day 12.5, E12.5) mouse
tetraploid-diploid chimeras, the tetraploid cells contribute well
to the derivatives of the trophectoderm and hypoblast (primitive
endoderm) but are usually excluded from the fetus and other
epiblast derivatives. Previous studies have shown that tetraploid
cells are present in the inner cell mass (ICM) of early chimeric
blastocysts but are largely excluded from the epiblast lineage
by E7.5. The aim of the present study was to test whether
tetraploid cells are excluded from the epiblast, when it forms at
the blastocyst stage, or lost from the epiblast lineage at a later
stage.
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Methods: Confocal microscopy was used to analyse the
contribution of tetraploid cells to different regions of tetraploid-
diploid chimeric blastocysts, in which either the tetraploid or
diploid cells expressed a tau-tagged green fluorescent protein
(tauGFP) transgene. Some E3.5 blastocysts were surgically
transferred to recipient females, treated with the anti-oestrogen,
tamoxifen (10µg on the day of transfer). This induced diapause
and allowed the blastocysts to continue to grow to E5.5 or E7.5
without implanting.
Results and Discussion: Tetraploid cells were identified in the
presumptive epiblast region of the ICM in 39/45 E3.5 and 16/19
E4.5 chimeric blastocysts cultured in vitro. Tetraploid cells were
also seen in the differentiated epiblast in 3/7 E5.5 and 3/4 E7.5
chimeric blastocysts, maintained in vivo in a state of diapause.
This shows that tetraploid cells initially colonise the epiblast
and must be lost from tetraploid-diploid chimeras at a later stage
(before E7.5 in normally implanted embryos).
This study was supported by a University of Edinburgh PhD
studentship and a grant from the Wellcome Trust.
P15. Abnormal mouse fetuses after preimplantation exposure
to ammonium chloride.
S Sinawat1,4, W-C Hsaio1,5, JH Flockhart1, MH Kaufman2, J Keith3
& JD West1. 1Department of Reproductive and Developmental
Sciences, University of Edinburgh , Edinburgh, UK; 2Department
of Biomedical Sciences, University of Edinburgh , Edinburgh,
UK; 3Simpson Centre for Reproductive Health, The Royal
Infirmary of Edinburgh, Edinburgh, UK; 4Department of
Obstetrics and Gynecology, Khon Kaen University, Thailand;
5North Town Women and Children’s Hospital, Taipei, Taiwan.
Introduction: A previous study (Lane & Gardner, J. Reprod.
Fert. 102, 305-312, 1994) showed that preimplantation exposure
of mouse embryos to 0.03mM ammonium chloride resulted in
retarded fetal development and a high frequency of exencephaly
(>20% exencephaly in some groups). The aim of the present
study was to re-evaluate this evidence for preimplantation
teratology in the mouse.
Methods: 1-cell (C57BLxCBA/Ca)F2 mouse embryos were
cultured in M16, mMTF or KSOM media containing 0 or 0.3mM
ammonium chloride for 3 days and 2-cell embryos were cultured
in M16 or KSOM media containing 0, 0.3mM or 0.6mM
ammonium chloride for 2 days. After transfer to recipient females,
postimplantation development was evaluated on embryonic day
15.5 (E15.5) or E18.5. In vivo control fetuses were examined at
E15.5 to determine the background frequency of exencephaly.
Results and Discussion: There was no consistent effect of
preimplantation exposure to ammonium chloride on fetal weight
or crown-rump lengths. All 195 in vivo control fetuses and all
fetuses resulting from control cultures (168 examined at E15.5
and 70 at E18.5) were normal. After preimplantation exposure to
ammonium chloride, all 101 fetuses examined at E18.5 were also
normal but 5/217 E15.5 fetuses were abnormal (3 with exencephaly
and 2 with polydactyly). Although 5/217 was much lower than
was found in the previous study it was significantly higher than
0/363 for the pooled groups of E15.5 control fetuses (P=0.007).
The combined E15.5 and E18.5 frequency was also significantly
higher than the controls (5/318 versus 0/433, P=0.013). The results
indicate that abnormal preimplantation culture conditions can
cause fetal abnormalities but the risk may be lower than
previously suggested. Although this risk needs further
evaluation, it should not be ignored when designing new
strategies for human assisted conception.
P16. Effect of quality of sperm chromatin structure on IVP in
cattle.
L Katska-Ksiazkiewicz, B Rynska & M Bochenek. Department
of Animal Reproduction, National Research Institute of Animal
Production, Balice/Krakow, Poland.
Introduction: Bull effect on IVP results has been well
documented. Recently it has been found significant relationship
between fertility of bulls qualified for AI and the percentage of
spermatozoa with high susceptibility to chromatin denaturation
(Bochenek et al, Theriogenology 2001, 56, 557-567). The aim of
the present study was to find the relationship between quality
of bull sperm chromatin and its effect on in vitro embryo
production.
Methods: Bovine in vitro matured oocytes (TCM 199 + 20%
estrus cow serum, at 38.5°C, 5% CO2 in air for 22 to 24 h) were
fertilized in vitro using capacitated spermatozoa (freshly
ejaculated or frozen-thawed) of 10 bulls. Semen was
simultaneously processed according to the sperm chromatin
structure assay (SCSA) method and was analysed by flow
cytometry. At least 3 replications of IVP with the same semen
sample were done.
Results and Discussion: The percentage of spermatozoa with
abnormal chromatin ranged from 0.4% to 23.8%. Results of IVF
and embryo development to the blastocyst stage correlated
significantly with sperm chromatin abnormalities. When sperm
with low level of abnormal chromatin (0.4% to 1.7%) was used
for IVP the efficiency of blastocyst production was
approximately 30% whereas for sperm with high level of
chromatin abnormalities (23.8%) only 8.8% blastocysts were
obtained. The SCSA method may be used as a practical indicator
of suitability of bull ejaculate for IVP purposes.
P17. Zygote donor nutrition affects ovine fetal development
following in vitro embryo culture.
KD Sinclair1, KA Powell1, TG McEvoy1, CJ Ashworth1, JA Rooke1,
LE Young2, I Wilmut3 & JJ Robinson1. 1SAC, Aberdeen, UK;
2School of Human Development, University of Nottingham, UK;
3Roslin Institute, Roslin, Midlothian, UK.
Introduction: The present study tested the hypothesis that
alterations in donor-ewe nitrogen (N) metabolism during antral
follicle development increases the incidence and severity of
aberrant fetal development following the transfer of in vitro
cultured embryos.
Methods: Zygote donor ewes were offered one of two diets
with no (LN) or supplemental (3%, HN) urea for a 2 week period
during which superovulation and insemination (AI) took place.
Zygotes were recovered 36 h after AI and cultured in synthetic
oviductal fluid medium (SOF) to which steer serum (10% v/v;
SOF+) or albumin (0.4% w/v; SOF-) were added, at 38.5° C under
oil in a humidified atmosphere of 5% CO2 and 5% O2 for 5 days.
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In vivo control (C) blastocysts were recovered from the same
cohort of superovulated ewes. All embryos were transferred
singly to recipient ewes.
Results and Discussion: Plasma urea concentrations prior to
zygote collection were 4.3 and 7.7 mmol/l for LN and HN ewes
respectively (SED = 0.52: P< 0.001). Blastocysts per zygote
cultured were 42.6, 60.9, 42.9 and 73.0% (P<0.01); and Day 125
pregnancy rates were 16/28, 14/35, 16/31, and 6/38 (P<0.001) for
LN/SOF-, LN/SOF+, HN/SOF- and HN/SOF+ respectively. Day
125 fetal weights (mean ± SD) were 3.3 ± 0.37, 3.7 ± 0.67, 4.0 ±
0.82, 3.8 ± 0.83 and 3.6 ± 0.14 kg, for C, LN/SOF-, LN/SOF+, HN/
SOF- and HN/SOF+ respectively. The incidence of heart:fetal
and kidney:fetal weight ratios >3SD above mean of C were 26.7,
29.6, 26.7 and 33.3%; and 46.7, 50.0, 40.0 and 50.0% for LN/SOF-
, LN/SOF+, HN/SOF- and HN/SOF+ respectively. The variance
associated with these two indices of development was between
1.5 to 2.0 times greater for LN/SOF+, HN/SOF- and HN/SOF+
relative to LN/SOF-. Culture without serum can induce aberrant
fetal development, but dietary N background and serum in
culture enhance the incidence and severity of such aberrations.
Funded by Defra.
P18. The effects of hormone stimulation and lamb age on in
vitro production of embryos from prepubertal lambs.
KM Morton1, SL Catt2, WMC Maxwell1 & G Evans1. 1Centre for
Advanced Technologies in Animal Genetics and Reproduction
(ReproGen), Faculty of Veterinary Science, The University of
Sydney, Sydney, Australia; 2Sydney IVF, Sydney, Australia.
Introduction: Developmental competence in vitro is lower in
prepubertal lamb than adult oocytes (O’Brien et al.,
Theriogenology, 47:1433-43, 1997). The effects of stimulation
and lamb age on developmental competence of prepubertal lamb
oocytes were investigated.
Methods: Oocytes were collected from 3-4 week unstimulated
(n=10) and stimulated 3-4 (n=12) and 6-7 week lambs (n=12).
Stimulation consisted of 50 ug Oestradiol Benzoate (Mesalin;
Intervet), a 1.5 mg Norgestomet implant (Crestar; Intervet) left
in situ for 10 days. Seven days after implant insertion lambs
received 400 IU PMSG (Pregnecol; Bioniche Animal Health
Australasia) and 50 mg pFSH (Folltropin-V; Bioniche), and 80
mg pFSH over two days. After 22-26 h maturation, selected
COCs were transferred to SOF plus 2% sheep serum and cultured
with 0.5 x 106 mL-1 spermatozoa (2-3 h). Presumptive zygotes
were transferred to SIVF cleavage and blastocyst media (Cook
IVF, Australia) for 4 and 5 days, respectively. Stimulation and
lamb age effects were determined by comparison of data from 3-
4 week unstimulated and stimulated, and stimulated 3-4 and 6-7
week lambs by ANOVA and Chi2 test (Ethics Approval No. NOO/
9-2002/3/3630).
Results and Discussion: Stimulation increased uterine (4.4 ±
0.4 vs. 11.8 ± 0.4 g) and ovarian (0.7 ± 0.2 vs. 6.3 ± 0.7 g) weight,
number of follicles (29.9 ± 15.3 vs. 70.6 ± 8.2) and total oocytes
(18.3 ± 6.3 vs. 39.3 ± 5.8) per ovary, and oocyte utilisation
(cultured/retrieved, 192/367, 52.3% vs. 661/1000, 66.1%). Lamb
age increased uterine weight (11.8 ± 0.4 vs. 13.6 ± 0.6 g; P<0.05).
Proportion of oocytes cleaving increased with stimulation (17/
192, 8.9% vs. 332/661, 50.2%) and lamb age (332/661, 50.2% vs.
321/562, 57.1%; P<0.05). Blastocyst formation increased with
stimulation (0/17, 0% vs. 135/332, 40.7%) and lamb age (135/332,
40.7% vs.157/321, 48.9%; P<0.05).
These results illustrate the importance of stimulation and lamb
age on in vitro developmental competence of prepubertal lamb
oocytes.
Supported by The Australian Research Council and XY inc.
(Fort Collins, CO, USA).
P19. Secretion of interferon-tau (IFN-t), interleukin-1B (IL-
1B) and leukaemia inhibitory factor (LIF) by ovine pre-
implantation embryos during in vitro culture (IVC).
JA Rooke, M Ewen, ME Staines, GJ McCallum, TG McEvoy &
CJ Ashworth. Animal Biology Division, SAC, Aberdeen, UK.
Introduction: Although RNAs coding for cytokines have been
isolated from ovine pre-implantation embryos produced in vitro,
with the exception of IFN-t, there are few reports of cytokine
protein secretion by ovine embryos. This study quantified
secretion by ovine embryos of IFN-t, IL-1B and LIF at different
stages of IVC using contrasting culture media.
Methods: Using abattoir-derived oocytes and after standard in
vitro maturation and fertilisation procedures, IVC was performed
in modified synthetic oviductal fluid containing either 0.3%
albumin (SOFA) or 10% serum (SOFS). In a preliminary
experiment, groups of oocytes (range 30 to 67; 5 replicates)
were cultured in 0.5 ml SOFA or SOFS (steer serum) in duplicate
and media samples representing days 0-6, 6-7 or 6-8 of IVC
assayed using ELISAs for ovine IFN-t, ovine IL-1B and human
LIF. In a subsequent experiment, after IVC for 6 or 7d in SOFA or
SOFS (sheep serum), 1-14C pyruvate oxidation was measured in
blastocysts which were then cultured individually in 0.05 ml
drops of SOFA or SOFS for a further 48h following which IFN-t
concentrations and cell numbers were determined.
Results and Discussion: Low concentrations of IL-1B (0.2-0.4
ng/ml) and LIF (7-16 pg/ml) were sporadically detected in media
following culture but concentrations were unrelated to stage of
embryo development or culture media. IFN-t concentrations (ng/
ml; s.e.d. 0.56; P<0.001) increased (0.5, days 0-6; 1.6, days 6-7;
5.0, days 6-8) with time in culture and were greater (days 6-8) in
SOFS (7.4) than SOFA (2.8). SOFA blastocysts oxidised more
pyruvate (36 v 22 pmol/blastocyst/3h; s.e.d. 3.1; P<0.001),
produced less IFN-t  (6.0 v 16.1 ng/ml; s.e.d. 0.82; P<0.001) during
48 h incubation and had more cells (133 v 122; s.e.d. 5.0; P<0.05)
than SOFS blastocysts. In conclusion, culture of ovine embryos
in serum increased blastocyst IFN-t production but this was
not related to cell number or pyruvate oxidation.
SAC receives financial assistance from SEERAD.
P20. A pilot prospective trial comparing two commercially
available sequential embryo culture media.
C Leary, K Yallop, M Herbert, A Murdoch & J Fenwick.
Newcastle Fertility Centre at Life, Newcastle Upon Tyne, UK.
Introduction: Here we report a pilot prospective trial comparing
fertilisation rate and embryo quality markers of oocytes and
embryos cultured in Irvine Scientific (IS) or Sydney IVF (Cook)
culture media.
Methods: Consecutive patients undergoing treatment (n=84)
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were allocated alternatively to Cook (n=29IVF/15ICSI) and IS
(n= 16IVF/24ICSI) according to the day of oocyte retrieval.
Pairings were reversed weekly to eliminate patient bias. There
were no differences between the two groups in patient age or
ovarian response. Fertilisation rate (FR); proportion of embryos
cleaving 25h after insemination/injection (EC); Day2 cell number
and morphology score, and proportion of spare embryos forming
blastocysts (BR), were compared. IVF and ICSI cases were
analysed separately using chi-squared, Fishers exact test.
Results and Discussion: There was no difference in FRs of
oocytes inseminated in IS (n=184) compared with Cook
(n=272;68% vs 71.7%). Similarly, the FRs following ICSI did not
differ between IS (n= 188) and Cook (n=142). Similar proportions
of IVF zygotes underwent EC in Cook (19 %) and IS (17%).
However, significantly fewer ICSI zygotes underwent EC in Cook
(5%) compared with IS (27 %;p=0.007). Consistent with this
Cook ICSI embryos had a lower mean cell number on day 2 (2.69
vs 3.53 in IS; p<0.001). Cell number was also lower in IVF embryos
(3.08) in Cook compared with IS (3.32;p=0.05). However, embryo
morphology scores for both ICSI (p<0.0001) and IVF (p=0.016)
were higher in Cook medium. There was no difference in BR of
IVF embryos between Cook (9/49) and IS (22/79). However, BR
of ICSI embryos was significantly (p=0.04) lower in Cook (0/28)
compared with IS (6/40). The data indicate that IS medium, which
has a relatively simple formulation compared with the more
complex Cook medium, supports faster cell division in ICSI
embryos and a higher BR in the population of spare ICSI embryos.
P21. Does the thymus gland follow cyclical variation to
hormonal control?
N Giles & M Legge. Department of Biochemistry, University of
Otago, Dunedin, New Zealand.
Introduction: Previous research has demonstrated that the
absence of the thymus gland results in ovarian dysgenesis and
infertility in mice. However, this link between the reproductive
and immune systems is poorly understood. The objective of
this research was to determine whether the thymus gland and
the ovary had synchronous cycles to hormonal control.
Methods: C57BL/6J mice were staged for oestrous and
metoestrous using vaginal smears (n=10/stage). Thymus glands
and ovaries were dissected from euthanised mice and processed
for frozen histology sections. A second tissue cohort was ‘snap’
frozen for proteomics. Immunohistochemical localisation for
oestrogen, progesterone and FSH receptors was undertaken
using frozen sections and imaged using an Olympus BX40F
microscope with Olympus Utility Software version 3.0. For
proteomic analysis the tissues were homogenised and analysed
using two-dimensional gel electrophoresis on 15% gels.
Results and Discussion: Immunohistochemistry identified a
cyclical variation of hormone receptors in the thymus gland
with tissue specific differences between the cortex and medula.
Induced ovulation altered the abundance of the oestrogen
receptor and tissue distribution pattern of the progesterone
receptor. Electrophoresis identified cyclical changes in protein
expression for both tissues. However, when ovulation was
induced major changes in thymus gland protein expression
occurred which did not correlate with the oestrous cycle. This
study has identified that the thymus gland is selectively
influenced by the ovarian cycle and that induced ovulation
appears to down-regulate protein synthesis in the thymus gland.
These results may have implications for the long term
management of human infertiity and the development of
autoimmune responses.
P22. HSC70 and HSP70 differential expression in
preimplantation porcine embryos exposed to environmental
stress.
C Bernardini, P Fantinati, A Zannoni, M Forni & ML Bacci.
Department of Veterinary Morphophysiology and Animal
Production, University of Bologna, Italy.
Introduction: Heat shock genes are highly conserved in plant
and animal kingdom. HSP synthesis is induced by various
stressors, with heat stress being the most studied. In particular
heat shock proteins 70 are chaperones involved in important
cellular processes and have been classified into inducible
(HSP70) and constitutive (HSC70) forms, even if HSC70
expression is influenced by oxidative stress (Su et al., J Mol Cell
Cardiol, 1999, 31:845). Several studies have analysed the
developmental control of these genes in embryos (Heikkila et
al., Can J Genet Cytol 1986, 28:1093; Luft & Dix, Cell Stress &
Chaperones, 1999, 4:162). Kojima et al. (Mol Reprod Dev, 1996,
43:452) observed HSP70 in pre-implantation heat stress pig
embryos, even if they used an antibody ineffective in
discriminating the HSP/HSC isoforms. The present study aimed
to evaluate the presence of HSC70 and HSP70 in porcine embryos
and to asses if environmental stresses influence their expression.
Methods: Porcine embryos were collected by surgical uterine
horn flushings 2d post AI of superovulated prepubertal gilts.
Oxidative stress experiment: embryos were cultured in humidified
atmosphere (39°C-5%CO2) in the presence of either 5%O2 or air
for 4d. Heat stress experiment: embryos were cultured in
humidified atmosphere (39°C-5%CO2-5%O2) for 3d, then exposed
for 1h to 42°C. Embryos were collected after 14h of recovery.
HSC70 and HSP70 were determined in treated embryos and
control (in vivo and in vitro) by Western Blot analysis.
Results and Discussion: Oxidative stress: HSC70 was clearly
detected in all samples: however a higher expression was
observed in embryos cultured 20%O2. Heat shock experiment:
HSP70 was significantly higher in embryos heat shocked. In
conclusion, porcine embryos express HSP70 and HSC70 at basal
level and differentially respond to oxidative or heat stress thus
up-regulating HSC70 and HSP70 respectively.
P23. Fatty acid content of polar and neutral lipids from bovine
blastocysts produced in vitro in the presence or absence of
serum.
A Reis1,2, JA Rooke1, GJ McCallum1, M Ewen1, ME Staines1,
MA Lomax2 & TG McEvoy1. 1Animal Biology Division, Scottish
Agricultural College, Aberdeen,UK; 2Department of Agriculture
and Forestry, University of Aberdeen, Aberdeen, UK.
Introduction: Fatty acid accumulation is a consequence of
embryo culture in the presence of serum (Reis et al., 2002; Reprod
Abs Ser 28:15), but effects on constituent lipid classes have not
been measured.
Methods: To investigate fatty acid profiles in polar
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(phospholipids plus free fatty acids) and neutral (triglycerides
plus cholesterol ester) lipids following bovine embryo
production in vitro, cleaved zygotes were cultured in Synthetic
Oviduct Fluid, with 0.4% w/v fatty acid-free BSA (SBSA, n=552)
or 10% Adult Bovine Serum (SABS, n=550), from Days 3 to 8
(IVF, Day 0; 9 replicates), and resultant blastocysts (18-25 per
sample; 5 samples per treatment) were assayed. Following lipid
separation into polar and neutral classes (solid-phase extraction;
aminopropyl silica columns), fatty acid composition was
determined by gas chromatography (splitless method).
Blastocyst yields (Generalised Linear Model; binomial
distribution) and fatty acid profiles (ANOVA) were compared.
Results and Discussion: Presence of serum increased blastocyst
yields (SABS vs. SBSA; mean ± s.e.m.: 32 ± 1.6 vs. 25 ± 0.8%;
P<0.01). Total fatty acid content (ng/embryo) was greater in
SABS blastocysts (90 ± 3.4 vs. 69 ± 4.5; P<0.01), reflecting an
increased fatty acid complement in neutral lipids (51 ± 2.6 vs. 41
± 1.9; P<0.01). Fatty acid content in polar lipids did not differ
significantly (37 ± 2.9 vs. 30 ± 1.2 ng/embryo). SABS blastocysts
had a greater polyunsaturated fatty acid (PUFA) complement
(16 ± 0.9 vs. 7 ± 0.8 ng/embryo, P<0.001). Within treatments,
arachidonic acid (C20:4n-6) was more abundant (ng/embryo) in
neutral than in polar lipids (SBSA: 1.3 ± 0.1 vs. 0.3 ± 0.04, P<0.001;
SABS: 2.9 ± 0.3 vs. 0.1 ± 0.05, P<0.001), but docosahexaenoic
acid (C22:6n-3) was more abundant in polar lipids (SBSA: 0.4 ±
0.2 vs. 1.8 ± 0.2, P<0.001; SABS: 0.4 ± 0.1 vs. 3.1 ± 0.4, P<0.001).
These findings indicate that neutral lipids accounted for most
fatty acids accumulated in the presence of serum and also
indicate non-random partitioning of long-chain PUFAs.
Funded by SEERAD; AR supported by Portuguese Ministry of
Science & Technology (Praxis XXI) .
P24. Is assisted hatching of embryos beneficial?
JA Krapez, AC Gordon & SC Gadd. Bath Assisted Conception
Clinic, Royal United Hospital, Bath, UK.
Introduction: Assisted hatching (AH) of embryos has been
used for more than ten years to try to increase pregnancy rates
in women with a poor prognosis for standard IVF treatment. It is
thought AH may be helpful in women of advanced age, with
elevated FSH levels, thickened zonae, or repeated unsuccessful
treatments. Although many studies of AH have been published,
it remains unclear whether the technique confers any benefit.
Since February 2000 it has been our practice to offer AH to
selected women and this report presents a retrospective analysis
of our experience.
Methods: AH was offered to women undergoing IVF or ICSI,
with one or more of the following factors:1: age >38; 2: raised
FSH (> 9.5); 3: two or more previous unsuccessful cycles, and 4:
oocytes with thickened zonae (>15 microns). Written consent
was obtained and hatching performed mechanically just prior to
transfer. Embryos were inspected for damage before replacement.
Data were analysed retrospectively.
Results and Discussion: In all, 39 women were treated (52
treatment cycles). AH was carried out on 122 embryos; damage
was observed in only one embryo. No pregnancies were
achieved for any women over 38 years (15 subjects, 17 treatment
cycles) or with raised FSH (6 subjects, 7 treatment cycles). There
were 7 clinical pregnancies (32% per cycle) in women whose
sole reason for undergoing AH was at least 2 previously
unsuccessful cycles (14 patients, 22 cycles). For those patients
that underwent AH solely due to thick zonae (7 women, 8
treatment cycles) there were 4 clinical pregnancies (50% per
cycle).
Our data suggest that AH confers no advantage in older women
or those with high FSH levels. Our results in women with
recurrent unsuccessful treatments or with thickened zonae are
encouraging but require formal comparison with standard
treatment before AH can be recommended.
P25. Expression and distribution of androgen receptors in first
trimester extragenital fetal tissues.
Y Sajjad1, SM Quenby2, P Nickson2, DI Lewis-Jones1, 2 & G Vince3.
1Reproductive Medicine Unit, Liverpool Women’s Hospital,
Liverpool, UK; 2Department of Obstetrics and Gynaecology,
University of Liverpool, Liverpool, UK; 3Department of
Immunology, University of Liverpool, Liverpool, UK.
Introduction: Androgen receptor (AR), belongs to the nuclear
receptor family, a ligand-responsive transcription regulator.
Androgens act via AR, to promote differentiation, development
and maintenance of reproductive tissues. Animal experiments
show AR are expressed in a wide variety of tissues and cell
types. We investigated AR expression in the developing
extragenital tissues of the human first trimester fetus.
Methods: Human fetal tissues was collected from the women
undergoing therapeutic termination of pregnancy, with informed
consent. Ethical approval was granted by the local ethical
committee. AR distribution in the extragenital organs was
examined by immunohistochemistry in embryos from 8-12 weeks
gestation. PCR was used to determine the sex of the samples
used.
Results and Discussion: There was no difference in the
distribution of AR in male and female embryos at any gestational
age in all these organs examined. Total of 54 fetal samples were
analysed for different extragenital organs.
Spinal cord: AR was positively identified in the spinal cord
Hands: AR were observed in the mesenchyme of the
intermetacarpal clefts of the hands. At 8 weeks the staining was
observed in 80% of the samples analysed. At 9, 10 and 11 weeks
staining was only seen in 10 % of the samples. At 12 weeks no
AR staining was observed.
Lungs: AR was localised within the epithelium of the developing
and branching bronchi whilst the surrounding mesenchyme was
free of any staining.
Heart: AR was seen in the heart valves. Whilst the surrounding
muscle was free of any staining.
Thymus: Diffuse staining of AR was seen throughout both the
lobes. Approximately 50 % of the cells were positively stained.
Its not possible to differentiate by light microscopy between
thymic epithelial cells or thymocytes.
No AR staining was observed in the Kidney and Adrenals.
The presence of AR in all these organs suggest that AR may
play a role in cellular growth in addition to its role in genital tract
sexual differentiation.
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P26. Oocyte biochemical modification as a result of
cryopreservation.
M Legge & N Giles. Department of Biochemistry, University of
Otago, Dunedin, New Zealand.
Introduction: Despite extensive modification of oocyte
cryopreservation procedures successful long-term storage and
functional recovery is still poor. As part of our research
programme investigating cryoprotectant agents (CPAs)
formulation we are determining the biochemical interaction
between cryoprotectants and oocytes. In this presentation we
report the effects of dimethyl sulphoxide (DMSO) and 1,2-
propanediol (PROH) an cortical granule stability, redox indicators
and reactive oxygen species.
Methods: DMSO and PROH were investigated at concentrations
of 1 to 4M in PBS. Oocytes were collected from C57BL/6J mice
following induced ovulation with PMSG and hCG given 48 hours
apart. Oocytes were assessed pre- and post-cryoprotectant
exposure. Cortical granule integrity was established using FITC-
labelled Lens culinaris and fluorescence microscopy. Reduced
glutathione (redox indicator) was determined using
monochlorodihydrobimine and reactive oxygen species (ROS)
determined using dichlorodihydroxyfluorescein. Both were
determined using fluorescence microscopy.
Results and Discussion: At the CPA concentrations
investigated cortical granule location and integrity was not
affected. However, reduced glutathione decreased with
increasing concentrations of both CPAs but ROS generation
did not increase with CPA exposure. The retention of cortical
granule integrity following CPA exposure casts doubt over the
hypothesis that exocytosis occurs following CPA exposure and
lends support to the proposal that the CPA interacts with the
zona pellucida to cause the zona pellucida hardening effect.
The loss of reduced glutathione would significantly alter the
oocyte intracellular redox status, which could compromise
viability, however, in the absence of ROS generation by the
CPAs alternative mechanisms for glutatione reduction by CPAs
need to be considered.
P27. Fertility risk factors causing breast cancer.
R Mohammadi1, F Kashfi1, 2, A Nikoofar2 & F Hossani2.
1Department of Health, Nursing and Midwifery Faculty, Medical
Sciences University, Tehran, Iran; 2Health Care Centers Related
to Ministry of Health and Medical Education in Tehran, Iran.
Introduction: Next to lung cancer,breast cancer is the second
cause of mortality among women.Although the prevalence of
this disease has been increased, but the rate of mortality has
not been changed during last three decades.The aim of this
study is to determine fertility risk factors of breast cancer in
women.
Methods: This research is a case-control study which was
performed in 1999 on three educational treatment centers related
to Ministry of Health and Education in Tehran. Personal, fertile
characteristics in women with breast cancer were determined
and compared with control group. 120 patients with breast cancer
were selected randomly and compared with 120 healthy women.
Results and Discussion: Majority (70%) of women with breast
cancer were between 35 to 54 years old and there was significant
relation between marital status and breast cancer (P<0.006).
There was not any relation between cancer and age of first
menstruation,marriage age,number of pregnancy,age of first and
last pregnancy, history of multiple pregnancy, history of breast
feeding, duration of using OCP and age of menopause.But there
was significant relation between number of abortion (P<0.046).
In this study, risk factors of breast cancer were marital status,and
there was a weak relation between number of abortion and breast
cancer.
Unfortunately some of this factors are not preventable, but for
those factors which are managable,proper program should be
provided in order to make people aware of risk factors and ways
of their prevention.
P28. Proteomic patterns in peritoneal fluid of infertile women
with endometriosis.
S Ferrero1,2, DJ Gillott1, P Anserini2, V Remorgida2,
R Navaratnarajah1, KM Price1, N Ragni2 & JG Grudzinskas1.
1Department of Obstetrics and Gynaecology, St Bartholomew’s
School of Medicine and & Dentistry, QMW College, London,
UK; 2Department of Obstetrics and Gynaecology, San Martino
Hospital, University of Genoa, Italy.
Introduction: Cellular and humoral components of peritoneal
fluid (PF) may participate in the development of endometriosis
and affect fertility. The aim of this study was to evaluate the
peritoneal environment in infertile women with endometriosis
by establishing 2-dimensional polyacrylamide gel
electrophoresis (2D-PAGE) protein maps.
Methods: PF was obtained from 3 infertile women with
endometriosis and from 2 women with unexplained infertility
without evidence of endometriosis to use as controls. All
samples were collected during the luteal phase of the menstrual
cycle. 2D-PAGE was performed on PF samples. The gels were
digitally captured and Phoretix 2D software was used to compare
the protein spots detected on silver stained gels. The volume of
each spot was calculated by considering spot area and staining
intensity. The quantification of each spot of interest was
expressed as normalized percent volume (%V = spot volume /
volume of all spots in the gel). Protein spots were characterised
in terms of their molecular weight and isoelectric point.
Results and Discussion: A mean number of 371 ± 30 protein
spots per gel was detected in the peritoneal fluid of infertile
women with endometriosis. All the protein spots present in PF
of women with endometriosis were apparently present in PF of
women with unexplained infertility. The intensity of two protein
spots appeared significantly higher in infertile women with
endometriosis when compared with patients with unexplained
infertility (p <0.05).
To our knowledge, these preliminary data define for the first
time the proteome of PF in infertile women with endometriosis
and in women with unexplained infertility. We believe that the
systematic application of proteomics technology to the analysis
of PF may provide new information regarding the pathogenesis
of infertility in women with endometriosis.
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P29. Protein expression of steroidogenic enzymes in ovarian
follicular cysts of dairy cows.
M Fenech1, M Lopez-Bejar1, F Lopez-Gatius2, CJ Corbin3,
SM Mapes3 & AJ Conley3. 1Department of Animal Health and
Anatomy, Veterinary Faculty, Universitat Autonoma de
Barcelona, Bellaterra, Spain; 2Department of Animal Production,
School of Agricultural Engineering, Universitat de Lleida, Lleida,
Spain; 3Department of Population Health and Reproduction,
School of Veterinary Medicine, University of California, Davis,
US.
Introduction: Cystic ovarian disease is an important cause of
reproductive failure and economic loss for the dairy industry.
Dairy cows with ovarian cysts are thought to have higher
concentration and pulse frequency of LH (Cook et al., 1991; J
Reprod Fertil 91:19-28) that could affect the steroidogenic
competence of recruited follicles. The objective of this study
was to compare protein expression of the steroidogenic enzymes
P450c17, cytochrome b5, P450aromatase, NADPH-
P450reductase and 3βHSD in ovarian follicular cysts and normal
dominant follicles.
Methods: Ovaries were obtained from a commercial abattoir and
were fixed in 4% paraformaldheyde. Ovarian follicular structures
larger than 25 mm in absence of corpus luteum were considered
to be a dominant cyst (DC; 37.7 ± 8.7 mm). Large antral follicles
in cystic ovaries were considered young cysts (YC; 23.2 ± 6.9
mm). Dominant follicles (DF) showed a mean diameter of 16.2 ±
1.6 mm. The protein expression was detected by
immunohistochemistry.
Results and Discussion: Expression of P450c17 and its allosteric
regulator, cytochrome b5, were evident in the theca interna of
small antral follicles, and the staining intensity and percentage
of positive cells were highest in DC, YC and DF. Staining intensity
of P450aromatase and the redox partner protein, NADPH-P450
reductase, was strong in granulosa cells of DC, YC and DF. The
immunostaining for 3βHSD was mainly localized in the granulosa
layer and less intensely in the theca interna of DC, YC and DF.
There were no significant differences in the staining intensity
and the percentage of positive cells among DC, YC and DF for
the analysed steroidogenic enzymes, in agreement with Calder
et al. (2001; Biol Reprod 65:471-476) in relation to mRNA
expression of P450c17, P450aromatase and 3βHSD. These results
suggest that an alteration of follicular steroidogenic competence
is not involved in the development of ovarian cysts of follicular
origin.
P30. Frequency of a vascular endothelial growth factor
polymorphism (G-634C) and IVF outcome.
H McCallum1, S Bhattacharya1, H McBain1, G Hoad2,
K Andrews2, C Openshaw1, DM Campbell1 & P Haggarty1,2.
1Department of Obstetrics and Gynaecology, University of
Aberdeen, Aberdeen, UK; 2Rowett Research Institute,
Aberdeen, UK.
Introduction: Angiogenesis within the ovary and endometrium
is required for maturation of follicles, delivery of nutrients to the
developing oocyte and the process of implantation. Vascular
endothelial growth factor (VEGF) is an important regulator of
angiogenesis and the G-634C polymorphism within the within
the 5'-untranslated region of the VEGF gene is associated with
altered VEGF synthesis. The aim of this study was to compare
the frequencies of the G-634C polymorphism in a fertile and
infertile population and to relate the frequency to the nutrient
composition of follicular fluid (FF) and IVF outcome.
Methods: Ethical approval for the study was granted by
Grampian Research Ethics Committee. DNA obtained from a
mouthwash sample was genotyped using Taqman technology
in women undergoing IVF (n = 257; age 34 SD 0.3yrs) and those
conceiving naturally (n = 171; age 29 SD 6yrs). Standard IVF
techniques were used in the infertility group and a maximum of
2 embryos were transferred. The nutrient composition (B
vitamins, amino acids, glucose, total lipid) of FF was determined
by HPLC, radio- and enzymatic assays. Statistical significance
of differences in genotype frequencies was assessed by chi-
squared test.
Results and Discussion: The frequency of carriers of the C
allele (GC/CC) within the infertile population (47.3%) was similar
to that in the fertile population (53.8%). There were, however,
significant differences in relation to IVF outcome. The frequency
of carriers of the C allele was 50.0% in women not conceiving
(n=190), 29.8% where one fetal heart was detected (n=47) and
60.0% where two fetal hearts were detected (n=20) (p=0.022).
There was no significant relationship between VEGF genotype
and the FF concentration of nutrients. The association between
VEGF genotype and IVF outcome is deserving of further study
and may lead to improvements in the treatment of fertility.
Study supported by a CSO project grant.
P31. Dietary determinants of the concentration of homocysteine
in follicular fluid.
K Andrews2, S Bhattacharya1, H McBain1, H McCallum1,
G Hoad2, S Duthie2, G McNeill3 & P Haggarty1,2. 1Department of
Obstetrics and Gynaecology, University of Aberdeen, Aberdeen,
UK; 2Rowett Research Institute, Aberdeen, UK; 3Department of
Occupational Medicine, University of Aberdeen, Aberdeen, UK.
Introduction: Folate and vitamin B12 are essential components
of the folate/methionine cycle which underpins DNA synthesis
and methylation. Homocysteine is a by-product of the cycle
and an inhibitor of angiogenesis. The folate used by the pre-
implantation embryo is thought to be already present in the
oocyte. The aim of this study was to determine the relationship
between the dietary intake of Folate and B vitamins and the
concentration of folate, vitamin B12 and homocysteine in the
plasma and follicular fluid (FF).
Methods: Ethical approval for the study was granted by
Grampian Research Ethics Committee. FF was collected at oocyte
recovery in women undergoing IVF treatment (n=290). A self-
administered validated food frequency questionnaire was used
to estimate the dietary intake of folate and B12 from natural
foods and supplements. Folate and vitamin B12 were determined
by Simultrac Radioassay Kit. Homocysteine was measured by
reverse phase HPLC using a DS30 Hcy Homocysteine Kit. The
strength of associations was determined by multiple linear
regression using SPSS statistical package.
Results and Discussion: The FF concentration of homocysteine
was influenced by the energy adjusted intake of vitamin B12
and folate (adj r2=12%; p<0.001). The concentration of
homocysteine in follicular fluid was linearly related to that in the
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plasma (adj r2=53%; p<0.001) but the range within the plasma
was greater than that in the follicular fluid suggesting that the
follicular fluid homocysteine may be derived from the plasma.
The concentration of vitamin B12 and folate in the plasma is
only weakly related to the energy adjusted intakes of these
nutrients; adj r2=2%; p=0.026 for vitamin B12; adj r2=2%; p=0.041
for folate. The results suggest that the activity of the folate/
methionine cycle and the concentrations of homocysteine in
the follicular fluid are affected by the dietary intake of folate and
vitamin B12.
Study supported by CSO.
P32. Embryo development of prepubertal goat oocytes treated
prior to in vitro maturation with roscovitine.
AR Jimenez-Macedo, D Izquierdo, A Urdaneta & MT Paramio.
Ciencia Animal i dels Aliments, Universitat Autonoma de
Barcelona, Barcelona, Spain.
Introduction: The low number of embryos obtained from IVM-
IVF-IVC oocytes of prepubertal goats is caused by abnormal or
incomplete cytoplasmic maturation (Izquierdo et al. 1998).
Roscovitine (ROS) is a purine known to inhibit MPF kinase
activity and maintains the oocyte at Germinal Vesicle (GV). The
objective of this study was to evaluate if oocytes cultured with
ROS, before IVM, were capable to acquire greater developmental
competence.
Methods: Ovaries from 45-days old goats were collected at
slaughterhouse. Oocytes were cultured at concentrations of 0,
12.5 and 25 microM of ROS for 24 h (Mermillod et al., 2000). A
sample of oocytes was stained to evaluate the nuclear stage
and the rest of oocytes were placed in IVM medium (Rodriguez
et al. 2000) for 24 h. The control group was IVM-oocytes not
cultured previously. IVM-oocytes were fertilized with fresh
semen selected by swim-up and diluted 1:1 in mDM (Younis et
al, 1991) containing 200nM of ionomycin and 10 microgrames/
ml of heparin and incubated for 15 min (Wang et al., 2002).
Following 24 hour of sperm exposure, a sample of oocytes was
fixed to assesses the fertilization and the rest of oocytes were
cultured 7 days more in SOF (Tervit et al, 1972).
Results and Discussion: Oocytes cultured with ROS and arrested
at VG stage were 11 and 14% for concentration of 12.5 and 25
microM, respectively. The oocytes correctly fertilized (2
pronucleus) were 33.3, 39.2, 47.4 and 44.9% ( 0, 12.5, 25 microM
of ROS and control oocytes, respectively).The total embryos
produced were 54.7, 42.0, 46.1 and 48.2% (0, 12.5, 25 microM of
ROS and control oocytes, respectively).In conclusion ROS has
been unable to block GVBD in these oocytes however, there
were no differences in embryo development between oocytes
cultured for 48 h and 24 h prior to fertilization.
P33. Does oestradiol act on bovine oocytes via a plasma
membrane receptor?
AR Beker, B Colenbrander & MM Bevers. Department of Farm
Animal Health, Faculty of Veterinary Medicine, Utrecht
University, Utrecht, The Netherlands.
Introduction: Classically, oestradiol (E2) exerts its function by
binding to intracellular receptors and activating gene
transcription and protein synthesis (genomic pathway).
Additionally, a plasma membrane E2 receptor (non-genomic
pathway) has been described in a wide range of cell types. We
recently reported that E2 has a detrimental effect on in vitro
nuclear maturation of bovine oocytes (Beker et al. 2002;
Theriogenology 58: 1663-1673). However, the mechanism by
which E2 exerts this effect remains unclear. The aim of this study
was to investigate whether the effect of E2 on nuclear maturation
of bovine oocytes is exerted via a plasma membrane receptor.
Therefore, the effects of free E2 and E2 conjugated with bovine
serum albumin (E2-BSA; which cannot cross the plasma
membrane of living cells), were compared.
Methods: Cumulus-oocyte complexes were aspirated from 2-
8mm follicles of slaughtered cow ovaries, denuded and
incubated in: 1) TCM199 + 6.9 ug/ml BSA (Control; n=588); 2)
TCM199 + 8.3ug/ml E2-BSA conjugate (n=641) or 3) TCM199 +
1ug/ml E2 + 6.9ug/ml BSA (n=336), at 39°C and 5% CO2. After
22h of maturation, oocytes were fixed and the nuclear stage was
assessed after DAPI staining. Results were analyzed using Chi-
square tests.
Results and Discussion: The presence of E2-BSA conjugate
during IVM did not affect (P>0.05) the percentage of oocytes in
GV, MII or nuclear aberrations (respectively 5.3; 57.6 and 3.1%
vs 5.1; 62.4; and 5.1% for the control group). However, free E2 +
BSA (not conjugated) during IVM reduced the percentage of
MII oocytes (14.0%; P<0.0001) and increased the percentage of
GV and nuclear aberrations (24.7 and 8.6%, respectively; P<0.05).
In conclusion, the detrimental effects of E2 on nuclear maturation
of bovine oocytes were only observed when E2 was present in
the free form and not as E2-BSA conjugated, suggesting that E2
does not exert its action via a plasma membrane receptor.
P34. The effect of different pre-mating nutritional regimes on
ovulation rate, oocyte maturation and embryo survival in the
pig.
EM Ferguson1, J Slevin2, MG Hunter2, SA Edwards3 &
CJ Ashworth1. 1Department of Animal Biology, SAC, Aberdeen,
UK; 2University of Nottingham, Loughborough, UK; 3University
of Newcastle, Newcastle Upon Tyne, UK.
Introduction: This study describes the effect of different pre-
mating nutritional regimes varying either in feed intake levels or
specific dietary components on embryo survival and oocyte
maturation rates in LW x LR gilts.
Methods: In experiment 1, gilts received either maintenance (M),
1.8xM, or 2.6xM of a complete diet or M + starch, M + potato
protein or a high fibre (HF) diet (n=10 gilts/diet) from day 1 of
their third oestrous cycle until they were artificially inseminated
in the following cycle. Following slaughter on day 27-30 of
pregnancy, corpora lutea (CL) were counted and weighed. Each
foetus was weighed and measured. Experiment 2 investigated
whether the increased embryo survival following the HF diet
was related to an alteration in oocyte maturation rates. Gilts
were fed, either HF or 1.8xM (control (C)) and either slaughtered
on day 19 or 30 days after insemination. Day 19 oocytes were
matured in vitro for 46 hours at 38.8oC in 5% CO2 in air with 10%
of their own follicular fluid, fixed and stained to determine the
stage of nuclear maturation. Data were analysed by ANOVA
with ovulation rate as a co-variate.
Procedures accorded with A(SP) A following local ethical
approval.
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Results and Discussion: In experiment 1, gilts fed the HF diet
had the highest number of viable foetuses and percentage ES
with values of 14.4 ±-0.4 and 89.2% ± 2 respectively. HF and C
results were combined for experiments 1 & 2. Percentage ES was
85.2% ± 3.3 vs 76.7% ± 3.0 (P < 0.05) for HF compared to C diets,
respectively. Mean foetus and CL weights were similar for both
diets. More oocytes from HF gilts matured in vitro compared to
C gilts (77.3% ± 2.1 (n=12) vs 68.4% ± 2.7 (n=12, P=0.033))
respectively. The results indicate that the improved embryo
survival is via an alteration to the oocyte.
Supported by Defra, MLC and JSR Healthbred Ltd in the LINK
Sustainable Livestock Production programme.
P35. Possible involvement of F-actin in rat egg activation.
A Tsaadon, E Eliyahu & R Shalgi. Department of Cell and
Developmental Biology, Tel Aviv University, Tel Aviv, Israel.
Introduction: Various studies suggest a possible involvement
of protein kinase C (PKC) in egg activation in general, and in
cortical reaction (CR) in particular. PKC has been shown to be
associated with cytoskeletal components and/or to
phosphorylate them. In other cells filamentous actin (F-actin) is
suggested to act as a barrier to exocytosis by excluding
secretory vesicles from the plasma membrane, but the exact
mechanism of microfilament function in exocytosis is still elusive.
We examined the involvement of F-actin in CR
Methods: Expression of actin in mature (MII) rat eggs and in
TPA (12-O-tetradecanoyl-phorbol-13-acetate) activated eggs,
by using Western blot analysis. Distribution of actin in the eggs
was monitored by immunohistochemistry using confocal
microscopy.
Results and Discussion: We found no difference in the amount
of total actin, in MII eggs as compared to TPA activated eggs,
and that the isoenzyme PKC alpha interacts with actin in both
MII and TPA activated eggs. Actin filaments in MII eggs are
localized at the cortex, mainly above the meiotic spindle, and are
homogeneously distributed throughout the cytosol. Upon TPA
activation, we observed a decrease in actin labeling, correlated
with the duration of incubation. Treating the eggs with drugs
that polymerize and depolymerize actin [Jasplakinolide (JAS)
and Cytochalasin D (CD), respectively] did not induce CR in the
eggs. Treatment with CD or JAS followed by activation with
TPA did not prevent the eggs from undergoing CR. However,
treating MII eggs with CD and then activating them with TPA,
resulted in an increase in the number of cortical reacted eggs,
compared to that of eggs treated with TPA alone. JAS did not
cause a similar effect.
Our results raise the possibility that in response to activation
by TPA, actin severing proteins and/or PKC are activated. This,
in turn, may cause a remodeling of the cortical microfilamentous
actin that is ultimately required for CR.
P36. The involvement of Src family kinases in egg activation
R Tomashov-Matar, A Talmor-Cohen, R Kaplan-Kraicer &
R Shalgi. Department of Cell and Developmental Biology, Tel
Aviv University, Tel-Aviv, Israel.
Introduction: The transition from egg to embryo in mammals,
known as ‘egg activation’, is initialized by the fertilizing
spermatozoon through a series of Ca2+ transients. The early
activation events following the Ca2+ rise are exocytosis of the
cortical granules (CGE), which establishes the block to
polyspermy, and resumption of the cell cycle (RM). Src family
kinases (SFKs) are expressed in eggs of invertebrates and of
some vertebrates. The hypothesis that SFKs are necessary and
sufficient for triggering Ca2+ transient at fertilization is well
supported in marine invertebrates eggs but not in mammalian
eggs.
Methods: Expression of c-Src, c-Yes and Fyn was demonstrated
by western blot analysis. Localization of these SFKs was
revealed by immunofluorescence confocal microscopy.
RM was monitored by separation of the chromosomal diads
using Hoechst 33342 dye; CGE by Lens Culinaris Aectin (LCA)
conjugate to Texas Red using confocal microscopy.
Results and Discussion: c-Src, c-Yes and Fyn are expressed in
rat eggs. The three proteins are distributed throughout the egg
cytoplasm. Fyn and c-Yes concentrates at the egg cortex as
well, while only Fyn is localized to the spindle. Localization of
the three SFKs members is not changed upon egg activation.
When activating the eggs by ionomycin in the presence of SFKs
inhibitors (PP2, SU6656) the RM is blocked in a dose dependent
manner but not the CGE. These results imply that SFKs are in
the pathway triggered by the Ca2+ rise leading to RM but not to
CGE. The possible involvement of SFKs in the pathway within
the rat egg, leading from the sperm-egg fusion up to the Ca2+
rise remains unclear.
P37. Body composition and dietary energy intake affect
folliculogenesis, oocyte quality and early embryo development
in cattle
SJ Adamiak1,2, K Mackie1, KA Powell1, RG Watt1, DF Doleman1,
R Webb2 & KD Sinclair1. 1SAC, Craibstone Estate, Aberdeen,
UK; 2School of Biological Sciences, University of Nottingham,
UK.
Introduction: The present study sought to determine the effects
of alterations in body composition and dietary energy intake in
heifers on systemic concentrations of insulin, oocyte quality
and subsequent embryo development in vitro.
Methods: In a 2x2 factorial experiment, 24 beef x dairy heifers of
low (2.0 units (L)) or high (3.5 units (H)) body condition (scale 1-
5 units) were fed at maintenance (M) or twice maintenance (2M)
for a 9-week period in the spring and again in the autumn of
2002. Cumulus-oocyte-complexes (COCs) were retrieved from
heifers by transvaginal ultrasound guided follicular aspiration
on Days 5 and 12 of three successive oestrous cycles in each
season. Individual animal identity was retained whilst these
COCs were matured, fertilised and cultured in vitro in synthetic
oviductal fluid medium with BSA (0.4% w/v) at 38.5°C under oil
in a humidified atmosphere of 5% CO2 and 5% O2 for 6 days.
Results and Discussion: Mean (± SEM) plasma insulin
concentrations 2 h after feeding during the experimental periods
were 10.8 ± 0.66, 22.2 ± 0.93, 18.2 ± 1.09 and 42.1 ± 2.22 mIU/l for
LM, L2M, HM and H2M respectively (P<0.01). The mean number
of medium and large follicles 4 days prior to ovulation were 3.6
± 0.38, 4.5 ± 0.32, 3.9 ± 0.34 and 5.3 ± 0.5 (medium; P<0.05) and 0.8
± 0.11, 1.4 ± 0.19, 1.2 ± 0.22 and 1.8 ± 0.28 (large; P<0.05) for LM,
L2M, HM and H2M respectively. The cleavage rates of oocytes
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from aspirated follicles was 65.3% and was unaffected by
treatment. Mean blastocyst yields of 12.5, 25.3, 20.5 and 17.3%
for LM, L2M, HM and H2M respectively were not significantly
different. However, blastocyst yields changed over time for L2M
and H2M (b = 0.25 and -0.45 respectively; P=0.05), but not for
LM and HM (b = -0.05 and 0.02 respectively). Thus, high plane
feeding, whilst beneficial for follicular development, is detrimental
to oocyte quality in high condition animals.
Funded by Defra. Presenting Author is supported by the Perry
Foundation.
P38. Inhibition of both histone deacetylase and DNA
methyltransferase induces maternal chromatin demethylation
after fertilization in mouse oocytes.
M Spinaci1, C Cappannari1 & M Mattioli2. 1University of Bologna,
Italy; 2Dipartimento Scienze Biomediche Comparate, University
of Teramo, Italy.
Introduction: Immediately after fertilisation an asymmetric
remodelling of parental chromatins is performed by the ooplasm.
Acetylated histone H4 is rapidly introduced into male chromatin
and paternal DNA is actively demethylated within 4h. On the
contrary, acetylation of histone H4 in maternal chromatin is slow
and genome wide demethylation of female DNA occurs in a
replication dependent mechanism after the two-cell-embryonic
stage (Santos et al., Dev. Biol. 241:172, 2002). The aim of this
research was to examine the role and the mutual regulation of
the ooplasmic enzymes involved in chromatin remodelling and
to study the resistance of maternal DNA to active demethylation.
Methods: Mouse oocytes were treated during IVM and IVF
with Trichostatin A (TSA), a reversible HDAC inhibitor, or 5-
Azacytidine (5-AzaC), a methyltransferase inhibitor, or with a
combination of these drugs. Modifications of global methylation
patterns of parental genomes were evaluated using
immunofluorescent labelling of 5-methyl-cytosine.
Results and Discussion: Eggs treated with both the inhibitors
were characterized by a dramatic reduction of maternal DNA
methylation after fertilization. Four hours after fertilization 5-
methyl-cytosine signal observed in female pronucleus was
similar to that recorded in the normally demethylated male
pronucleus. Similar results were obtained treating oocytes with
TSA during IVM and TSA + 5-AzaC during IVF. We can
hypothesize that the treatment with both TSA and 5-AzaC
induces an hyperacetylation of histones, resulting in opening
of chromatin structure permitting the access to demethylating
enzymes, associated with an inibition of methyltransferase that
might be no more able to maintain normal methylation pattern.
This might offer an explanation for the lack of any effect using
5-AzaC or TSA alone. Further investigations on the relationship
between DNA methylation and histone deacetylase activity are
needed and may have applied implications in aberrant
reprogramming conditions like in cloned preimplantation
embryos.
Work supported by MIUR-COFIN and ‘Progetto Pluriennale
di Ateneo’.
P39. Expression of DNA demethylase in mouse oocytes
correlates with the maturation-acquired ability to demethylate
paternal chromatin.
A Zannoni, M Forni & M Spinaci. Department of Veterinary
Morphophysiology and Animal Production, University of
Bologna, Italy.
Introduction: Paternal chromatin demethylation after fertilization
is a well described event in mouse and is consistent with the
hypothesis that an active demethylase is present in the oocyte
even if the nature of the enzyme involved is not fully defined to
date (Oswald et al., Curr. Biol. 2000, 10:475).
The aims of this research were to assess demethylase expression
in mouse oocytes and to verify if the demethylase expression
changes during meiotic maturation together with the oocyte
ability to modify global methylation of sperm DNA.
Methods: Germinal vesicle (GV) and metaphase II (MII) oocytes
were obtained from CD-1 female mice. GV oocytes, after break
down of nuclear envelope (GVBD), and MII oocytes were
fertilized in vitro. Modifications of global methylation patterns
of parental genomes were evaluated using immunofluorescent
labelling of 5-methyl-cytosine.
To detect dMTase expression RNAs extracted from groups of
100 oocytes were submitted to RT-PCR analysis utilising human
primers (Hattori et al., Cancer Letters 2001, 169:155). Data were
reported as arbitrary units (AU) respect to mouse B-actin.
Results and Discussion: After fertilization of MII oocytes the
pattern of maternal DNA methylation remained constantly
intense while paternal genome demethylation was completed
within 4h from fertilization. When oocytes were fertilized shortly
after GVBD parental genome remained fully methylated. dMTase
expression was low in GV oocytes (15.62 AU) , increased in MII
ones (46.48 AU) and reached the maximum in MII fertilized
oocytes (63.68 AU). Demethylase seems therefore to be
expressed in mouse oocytes and its expression seems to correlate
with the maturation stage. These findings, together with the
modification of global methylation pattern, let us to hypothesize
that paternal demethylation is performed by a dMTase even if
different data have been reported by others (Santos et al., Dev
Biol. 2002, 241:172).
Work supported by MIUR-COFIN and ‘Progetto Pluriennale
di Ateneo’.
P40. Localisation of RII-PKA, ER and mitochondria in mouse
oocytes.
RJ Webb, R Zeineldine, G FitzHarris & J Carroll. Department of
Physiology, Univeristy College London, London, UK.
Introduction: It has recently been shown that the RI and RII
isoforms of the regulatory subunit of Protein Kinase A (PKA)
are present in mouse oocytes. PKA-RII is known to associate to
A Kinase Anchoring Proteins (AKAPs) on a number of
intracellular structures, including the endoplasmic reticulum (ER),
mitochondria and golgi. In oocytes the RII subunit localises
around the peri-nuclear region of the germinal vesicle (GV). The
aim of this study is to identify the structure which binds the
oocyte RII subunit.
Methods: GV oocytes were recovered from gonadotrophin
primed MF1 mice, half of which were maintained in arrest with
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IBMX (200uM) and half left to undergo GVBreakdown (GVBD).
They were then microinjected with the rhodamine labelled RII
subunit (Rh-RII), or the lipophilic ER marker DiI18. The
mitochondria were labelled by incubation in
tetramethylrhodamine ethyl ester. The cells were then scanned
using a confocal microscope.
Results and Discussion: In GV stage oocytes, Rh-RII was
localised in a ring around the GV with some punctate distribution
throughout the cytoplasm. This was similar to the distribution
of mitochondria and ER. However, in oocytes that had
undergone GVBD, only the punctate distribution of the Rh-RII
subunit in the cytoplasm remained. In contrast, the ER and
mitochondria accumulated around the developing 1st meiotic
spindle. Although the distribution of the RII subunit shares a
similar pattern to both ER and mitochondria in GV oocytes, after
GVBD the distributions are markedly different. From these data
we suggest that RII-PKA is not bound to the ER or mitochondria
in mouse oocytes or that during GVBD RII-PKA is redistributed.
P41. Endonuclease activity in MII mouse oocytes.
A Zannoni, M Spinaci, ML Bacci & M Forni. Department of
Veterinary Morphophysiology and Animal Production,
University of Bologna, Italy.
Introduction: Recent data show that MII mouse oocytes are
able to activate a rigorous checkpoint of DNA damage which
could be influenced by DNA parameters as exogenous DNA
concentration, methylation status, DNA association with
secondary components (Perry, 2000 Mol Reprod Dev 56:319).
This work aimed to evidentiate the presence of endonuclease
activity in MII mouse oocytes.
Methods: Exogenous DNA detection after microinjection -
Groups of 10-20 MII CD-1 mice oocytes were microinjected with
up to 10pl of pEGFP plasmid (Clontech) 2ug/µl normal or fully
metilated by Sss I. After injection MII oocytes were incubated
for 15 min. at 37°C. Control MII oocytes were immediately frozen.
After lysis, DNA was amplified by PCR with specific primers for
pEGFP. Products were separated on agarose gel.
Zymography - Total protein extracts from 50-100 MII CD-1 mice
oocytes were loaded onto standard PAGE gels (12%) with calf
thymus DNA (250 ug/ml). After electrophoresis gels were stained
with ethidium bromide and viewed on a UV transilluminator.
Ca2+ (2mM) and Mg2+ (5mM) were then added to activate
endonuclease. The gels were incubated at 37°C and
endonuclease activity was recorded daily for a week.
Results and Discussion: After incubation only 4.57% of
microinjected exogenous DNA was detectable. Methylation
partially protected DNA from degradation increasing the
percentage of residual DNA up to 16%.
The zymography showed, after 4 days of incubation, a clear
band of enzymatic activity in MII extract comparable in molecular
weight with purified DNase I control. These findings are
consistent with the presence in MII mice oocytes of a DNase I
like activity. Moreover, in mice zygotes DNA breaks in the
decondensing sperm head are reported and are interpreted as a
transient process of chromatin rearrangement (Kriessling and
Markoulaki, 2000, Mol. Reprod. Dev. 56:271). This period could
allows a great opportunity for exogenous DNA to be integrated
in the zygote genome.
P42. In vivo maturation of porcine oocytes in relation to the
preovulatory LH surge.
W Khalil1, C Wrenzycki2, J Reischl1 & W Holtz1. 1Institute of
Animal Husbandary and Genetics, University of Goettingen,
Goettingen, Germany; 2Department of Biotechnology, Institut
fuer Tierzucht, Marriensee, Germany.
Introduction: With the intention to establish suitable conditions
for in vitro production of porcine embryos, the processes of in
vivo maturation, both nuclear and cytoplasmic, were studied.
Methods: Blood samples were taken from 59 nulliparous
Goettingen miniature pig sows at 2 h intervals to pinpoint the
preovulatory LH surge. Ovaries were removed after slaughter
before (control) or up to 10, 20, 30 or 40 h after the LH surge (10
to 13 animals each). Oocytes were aspirated from follicles less
and more than 4 mm in diameter. Ovulated oocytes were
recovered from the oviduct. One half of the oocytes was stained
with orcein to assess nuclear maturation. The other half was
used for semi-quantitative RT-PCR for mRNA content of genes
CDC2, Cyclin B, ERK2 and c-mos, known to be involved in
oocyte maturation.
Results and Discussion: Most oocytes originating from follicles
up to 4 mm had not progressed beyond the early stages of
meiosis (12% Germinal Vesicle, 70% Diakinesis). Oocytes from
follicles larger than 4 mm had resumed maturation and by 30 h
after the LH peak 39% and by 40 h, 50% had already arrived at
the Metaphase II stage. All ovulated oocytes were in an
advanced stage of maturation (8% Telophase I, 92% Metaphase
II). In the smaller class follicles, the amount of mRNA for all four
sets of genes was higher than in larger follicles. Differences
were significant (P< 0.05) after 20 h for CDC2 and ERK2. mRNA
content for each of the four genes was significantly lower in
ovulated than in non-matured oocytes (P< 0.05). We conclude
that in follicles larger than 4 mm in diameter the LH surge induces
oocyte maturation, where stored mRNA is used to synthesise
the proteins maturation promoting factor, MAP kinase and c-
MOS, which are relevant for oocyte maturation.
P43. Intra-oocyte variation in mtDNA content on bovine oocytes.
M Tamassia1, P May-Panloup2, P Reynier2, Y Heyman3 &
S Chastant-Maillard1. 1Biologie du Développement et de la
Reproduction, Ecole Nationale Vétérinaire d’Alfort, Maisons
Alfort, France; 2Laboratoire de Biochimie et Biologie Moléculaire,
CHU d’Angers, Angers, France; 3INRA, Jouy en Josas, France.
Introduction: To drive energy-requiring cellular activities,
oocytes contain large numbers of mitochondria each containing
several copies of mtDNA. An accumulation of mitochondria is a
hallmark of oocyte maturation during which the total number of
organelles increases while the number of mtDNA molecules per
mitochondrion decreases. Using real time quantitative PCR it
was observed a considerable degree of variability in the number
of mtDNA copies between individuals as well as a wide variation
intra-oocytes from the same individual.
Our objective is to evaluate mtDNA content in immature bovine
oocytes of the same animal collected at different times.
Methods: Oocyte collection was performed by ultrasound guided
follicular aspiration (OPU), twice a week in two series of 6 weeks
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one year apart, on the same six cows. IVF grade oocytes found
had their cumulus cells stripped from them before freezing.
Slaughterhouse oocytes were used as control.
DNA was extracted from each oocyte using High Pure PCR
Template Preparation Kit (Roche Diagnostics, Mannheim,
Germany) according to the manufacturer’s instructions. To
determine the mtDNA copy number a quantitative real time PCR
was performed using a Roche LightCycler and LightCycler-
Faststart DNA master SYBR Green 1 kit (Roche).
Results and Discussion: There was no difference in mean overall
mtDNA copy number between the two series (mean = 372049
mtDNA/oocyte; n= 346). Nevertheless, animal mtDNA
increased or decreased significantly between the two sampling
series, increasing roughly three folds for one animal (from 183
096 to 536 955 copies mtDNA/oocyte). Only one animal didn’t
show significant change in mtDNA copy numbers although the
CV for this animal was 72.1% and 64.4% for series one and two
respectively. Coefficients of variation ranged from 31.0% to
121.0% revealing an important between-oocyte intra-animal
variation of mtDNA. This need to be further explored to as to
understand the correlation that it may have with IVF and embryo
production.
P44. The effect of a single long-acting injection of GnRH
antagonist on ovarian follicular development in sheep
A Gonzalez-Bulnes1, CJH Souza2, BK Campbell3, RJ Scaramuzzi4
& DT Baird2. 1Departamento de Reproducción Animal, Madrid,
Spain; 2Department of Obstetrics and Gynaecology, University
of Edinburgh, Edinburgh, UK; 3School of Human Development,
University of Nottingham, Nottingham, UK; 4Department of
Veterinary Basic Sciences, Royal Veterinary College, London,
UK.
Introduction: The superovulatory response to FSH in sheep
and goats can be improved by suppressing the development of
large antral follicles prior to treatment by daily injections of
GnRH antagonists. In the present study, we have investigated
the effect of a long acting depot preparation of the GnRH
antagonist Teverelix on the dynamic of follicle development in
sheep.
Methods: Teverelix (22mg of acetate) was injected
subcutaneously into six mature Merino-cross ewes on Day 7 of
the oestrous cycle. Follicle development was monitored in treated
and six control ewes by ultrasonographic measurement of all
follicles ≥ 2mm, every 2 days for the first 12 days after the
administration of the treatment and then weekly for 60 days.
Results and Discussion: The appearance of follicles ≥ 5mm was
suppressed for at least 42 days in treated ewes in contrast to
controls. The two largest follicles were smaller in the treated
ewes (3.8 ± 0.2mm and 3.0 ± 0.1mm) as compared to the controls
(4.5 ± 0.1 and 3.6 ± 0.1mm, p<0.005). The total number of follicles
≥ 2mm increased progressively in the treated group from 6.6
±.5mm on Day 0 to 13.0 ± 1.1mm on Day 43 (p<0.0005); achieving
a two-fold increase (p<0.00005) when compared to the control
group, which remained in a mean of 7.0 ± 0.2 follicles. These
findings suggest that a single depot injection of a GnRH
antagonist can suppress the development of large follicles for
some weeks and hence provide a favourable environment for
the stimulation by FSH of a large number of responsive follicles.
P45. The effect of daily injections of GnRH antagonists on
pituitary function in goats.
A Gonzalez-Bulnes1, RM Garcia-Garcia1, J Santiago-Moreno1,
CJH Souza2, A Lopez-Sebastian1 & AS McNeilly3.
1Departamento de Reproducción Animal, Madrid, Spain;
2Department of Obstetrics and Gynaecology, University of
Edinburgh, Edinburgh, UK; 3MRC Human Reproductive
Sciences Unit, Centre for Reproductive Biology, Edinburgh, UK.
Introduction: The use of daily doses of the GnRH antagonist
Teverelix during the progestagen treatment commonly used prior
superovulatory protocols in goats suppresses large follicles,
allowing a two-fold increase in the number of smaller follicles
able to grow and ovulate in response to the exogenous FSH
treatment. However, this pre-treatment involves a daily handling
of animals during the 11 days treatment period. The aim of current
study was to determine the effect of Teverelix on FSH and LH
secretion, to determine whether the number of doses could be
reduced.
Methods: A total of 10 Spanish breed goats were treated with
45mg FGA sponges (Chronogest) for 14 days. Five does were
treated with daily subcutaneous injections of 0.5mg of Teverelix
in saline for 11 days from the second day of progestagen
insertion (Day 0), while five ewes acting as controls received
saline. Pituitary activity was monitored by the measurement of
FSH and LH in blood samples collected daily from day of sponge
insertion to Day 12.
Results and Discussion: FSH levels in control goats showed a
well-defined wave-like pattern. In treated does, the FSH levels
decreased linearly during the treatment (0.8 ± 0.1 to 0.5 ± 0.1ng/
ml, p<0.01) and remained lower than the mean concentration in
control goats (0.8 ± 0.1 ng/ml, p<0.005). Mean LH levels were
also lower during the period of treatment in goats treated (0.6 ±
0.2 vs 0.4 ± 0.1 ng/ml, p<0.0005). LH levels decreased after the
very first injection of Teverelix and remained lower than 0.5 ng/
ml during the period of antagonist administration. Such data
indicate that GnRH antagonist reduced LH and FSH from the
start of treatment, suggesting that the number of doses could
be reduced without affecting efficiency of the treatment.
P46. Antral follicular development and FSH secretion during
sexual maturation in the ewe lamb.
PM Bartlewski1, AP Beard2 & NC Rawlings1. 1Department of
Veterinary Biomedical Sciences, University of Saskatchewan,
Saskatoon, Canada; 2University of Newcastle, Newcastle upon
Tyne, UK.
Introduction: Ultrasonography has been used to study antral
follicular development in prepubertal cattle and sheep, but there
has been no systematic study of ovarian follicular dynamics in
relation to FSH secretion, from birth to puberty, in the ewe lamb.
Methods: Eight February-born Suffolk ewe lambs underwent
transrectal ovarian ultrasonography every 2 wks and during
seven 10 d periods, with starting dates every 5 wks, from 6 to 38
wks of age. Blood samples were taken before each examination
for radioimmunoassay of FSH and daily, from 30 wks of age, for
measurement of progesterone.
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Results and Discussion: Six of 8 ewe lambs reached puberty
(defined as an elevation in serum progesterone concentrations
greater than or equal to 0.1 ng ml-1 for at least 7 d) between 32
and 36 wks of age (34.0 ± 0.5 wks). The total number of all
follicles greater than or equal to 2 mm in diameter ewe-1 increased
from 12 to 14 wks, declined from 24 to 28 wks, rose from 28 to 32
wks, and then decreased after 32 wks of age (n=6; P<0.05). The
diameter of the largest follicle increased from 8 to 14 wks,
declined from 14 to 22 wks, and finally increased between 32
and 38 wks after birth (P<0.05). Mean serum FSH concentrations
peaked at 30 and 4 wks before attainment of puberty (P<0.05).
There were 2.4 ± 0.09 peaks in FSH concentrations and 0.8 ± 0.1
emerging follicular waves ewe-1(follicles growing to or exceeding
5 mm in size; P<0.05) over each 10 d scanning period, and their
numbers did not change significantly throughout the study. In
conclusion, antral follicle recruitment and growth was increased
after the first two months of age and just before puberty in ewe
lambs. The rhythmic pattern of follicular wave emergence, as
seen in adult ewes, was not established in pre- and peripubertal
ewe lambs.
P47. The effect of inducing early first ovulation postpartum on
reproductive performance in dairy cows.
JG Gong, A Moghaddam, X Luo, KD Troup, E McCullough &
WJ Lee. Roslin Institute, Roslin, Edinburgh, Midlothian, UK.
Introduction: The timing of the first ovulation postpartum has
been shown to influence fertility in dairy cattle. This study
investigated the effect of advancing first ovulation postpartum
on reproductive performance in lactating dairy cows.
Methods: Thirty-three high (H) and 31 low (L) genetic merit
cows were treated with 0.2mg GnRH (Fertagyl, Intervet) 2 to 3
weeks after calving, whilst 34 H and 35 L untreated cows served
as controls. Plasma was collected and ovaries scanned before
and after GnRH treatment to determine LH and ovarian response.
Milk samples were collected 3 times a week for the first 105 days
of lactation, for progesterone measurement by RIA.
Inseminations to observed oestrus were initiated from 50 days
postpartum.
Results and Discussion: The H and L cows were treated with
GnRH at 17.1 ± 0.9 and 18.3 ± 1.1 (p>0.05) days postpartum
respectively, when 3/33 H and 10/31 L cows (p<0.05) had already
ovulated. GnRH induced a LH surge in all cows, but only 28/33
H and 26/31 L cows (p>0.1) ovulated. The intervals from calving
to first ovulation, to first service and to conception, and
conception rate to first service (derived from farm records and
milk progesterone profiles) in GnRH-treated cows were 19.4 ±
1.2, 58.6 ± 4.9, 91.4 ± 8.1 days, and 56.7% for L line and 18.5 ± 1.1,
62.3 ± 5.2, 104.8 ± 8.9 days, and 42.8% for H line respectively.
The corresponding values for controls were 25.2 ± 1.6, 69.1 ±
5.1, 105.5 ± 8.4 days, and 48.5% for L line and 36.3 ± 1.9, 83.4 ±
6.6, 120.9 ± 11.3 days, and 33.3% for H line respectively. For
both H and L lines these parameters in GnRH-treated cows
compared favourably to those in controls. These differences
were significant (p<0.05) when cows that had already ovulated
at GnRH administration were excluded. These results suggest
that reproductive performance can be improved by inducing
early first ovulation postpartum in lactating dairy cows.
Supported by DEFRA.
P48. Paracrine regulation of porcine granulosa and theca cell
function in a serum free co-culture system by oocyte secreted
factors and stem cell factor.
V Brankin, MRP Mitchell, MG Hunter & R Webb. School of
Biosciences, University of Nottingham, Sutton Bonington
Campus, Loughborough, UK.
Introduction: Oocytes control both granulosa and theca cell
function. A feedback loop involving several growth factors may
exist between these cell types. This study examined the role of
oocyte-secreted factors on co-cultured granulosa/theca cells
and the effect of stem cell factor; a granulosa cell derived peptide
that has many roles in follicle development.
Methods: Granulosa and theca cells were isolated from 2-6mm
healthy follicles of mature porcine ovaries and cultured under
serum-free conditions, either separately or in co-culture,
supplemented with: 100ng/ml LR3 IGF-1, 10ng/ml insulin, 100ng/
ml testosterone, 0-10ng/ml SCF, 1ng/ml FSH (granulosa), 0.01ng/
ml LH (theca) or 1ng/ml FSH and 0.01ng/ml LH (co-culture) and
with/without 5 oocytes per well in a 96 well plate. Cells were
cultured for 144h, after which viable cell numbers were determined.
Medium was replaced every 48h and spent medium analysed
for steroids.
Results and Discussion: SCF increased both progesterone
(P<0.001) and oestradiol (P=0.004) production by granulosa cells.
Progesterone and oestradiol synthesis was suppressed
(P<0.001) and stimulated (P=0.008), respectively by oocyte
addition. These effects were also observed with co-cultured
granulosa and theca cells with the exception that oocyte addition
significantly suppressed (P<0.001) oestradiol synthesis. In
contrast, SCF elicited a decrease in both progesterone (P=0.002)
and oestradiol (P=0.005) production by theca cells. However,
oocyte addition further decreased progesterone output as
observed in granulosa and granulosa/theca co-cultures. Thecal
androstenedione synthesis was reduced with the addition of
SCF (P=0.032), whilst the addition of oocytes suppressed both
androstenedione (P=0.08) and oestradiol (P=0.031) synthesis.
These findings suggest a co-ordinated paracrine interaction
between somatic cells and germ cells, whereby oocyte derived
signals are mediated between granulosa and theca cells and
hence granulosa and theca cells interact locally. SCF modulates
this local interaction. The oocyte is an effective modulator of
granulosa-theca interactions, one role being the inhibition of
luteinization.
P49. Exposure to the xenoestrogen 4-tert-octyl phenol alters
sheep preantral follicle growth and development in vitro.
J Su, SE Harris, P Jin & HM Picton. Department of Obstetrics
and Gynaecology, University of Leeds, Leeds, UK.
Introduction: In recent decades increasing evidence has
suggested that exposure to environmental chemicals with
oestrogenic effects has impaired the reproductive function of
humans and wildlife populations. The impact of xenoestrogens
on ovarian follicle turnover is important as perturbation of this
event may alter fertility and reproductive longevity. This study
therefore, investigated the direct effects of the environmental
oestrogen 4-tert-octylphenol (OP), on the in vitro development
of ovine preantral follicles.
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Methods: Preantral follicles of 180-220 um diameter were
enzymatically isolated from fresh and cryopreserved ovine
ovarian cortical tissue. Follicles were cultured individually for
30 days in serum-free medium containing 0.5 ng/ml oFSH and
0.1 ng/ml oLH in the presence of 0, 1 or 100 ng/ml OP or 100 ng/
ml oestradiol-17B. Follicle development was assessed by
measurement of follicle diameter, antral cavity formation and
cell division.
Results and Discussion: The data show that inclusion of 1 ng/
ml OP (586.8 ± 40.2 µm, n=119) or 100 ng/ml oestradiol (552.5 ±
27.5 um, n=118) had no significant effect (P>0.05) on follicle
growth rates or day 30 follicle diameter compared to controls
(573.2 ± 32.3 um, n=121). In contrast, growth rates were retarded
and the terminal diameter was significantly reduced (P<0.05) in
follicles exposed to 100 ng/ml OP (452.1 ± 24.4 um, n=122). These
changes were reflected by a significant (P<0.05) decrease in
antral cavity formation in follicles exposed to 100 ng/ml OP (13.2
± 2.8%) compared with 1 ng/ml OP (23.9 ± 4.6%), control (36.2 ±
6.8% ) and oestradiol treated tissue (31.7 ± 5.9%). There was no
significant difference between the growth rates of follicles
isolated from fresh or cryopreserved tissue. These results
suggest that the weak oestrogen OP exerts a dose dependent
inhibitory effect on early follicle development in vitro. These
observations add to our understanding of the impact of
xenoestrogens on female reproductive function.
P50. Evidence for direct interaction between leptin and ovarian
steroidogenesis in cattle.
JG Gong1, G Baxter1, CO Hogg1, X Luo1, MRP Mitchell2, R Webb2
& DG Armstrong1. 1Division of Integrative Biology, Roslin
Institute, Roslin, Midlothian, UK; 2School of Biosciences,
University of Nottingham, Sutton Bonington Campus,
Loughborough, UK.
Introduction: Increasing evidence from a number of species
has implicated leptin as a signal linking nutritional status with
reproductive function. This study investigated if there are direct
interactions between leptin and ovarian steroidogenesis in cattle.
Methods: The oestrous cycles of 16 heifers were synchronized
using a standard protocol with progesterone, prostaglandin and
GnRH. Heifers were fed either 1X (group M, n=8) or 2X (Group
2M, n=8) maintenance ration for 2 weeks. Plasma samples were
collected throughout the experiment and assayed for leptin by
RIA. The effect of leptin on ovarian steroidogenesis was
examined using primary cultures of bovine theca and granulosa
cells in serum-free conditions.
Results and Discussion: Whilst plasma concentrations of leptin
in group M remained constant throughout the experiment, they
increased significantly in the 2M group. This increase occurred
within 2 days of the start of increased feeding and was
maintained for the duration of the experiment. Plasma leptin
concentrations showed an additional significant increase 2 days
after GnRH treatment in group 2M. In in vitro studies, leptin at
doses of 20ng/ml significantly inhibited LH-stimulated but not
basal androstenedione secretion by theca cells from small and
medium-sized follicles. Leptin also significantly suppressed FSH-
stimulated oestradiol production by granulosa cells from small
but not medium-sized follicles. However, the level of dietary
intake had no effect on the inhibitory effects of leptin on theca
or granulosa cell steroidogenesis. The results indicate that
oestrogen and androgen production by the ovary is inhibited
by leptin at physiological concentrations. In addition, ovarian
steroids may interact with nutritional status to directly regulate
the secretion of leptin from adipocytes. It is concluded that
leptin, ovarian steroids and nutritional status are capable of
interacting directly with each other in cattle, but the mechanisms
underlying these interactions remain to be elucidated.
Supported by DEFRA and BBSRC.
P51. Ovarian development in intrauterine growth retarded and
normally developed piglets originating from the same litter.
P Da Silva-Buttkus1, R van den Hurk1, ER te Velde2 &
MAM Taverne1. 1Department of Farm Animal Health, Faculty
of Veterinary Medicine, Utrecht University, Utrecht, The
Netherlands; 2Division of Obstetrics, Neonatology and
Gynecology, University Hospital Utrecht, Utrecht, The
Netherlands.
Introduction: We previously indicated that the absence of
differences in ovarian development between small and normal
porcine fetuses was due to the heterogeneity in the degree of
growth impairment within the small group (Da Silva et al., 2002,
Reproduction Abst Ser 28, 69). The aim of the present study
was to statistically identify naturally occurring intrauterine
growth retarded newborn piglets and compare ovarian
development with their normally grown littermates.
Methods: The experiment was approved by the Animal Ethics
Committee of the Veterinary Faculty of Utrecht University.
Intrauterine growth retarded piglets were identified on the basis
of statistical analysis of the birth weight distribution within each
litter (van der Lende et al., 1990, Liv Prod Sci, 26: 53-65). At birth,
ovaries were collected from intrauterine growth retarded (runts,
n=14) piglets and their respective average weight (normal, n=14)
littermates. Ovaries were weighed, fixed and germ cell
development was quantified in haematoxylin and eosin stained
paraffin sections using an image analysis system. In ovarian
sections, we also examined germ cell DNA fragmentation using
TUNEL assay and follicle cell activity using
immunohistochemistry for vimentin. Results were compared by
paired t-tests.
Results and Discussion: Body weight and absolute ovarian
weight were significantly lower in runt piglets when compared
with their respective normally grown littermates (mean ± SEM,
733 ± 38.5 vs. 1530 ± 39.7g and 51 ± 3.0 vs. 108 ± 9.6mg, P<0.001,
respectively). In the ovary, the proportion of nests of oogonia,
the number of oocytes and TUNEL-positive cells and the
localization and intensity of vimentin immunoreactivity were
not different between runt and normal littermates. However, runts
had fewer primary follicles (11 ± 2.0 vs. 20 ± 3.0 per mm2 of cortex,
P=0.003) and no secondary follicles compared with normal
piglets. The present results indicate that the naturally occurring
form of intrauterine growth retardation in the pig delayed ovarian
follicular development at birth.
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P52. Endocrine and ovarian response associated with the first-
wave follicle dominant in sheep synchronized either CIDR or
prostaglandin.
LF Uribe-Velásquez1, E Oba2, LC Lara-Herrera2, MIL Souza2,
H Villa-Velásquez2, LA Trinca2 & CAC Fernandes3. 1Department
of Animal Health, University of Caldas, Manizales, Caldas,
Colombia; 2UNESP, Botucatu, Sao Paulo, Brazil; 3University of
Alfenas, Alfenas, Minas Gerais, Brazil.
Introduction: The sucess of estrus synchronization programs
using progestagens varies considerably. In view of the recent
evidence in cattle that exogenous progestin alter follicular
dynamics, it may be that the stage of the estrous cycle at wich
the synchronization protocol is begun affects the synchrony of
ovulation. The effect of prostaglandin vs CIDR and eCG (equine
chorionic gonadotrophin) on follicular dynamics of wave 1 and
its relation with progesterone and estradiol plasma
concentrations were investigated in cyclic ewes.
Methods: Fourteen Bergamascia ewes were used, Group 1 (G1)
synchronized by two i.m. injections of PFG2alpha and Group 2
(G2) treated for 14 d with CIDR and 500 IU of eCG at dispositive
withdrawal on day 14. Ovarian follicular dynamics were
monitored daily with transrectal ultrasonography Aloka 500 with
7.5 MHZ prostatic trasnducer. All ovarian follicles > 2mm were
measured and their relative locations were recorded on an ovarian
map in order to follow the sequential development of each
individual follicle. Blood samples for progesterone and estradiol
determination were collected daily from 1d before the second
injection of PGF2 alpha (G1) and administration of eCG (G2) until
day 10 after ovulation of the cycle.
Results and Discussion: Diameter of the largest follicle of wave
1 in control animals (4.29 mm) was less (P<0.05) than that of
treated animals (5.36 mm). A significant interaction was observed
between treatment (CIDR + eCG versus control) and days (days
0-10) (P<0.05). Administration of eCG (500 IU) produced
increasing of small follicles at the days -2 and -1 before ovulation
and day 6 after ovulation. There were significant differences in
progesterone and estradiol plasma concentrations between
treatments. The CIDR + eCG (500 IU) treatment enhanced the
recruitment of smaller follicles and enhanced the maximum
diameter and growth rate of large follicles during wave 1.
P53. Comparison of pregnancy rate following different
estrus synchronization and fixed timed AI protocols as well
as AI at estrus following two PGF2a
 
injections in Holstein
dairy heifers.
AA Moghaddam, A Niasari & M Bolourchi. Department Clinic
Med Fac., Razi University, Kermanshah, Science Clnic,
Veterinary Med Fac, Tehran University, Tehran, Iran.
Introduction: Our objectives were to compare the relative
efficacies of three protocols designed to synchronize estrus
and ovulation for timed artificial insemination (AI), as well as
with two injections of PGF2a and AI at observed estrus.
Methods: On day 0,experimental heifers were at random stages
of the estrous cycle and were randomly assigned to following
groups. Control group heifers (n=43) received two i.m injections
of PGF2a, 11 days apart, and were inseminated within 12 hours
after estrus detection. Crestar group heifers (n=44), received
norgestomet implant for 10 days and an i.m injections of
Norgestomet (3mg) and Estradiol Valerate (5 mg) at the time of
implant insertion. They were inseminated within 48 hours after
implant removal.Ovusynch group heifers (n=43) were given
GnRH (250 ug) on day 0, and PGF2a (25 mg) on day 7, followed
with another GnRH, 48 hours later. Steroid group heifers (n=38),
received the same protocol as Ovusynch, with a replacement of
the first GnRH with steroids (Estradiol Benzoate, 2 mg, and
Progesterone, 100mg,). Both groups were inseminated at 15 hours
after the last treatment.Pregnancy diagnosis was conducted 30
days after initiation of treatment by ultrasonography.
Results and Discussion: The pregnancy rates to first AI were
30.2, 29.5, 27.9 and 31.6 percent in control, Crestar, Ovusynch
and steroid groups respectively (p>0.05) . Return to next estrus
within 42 days after the end of treatment, was 80, 58, 67.7 and
69.2 Percent (p>0.05) , with pregnancy rates to AI within 12
hours after estrus detection, of 43.3, 41.9, 30.7 and 46.1 percent
(p>0.05), in control, Crestar, ovusynch and steroid groups
respectively. In conclusion, fixed-time AI following steroid-PG-
GnRH may be a cost effective alternative to Ovysynch and
Crestar protocols or AI based on estrus detection following
two injections of PG.
P54. Quantification of S-adenosyl methionine (SAM) and S-
adenosyl homocysteine (SAH) in bovine granulosa cells (BGC)
and blastocysts under differing cultural conditions
JA Rooke, J Anderson, ME Staines & KD Sinclair. Animal
Biology Division, SAC, Aberdeen, UK.
Introduction: Disruption to DNA methylation may lead to altered
gene expression associated with the large offspring syndrome
(LOS). SAM is the substrate for most transmethylation reactions
and SAH, a product of transmethylation, a potent inhibitor of
SAM-dependent transmethylation; the ratio, SAM to SAH, is
an index of transmethylation potential. Therefore, SAM and
SAH were measured in BGC and blastocysts under cultural
conditions associated with LOS.
Methods: BGC (4 batches) from 4-8 mm ovarian follicles, after
pre-incubation (5x105/ml) for 48 h in RPMI1640 containing 25uM
methionine (ICN) and supplemented with ITS, BSA (1 mg/ml)
and testosterone, were incubated for a further 48 h with or
without 0.625 mM NH4Cl (8 replicates/treatment/batch). SAM
and SAH were labelled by incubation for 2h with 35S-methionine
(3KBq/nmol). After standard in vitro maturation and fertilisation
procedures, culture was performed in modified synthetic
oviductal fluid containing either 0.3% albumin (SOFA) or 10%
steer serum (SOFS). To quantify SAM and SAH, blastocysts
were incubated in pairs for 2h in ovum culture medium containing
25uM methionine (200 KBq/nmol). After washing, BGC and
blastocysts were lysed, protein precipitated with perchloric acid
and SAM and SAH isolated from supernatants by HPLC.
Results and Discussion: Addition of NH4Cl did not change
(pmol/2h/106cells) SAM (24 (absent) v 26 (present); n=32, s.e.d.
2.8) or SAH (2.4 v 2.6, s.e.d. 0.49) production by BGC although
the ratio SAM/SAH tended to be greater in the absence (13.8 v
11.6, s.e.d. 1.14, P=0.06) of NH4Cl. More (fmol/2h/blastocyst)
SAM (26 v 68 ; SOFA v SOFS; n=13, s.e.d. 15, P=0.011) was
produced by SOFS blastocysts but treatment did not differ in
SAH production (6.1 v 4.2, s.e.d. 2.17, NS). Therefore the ratio
SAM/SAH was greater for SOFS blastocysts (8 v 26, s.e.d. 7.9,
67
P=0.026). Thus culture with serum, which is associated with
occurrence of LOS, changed the transmethylation potential of
blastocysts.
SAC receives financial assistance from SEERAD.
P55. Evidence for a paracrine role of progesterone in luteal
remodelling.
E Gay & WC Duncan. Reproductive and Developmental
Sciences, University of Edinburgh, Edinburgh, UK.
Introduction: We have shown that matrix metalloproteinases
(MMPs), notably MMP-2, are increased in the human corpus
luteum (CL) during luteolysis and that exposure to hCG during
luteal rescue prevents this increase. The major site of MMP-2
mRNA synthesis in the CL, as detected by in situ hybridisation,
is the stromal fibroblasts. These fibroblasts do not express LH
receptors but they do contain genomic progesterone receptors.
As progesterone withdrawal is associated with MMP expression
in other reproductive tissues, we aimed to investigate whether
progesterone had any affect on MMP secretion from luteal
fibroblasts.
Methods: Fibroblasts were obtained from cultures of luteinised
human granulosa cells obtained at oocyte retrieval during
stimulated in vitro fertilisation cycles. Luteinised granulosa cells
were separated on a percoll gradient and cultured in DMEM/F-
12HAM medium supplemented with 10% fetal bovine serum for
4-6 weeks. At this stage luteinised granulosa cells could not be
identified and fibroblast confluence was reached. Fibroblasts
were cultured in supplemented serum free medium with different
concentrations of hCG, LDL and progesterone. Medium was
collected every 24 hours for gelatin zymography.
Results and Discussion: Culture medium from fibroblasts
contained both MMP-9 and MMP-2 activity as assessed by
gelatin zymography, with MMP-2 activity dominant. The addition
of hCG (100 ng/ml) had no effect on MMP secretion as measured
by band densitometry. The addition of progesterone (10 uM)
significantly reduced the expression of both MMP-9 (p<0.05)
and MMP-2 (p<0.05). These data suggest that progesterone
from the steroidogenic cells of the corpus luteum may have an
influence in MMP secretion from luteal fibroblasts. It is possible
that during luteolysis the falling progesterone concentrations
increase fibroblast MMP expression and during luteal rescue
the continued progesterone exposure inhibits MMP secretion.
These data provide indirect evidence for a paracrine role of
progesterone in luteal remodelling.
P56. Control of mammalian and avian ovarian cell function by
leptin: The role of IGF-I and intracellular mechanisms.
AV Sirotkin1, I Florkovicova1, Z Kuklova1, H-J Schaeffer2,
R Grossmann3, M Mlyncek4, O Svarcova1 & A Armaiova1.
.1Research Institute of Animal Production, Slovakia;
2Universitats-Frauenklinik, Germany; 3Institute of Animal
Science, Mariensee, Germany; 4City Hospital, Slovakia.
Introduction: The aim of our experiments was to examine the
role of leptin (L), in controlling ovarian function in different
species.
Methods: In in-vivo experiments, rabbits were subjected to food
restriction and IGF-I treatments, whilst plasma L and IGF-I levels
were measured using RIA/EIA. In in-vitro experiments, rabbit,
human and chicken ovarian cells were cultured in the presence
of L, antiserum against IGF-I, inhibitors of MAP and of CDC2
kinase or their combination. Expression of intracellular peptides
associated with proliferation (PCNA), apoptosis (bax), Cdc2/
p34 kinase, cyclin B, protein kinase A (PKA), ERK1, 2 MAP
kinase, CREB-1 and IGF-I, as well as the secretion of
progesterone (P), estradiol (E), IGF-I, IGFBP-3 and vasotocin
were determined using Western blotting, immunocytochemistry,
RIA and ELISA.
Results and Discussion: Food restriction in rabbits results in a
reduction in plasma L and IGF-I levels. IGF-I addition increased
plasma L level. L addition altered P, E, IGF-I, IGFBP-3 and
vasotocin release by cultured rabbit, human and chicken ovarian
cells, as well as changing the expression of IGF-I, PCNA, bax,
PK A, ERK1, 2 MAP kinase, p34 CDC2 kinase, cyclin B and
CREB. Previous food restriction enhanced the response of rabbit
and chicken ovarian cells to L treatment. Immunoneutralisation
of IGF-I reversed the effects of L on the secretory activity of
human granulosa cells. Inhibitors of MAP kinase and CDC2
kinase were able to reverse the effects of L on hormone secretion
by chicken ovarian cells.
The present observations suggest that L is produced under the
control of nutritional factors and IGF-I, and that it can directly
control proliferation, apoptosis, production of hormones, IGF-I,
IGF binding proteins and intracellular signaling pathways in
mammalian and avian ovarian cells. Thus, the L/IGF-I system is
a potential mediator of the effect of nutrition on reproduction. L
effects on ovarian cells may be mediated by local IGF-I-, MAP
kinase- and CDC2 kinase-dependent intracellular mechanisms.
P57. Thrombopoietin as a regulator of ovarian cell function.
AV Sirotkin1, P Sanislo1, H-J Schaeffer2, I Florkovicova1,
J Kotwica3 & L Hetenyi1. 1Research Institute of Animal
Production, Slovakia; 2Universitats-Frauenklinik, Germany;
3Institute of Animal Production and Food Research, Poland.
Introduction: Thrombopoietin (TPO) stimulates
megacariocytopoesis, but its role in the ovary is unknown. The
aims of our study were to determine whether TPO can regulate
ovarian cell function and to identify intracellular mediators of
its action.
Methods: The effect of TPO, with and without blockers of protein
kinase A (PKA, KT5720) and mitogen activated protein kinase
(MAPK, PD98059), was investigated using cultured porcine
ovarian cells. Expression of intracellular peptides associated
with proliferation (PCNA), apoptosis (bax), tyrosine kinase (TK,
phosphotyrosine), Cdc2/p34 kinase, PKA, MAPK/ERK1, 2 and
CREB-1, secretion of progesterone (P), androstenedione (A),
estradiol (E), oxytocin (OT), inhibins A and B, IGF-I, TGF2 beta
and IGFBP-3 were determined using SDS PAGE-Western
blotting, immunocytochemistry, RIA and ELISA.
Results and Discussion: TPO increased the expression of PCNA,
bax, PKA, MAPK, TK, cdc2/p34 and CREB, but inhibited A, E,
TGF and IGFBP-3 secretion and stimulated P, OT, inhibins and
IGF-I output. The PKA blocker reduced the expression of bax,
TGF and MAPK, augmented the expression of PKA, CREB and
OT, but did not influence the other parameters studied. The
MAPK blocker inhibited the secretion of inhibins but not other
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substances. When given together with TPO, the PKA and
MAPK blockers prevented, reversed or augmented the action
of TPO on the majority of measured parameters.
These results offer the first evidence that TPO is a potent
regulator of ovarian cell functions, including proliferation,
apoptosis, the secretion of steroids, peptides, growth factors
and binding proteins, and the expression of some intracellular
messengers. They also demonstrate the importance of PKA and
MAPK in controlling cellular activity and show that TK and
cdc2/p34 mediate the effects of TPO on ovarian cells.
P58. pO2 in swine follicular fluid.
F Bianco1, G Basini1, F Grasselli1 & C Tamanini2. 1Dipartimento
di Produzioni Animali - Sezione di Fisiologia, Università di Parma,
Italia; 2DIMORFIPA, Università di Bologna, Italia.
Introduction: It has been hypothesized that the development of
a hypoxic environment could represent a stimulus for
angiogenesis, though few studies have been carried out on this
condition in the ovarian follicle. We have previously
demonstrated that Vascular Endothelial Growth Factor (VEGF)
production changes in relation to follicular size and that it can
be significantly increased by hypoxia. We have undertaken the
present work in order to quantify the oxygen tension in swine
ovarian follicles at different stages of development.
Methods: Swine ovaries were collected at a local slaughterhouse
and follicles were divided into 3 classes depending on the
diameter: small (<3mm), medium (3-5 mm) and large (>5 mm).
Follicular fluid was collected from 20 follicles of each class,
loaded in special cartridges and assayed for pO2 by means of an
i-STAT Portable Clinical Analyzer (i-STAT Corporation,
Princeton, NJ, USA).
Results and Discussion: pO2 levels were significantly different
between small and medium follicles (p<0.02; 137.1 ± 6.1 vs 102 ±
3.7 mmHg, mean ± SEM); a further significant (p<0.01) decrease
was observed in large follicles (78.7 ± 6.6 mmHg). These data
indicate that the pO2 gradually decreases in the follicular fluid
during follicle maturation; these and other previous findings
suggest a strict relationship between the establishment of a
hypoxic environment and the angiogenic process in the growing
follicle. Therefore, we can hypothesize that the decreased pO2
in large ovarian follicles might represent an angiogenic stimulus,
essential for follicle maturation and for the developmental
competence of the corresponding oocyte.
This work was supported by a MIUR-COFIN grant.
P59. Effect of a GnRH antagonist on follicular development and
angiogenesis.
PD Taylor1, HM Fraser1 & SG Hillier2. 1MRC Human
Reproductive Sciences Unit, Edinburgh, UK; 2University of
Edinburgh, Department of Reproductive and Developmental
Sciences, Edinburgh, UK.
Introduction: Angiogenesis is required for normal follicular
development, but the role of the gonadotrophins in the process
remains to be elucidated. The aim was to determine the effects
of treatment with GnRH antagonist on follicular development
and angiogenesis in the primate marmoset (Callithrix jacchus)
ovary.
Methods: Experiments were carried out under the Animals
(Scientific Procedures) Act, (1986) and approved by the local
Ethical Review Committee. Timing of ovulation was
synchronised by administration of prostaglandin in the previous
luteal phase. GnRH antagonist (Antarelix) was administered on
Day 0 or Day 5 of the follicular phase, and ovaries collected on
follicular Day 10. Ovaries where serially sectioned (5um) for
immunocytochemical (ICC) analysis. Every 40th section was
stained with haematoxylin and eosin (H&E) for morphological
analysis. Cell proliferation was assessed by ICC localisation of
bromo-deoxyuridine and the extent of vascularisation by ICC
localisation of CD31.
Results and Discussion: Ovaries from control marmosets had 2
or 3 preovulatory follicles or newly formed corpora lutea. All
ovaries contained uniformly healthy secondary (preantral)
follicles. Administration of GnRH antagonist on Day 0 limited
the growth of preovulatory follicles. Although large antral
(~1000um) follicles were present, they were morphologicaly
atretic. Administration of the antagonist on follicular Day 5 did
not inhibit the growth of large follicles (~2000um), although
again these were morphologically atretic.
GnRH antagonist treatment had no effect on theca or granulosa
cell proliferation up to and including the late secondary stage of
development. However, proliferation the theca and the granulosa
cells in tertiary follicles was significantly suppressed by both
treatments.
The extent of vascularisation of the growing follicles was not
affected by either of the treatment regimens.
GnRH antagonist treatment prevented the growth of healthy
preovulatory follicles and decreased the rate cell proliferation in
follicles with an antral cavity, but had no apparent effect on
vascularisation.
P60. FSH and IGF promote secretion of ‘total’ follistatin by
bovine granulosa cells but do not alter the relative abundance
of different molecular weight variants.
C Glister1, SA Feist1, NP Groome2 & PG Knight1. 1School of Animal
and Microbial Sciences, The University of Reading, Reading,
UK; 2School of Biomolecular Sciences, Oxford Brookes
University, Oxford, UK.
Introduction: Follistatin is a high-affinity binding protein for
activin and several other TGFB superfamily members. SDS-
PAGE/western-blotting analysis of bovine follicular fluid using
follistatin antibodies reveals the presence of 4-5 different
isoforms generated by differential mRNA splicing and
posttranslational modification. It has been hypothesized that
different follistatin isoforms may subserve different
physiological roles since the shorter isoforms bind to cell-surface
proteoglycans with much greater affinity than the longer
isoforms. In this study, we have used isolated bovine granulosa
cells (GC) to test the hypothesis that treatment with FSH and
IGF modifies the distribution pattern of different size variants of
follistatin in cell-conditioned media.
Methods: In three independent experiments GC were cultured
(12-well plates; 0.5 million cells/well) for 6 days ± FSH, LR3-IGF-
1 (IGF) and FSH+IGF (see Glister et al., 2001 BOR 65:120-128).
Media were changed every 2 days and day 4-6 conditioned
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media were pooled and analysed for ‘total’ follistatin by ELISA;
4 other analytes were also measured by immunoassay. Samples
(12ml) were then desalted and concentrated to 0.1ml using10K
cut-off ultrafiltration devices and retentates analysed by SDS-
PAGE/western blotting (non-reducing conditions) using mouse
monoclonal antibodies against follistatin (Mab 1/1+8/1 mix).
Membranes were probed with 125I-labelled anti-mouse IgG and
images captured/quantified using a phosphorimager.
Results and Discussion: ELISA analyses showed that both
FSH and IGF alone enhanced secretion of ‘total’ follistatin with
co-treatment promoting the greatest response (~12-fold increase
over basal; P<0.001). ‘Fold-increases’ observed by ELISA
accorded well with results obtained by summation of individual
band intensities derived from western-blots. Four follistatin
isoforms (31, 33, 36, 41kDa) were clearly detected although the
abundance of each isoform increased in parallel in response to
treatment with FSH and IGF, alone and in combination. Therefore,
our hypothesis that FSH and IGF promote differential expression
of distinct follistatin isoforms by granulosa cells was not
supported.
Supported by BBSRC grant 45/S14995.
P61. Role of aerobic and anaerobic metabolism in mouse follicle
growth in culture.
G Wycherley & AC Hynes. Department of Physiology, National
University of Ireland, Galway, Galway , Ireland.
Introduction: We recently reported a novel inverted culture
system which produced improved growth of mouse follicles.
Because we hypothesized that the inverted method provided
improved oxygenation of the follicle, we have examined the role
of aerobic and anaerobic metabolism in follicle growth by
measurement of lactate production and the use of metabolic
inhibitors.
Methods: Follicles from MF1 inbred mice were cultured in 96-
well round-bottomed plates for 6 days (Wycherley et al.,
Reproduction Abstr Ser 29, A35) in 100µl inverted drops without
oil and in upright drops with and without oil overlay.
Results and Discussion: Lactate production per nl of follicle
volume remained constant in the inverted system over days 2, 4
and 6 and was markedly less than production in both upright
systems (P< 0.001). This indicates that anaerobic glycolysis is
less active in follicles cultured in the inverted system.
The TCA cycle inhibitors, monofluoroacetate and malonate (10
mmol l-1) were examined in the inverted system;
monofluoroacetate decreased follicle growth from day 2-day 6
(P< 0.001) but malonate had no effect on follicle growth. 2,4-
Dinitrophenol (DNP), an uncoupler of oxidative
phosphorylation, was examined in the inverted system; 0.5 and
1 mmol l-1 DNP completely abolished follicular growth and 0.1
mmol l-1 decreased growth from day 2-day 6 (P<0.001). In the
inverted system, cyanide (1 mmol l-1) had no effect on follicle
growth, but in the upright system with oil, cyanide totally
abolished follicle growth. The failure of cyanide to inhibit growth
in the inverted system is probably due to the volatility of cyanide
gas in the absence of an oil barrier.
We conclude that the TCA cycle and oxidative phosphorylation
are essential for normal growth of mouse follicles and this activity
is facilitated by an improved oxygen supply in the inverted
system.
Research funded by the Health Research Board (Ireland).
P62. Modification of follicular status in sheep treated with single
short-acting doses of GnRH antagonist.
C Lopez-Alonso1, T Encinas1, RM Garcia-Garcia2, A Veiga-
Lopez2, JM Ros1 & A Gonzalez-Bulnes2. 1Catedra Farmacologia,
Universidad Complutense de Madrid, Madrid, Spain;
2Departamento de Reproduccion Animal, INIA, Madrid, Spain.
 Introduction:The superovulatory response in sheep is enhanced
when a high number of small follicles with 2-3mm in size, in
absence of dominant follicles, is present in the ovaries at starting
an FSH treatment. Such condition can be achieved by the use of
pre-treatments with daily injections of GnRH antagonists. This
treatment is hardly for application in practice, so we have studied
the effect of two different single doses of a short-acting
preparation of antagonist on follicular population.
Methods :One day after the insertion of a progestagen sponge
(Chronogest), ewes were treated with a single subcutaneous
injections of 1.5mg (n=6) or 3mg (n=6) of GnRH antagonist
Teverelix in saline or acted as controls receiving only saline
(n=6). Follicular development was assessed by daily
ultrasonographies for 7 days.
Results and Discussion: Both doses were related with a
decrease in the number of large follicles (6mm), higher on Days
2-3 after the treatment (0.2 ± 0.1 for 1.5mg and 0.3 ± 0.3 for 3mg)
when compared to the control group (1.2 ± 0.2, p<0.005). There
were no differences in number of 2-3mm follicles between groups
on Day 0 (8.2 ± 1.2 for 1.5mg, 7.2 ± 0.6 for 3mg and 5.5 ± 1.4 for
control). Such number increased sharply in ewes treated with
1.5mg, reaching its maximum on Day 2 (19.8 ± 2.7 vs 5.8 ± 0.6 in
control, p<0.005) and remaining thereafter in a mean of 17.2 ± 2.0
until started to decrease on Day 5. Conversely, ewes treated
with 3mg showed a slower increase in the number of 2-3mm
follicles, reaching its maximum on Day 4 (18.7 ± 1.8 vs 5.5 ± 1.0 in
the control, p<0.0001) to decrease harshly to 8.2 ± 0.2 on Day 6.
Hence, both doses increase the number of smaller follicles in a
short period of time, which would be beneficial for the efficiency
of superovulatory protocols. Differences in follicular
development suggest a dose-dependent effect of the antagonist
on FSH and LH secretion.
P63. HFEA ‘league tables’ - choose green to pass go.
JA Hamilton, P Kalia, Y Khalaf, A Taylor & P Braude. Assisted
Conception Unit, Guy’s and St. Thomas’ Hospitals, London.
UK.
Introduction: Couples are now encouraged to select a centre
for IVF treatment based on the recently introduced HFEA ‘league
tables’. These tables may be misleading as overall figures do
not reveal the clinical characteristics of the women treated which
may influence the likelihood of success.
Methods: In 171 unselected women, the day 9/10 stimulation
ultrasound picture, female age, FSH level and history of previous
IVF attempts were used to prospectively assign a likelihood of
success, from green (likely to conceive) through orange to red
(unlikely to conceive), prior to each of oocyte retrieval (OR) and
embryo transfer (ET).
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Results and Discussion: Clinical pregnancy rates (CPRs) were
significantly different between the three groups [62.3% (48/77)
vs 33.9% (20/59) vs 20% (7/35), green vs orange vs red,
respectively; p<0.0001, chi-squared analysis]. Of the women
who reached ET, the colour assigned prior to each of OR and ET
(based on the number and quality of the embryos) agreed in
53.8% (85/158) cases. In 18.4% (29/158) and 27.8% (44/158) of
women the grading improved and deteriorated, respectively. A
significant difference was again found in CPRs between the
new categories [72.9% (43/59) vs 41.3% (26/63) vs 19.4% (7/36),
green vs orange vs red, respectively; p<0.0001, chi-squared
analysis].
Conclusions: A group of women likely to do well in treatment
cycles can be accurately predicted from basic clinical
characteristics and this can be refined by knowledge of embryo
quality. Centres who treat a greater proportion of these women
are likely to appear higher in league tables.
P64. Survey of autoantibodies in recurrent spontaneous
abortion.
H Hadi Nedoushan1 & A Aflatounian2. 1Department of
Immunology, Shahid Sadoughi, Yazd, Iran; 2Gynaecology &
Obstetrics, Shahid Sadoughi, Yazd, Iran.
Introduction: Recurrent spontaneous abortion (RSA) is one the
complications of pregnancy. Some studies show the presence
of a large variety of autoantibodies in sera of women with
recurrent spontaneous abortion, endometriosis, unexplained
infertility and IVF failure.
Methods: We studied 33 healthy pregnant women without any
history of abortion as control and 56 women with recurrent
spontaneous abortion (at least 3 times) who were normal in
karyotype, Torch negative and had no anatomical and endocrine
problems. Sera were examined for the presence of
antiphospholipid (APA), (IgG/M), antinuclear (ANA), (IgG/M)
and anticardiolipin(ACL) (IgM/G/A) autoantibodies by ELISA
method. Rheumatoid Factor (RF) was also measured by a latex
agglutination test.
Results and Discussion: In the control group, the mean age
was 26.3 ± 4.8 years, mean gravidity rate was 2.4 and mean fetal
age was 3.4 months.The frequencies of autoantibodies were as
follows: ACL from IgG class 3%, ANA from IgG class 6%, APA
from IgG class 3%, and RF 6%.The mean age women with RSA
was 28.2 ± 4.4 years. Mean frequencies of spontaneous abortion
was 4.2.The frequencies of autoantibodies were as follows: ACL
from IgG class 3.6% IgA class 1.8%, ANA from IgG class 3.6%,
APA from IgM 1.8% and from IgG class 7.2% and RF 53.5%.
There was significant differences between RSA and control
group for RF (P<. 05)
We suggest that to determine the role of antiphospholipids and
antinuclear in recurrent spontaneous abortion the study should
be design a greater sample size and Rheumatoid Factor assay in
RSA should be considered.
P65. Maternal genistein causes no reduction in either litter
sizes or sex ratios.
MCL West, LCM Anderson, N McClure & SEM Lewis.
Obstetrics & Gynaecology, Queen’s University Belfast, Northern
Ireland.
Introduction: Phytoestrogens are becoming ubiquitous in the
Western diet and there are concerns that they may have a
detrimental effect on male fertility and be a contributing factor
in the reported global reduction of sperm counts. Their
oestrogenicity may also have a feminising effect on offspring,
causing a decrease in the sex ratios in the resulting litters.
The aim of this study was to investigate the effect of a maternal
high oestrogen diet on (i) litter size and (ii) sex ratio of the pups.
Methods: Sprague Dawley rat dams from an oestrogen-free
colony were fed 30ug/kg food genistein, equivalent to levels in
an Eastern diet, or 10ul/kg food Diethylstilbestrol (DES) as a
positive control, from birth and throughout their pregnancy.
The pups from the first five litters in each dietary group were
counted and their genders assigned.
Results and Discussion: There was no significant change in
the male: female sex ratios in the litters of mothers fed either
genistein or DES. Only maternal DES caused a reduction in the
average litter size (5.4:9.2 p=0.046). This may be explained by
the growth retardation seen in DES-treated animals resulting in
these dams being physically unable to carry larger numbers of
offspring. This evidence is reassuring as it suggests that no
feminisation of offspring occurs in utero as a result of maternal
ingestion of high levels of phytoestrogens during pregnancy.
Numbers in this study are currently being extended to confirm
or negate this preliminary data.
This study was supported by the Department for Education
and Learning, Northern Ireland and Ferring Pharmaceutical
Company.
P66. Comparison of psychological problems in infertile and
fertile women.
F Shamsaei & F Cheraghi. Faculty of Nursing, Hamedan
University of Medical Science, Hamedan, Iran.
Introduction: An estimated 8% of married women between the
ages of 20 to 29 are infertile; 15% of women 30 to 34; 22% of
women 35 to 39; and 29% of 40 to 44 .
Researches find that women’s reproductive health problems are
responsible for about 50% of infertility cases, while men’s
problems are responsible for 40%.
Purpose of study: This study assessed and compared
psychological problems in infertile and fertile women in Fatemeih
hospital in Hamedan city.
Methods: This research was a cross sectional study. The
subjects were 200 infertile and fertile females. That sampling
had an randomize method. The participants completed a
demographic questionnaire that also included health background
questions. SCL-90 test was used to assess and comprised
psychological problems(depression, anxiety, somatization,
interpersonal relationship, obsessive, paranoid, phobia,
hostility) in two groups.
Results and Discussion: The mean age of the participants was
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36 years. Most (45%) had completed elementary education.
Significant differences were found between fertile and infertile
women. Finally, the infertile women had greater depression,
anxiety, somatization, interpersonal relationship sensitivity and
psychological problems higher than those in the fertile women.
P68. A population-based cohort study of the relevance of
operative delivery to future fertility: Analysis of qualitative
data.
M Porter1, S Bhattacharya1, E van Teijlingen2, D Campbell1,
M Hall1, J Mollison2 & A Templeton1. 1Department of Obstetrics
& Gynaecology, Aberdeen University, Aberdeen, UK;
2Department of Public Health, Aberdeen University, Aberdeen,
UK.
Introduction: Women delivering by caesarean section (CS) are
more likely to have secondary infertility than those delivering
vaginally. Few studies have examined why CS is associated
with subfertility, or its role in women’s decisions about future
childbearing. We used quantitative methods to examine the
relationship between CS and subfertility and qualitative methods
to explore reproductive decision-making in greater depth.
Methods: A cohort of 1661 women who had their first baby by
CS in Aberdeen (Scotland) between 1980 and 1995 and who had
no further successful pregnancies within five years, was
identified from the Aberdeen Maternity Neonatal Databank. With
local ethics Committee approval, they were sent a questionnaire,
and a representative sub-sample was interviewed.
Results and Discussion: Of 1117 women returning a valid
questionnaire, 771 (69%) were willing to be interviewed and 49
completed a semi-structured tape-recorded interview. Over two
thirds (66%) of the women had voluntary subfertility. Adverse
circumstances relating to their first childbirth, was the main
reason for the choice. Maternal age, money and broken
relationships were also important factors. A degree of ambiguity
towards future pregnancies was apparent in some women’s
contraceptive behaviour. A number of women had revisited the
decision about having further children many times, and were
still deciding. Women appeared defensive about having only
one child or leaving a large gap between children, and the citing
of ‘medical reasons’ for these unusual choices should be viewed
in this context. This study suggests that the main reason for
any reduced fertility, is that women are discouraged by their
experience of CS, or by complications leading up to or resulting
from the operation.
Funded by Chief Scientist’s Office, Scotland.
P70. Survey of use of complementary and alternative medicine
by infertile couples.
C Coulson & J Jenkins. University of Bristol, Centre for
Reproductive Medicine, Bristol, UK.
Introduction and Method: Infertility patients are a vulnerable
group and often search for a non-medical solution for their failure
to conceive. This study seeks to determine the prevalence of
use of complementary and alternative medicine (CAM) by
infertility patients in 2 different clinic settings.
Results and Discussion: One hundred and sixty-one patients
(male 39 female 122) completed the questionnaire in the private
clinic and 174 patients completed the questionnaire in the NHS
clinic (male 53 female 121).
CAM was used by 13% males vs. 40% females in the private unit
(p<0.01) and 11% males vs. 24% females in the NHS clinic
(P=0.06).
The most popular forms of CAM used by patients were
nutritional advice (10.7%), reflexology (9.8%) and acupuncture
(8.3%). Other forms of CAM included herbalism (4.4%),
traditional Chinese medicine (3.8%), spiritual healing (2.7%),
hypnosis (2.1%) and homeopathy (<1%).
Conclusions: Despite lack of evidence of efficacy, CAM is
frequently used by infertile couples, particularly women receiving
private treatment. Research is required to establish whether CAM
is beneficial, justifies the costs and does not have adverse
effects. Comments made by patients suggested that they wanted
guidance on the efficacy of CAM.
P72. Teenage males’ experience of decision making and sperm
banking following a cancer diagnosis.
MA Crawshaw. Department of Social Policy & Social Work,
University of York, York, UK.
Introduction: Sperm storage following diagnosis of teenage
cancer involves paediatric oncology and assisted conception
centres. Under UK law, only minors themselves can give consent
to sperm storage. This small scale, exploratory pilot study,
conducted in 2002-3, assessed the feasibility of interviewing
teenagers and their parents about the decision making and
banking process.
Methods: Local Research Ethics approval was obtained and an
Advisory Group established. Interviews were conducted with
twenty professionals in both sites and analysed to identify local
procedures and areas of professional concern.
Seven young males and five parents were recruited. Interviews
were undertaken in a location of the respondents’ choosing
using an approach designed to allow respondents to raise issues
pertinent to them. Transcribed data were analysed by two
researchers using the ‘framework analysis’ method. A draft report
was sent to all respondents for comment before being finalised.
Results and Discussion: There was a higher than anticipated
take-up of the study, but lower than anticipated numbers of
teenage males eligible to participate. There was a good range of
experience according to age, ethnicity, educational attainment,
living arrangements, type of cancer, length of treatment, and
prior disability. Males who did and did not bank were included.
The interviews showed mainly very high levels of recall;
respondents were highly reflective and emotionally articulate
and had clear ideas about ways in which the services could be
improved. Certain themes emerged including the importance of
choice, the pressure of decision making, the importance of
relationships with professionals, family and friends, the need
for information, the demands of managing feelings and the
significance of fertility preservation.
A three year study is now planned to include interviews with
two mixed gender groups of cancer patients/survivors from three
areas: one of teenagers, one of people in their 20s; and the
development of written materials.
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P74. Patients views on consenting to research studies and their
perceptions of risk.
CJ Brown. CHILD, The National Infertility Support Network,
Bexhill on Sea, East Sussex, UK.
Introduction: CHILD accepted an invitation from the Medical
Research Council (MRC) and the Human Fertilisation and
Embryology Authority (HFEA) to join a Working Group formed
to advise on research in assisted reproduction. It became clear
from our first meeting that little was known about patients
perception of risk and their views on consenting to research
studies using their data. It was decided that a survey should be
performed of patients by CHILD.
Methods: A short questionnaire was compiled by CHILD in
conjunction with and the approval of, the MRC. The scope of
the survey included background information on what assisted
reproduction treatments respondents had received and whether
they had previously been invited to take part in research.
Respondents were asked to give reasons for either agreeing or
refusing to take part. The respondents opinion was then sought
on at what stage in their treatment would they be willing to be
approached to take part in research, including what information
they would need to know prior to consent, both for them
personally and for children conceived through assisted
reproduction treatment.
Results and Discussion: 825 questionnaires were distributed
to infertility patients in November 2002. 739 questionnaires were
sent by post to CHILD members and 86 were distributed by
CHILD representatives to patients attending local support group
meetings. A total of 306 completed questionnaires were returned
giving an overall response rate of 37.1%. The findings indicate
that the vast majority of patients would be willing to consider
taking part in research with only 0.3% stating they would not
want to be approached to take part. It is clear that patients feel
that the most important information they would require before
consenting, either for them personally or for children conceived,
was the reason for the research and any risk factors involved.
These outweighed anonymity and time commitment issues by
26%.
P75. The influence of human-animal interaction during
pregnancy on fertility and the pituitary-gonadal and pituitary-
adrenal axis in blue foxes.
LV Osadchuk1, BO Braastad2, A-L Hovland2 & M Bakken2.
1Institute of Cytology and Genetics, Novosibirsk, Russia;
2Department of Animal Science, Agricultural University of
Norway, Norway.
Introduction: Extensive research into human-animal interactions,
particularly in farm-bred foxes, has led to the proposal that high
fear of humans can induce stress response and reduce
reproductive success. The present study was designed to
examine effects of handling given to pregnant blue foxes on
fertility and certain morphometric and hormonal parameters of
gonadal and adrenocortical function in pregnant vixens and the
offspring.
Methods: Blue fox females were subjected to a daily handling in
late pregnancy (term = 52 days). Plasma concentrations of
oestradiol, testosterone, progesterone, ACTH and cortisol,
gonadal and adrenal in vitro productions of steroids as well as
their responsiveness to hCG and ACTH, respectively, were
measured by RIA in control (C) and handled (H) pregnant vixens
and their fetuses (47-48 days of pregnancy), neonatal (10-day-
old) or prepubertal (6-7-month-old) offspring.
Results and Discussion: In pregnant foxes, handling increased
plasma concentrations (C 6.8  1.6 ng/ml versus H 22.8 ± 5.9,
P<0.05) as well as adrenal in vitro production of cortisol
indicating a stress response and decreased litter size, body and
ovarian weights. The data have shown that the increased plasma
cortisol concentration in the stressed pregnant foxes can cross
the placenta and influence the development of the HPG and
HPA axis in the offspring. Fetuses of handled vixens had lower
body, adrenal and ovarian weights, decreased gonadal content
and in vitro production of sex steroids and higher plasma cortisol
(males C 9.2 ± 0.4 ng/ml versus H 11.8 ± 0.7; females C 9.2 ± 0.4
ng/ml versus H 13.2 ± 0.7, P<0.001) and progesterone
concentrations. Maternal stress decreased gonadal weights and
ovarian in vitro productions of oestradiol and testosterone in
neonates and plasma corticosteroid concentrations in
prepubertal animals. In conclusion, the human contact directed
to pregnant blue foxes, through stress response, can limit fertility
and have detrimental effects on the early development of
gonadal and adrenocortical function in the offspring.
P76. Modified assay for luteinizing hormone in plasma.
JI Raeside & HL Christie. Department of Biomedical Sciences,
University of Guelph, Guelph, Canada.
Introduction: The divergence between immunoactivity and
bioactivity due to LH isoforms (microheterogeneity) has been
documented for both pituitary extracts and plasma. It may be
advantageous in some situations, therefore, to measure bioactive
LH for a more meaningful assessment of the hormonal status. A
brief report on the development of a modified method for
measurement of bioactive LH, using neonatal porcine testes, is
presented.
Methods: Leydig cell-enriched preparations (Percoll gradient)
obtained from collagenase digestion (10-15 min) of testes from
neonatal pigs (2-3 weeks old) were used as an alternative to the
‘standard’ bioactive LH assay based on the response of mouse
testes preparations to LH stimulation. Steroid production was
assessed by radioimmunoassay (RIA) of testosterone or other
steroids in the media after 2 or 4h of incubation of the cells. Two
preparations of LH (ovine LH-NIH and an equine pitiutary LH,
from L.E.Reichert Jr) were tested, using RIAs specific for
testosterone, androstenedione (A4), dehydroepiandrosterone
sulphate (DHEAS) or estrone sulphate (E1S).
Results and Discussion: Optimal conditions for the duration
and the number of cells per treatment were determined in initial
experiments using oLH over a dose range of 0 to 10 ng/ml. A
linear response was seen from 0 to 5ng with 100,000 cells
incubated in 1ml of medium for 4h. The eqLH preparation was
about 5 times more potent with a linear response from 0 to 1ng
for E1S production and detection of 0.1 ng LH. The lower limit
with the other steroids was 0.25 ng LH. Production of steroids
from incubation with 1 ng of eqLH varied greatly from about 3.5
ng of testosterone to 275ng of A4. A preliminary assay for plasma
from mares in the breeding season gave values in the normal
range (11-64 ng/ml, n=14). Thus, a relatively simple assay for
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bioactive LH, which seems to be independent of species, can be
based on neonatal porcine testes from routine castration.
P77. Comparison ELISA and SpermMar test for measurement
of antisperm antibody: Case report.
MR Sadeghi1, A Talebian1,3, MM Akhondi1, M Jalali3 & M Jeddi
Tehrani2. 1Department of Reproductive Endocrinology &
Embryology, Avesina Research Centre, Tehran, Iran; 2Department
of Reproductive Immunology, Avesina Research Centre, Tehran,
Iran; 3Department of Clinical Nutrition & Biochemistry, Tehran
Medical Sciences University, Tehran, Iran.
Introduction: Antisperm antibodies (ASA) are confirmed as a
cause of immunological male and female infertility. It is, thus, of
great importance to establish a diagnostic test for precise
quantitation of ASA. ELISA and SpermMar Test are two main
diagnostic methods for ASA measurement that are utilized in
andrology laboratories. SpermMar Test is a qualitative test but
ELISA is quantitative. In some cases, results of ASA
measurements do not match the patient’s clinical signs. Even
the results of both measurement techniques also may not match.
Methods: We used ELISA (IBL Co. Germany) and SpermMar
Test (FertiPro N.V. Belgium) to measure and compare ASA (IgG)
in sera of 150 infertile male who visited our clinic. we found two
cases who were negative with ELISA(< 75 IU/mL) but were both
strongly positive with SpermMar Test (80-90%). When both
complement inactivated sera incubated for 1 hour with motile
spermatozoa followed by twice washing with serum free Ham’s
F10 medium, the SpermMar Test was still positive but
weaker(50%). To assess for the presence of ASA in these sera
we designed ELISA system in which membrane antigens of
spermatozoa were extracted by using two detergents SDS
(Sodium dodecyle sulfate) and LIS (Lithium iodi salysilate) and
used these antigens to coat the plates. In addition, whole intact
spermatozoa were used to coat the ELISA plates. No ASA were
detected with either of these systems.
Results and Discussion: Our results suggest that sperm
agglutination in such cases may be a consequence of
substances other than ASA, which cause SpermMar Test false
positive results and need to be defined further.
P78. A pilot study of home self-administration of misoprostol
for medical abortion up to 56 days gestation.
H Hamoda, PW Ashok, GMM Flett & A Templeton. Department
of Obstetrics and Gynaecology, University of Aberdeen,
Aberdeen, UK.
Introduction: In the UK, the anti-progesterone mifepristone in
combination with a prostaglandin analogue is licensed for
termination of pregnancy up to 63 days gestation. Mifepristone
in combination with misoprostol has been shown to be a highly
successful method for early medical abortion in a hospital setting
(Ashok et al 2002). Studies from the US have suggested the
feasibility of home administration of misoprostol for early medical
abortion with high patient acceptability. To date there have been
no published studies from UK centres on the feasibility or
acceptability of home administration of misoprostol for early
medical abortion.
The aim of this Pilot study was to assess the feasibility, patient
acceptability and efficacy of home self-administration of
misoprostol for early medical abortion.
Methods: Women requesting medical abortion up to 56 days
gestation received mifepristone in hospital followed 36-48 hours
later by home self-administration of 600 micrograms of sublingual
misoprostol. All women lived within five miles of the hospital
and both nulliparous and parous women were recruited.
Results and Discussion: We intend to recruit 50 women, 15 of
whom have so far been recruited. The mean (± SD) age and
gestation was 30 years (± 6.5) and 42 days (± 6.5) respectively.
Six women were nulliparous. Abortion occurred at home in 14
women. This was confirmed by ultrasound scan one week
following abortion. The mean (± SD) induction to abortion
interval was 3.5 hours (± 1.5). One woman opted to be admitted
to hospital to complete treatment following administration of
misoprostol at home. Of the 12 women who returned
questionnaires, all were satisfied with having treatment at home.
Results from the full pilot of 50 women will be presented at the
meeting. These initial results suggest the feasibility and patient
acceptability of home medical abortion, which now needs to be
confirmed in the context of a RCT.
P79. A pilot study of sublingual versus vaginal misoprostol for
medical abortion up to 63 days gestation.
H Hamoda, PW Ashok, J Dow, GMM Flett & A Templeton.
Department of Obstetrics and Gynaecology, University of
Aberdeen, Aberdeen, UK.
Introduction: The aim of this pilot study was to assess patient
acceptability, side effects and effectiveness of sublingual versus
vaginal administration of misoprostol in women undergoing early
medical abortion. Although vaginal administration of
misoprostol has been shown to be more effective than oral
administration, the oral route is more acceptable and offers more
privacy. Sublingual administration avoids the inconvenience of
vaginal examination, the first pass effect through the liver and
may be more effective than the oral route.
Methods: Women undergoing medical abortion up 63 days
gestation received misoprostol 600 micrograms sublingually or
800 micrograms vaginally following administration of
mifepristone 200 milligrams. A second dose of misoprostol 400
micrograms was administered three hours later sublingually in
the sublingual group or orally or vaginally in the vaginal group
when necessary.
Results and Discussion: Fifty-three women received
misoprostol vaginally and 94 sublingually. Complete abortion
without the need for surgical intervention occurred in 93 women
(98.9%) in the sublingual group and 51 (96.2%) in the vaginal
group (P=0.27). The mean (± SD) induction to abortion interval
was 3.2 (± 1.4) hrs and 4.06 (± 1.5) hrs in the sublingual and
vaginal groups respectively group (P=0.02). Although there was
no significant difference in side effects like nausea, diarrhoea,
shivering, tiredness, hot-flushes or dizziness, women who
received sublingual misoprostol were more likely to experience
vomiting (P=0.03) and unpleasant mouth taste (P=0.0001) while
those in the vaginal group experienced more headache (P=0.002).
There was no significant difference in satisfaction between the
sublingual (77%) and the vaginal (68%) groups (P = 0.25)
This study suggests the feasibility and acceptability of
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sublingual misoprostol for early medical abortion, which needs
to be confirmed in the context of a RCT.
P80. Current practice with regard to the surgical management
of azoospermia in Merseyside & North Wales: A questionnaire
based survey.
SJ Wood1, N Montazeri1, Y Sajjad1, S Troup1, CR Kingsland1 &
DI Lewis-Jones1,2. 1Reproductive Medicine Unit, Liverpool
Womens Hospital, Liverpool, UK; 2Department of Obstetrics &
Gynaecology, University of Liverpool, Liverpool Womens
Hospital, Liverpool, UK.
Introduction: We wished to investigate the current practice
amongst Urological and General surgeons with regard to the
management of azoospermia secondary to previous vasectomy
or non obstructive azoospermia.
Methods: This was a questionnaire based survey of 130 general
surgeons and urologists practising in Merseyside and North
Wales.
The questionnaire was designed to establish both the
practitioner’s practice with regard to the number of reversals
performed and the techniques used. Further questions were
directed at the practitioners with regard to success rates in
achieving patency and subsequent pregnancy, and whether
these were audited success rates. We also inquired as to the
practice with regard to investigation of the male and female
partner prior to surgery.
Further questions were directed with reference to the use of
cryopreservation of spermatozoa at the time of vasovasostomy
and from testicular biopsy for non obstructive azoospermia.
Results and Discussion: The response rate was 74%, with 24
urological surgeons and 14 general surgeons performing
vasectomy reversals. Urological surgeons performed
significantly greater numbers of procedures annually than
general surgeons, 8.5 v 5.3 (p=0.029) respectively. They were
also significantly more likely to utilise double layer closure and
microsurgical techniques. In spite of clear evidence within the
literature of their detrimental effects, stents were still utilised
extensively 29% (11/38) especially by general surgeons.
Urologists reported significantly greater patency rates 76% v
52% (p=0.017) without significant differences in subsequent
pregnancy rates 30%  v 25%. Alarmingly only 2.6% of
practitioners checked tubal patency in the female partner prior
to offering reversal of vasectomy.
Whilst the use of vasectomy reversal has been shown to be a
cost-effective treatment for males wishing to seek pregnancy
following vasectomy,close attention should be placed upon the
technique used by the clinician as well as proper audit of results.
It would appear to be obvious that the female partners of males
seeking reversal should have their fertility status established
prior to reversal, something that is clearly not done at present.
P81. Relationships between feed intake, leptin and oocyte
maturation in pigs.
NL Hepburn1,2,5, EM Ferguson2, MG Hunter3, SA Edwards4,
N Hawkins3, DG Hazlerigg5, P Trayhurn1 & CJ Ashworth2.
1Rowett Research Institute, Aberdeen, UK; 2Animal Biology
Division, SAC, Aberdeen, UK; 3School of Biosciences,
University of Nottingham, UK; 4School of Agriculture, Food
and Rural Development, University of Newcastle, Newcastle-
on-Tyne, UK; 5School of Biology, University of Aberdeen, UK.
Introduction: Leptin is believed to convey information about
an animal’s nutritional status to the reproductive axis. This study
examined plasma leptin concentrations, leptin expression in
backfat and oocyte maturation in gilts fed diets that improve
embryo survival.
Methods: Large White x Landrace gilts received either 1.35 kg d-
1 (maintenance (M) diet; n= 11) or 3.5 kg d-1 (high (H) diet; n=
12) from their third oestrus until slaughter 19 days later. Body
weight and backfat thickness at the P2 position was recorded at
the beginning and end of the dietary treatments. Blood samples
were collected from 6 gilts/treatment on alternate days. At
slaughter, blood and backfat samples were collected from all
gilts to measure plasma leptin concentrations and backfat
expression, respectively. Day 19 oocytes were recovered,
matured in vitro, fixed and stained to determine the stage of
oocyte nuclear maturation.
Procedures accorded with A(SP)A (1996).
Results and Discussion: At slaughter, H gilts were heavier (138
± 1.83kg versus 126 ± 1.78kg; P<0.001), with greater backfat
thickness (17.0 ± 0.34 mm versus 15.8 ± 0.23mm; P=0.015),
increased backfat leptin expression (1.60 ± 0.47 mRNA/GAPDH
versus 0.06 ± 0.01 mRNA/GAPDH; P=0.008) and increased
circulating leptin concentrations (3.20 ± 0.32 ng/ml versus 2.16 ±
0.26; P<0.025), respectively compared to M gilts. Leptin
concentrations were affected by feed intake within 3 days of
receiving experimental diets, and thereafter remained relatively
constant. More oocytes reached the final stage of nuclear
maturation (MII) in H gilts (68.2 ± 6.5% versus 88.3 ± 2.71%, P =
0.013). In H gilts, leptin concentration on day 19 of the cycle
was positively related to the proportion of oocytes reaching
MII (r = 0.89, P = 0.006). These data suggest that porcine plasma
leptin concentrations relate to feed intake rather than body
fatness and that leptin may be associated with improved oocyte
maturation rates in gilts fed the high diet.
Funded by Defra, MLC and JSR Healthbred in the LINK
Sustainable Livestock Production Programme.
P82. Does the aetiology of azoospermia affect the outcome of
ICSI cycles? A meta-analysis.
JDM Nicopoullos1, C Gilling-Smith1, PA Almeida1 &
JWA Ramsay1,2. 1Assisted Conception Unit, Chelsea &
Westminster Hospital, London, UK; 2Department of Urology,
Charing Cross Hospital, London, UK.
Introduction: The aim of this study was to define whether the
outcome of intracytoplasmic sperm injection (ICSI) using sperm
surgically retrieved from men with azoospermia is dependent on
the aetiology. Previous reports have differed as to the influence
of a non-obstructive cause.
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We first analysed our own data and then performed a meta-
analysis of published data to compare ICSI outcome in men
with obstructive (OA) and non-obstructive azoospermia (NOA).
Methods: 152 consecutive ICSI cycles were performed in 89
couples using surgically retrieved sperm (127 OA and 25 NOA).
Nine reports (1103 cycles), including our own, were identified
as suitable for meta-analysis. The primary outcomes analysed
were fertilisation rate (FR), implantation rate (IR), clinical
pregnancy rate (CPR) and live-birth rate per transfer (LBR).
Results and Discussion: Analysis of our data showed a
significantly lower FR (49.1% and 42.1%: p=0.05) and IR (15.2%
and 3.5%: p=0.02) using sperm from men with NOA. The CPR
(28.1% and 9.1%: p=0.06) and LBR (20.2% and 4.5%: p=0.08)
were also lower but these findings were of borderline statistical
significance (p<0.1). These findings could not be explained by
differences in patient characteristics or stimulation regimes. The
quality of embryos transferred was improved in the OA group
(Grade 1; 34.7% versus 22.8% and Grade 2-3 or worse; 8.5%
versus 19.3%). The mean number of embryos transferred was
therefore higher in NOA men (2.59 versus 2.38). Meta-analysis
showed a significantly improved FR (RR 1.18; 95% CI: 1.13-1.23;
p<0.001) and CPR (RR 1.36; 95% CI: 1.10-1.69; p=0.01) in men
with obstructive azoospermia with a non-significant increase in
LBR (RR 1.19; 95% CI: 0.87-1.61; p=0.28). There was no difference
in either IR or miscarriage. In summary, the outcome of ICSI
cycles in men with azoospermia is significantly affected by
aetiology with impaired fertilisation and pregnancy rates in men
with NOA.
P83. Outcome of surgical sperm retrieval (SST) followed by
intracytoplasmic sperm injection (ICSI) in men with obstructive
azoospermia.
DG Giannaris, S Bhattacharya & MPR Hamilton. Department of
Obstetrics & Gynaecology, University of Aberdeen, UK.
Introduction: ICSI following surgical sperm retrieval (SST) is a
treatment option in obstructive azoospermia associated with
epididymal obstruction, bilateral congenital absence of the vas
deferens (CBAVD) and vasectomy associated cases. We
analysed the outcome of SST in Aberdeen from 1995-2002.
Methods: 132 SST cases: Group A = vasectomy or failed
vasectomy reversal (n = 83), Group B = CBAVD (n = 16), and
Group C = other causes (n = 33). Subsequent ICSI in 57 (69%) of
Group A, 14 (88%) of Group B, and 21 (64%) of Group C. Male
and female factors contributing to treatment outcome were taken
into account in the analysis.
Results and Discussion: The 3 groups were similar in terms of
male & female age, female factors, and smoking habits. Sperm
was retrieved from 83 (100%) in Group A, 15 (94%) in Group B
and 29 (88%) in Group C. The median [IQR] number of motile
sperm was significantly different in the three groups:
(A=4.8M[0.5M],[11.9M],B=0.6M[0],[6.5M],C=0.1M[0],[4.6M],p=0.002).
Fewer mean (sd) straws of sperm (6.3 ± 3.8) were stored in Group
C, compared with Groups A (8.6 ± 2.4) and B (7.3 ± 3.4) (p=0.001).
The mean (sd) number of follicles (A=12.4 ± 6.0, B=13.0 ± 6.6,
C=14.0 ± 6.3, p=0.632), eggs obtained (A=10.7 ± 6.0, B=10.9 ±
4.9, C=12.8 ± 5.5, p=0.392), fertilisation rate (A=74.0% ± 19.2,
B=68.2% ± 25.2, C=64.2% ± 22.6, p=0.196) and number of embryos
transferred (A=2.0 ± 0.3, B=1.9 ± 0.3, C=2.1 ± 0.2, p=0.348) were
similar in the 3 groups. In group C the mean (sd) implantation
rate (11.8% ± 28.1) and LBR (17.6%) were lower [Group A (30.2%
± 38.2 & 37.5%) and Group B (32.1% ± 46.4 & 28.6%) (p=0.196 &
0.307)]. Our results confirm the efficiency of SST in obstructive
azoospermia. Cases other than vasectomy reversal or CBAVD
were associated with fewer motile sperm and lower implantation
rate. While numbers are too few to demonstrate statistical
significance, clinical advice to such patients should take account
of this trend.
P84. Leptin and leptin receptor immunolocalization in the mouse
mammary gland.
C Dalgeorgou1, N Malik2, LJ Pellat1 & JF Murray1,2. 1Department
of Clinical Developmental Sciences, St. George’s Hospital
Medical School, London, UK; 2Department of Basic Medical
Sciences, St. George’s Hospital Medical School, London, UK.
Introduction: Following day 6.5 of gestation the genetically
leptin-deficient (ob/ob) mouse no longer requires exogenous
leptin treatment for the maintenance of pregnancy, the apparently
normal development in utero of the ob/ob feti or normal
parturition. The new born pups, however, appear not to suckle
and fail to survive (1) suggesting that leptin is required for either
mammary gland development or lactogenesis. It was the aim of
this study to determine the pattern of expression of both leptin
and the leptin receptor (ObR) in the mammary glands of wild-
type mice during late gestation and lactation as the first step in
elucidating the role of leptin in normal mammary gland
development and lactogenesis.
Methods: Wild-type mice were sacrificed on days 14.5 and 18.5
post-coitum, days 2 and 14 of lactation and at involution (n=3 at
each point). Mammary glands were collected from each animal
and frozen. The tissues were serially sectioned in preparation
for immunohistochemistry. Four different primary polyclonal
antibodies were used: two antibodies to leptin, one that
recognises all forms of ObR and one specific to ObRb. The
antigen-antibody complexes were detected using a second
antibody conjugated with fluorescein isothiocyanate.
Results and Discussion: Leptin, using both antibodies, was
immunolocalized to the cytoplasm of the alveolar epithelial cells
and the lumen of some alveoli at all stages examined. Leptin
receptor was also immunolocalized to these same cells.
Importantly, ObRb was not detected suggesting that leptin is
not involved in the intracellular regulation of alveolar epithelial
cells. The presence of the other ObRs indicates that leptin is
being transported, possibly to the milk. Leptin has been detected
in the milk of several species. We hypothesize that leptin is an
important component of milk if pups are to thrive and survive.
1. Malik et al., (2001) Endocrinology, 142, 5198-5202.
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P85. Circadian and circannual rhythms of T3 and T4 secretions
in Polwarth-Ideal rams.
MIL Souza1, SD Bicudo1, LF Uribe-Velásquez2 & AA Ramos3.
1Department of Animal Reproduction and Radiology Veterinary,
FMVZ, UNESP, Botucatu, Sao Paulo, Brazil; 2Department of
Animal Health, University of Caldas, Manizales, Caldas,
Colombia; 3Department of Animal Science, FMVZ, UNESP,
Botucatu, Sao Paulo, Brazil.
Introduction: Thyroid hormones appear necessary for the
expression of neuroendocrine mechanism regulating seasonal
photorefractoriness or endogenous reproductive rhythms since
seasonal inhibition of reproductive activity is greatly reduced
when rams are submitted to thyroidectomy. In this study, plasma
concentrations of T3 and T4 were determined in adult Polwarth-
Ideal rams over 1 year. The objective was to examine possible
circadian and circannual rhythms in thyroid hormones in rams
exposed to environmental conditions of Botucatu, Sao Paulo,
Brazil, where daylength ranges between 13:29 (December 21)
and 10:40h (June 21).
Methods: Five Polwarth-Ideal rams, aged between 4 and 5 years
with a mean body weight of 65 Kg, were kept at a latitude of 22°
51S and longitude of 48°26 W in semi-confinement. Blood was
collected by jugular venipuncture every 2 h for 24 h during the
months of June, August, October, December, February and April
fo same year. The blood collection were done during the first
week of each month. Radioimmunoassay was performed using
commercial kits of T3 (MEDLAB; minimum detectable
concentration of 7.0 ng/dL and the intra-assay CV was 1,53%)
and T4 (MEDLAB; minimum detectable concentration of 0.25
µg/dL and the intra-assay CV was 2.34%).
Results and Discussion: The highest levels of T3 and T4 were
seen in the months with long days (October, December and
February) and the lowest levels were after daylenght had
declined (April). The overall means were 97.52 ± 21.45 ng/dL for
T3 and 4.30 ± 0.94 ug/dL for T4. T3 and T4 in rams tended to vary
during the 24 h period with highest concentrations ocurring in
the afternoon and lowest concentrations in the early morning
hours. The peaks in T4 and T3 observed at 14:30 and 16:30h,
respectively, may be important physiologically given the role of
thyroid secretions in cellular metabolic activity of nutrient
utilization. Results suggest circadian and circannual rhythms in
thyroid hormone secretion may be present in rams kept relatively
close to the equator.
P86. Abstract Withdrawn.
P87. Loss of the diurnal variation in testosterone during
administration of exogenous testosterone for male
contraception: Implications for replacement dosage.
BM Brady1, RA Anderson2 & DT Baird1. 1Contraceptive
Development Network, The University of Edinburgh, UK; 2MRC
Human Reproductive Sciences Unit, The University of
Edinburgh, UK.
Introduction: The aim of androgen replacement therapy in men
treated with gestogens or GnRH antagonists for contraception
is to provide enough testosterone to reproduce physiological
concentrations. Blood samples are usually collected in the
morning when there is a well recognized peak of testosterone
concentration. The physiological significance of this circadian
rhythm is not known but it is probably due to changes in
endogenous testicular production and/or changes in the rate of
metabolism. The aim of this study is to determine whether this
diurnal variation persists during administration of exogenous
testosterone.
Methods: 11 healthy men (mean age 32.6, range 27-38 years)
were recruited as part of a male contraceptive study investigating
the effectiveness of 3 etonogestrel implants with 400mg depot
testosterone pellets (Organon NV) administered every 12 weeks.
Local ethical committee approval was obtained. Serum samples
were taken pre-treatment and after 4 weeks and 12 weeks
treatment between 0730-0930 hours (am sample) and 1630-1830
hours (pm sample): testosterone and LH were measured by
immunoassay.
Results and Discussion: A significant difference between
morning and evening testosterone concentrations was
demonstrated in pretreatment samples, falling from 23.5 ± 1.8
(am) to 17.4 ± 1.9 nmol/L (pm) (p=0.002) with no significant change
in LH (3.6 (am) and 4.1 IU/L (pm)). However after 4 weeks
treatment this diurnal variation was absent, testosterone
concentrations being 15.4 ± 1.6 (am) and 14.8 ± 1.7 nmol/L (pm)
at which time LH was suppressed (<0.5IU/L in all men). Similar
results were obtained after 12 weeks treatment: 12.1 ± 1.5 (am) vs
10.1 ± 1.2 nmol/L (pm). This study confirms the physiological
diurnal variation in serum testosterone concentrations, and
demonstrates that this is lost during administration of exogenous
testosterone under conditions of induced hypogonadotrophism.
Calculations based on morning concentration probably
overestimate the amount of testosterone required for
physiological androgen replacement: this may be by as much as
45%.
This study was funded by the MRC and DFID grant number
G9523250.
P88. Maternal reproductive hormone levels during repeated
ACTH application to pregnant gilts.
F Schneider1, KP Brüssow1, E Kanitz2 & W Otten2. 1Department
of Reproductive Biology, Research Institute for the Biology of
Farm Animals, Dummerstorf, Germany; 2Department of
Behavioral Physiology, Research Institute for the Biology of
Farm Animals, Dummerstorf, Germany.
Introduction: Stress during pig pregnancy may impair maternal
functions and, moreover, induce reproductive failures in
offspring. Our experiments aimed to study stress-dependent
effects in sows.
Methods: A stressful situation was imitated in primiparous gilts
(n = 16) by the repeated application of each 100 IU ACTH (one
injection every 2nd day) from day 28 to 38 (I) or day 49 to 59 (II)
of pregnancy. Levels of LH analysed in serial blood samples
were detected by a sensitive ECLIA but concentrations of
steroids by RIA or EIA. The PULSAR program was used to
calculate and characterize pulses of secreted LH.
Results and Discussion: LH concentrations were low but
showed a distinct pulsatility. The mean number of LH pulses
within 6h calculated in saline-treated controls was 1.5 ± 0.8 (I)
and 2.0 ± 0.6 (II), respectively. ACTH treatment diminished the
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number of pulses to 1.3 ± 0.8 (I) and 1.4 ± 0.5 (II), but significantly
(P < 0.05) only in mid-pregnancy (II). The total amount of LH
released within a pulse was reduced by treatment in I and II. The
reason for the difference in LH pulse secretion between both
periods is seen in a stronger negative feedback of conceptus
estrogens during (I) when estrone sulfate concentrations were
elevated independently of ACTH treatment. Levels of
progesterone as well as 17a-hydroxy-progesterone increased
significantly (P < 0.05) for 2 to 3h after each ACTH treatment.
However, the function of transient increases in gestagens which
are probably of adrenal origin is not yet clear at this time. In
sum, it was demonstrated that chronically intermitted stress
imitated by repeated ACTH administration is able to influence
significantly the release pattern of maternal reproductive
hormones during sow’s mid-pregnancy. The detected changes
may affect, together with direct influences by ACTH, the
placental function and, hereby, important maternal-fetal
interactions.
P89. Food restriction can influence ovarian cell function
through IGF-I, leptin and cAMP-dependent intracellular
mechanisms.
O Svarcova1, AV Sirotkin1, H-J Schaeffer2, J Raffay1,
L Chrastinova1 & A Armaiova1. 1Research Institute of Animal
Production, Nitra, Slovakia; 2Universitäts Frauenklinik, Kõln,
Germany.
Introduction: The aim of our experiments was to elucidate the
influence and mechanism of action of plane of nutrition on the
reproductive functions.
Methods: Rabbits were subjected to 10-days food restriction
(50% of normal intake), IGF-I and IBMX treatments, whilst plasma
estradiol, progesterone, leptin and IGF-I levels were measured
using RIA/EIA. Granulosa cells isolated from ovaries of these
animals were cultured in the presence of IGF-I, leptin and
dbcAMP. Expression of intracellular peptides associated with
proliferation (PCNA), apoptosis (bax) and IGF-I was evaluated
using immunocytochemistry and Western blotting. Release of
estradiol and IGF-I were measured using RIA/EIA.
Results and Discussion: Food restriction resulted in reduction
in plasma progesterone, estradiol and leptin (but not IGF-I) level,
as well as in estradiol release, proliferation and apoptosis of
granulose cells. IGF-I, dbcAMP and leptin additions prevented
the inhibitory influence of food restriction on apoptosis, but
not on proliferation of ovarian cells. IBMX and IGF-I treatment
modified influence of food restriction on plasma progesterone,
estradiol and IGF-I release.
These results suggest that food restriction can influence rabbit
ovarian functions by inhibiting proliferation and apoptosis, IGF-
I, progesterone, estradiol and leptin release by ovarian cells.
IGF-I, leptin and cAMP - dependent intracellular mechanisms
can be mediators of the effect of nutrition on reproductive
function.
P90. Plasma and follicular NEFA (non esterefied fatty acids)
levels as related to circulating leptin in fasting prepubertal
gilts.
G Galeati, N Govoni, M Spinaci, E Seren & C Tamanini.
Department of Veterinary Morphophisiology & Animal
Production, University of Bologna, Ozzano Emilia, Italy.
Introduction: Leptin plays a key role in the regulation of food
intake and energy consumption but is also involved in the
modulation of reproductive activity; NEFA are related to the
mobilisation from adipose tissue. This research was aimed to
quantify leptin plasma levels during fasting and refeeding in
gilts and to verify whether these levels are correlated with those
of NEFA in both plasma and follicular fluid (FF).
Methods: Twelve Large White x Duroc prepubertal gilts were
divided into three groups (n=4) and ovariectomized (ovx) during
normal alimentation (group A), after 72h of fasting (group B) or
24h after refeeding at the end of a 72h fasting period (group C).
All the animals were i.m. injected with 1250 IU eCG 48h before
ovx to induce follicular growth. FF was collected from 6 follicles
>4 mm/each animal and assayed for NEFA content by a
colorimetric kit. Blood samples were collected at ovx and assayed
for both NEFA and leptin (Linco Research).
Results and Discussion: Leptin levels in plasma were lower
(P<0.001) in B than in A group (0.75 ± 0.02 vs 2.66 ± 0.21 ng/ml);
basal values were observed in C group (2.16 ± 0.05 ng/ml). NEFA
levels were higher in fasting that in control animals in both
plasma (380.5 ± 22.04 vs 179.8 ± 18.76 mEq/ml; P=0.003) and FF
(544.0 ± 27.15 vs 175.6 ± 16.72 mEq/ml; P<0.001); in fasting gilts,
NEFA concentrations were higher (P=0.002) in FF than in plasma.
NEFA levels in group C (plasma: 192.2 ± 46.96; FF: 233.0 ± 30.65
mEq/ml ) were similar to those of controls. Leptin and NEFA
levels in plasma are inversely related and both are severely
affected by fasting; however, refeeding promptly induces the
resumption of normal conditions. High NEFA concentrations
during fasting document an intense lipolysis while NEFA levels
higher in FF than in plasma indicate that the follicle is capable to
concentrate this metabolite.
Work supported by a MIUR-FIRB grant.
P91. Putative PDZ domain-binding motif-mediated interactions
between the human gonadotropin-releasing hormone (GnRH)
receptor and intracellular proteins delineated by a multi-step
proteomics approach.
AJ Pawson1, L Davidson1, P Barran2, RP Millar1 & SR Maudsley1.
1Human Reproductive Sciences Unit, Medical Research Council,
Edinburgh, UK; 2School of Chemistry, The University of
Edinburgh, Edinburgh, UK.
Introduction: Current understanding regarding the organization
of intracellular signalling pathways suggests that multimolecular
complexes of cell-surface receptors, signalling and structural
proteins are assembled at the plasma membrane. At the centre
of these complexes are members of the ‘scaffold’ protein family
containing multiple PDZ domains, which allow interactions with
PDZ domain-binding motifs located at the carboxyl-terminus of
many signalling molecules and cell-surface receptors. The
objective of the current study was to identify proteins involved
in such interactions with respect to the human GnRH receptor.
78
Methods: A putative Type II PDZ domain-binding motif located
at the carboxyl-terminus of an amino-terminally epitope-tagged
human GnRH receptor was mutated (L328A). The tagged wild-
type and L328A receptors were transiently expressed in HEK
293 cells. The ability of the L328A receptor to bind GnRH and
couple to Gq was tested by standard radioligand binding and
inositol phosphate assays. Wild-type and L328A receptors from
lysed HEK 293 cells were immunoprecipitated and subjected to
2-D isoelectric focussing gel electrophoresis. Well-defined
protein puncta were excised, trypsin-digested and analysed by
MALDI-TOFF mass spectrometry.
Results and Discussion: The L328A mutant receptor showed a
substantially decreased level of expression at the cell-surface
(Bmax ~20% of wild-type), and failed to couple to Gq efficiently,
with a calculated coupling efficiency of only ~30% of the wild-
type receptor. A comparison of the 2-D gels from wild-type and
L328A receptor immunoprecipitates revealed a protein ‘spot’
with a molecular weight of ~45 kDa and isoelectric point of ~8,
that was specifically lost from the wild-type gel pattern compared
with the L328A mutant gel pattern. Analysis of this ‘spot’ by
mass spectrometry identified a number of candidate proteins.
This study is the first to delineate putative interactions between
the GnRH receptor and intracellular signalling and structural
proteins via the PDZ domain-containing ‘scaffold’ protein family.
P92. Role for prostaglandins in mediating acute stimulation of
11B-hydroxysteroid dehydrogenase (11BHSD) activity by
interleukin-1B (IL-1B) in human granulosa-lutein (hGL) cells
KC Jonas1,2, LM Thurston2 & AE Michael1,2. 1Biochemistry and
Molecular Biology, University College London, London, UK;
2Veterinary Basic Science, Royal Veterinary College, London,
UK.
Introduction: In human ovarian surface epithelium and rat
granulosa cells, cortisol-cortisone inter-conversion by 11BHSD
can be increased by luteinising hormone (LH) and IL-1B. Since
gonadotrophins and cytokines are pro-inflammatory in the pre-
ovulatory follicle, the objectives of this study were to establish
whether human chorionic gonadotrophin (hCG) and IL-1B could
acutely increase 11BHSD activities in hGL cells and whether
any stimulation could be prevented by co-treatment with the
preferential prostaglandin H synthase 2 (PGHS-2) inhibitor:
meclofenamic acid (MA).
Methods: Human granulosa-lutein (hGL) cells were isolated from
follicular aspirates of women undergoing controlled ovarian
hyper-stimulation for IVF-ET (n=5). After isolation on 60%
Percoll, cells were cultured in serum-supplemented medium. On
day 3 of culture, cells were transferred to serum-free medium
and treated for 4 hours with either hCG (100ng/ml) or IL-1B
(10ng/ml), each ± 0.1mM MA. Over this 4 hour period, 11BHSD
activity was assessed by radiometric conversion assays using
100nM 3H-cortisol as substrate. Steroids were extracted,
resolved by TLC, and quantified using a radiochromatogramme
scanner.
Results and Discussion: The effects of hCG and IL-1B were
highly variable; in hGL cells with high basal enzyme activity,
these hormones were ineffective (n=2), while in cells with low/
moderate basal activities, hCG and IL-1B stimulated 11BHSD
activity by up to 190% and 147% respectively (P<0.01; n=3).
While MA had no effect on basal or hCG-stimulated 11BHSD
activities, this preferential inhibitor of PGHS-2 prevented
stimulation of cortisol oxidation by IL-1B (basal minus MA=8.0
± 2.7pmoles cortisone/4h; IL-1B minus MA =12.3 ± 3.6pmoles/
4h; basal plus MA=7.4 ± 1.8pmoles/4h; IL-1B plus MA= 8.4 ±
1.3pmoles/4h). Hence we conclude that while prostaglandins
do not appear to effect basal or gonadotrophin-stimulated
glucocorticoid metabolism in hGL cells, these pro-inflammatory
eicosanoids may mediate stimulation of ovarian 11BHSD activity
by IL-1B.
Supported by MRC studentship G69/1756.
P93. Relationship between the presence of large follicles and
oestradiol levels and embryonary production in the day of the
embryo flushing in heifers and beef cows.
CAC Fernandes1, E Oba2 & LF Uribe-Velásquez3. 1Faculty of
Veterinary Medicine, University of Alfenas, Alfenas, Brazil;
2Department of Animal Reproduction and Radiology Veterinary,
UNESP, Botucatu, Brazil; 3Department of Animal Health,
University of Caldas, Manizales, Caldas, Colombia.
Introduction: The great variation on the results of the current
protocols for superovulation in bovines is the major aspect that
limits the use of embryo transfer tecnique. The aim of this work
was to verify the influence of the presence of large follicles, in
the ovaries of heifers and cows in the day of the embryo flushing,
upon the estradiol plasma levels and upon the embryo recovery
rate.
Methods: Twenty-five cows and heifers (Limousin breed) of 17
months of age or older were used. All animals showed two
regular estrous cycles before the start of the experiment. The
animals were superovulated with Folltropin V (Ontario, Canada)
injected twice a day in decreasing doses (48,48, 36, 36, 24, 24, 12,
12 mg NIH-FSH-PI) starting on day 9 or 10 of the estrous cycle.
The embryos were recovered by non-surgical flushing at 7 days
after the begining of the estrus. From the day of estrus until the
day of embryo flushing, the ovaries were monitored daily by
transrectal ultrasonography with 8MHz real-time linear array
transducer. Blood samples were collected on the day of embryo
flushing. For the variables comparison, estradiol levels and
recovery rate, between animals that showed and the ones that
did not show large follicles at flushing day, the student test was
used.
Results and Discussion: The recovery rate from animals that
showed one or more follicles with diameter > 12 mm was lower
than on animals that did not show those follicles (37.42 ± 12.11
vs 65.13 ± 13.63; P<0,05). Those donors also showed greater
estradiol levels (17.62 ± 4.57 vs 10.82 ± 3.81 pg/mL; P<0,05). The
presence of large follicles that did not ovulate right after estrus
and remain with steroidogenic ability until flushing day, increase
the circulating levels of estradiol in these animals and may be
the responsible for a hormonal disturbance that alters the
transportation of the embryos up to the uterus, decreasing the
embryo recovery rate.
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P94. Insulin modulation of lactate and insulin-like growth factor
binding protein (IGFBP)-1 production by human granulosa cells
purified by removal of white blood cells.
MC Richardson, TE Hodge, CD Simonis, DDY Mukhtar &
IT Cameron. Maternal, Fetal & Neonatal Physiology Group,
University of Southampton, Southampton, UK.
Introduction: Our aim is to develop a purified preparation of
human granulosa cells (GC) suitable for the investigation of
insulin regulation of gene transcription, uncomplicated by
potential effects of insulin on other cell types such as white
blood cells (WBC). Because GC clusters incorporate embedded
WBC, effective purification of GC by removal of WBC must
involve prior dispersion of cell clusters. This has been achieved
as follows.
Methods: Cells were prepared from follicular aspirates obtained
at oocyte retrieval for IVF, with informed consent from patients.
Culture overnight in the presence of serum allowed attachment
and spreading of GC onto the culture surface. The cells were
washed and removed from the culture surface with trypsin.
Following exposure to magnetic beads conjugated with CD45
antibody, further dispersion occurred in the presence of EDTA
before removal of WBC using a magnetic field. After re-
attachment in serum-containing medium, culture continued in
serum-free medium with hormonal additions. Media were assayed
for lactate and IGFBP-1 and cells extracted for RNA.
Results and Discussion: Immunocytochemical identification of
WBC revealed that this component was reduced to less than
1% of the total. The purified GC retained ability to respond to
hCG in terms of progesterone production and this correlated
with the expression of steroidogenic acute regulatory protein.
Initially, however, characterization of insulin responses revealed
effects at supraphysiological concentrations of insulin, implying
that our method had removed influences important for insulin
action. Addition of extracellular matrix (Matrigel; Becton-
Dickinson) improved the characteristics of insulin action with
effects, both on stimulation of lactate output and inhibition of
IGFBP-1 production, apparent at lower, physiological
concentrations (ED50, 1-10ng/ml). To conclude, the
methodology employed to remove WBC from GC preparations
resulted in problems in later culture. Replacement of matrix was
helpful in re-establishing responses to insulin.
P95. Use of an adenoviral transfection system to study signalling
pathways involved in growth and death of ovine ovarian surface
epithelial cells.
O Gubbay1, W Guo1, M Rae1, AJ Zeleznik2 & SG Hillier1.
1Department of Reproductive & Developmental Sciences, Centre
for Reproductive Biology, University of Edinburgh,
Edinburgh,UK; 2Department of Cell Biology and Physiology,
University of Pittsburgh, US.
Introduction: Ovarian surface epithelial (OSE) cells are believed
to play an important role in the regulation of ovulation.
Immediately prior to ovulation, OSE cells are thought to apoptose
specifically at the site of ovulation and later re-populate the
surface of the ovary within the luteal phase. Our results suggest
that the stimulation of OSE cell growth/survival, by factors such
as IGF-1, occurs via the ERK MAPK and Akt/PI3K signalling
pathways in a CREB (cAmp Responsive Element Binding
protein)-dependant manner.
Methods: Using primary cultures of OSE cells, isolated from
sheep ovaries, we have investigated extracellular factors and
intracellular signalling pathways that are important for OSE cell
growth/death. Proliferation and death of OSE cells was measured
by reduction of Owen’s reagent and activation of caspase 3/7,
respectively (Promega). The expression of CREB protein was
achieved using an adenoviral transfection system and activation
of signalling proteins analysed by Western blot analysis. All
experiments were conducted in accordance with the UK Home
Office guidelines and the Animals (Scientific Procedure) Act
1986.
Results and Discussion: Factors that were shown to promote
OSE cell growth/survival include IGF-1 (Insulin Growth Factor
1), HGF (Hepatocyte Growth Factor) and hCG (human Chorionic
Gonadotrophin). The stimulation of OSE cell growth/survival
by IGF-1 was further shown to be dependant on the ERK MAPK
and Akt/PI3K signalling pathways. In order to examine the
involvement of CREB protein on OSE cell growth, a dominant
negative CREB mutant (S133A) was expressed in OSE cells using
an adenoviral expression system. When expressed in OSE cells,
this mutant CREB protein was shown to induce cell death. Our
results therefore suggest that CREB is a necessary survival
factor for OSE cells that may be regulated by such factors as
IGF-1, acting via the ERK MAPK and/or Akt/PI3K signalling
pathways.
Supported by MRC Programme Grant 0000066.
P96. Ghrelin is a potential paracrine stimulator of 11B-
hydroxysteroid dehydrogenase (11BHSD) in the human ovary.
TM-M Tan1,2,3, KC Jonas3,4, LM Thurston3, MP Vanderpump1,
PJ Hardiman2 & AE Michael3,4. 1Department of Medicine, Royal
Free Hospital, London, UK; 2Department of Obstetrics &
Gynaecology, Royal Free Hospital, London, UK; 3Reproduction
& Development Group, Department of Veterinary Basic Sciences,
Royal Veterinary College, London, UK; 4Department of
Biochemistry & Molecular Biology, Royal Free & University
College Medical School, University College London, London,
UK.
Introduction: Within ovarian cells, cortisol can be oxidised to
the inert metabolite, cortisone, by isoforms of the enzyme
11BHSD. Recently, we have demonstrated that human follicular
fluid (hFF) contains both hydrophilic components that can
acutely stimulate and hydrophobic compounds that can inhibit
the NADP(H)-dependent isoform of 11BHSD. The objectives of
the current study were to establish whether the hydrophilic
peptide, ghrelin, recently shown to be expressed in the human
corpus luteum, might act as a paracrine stimulus to 11BHSD in
the human ovary.
Methods: Samples of hFF containing human granulosa-lutein
(hGL) cells were aspirated from patients undergoing controlled
ovarian hyper-stimulation for IVF-ET. After precipitating cells,
aliquots of hFF were loaded onto C18 columns, eluted with
increasing concentrations of methanol (0-100% v/v) and the
ghrelin content of each hFF fraction was measured using a
commercial radioimmunoassay. In subsequent experiments, hGL
cells, purified on 60% Percoll, were cultured in serum-
supplemented medium. On day 3 of culture, 11BHSD activities
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were assessed by incubating cells for 4 hours in serum-free
medium containing 100nM 3H-cortisol plus 0-1000pM ghrelin.
Steroids were extracted, resolved by TLC, and quantified using
a radiochromatogramme scanner. Experiments were repeated
using cells from 7 different patients.
Results and Discussion: All of the ghrelin present in hFF samples
was contained in those hydrophilic fractions eluted by 0% and
10% methanol (10.8-18.6pM and 3.5-15.0pM ghrelin,
respectively) with no detectable ghrelin (<3pM) in those
fractions eluted by 20-100% methanol. Treatment of hGL cells
with ghrelin for 4 hours increased cortisol oxidation in a
concentration-dependent manner; while 1pM ghrelin had no
significant effect, at concentrations of 10, 100 and 1000pM,
ghrelin increased 11BHSD activities by 53 ± 12%, 64 ± 12 and 60
± 11%, respectively (P<0.01 for each concentration). Hence we
conclude that ghrelin may be one of the hydrophilic components
of hFF capable of acutely stimulating cortisol-cortisone
interconversion by 11BHSD.
P97. Spontaneous pregnancy after ovarian tissue
cryopreservation by vitrification and intra-uterine
transplantation.
TM Elbarbary1, H Lucas1, F Urner1, C de Vantery1, F Pelte2,
A Feki1, A de Agostini1 & D Chardonnens1. 1Department of
Sterility, Maternity, Geneva University, Geneva, Switzerland; 2
Department of Pathology, Geneva University, Geneva,
Switzerland.
Introduction:  Advances in diagnosis and treatment of
childhood, adolescent and adult cancer have greatly enhanced
the life expectancy of premenopausal women with cancer.
Cryopreservation of the ovaries is one of the means for long-
term preservation of female germ cells. This study aims to evaluate
vitrification as a method of ovarian tissue cryopreservation, to
evaluate the uterus as a site of ovarian tissue transplantation,
and to evaluate the role of hCG in ovarian tissue transplantation.
Methods: The left ovary was obtained from twelve- to twenty-
week-old OF1 female mice and divided into 2 groups, group 1
was not frozen (control group) and group 2 was vitrified using a
procedure reported by Sugimoto et al., 1999. Ovarian biopsies
from both test (n = 9) and control (n = 9) groups were prepared
for histological and immunohistochemical examinations to
detect apoptosis. The ovarian biopsies from both control and
test groups were autotransplanted either in one (n = 49) or both
(n = 40) uterine horns with simultaneous removal of the right
ovary and half of these mice were given hCG in the first month
after transplantation. Ovarian grafts from 4 test and 3 control
mice were examined histologically and immunohistochemically
and mating was tried with the others looking for pregnancy.
Results and Discussion: Histological examination of the fresh
and vitrified ovarian biopsies before and after transplantation
revealed morphologically normal ovarian follicles.
Pregnancy had happened in 4 mice, (2 test mice and 1 control
mouse with unilateral transplantation and hCG support, and 1
control mouse with bilateral transplantation and without hCG
support). Using Chi-square test, the proportion of normal
primordial, primary, and secondary follicles in both control and
test groups, and the number of pregnancies in mice with and
without hCG support revealed statistically insignificant
difference. (The ovary can tolerate vitrification and the uterus is
a suitable place for transplantation and can result in spontaneous
pregnancy)
P98. The effect of chronic spinal cord injury on sperm
parameters in rats.
A Abbasi1, H Hadinedoushan2, MA Khalili2, M Anvari2 &
F Saad-lou3. 1Department of Anatomy, Shahid Sadoughi
University, Yazd, Iran; 2Research & Clinical Center for Infertility,
Yazd, Iran; 3Department of Neurosurgery, Shahid Sadoughi
University, Yazd, Iran.
Introduction: To investigate the effects of chronic spinal cord
injury (CSCI) on sperm parameters in adult rats.
Methods: Adult Wistar rats weighing between 225-270g were
divided into 3 groups of control (n=5), sham (n=10), and
experimental (n=10). The sham animals were operated with
laminectomy at T10. The CSCI was done on experimental rats,
with 10g weight dropped 5cm above the exposed T10 level. All
animals were anesthetized 50 days post experiment to extract
epididymal samples. Sperm parameters of count, motility,
morphology along with number of round cells were evaluated.
Results and Discussion: The results showed that progressive
motility was significantly reduced in CSCI group (P less than
0.05). Also, mean no. of round cells was increased from 0.8 ± 1.2
in control to 4.1 ± 3.3 millions in CSCI rats. Other parameters
were relatively similar.
The results suggest that significant sperm progressive motility
deficit occurs in rats following CSCI, which may disturb the
fertility potential of spermatozoa.
P99. Effect of 3-MCPD on male fertility, sperm parameters and
hormonal secretion in the rat.
SJ Kwack1, SS Kim1, GS Rhee1, KH Sohn1, RD Lee1, SY Chae1,
CH Park1, YW Choi1, HJ Lee1, YH Chung2, J Yu2 & KL Park1.
1Division of Reproductive & Developmental Toxicology, NITR,
Seoul, Korea; 2Occupational Safety & Health Research Institute,
Taejon, Korea.
Introduction: 3-MCPD is a toxic compound, often present in
different foods containing acid hydrolyzed (AH) protein, like
seasonings and savory food products. In Korea, 3-MCPD is
currently being a problem because of its toxicity in AH soybean
sauce. The purpose of the present studies was to investigate
the effects of 3-MCPD on male fertility, sperm and testosterone
secretion.
Methods: 3-MCPD was given daily to animals by gavage. The
doses were set at 0.01, 0.05, 0.25, 1 or 5 mg/kg bw. Dams were
sacrificed on gestational day 20 and males were demonstrating
successful induction of pregnancy were sacrificed on that day
to assess sperm parameters, spermatogenesis and
histopathology of reproductive organs. Leydig cell was isolated
and cultured from rat testes. 3-MCPD was added to cell cultures
at the concentration of 0.001, 0.01, 0.1, 1 or 10mmol/L each and
cells were cultured 6, 12, 18 or 24 h. Hormone assay was
performed for observing the effects of 3-MCPD on testosterone
and LH in blood and testes of male SD rats and cultured primary
Leydig cell.
Results and Discussion: Four-week paternal administration with
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3-MCPD resulted in adverse effects on male fertility and
pregnancy outcome without remarkable histopathological
changes in testes and epididymis; sperm motility, copulation
index and fertility index were markedly decreased in the treated
group and numbers of live fetuses showed steep dose-response
curves. However, no effects were observed on production of
sperm in testes and related hormones. These results indicated
that paternal treatment with 3-MCPD induced spermatotoxic
effect, which caused a antifertility in males.
P100. Experience of junior doctors in laparoscopic ectopic
management - a national survey.
AJ Drakeley. Liverpool Womens’ Hospital, Liverpool, UK.
Introduction: Trainees provide the bulk of service out of hours.
The laparoscopic management of ectopic pregnancy is often
performed out of hours by trainees and requires rigorous training
to ensure operator proficiency. We were interested in how many
trainees were trained to perform the above procedure and the
opportunities available to maintain skills.
Methods: Between 1st May and 31st July 2002, the RCOG
National Trainees Committee conducted a national survey of
training. The RCOG database of trainees was used.
Questionnaires were distributed to all trainees in Obstetrics and
Gynaecology in the British Isles. A trainee was defined as a
junior doctor who wished to pursue a career in Obstetrics and
Gynaecology. Distribution took place in two main mailings, the
first in April via District (College) Tutors, the second in June via
the Regional Trainees Committees. Data was entered and
analysed anonymously.
Results and Discussion: The estimated number of trainees in
post calculated from the May 2001 RCOG Census and District
(College) Tutor returns was 1857. The Survey of Training 2002
produced 930 (50.1%) completed questionnaires. 116 (33.5%) of
junior SpRs (1-3) and 133 (69.3%) of senior SpRs (4-5) stated
they had been trained to manage ectopics laparoscopically,
however only 5 junior SpRs and 1 senior SpR had performed
more than 5 over the previous 12 months.
For procedures which are performed by trainees out of hours,
guidelines are needed covering competence and maintenance
of skills.
P101. Combined retrospective and prospective study of
surgically treated ectopic pregnancy at the Royal London
Hospital.
TZ Jacobson, P van den Hurk, W Chan, A Ihenacho, M Gjebagje
& C Davis. Obstetrics and Gynaecology, Royal London Hospital,
London, UK.
Introduction: The incidence of ectopic pregnancy varies from
1:200 conceptions to 1:50 depending on the local population.
12.2% of Direct Maternal deaths in the UK are due to ectopic
pregnancy. Laparoscopic management has been shown to be
preferable to laparotomy.
Methods: The prospective data was collected from a pro-forma.
(July 02 - ongoing).
Retrospective data was collected case notes (July 01 to June
02).
Results and Discussion: In the retrospective study there was a
total of 41 surgically treated ectopic pregnancies. Prospectively
study there are 22 cases. We found no major differences in age
range, BMI, presenting symptoms or ultrasound findings.
In the majority of prospective cases, place of first presentation
was in A&E whereas in the retrospective cases there was equal
presentation to A&E and EPAU.
Time from first presentation to surgery was quicker in the
prospective cases, 41% compared to 26% in the retrospective
cases. 41<24hrs cf 26%. In both the groups the supervising
surgeon >80% was a consultant/senior registrar or senior staff
grade.
At laparoscopy >80% of the cases the contra-lateral tubes was
examined with >60% normal tubes were found. In the
retrospective group 84% had a salpingectomy, 8% salpingotomy
and 8% tubal abortion. In the prospective group 74% had a
salpingectomy, 16% salpingotomy, 5% tubal abortion and 5%
not recorded.
Surgical treatment by laparoscopy had improved in the
prospective data (86%) compared to 63% in the retrospective
data. Of the 3 patients who underwent a laparotomy in the
prospective group one was converted from a laparoscopy due
to poor view. There were seven laparotomies in the retrospective
group and of those 4 were converted. Two due to excessive
bleeding/unstable patient, 1 due to adhesions and 1 due to poor
view.
One complication occured - a retained redivac drain after
laparotomy requiring a further GA.
Conclusions: Laparoscopy rates have appears to improve from
63% retrospective compared to 84% prospective.
Pro-formas have improved data collection.
P102. Is there a correlation between the visual and histologic
examination of pelvic endometriosis?
N Potdar, S Tumula, C Hunt & OA Odukoya. Department of
Obstetrics & Gynaecology, North Lincolnshire and Goole NHS
Trust, Scunthorpe General Hospital, Scunthorpe, UK.
Introduction: Endometriosis is responsible for 30-50% of chronic
pelvic pain in women. In clinical practice the gold standard for
the diagnosis of endometriosis is laparoscopy. The appearances
vary from subtle to the classic blue-black implants. There are
differences of opinion regarding the confirmation of visual
diagnosis by histological means prior to the initiation of
treatment. This study aims to determine the association between
the histological and visual diagnosis of these lesions.
Methods: A retrospective study of 182 case notes of women
who underwent laparoscopy for chronic pelvic pain from 1998-
2001.Visual diagnosis of endometriosis was made by laparoscopy
according to the American Fertility Society criteria. Excision of
lesions was performed and tissue sent for histology. Histological
diagnosis was made by a combination of glandular & stromal
tissue and haemosiderin deposits in the biopsy sites, mainly
the peritoneum and the ovary. The control group consisted of
all women without endometriosis and the biopsy was obtained
from the normal looking peritoneum.
Results and Discussion: Sixty four women were diagnosed with
endometriosis on laparoscopy. These women were aged
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between 23 to 44 years. Thirty two of 64 underwent excision of
the visual lesions. Of these 26 (81.3%) were positive on histology
for the presence of endometriosis. The sensitivity of histological
diagnosis is 81.25 %, specificity of 92%, positive predictive value
of the test is 86.66% and negative predictive value of 88.4%.
From our study we conclude that histology of the suspicious
lesions provides objective proof of the disease. Visual diagnosis
does help in the immediate treatment of the lesions by excision
or diathermy but has moderate sensitivity, specificity and the
outcome depends upon the skill and experience of the surgeon.
The definitive diagnosis of endometriosis can be confidently
assessed by the histological confirmation of the visual lesions.
P103. Practice makes perfect? Endoscopic training using
medical simulation.
SJ Barnes, TZ Jacobson & CJ Davis. Department of Obstetrics
and Gynaecology, St. Bartholomew’s and The Royal London
Hospitals, London, UK.
Introduction: Endoscopic surgery has many advantages over
open surgery with decreased hospital stay and adhesion
formation, however, it is an area of high litigation. Training
requires both apprenticeship and a didactic approach. We have
analysed the effects that a structured training course using
simulators has had on trainees in Obstetrics and Gynaecology.
Methods: Trainees of different levels of experience, who enrolled
on a gynaecological endoscopic training course, made a
subjective measurement of their confidence and had an objective
assessment of their skills prior to undergoing a two day training
programme in theoretical and practical aspects of endoscopic
surgery using simulators. At the end of the course they again
made a subjective assessment of their confidence and underwent
a series of standardised tasks and their performance was
measured. The standardised tasks were related to hand-eye co-
ordination and dexterity by transfer of clips from one side of the
pelvitrainer to the other, and surgical techniques using
application of endoloops and cutting between two lines a set
distance apart. A time limit was imposed and the task was only
considered to be completed if all aspects were carried out
completely.
Results and Discussion: All delegates registered an
improvement in their confidence in performing endoscopic
surgery. The increase in confidence was inversely related to
their experience. Objective experience showed differences in
ability in completing tasks and the major reason for failing the
task was inability to complete it in the time allocated.
Confidence is an important aspect of surgery and the course
clearly provided the opportunity to improve in this area.
Developing surgical techniques without operating on an
anaesthetised patient is beneficial and practice improves
performance.
P104. In vitro effect of gangliosides on lipid peroxidation in
human spermatozoa.
M Gavella, R Rakos & V Lipovac. Department of Cell
Biochemistry, Vuk Vrhovac University Clinic for Diabetes,
Endocrinology and Metabolic Diseases, University of Zagreb,
Zagreb, Croatia.
Introduction: Lipid peroxidation-induced changes in physical
properties of sperm membrane may have deleterious
consequences on spermatozoa functioning. Since gangliosides
- a sialic acid containing glycosphingolipids were shown to
have inhibitory effect on lipid peroxidation (LPO) in several cell
types, we examined the effect of gangliosides on lipid
peroxidation in the spermatozoa.
Methods: The in vitro effect of gangliosides on LPO induced
by 0.2 mM ferrous sulphate/1 mM ascorbate system in
spermatozoa from 42 infertile men was investigated. The study
was approved by the ethical committee at the Vuk Vrhovac
University Clinic. The sperm concentration (mean ± SD) was
83.3 ± 65.1 X 106/ml; motility 53.8 ± 18.3%; progressive motility
35.6 ± 15.2%; vitality 62.0 ± 16.0%, hypo-osmotic swelling test
51.5 ± 12.2% and leukocytes < 1 X 106. Experimentally induced
LPO was performed for 60 min at 37°C with and without
gangliosides (disialoganglioside GD1a and trisialoganglioside GT1b,
Sigma, USA). Accumulation of malondialdehyde (MDA) was
estimated spectrophotometrically using thiobarbituric acid-
reactive substances (TBARS) assay.
Results and Discussion: Initial experiments have shown that
the reduction of MDA generation was obtained only in the
presence of more polar GT1b (40.6 ± 9.9 vs. 27.3 ± 6.6 nmol TBARS
/108 sperms in the presence of GT1b; n=8) whereas an equal
concentration of GD1a (100 uM) did not reveal any influence on
LPO (39.9 ± 11.6 vs. 39.1 ± 10.5 nmol/108 sperms). GT1b affected
LPO in a concentration-dependent manner (23, 33 and 55 % in
the presence of 25, 50 and 100 uM GT1b, respectively). GT1b (100
uM) significantly inhibited LPO in the spermatozoa of 42 infertile
men (29.7 ± 11.3 nmol TBARS/ 108 sperms without gangliosides
vs. 23.2 ± 6.9 nmol/108 sperms in the presence of GT1b; p<0.0001).
This study shows that the application of extracellular
gangliosides provides some protection to spermatozoa against
LPO, probably being related to a stabilizing effect on sperm
membrane.
P105. Assessing sperm membrane and DNA integrity in
normospermic men: Oxidation damage and antioxidants.
M Arabi. Department of Biology, Shahrekord University, Iran.
Introduction: We aimed to investigate the impact of nicotine ,as
an environmental hazard derived from tobacco leaf , on the
integrity of plasmatic membrane and DNA with checking the
effectiveness of antioxidants.
Methods: The semen samples were obtained from healthy donors
(without smoking) . The selected antioxidant supplementations
(alone/in combination) were: ascorbate (1mM), GSH (5mM) and
trolox (0.02mM). Water test used to asses the functional integrity
of sperm membranes. The Comet assay was carried out to check
the DNA integrity. The lipid peroxidation/LPO was also assessed
by determination of TBARS/MDA formation in presence and/
or absence of ferrous LPO promoter system .
Results and Discussion: The water-test showed a reduced
swelling reaction in spermatocrit as lowered membrane integrity.
The comet assay data shown that DNA integrity was severely
affected as judged by determination of DNA strand breaks in
spermatozoal samples. Nicotine additions (0.5 & 1 mM) resulted
in elevated levels of TBARS in media (51.5 & 78%, Student’s τ
test). Ferrous plus nicotine caused a further increase in TBARS
levels.These negative impacts were modulated by antioxidants.
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The increased levels of TBARS and decreased membrane
integrity suggested that nicotine could impose a severe
peroxidation in plasmatic membrane by oxygen free radicals .
Trolox functioned as a potent antioxidant to reverse oxidation
impacts. Nicotine can induce strand breaks in human sperm
DNA ladder. The above negative impacts was somewhat
reversible by antioxidant supplementations to samples.
P106. Seminal glutathione system (glutathione peroxidases 1
and 4, and glutathione reductase) expression and activity is not
correlated with classical semen parameters.
N Garrido1, M Meseguer1, C Simón1,2, J Remohi1,2 & A Pellicer1,2,3.
1Andrology Laboratory and Semen Bank, IVI Valencia, Valencia,
Spain; 2Department of Paediatrics, Obstetrics, and Gynecology,
School of Medicine, University of Valencia, Valencia, Spain;
3Department of Gynecology, Hospital Dr. Peset, Valencia, Spain.
Introduction: Protection against oxidative stress situations has
been revealed essential for sperm features and fertilizing ability.
So far, no molecular test has been implemented to the routine
semen analysis in the Andrology Laboratory with accurate
diagnostic and prognostic abilities to detect toxic effects of free
radicals on sperm samples. Glutathione system (GS) has been
extensively described to be a relevant defence system against
free radicals in spermatozoa. Our aim with this study was to
achieve knowledge of concrete parts of the complex semen
glutathione system biology and to determine its role in sperm
function, by correlating glutathione peroxidases-1 and 4 (GPX-
1 and 4), and glutathione reductase (GR) mRNA expression and
enzymatic activity with classic seminal parameters.
Methods: Semen from 75 males were obtained after 3-5 days of
sexual abstinence together with previous signed consent. All
were studied according with WHO statements for volume,
concentration and motility in the routine semen analysis by two
observers (NG and MM). We measured gene expression by
fluorescent quantitative PCR. Intracellular glutathione (GSH)
concentrations and enzymatic activities were measured by
spectrophotometry by controlled biochemical reactions, and
normalized quantifying total protein by Bradford’s method. Linear
regression analysis was used to determine the extent of
correlation between parameters of routine semen analysis and
all the components of (GS) compared.
Results and Discussion: No significative correlation was found
between any of the parameters included in the basic semen
analysis of % of A+B forms, volume, density, and total number
of motile cells, and the molecular determinations of GS, neither
mRNA expression, nor enzymatic activity. Moreover,
significances were considerably high, thus demonstrating the
total absence of interrelationship among them.
From our results, we can conclude that GPX-1 and -4, GR, and
GSH are not related with sperm quality, as measured by common
laboratory procedures. Nevertheless, the absence of relation
with the potential of initiating a pregnancy still needs to be
demonstrated.
P107. Effect of catalase and N2-gas on fresh bovine semen quality
during 6 days of storage.
S Verberckmoes, I De Pauw, A Van Soom, J Dewulf & A de Kruif.
Department of Obstetrics, Reproduction and Herd Health;
Faculty of Veterinary Medicine, University of Ghent, Merelbeke,
Belgium.
Introduction: Free radicals (e.g. O-) have a detrimental effect on
semen quality. The production free of radicals can be decreased
by 1) reduction of the O2-tension, and 2) by addition of anti-
oxidants (e.g. catalase) to the storage medium. In this study, the
effect of anaerobic conditions and catalase on bovine sperm
quality was determined during 6 days of storage the CEP diluent,
which is based on the ionic composition of Cauda Epididymal
Plasma.
Methods: Fresh semen of 3 bulls was stored at a concentration
of 25 x 106 spermazoa/mL, during 6 days at 5°C in airtight Falcon
tubes containing following media: 1) CEP, 2) CEP + 4.5% catalase,
and 3) CEP + 4.5% catalase + N2 gas. After collection and dilution
of the semen, it was slowly cooled down to 5°C. The sperm
concentration was determined by means of a Burker counting
chamber and light microscopy. The percentage of membrane
intact (MI) spermatozoa was determined by means of nigrosin
eosin staining and light microscopy (x 400). The acrosome
reaction was assessed by means of Pisum sativum Agglutinin
(PSA) staining with a fluorescence microscope (x 400). Motility
parameters were assessed with the Hamilton Thorn (HTM-Ceros)
on at least 1000 spermatozoa: velocity average pathway (VAP),
velocity straight line (VSL), linearity (LIN), straightness (STR),
beat cross frequency (BCF), and progressive motile spermatozoa
(PMS). Before assessment, samples were incubated during 5
min in open air at 37°C. The experiment was repeated 4 times and
the results were analysed using a linear mixed effect model.
Results and Discussion: After 6 days incubation at 5°C, no
significant difference in sperm quality parameters was observed
between spermatozoa stored in different media. In conclusion,
addition of catalase and storage under anaerobic conditions
did not improve sperm quality during storage in the CEP diluent.
P108. Diffusion barriers and domain organisation in boar
sperm plasma membranes.
PS James, C Hennessy & R Jones. Gamete Signalling Laboratory,
The Babraham Institute, Cambridge, UK.
Introduction: A characteristic feature of all differentiated cells
is segregation of the plasma membrane into compartments or
domains that are biochemically and functionally distinct from
one another. Well-known examples are inner and outer segments
of retinal rod cells, cell bodies versus axons of neurones and
head and tail plasma membranes of spermatozoa. Within these
compartments lipid rafts and protein microdomains are present
that range in size from tens of molecules to several hundred
nanometers in diameter. How this lateral asymmetry in the
membrane is generated and maintained against the randomising
forces of diffusion is one of the major problems in cell biology.
Methods: To elucidate the macromolecular organisation of boar
sperm plasma membranes we have investigated lipid diffusion
using a combination of fluorescence recovery after
photobleaching (FRAP), video FRAP, atomic force microscopy
(AFM) and single particle tracking (SPT). Central to these
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techniques has been the use of fluorescent reporter probes,
such a DiIC16, that intercalate into the outer leaflet of the lipid
bilayer.
Results and Discussion: Measured diffusion coefficients for
DiIC16 were 46.0, 44.0 and 10.6 x 10-9cm2/sec on the acrosomal,
postacrosomal and midpiece plasma membranes respectively.
These differences between surface domains cannot be explained
on the basis of diffusion barriers in the neck region (posterior
ring) or the posterior midpiece (annulus) as video-FRAP analysis
indicated that DiIC16 could diffuse across them in a distal
direction. SPT, however, has provided preliminary evidence that
DiIC16 particles on the acrosomal domain cannot traverse the
equatorial segment. These particles are ~200 nm in diameter and
are attached to, and within, the plasma membrane. Their
restricted movement suggests the presence of a diffusion barrier
between the equatorial segment and postacrosomal domains
that coincides with an abrupt change in the topographical
appearance of the plasma membrane as detected by AFM.
This work was supported by the BBSRC.
P109. Epididymal or testicular sperm in obstructive
azoospermia? A meta-analysis.
JDM Nicopoullos1, C Gilling-Smith1, PA Almeida1 &
JWA Ramsay1,2. 1Assisted Conception Unit, Chelsea &
Westminster Hospital, London, UK; 2Department of Urology,
Charing Cross Hospital, London, UK.
Introduction: The aim of this study was to define whether the
outcome of intracytoplasmic sperm injection (ICSI) using sperm
surgically retrieved from men with obstructive azoospermia (OA)
is dependent on the source of the sperm. We first analysed our
own data and then performed a meta-analysis of published data
to compare ICSI outcome in obstructive azoospermia between
cycles using epididymal and testicular sperm.
Methods: 154 consecutive ICSI cycles were performed in 91
couples using surgically retrieved sperm (127 epididymal and
27 testicular) from azoospermic men. Ten reports (734 cycles),
including our own, were identified as suitable for meta-analysis.
The primary outcomes analysed were fertilisation rate (FR),
implantation rate (IR), clinical pregnancy rate (CPR) and live-
birth rate per transfer (LBR).
Results and Discussion: Analysis of data from our centre
showed a non-significant increase in FR (49% and 46%), CPR
(25% and 22%), LBR (18% and 13%) and IR (13% and 11%)
using epididymal sperm compared to testicular sperm. When
only the cycles using sperm from OA men were analysed the
outcomes were almost identical (epididymal FR:49%, IR:15%,
CPR:28% and LBR:20%; testicular FR:51%, IR 15%, CPR:29%,
and LBR:21%). Our data suggests that there is no difference in
ICSI outcome according to source of sperm in similar patient
groups, and any difference is likely to be due to aetiology of
azoospermia. Meta-analysis comparing cycles using epididymal
and testicular cycles in obstructive azoospermia confirmed these
findings. There was no significant difference in either FR (RR
1.08; 95% CI: 0.97-1.18), IR (RR 1.1; 95% CI ; 0.64-1.93), CPR (RR
1.01; 95% CI: 0.81-1.25) or LBR (RR 0.98; 95% CI: 0.71-1.36). In
summary, the outcome of ICSI cycles in men with obstructive
azoospermia is not affected by the source of retrieved sperm.
P110. The fate of cryo-preserved progesterone receptor(s) of
canine sperm and its subsequent response to ligand stimulation.
FP Cheng1, JT Wu1, PS Tsai1, CTL Chang1 & SL Lee2. 1Department
of Veterinary Medicine, National Chung-Hsing University,
Taichung, Taiwan; 2Department of Animal Science, National
Chung-Hsing University, Taichung City, Taiwan.
Introduction: Cryo-modification of membrane progesterone
receptor (P4R) has not been investigated to explore its functional
change. This study was designed to demonstrate the freezing
effect on sperm P4R at molecular level.
Methods: To explore the functional and conformational changes
of P4R, pre-incubated (2-hours in CTM medium, 38°C) fresh and
frozen-thawed (Rota et al., 1997) sperm of fertile dogs (n=6)
were treated with 10 ug/ml P4 to induce the acrosome reaction
(AR). To detect the molecular evidence of P4R and its pattern
changes after cryo-modification, western blot analysis of
digitonin-treated sperm with antibodies directed against different
domains of the genomic P4R (mAb C262, NCL-PGR) and estrogen
receptor (h-151) was conducted. To determine the binding sites
of [3H]-progesterone, fresh and frozen-thaw sperm were
identically processed as described by Ambhaikar and Puri (1998).
Results and Discussion: The percentage of live AR (EthD-1 &
FITC-PNA staining) in fresh sperm was 9.6 ± 5.1% (pre-
incubated) and 31.0 ± 6.7% (P4 induced) while in frozen-thawed
sperm, 10.4 ± 2.7% (pre-incubated) and 21.6 ± 4.1% (P4 induced)
(P<0.05) was detected. The percentage of P4R staining (P4-BSA-
FITC) over acrosomal region was 18.3 ± 10.3% (fresh) and 36.0 ±
11.9% (pre-incubated) (P<0.05) while it was barely visualized in
frozen-thaw sperm regardless of pre-incubation. The protein
mass recognized by all mAbs was approximately 54 kDa as the
major and 65 kDa as the minor band. Cryo-process resulted in
alternation of protein pattern and undetectable P4R protein mass
of 65 kDa in sperm preparation of four dogs (n=6). Digitonin
treated fresh and frozen-thaw sperm, labeled with [3H]-
progesterone, revealed the P4 binding capacity decreased from
6.0 ± 4.4 to 3.0 ± 2.1 nM (n=6, P<0.05).These results indicate the
reduced AR incidence in response to P4 is evident in frozen
spermatozoa and suggestive to be due to the conformational/
degraded changes of P4R and/or reduced P4R density derived
from freezing injury.
Supported by the NSC 89-2313-B-005-054; 89-2313-B-005-
165; 90-2313-B-005-114, Taiwan.
P111. Effect of different extenders on post-thaw sperm survival,
acrosomal integrity and longevity in cryopreserved semen of
Formosan Sika and Formosan Sambar deer.
FP Cheng1, JT Wu1, JPW Chan1, JS Wang1, B Colenbrander2 &
KC Tung1. 1Department of Veterinary Medicine, National Chung-
Hsing University, Taichung City, Taiwan; 2Department of Farm
Animal Health, Utrecht University, Utrecht, The Netherlands.
Introduction: Formosan Sika (FSK) and Sambar (FSM) deer are
classified to be endangered Taiwan specific sub-species. This
study investigated the efficiency of five potential extenders used
in FSK and FSM to establish semen cryobank.
Methods: Pooled semen (n = 4) of 6 ejaculates from each species
was tested for efficiency of extender A, B (Dog: Rota et al.,
1997), C (Elds deer: Monfort et al., 1993), D (Fallow deer: Mulley
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et al., 1988) and E (Fallow deer: Jabbour et al., 1993), frozen at a
designed program (Rota et al., 1997).
Results and Discussion: FSK: Post-thaw motility was A: 71 ± 2
%; B: 66 ± 16 %; C: 73 ± 6 %; D: 9 ± 4 % and E: 26 ± 12 % while
C (74 ± 14 %) preserved more viable sperm (Sybr-14/PI staining)
than others. Five extenders showed the equivalence capacity of
acrosome protection (Fitc-PNA staining). Decline of longevity
(vigorous motility in 4 h incubation) was not observed in all
extenders. FSM: B (74 ± 6 %) and C (73 ± 2 %) were superior of
all extenders with respect to post-thaw motility. Similarly, A (70
± 7 %), B (76 ± 7 %) and C (79 ± 2 %) preserved more viable
sperm than D (25 ± 19 %) and E (29 ± 17 %). Sperm preserved in
B (86 ± 4 %) and C (83 ± 4 %) showed more intact acrosome than
those in A (54 ± 13 %), D (39 ± 22 %) and E (46 ± 22 %). Longevity
in A dropped by nearly 54% from the onset whereas only slight
decrease in others (P < 0.05). Conclusively, post-thaw sperm
species-specific characters revealed egg-yolk-tris-tes-glycerol
based C extender containing Equex is the optimal for freezing
FSK and FSM semen. Supported by the ROC Deer Farmer
Association.
P112. Characterization and purification of sperm progesterone
receptor(s).
JT Wu1, PS Tsai1, HP Fung1, SL Lee2 & FP Cheng1. 1Department
of Veterinary Medicine, National Chung-Hsing University,
Taichung City, Taiwan; 2Department of Animal Science, National
Chung-Hsing University, Taichung City, Taiwan.
Introduction: Little is known about the molecular and
pharmacological characteristics of nongenomic sperm
progesterone receptor(s) (P4R). This study demonstrated the
molecular characterization of these putative nongenomic P4R.
Methods: Sperm-ligand binding experiments were performed
using [3H]-P4 as tracer; unlabeled P4, 11BOH-P4, 11αOH-P4,
estradiol, testosterone and GABA as competitors. The
topography of P4R was identified by immunofluorescent staining
with different mAbs (C262, NCL-PGR, h-151) in membrane intact
and permeabilized sperm. A purification scheme of nongenomic
P4R proteins was developed based on ligand-receptor affinity
chromatography procedures.
Results and Discussion: P4 exhibited the greatest specificity to
P4R as compared to others competitors. Typical scatchard plot
analysis for [3H]-P4 binding to canine sperm revealed the
presence of two distinct binding sites. The affinity constant
and concentration of the high affinity site were 1.0 ± 0.7 nmol/L
and 10 ± 1 million sites/cell, while the low affinity site were 732.2
± 501.8 nmol/L and 2,449 ± 1,017 million sites/cell. C262 (against
C-terminus of genomic P4R) and h-151 (estrogen receptor)
recognized antigenic determinant over acrosomal domain of pre-
capacitated membrane intact and permeabilized sperm. Both
mAbs failed to recognize non-capacitated sperm, regardless of
membrane permeabilization. NCL-PGR (N-terminus of genomic
P4R) recognized acrosomal domain of membrane permeabilized
sperm, regardless of capacitation. Only mAb C262 and h151 had
significant inhibition on P4-induced acrosome reaction (AR).
The 74 and 63 kDa of boar membrane proteins from elution
fractions of P4-immobilized affinity chromatography were
recognized by C262. Sequencing of 74 kDa (undiscovered?)
protein showed a significant identity in the amino acid sequence
(XPXNIVLIFADDLGY) to residues 2-15 of arylsulfatase A (92
%) and to residues 2-10 of a 72 kDa (88 %) protein from boar
sperm membrane. However, neither of above proteins has an
identical sequence recognized by C262. Present results suggest
sperm and cytosol P4R may share at least in part the structural
homology but differ in topography and exposures of P4R are
associated with sperm capacitation and induction of AR.
Supported by NSC 89-2313-B-005-165; 90-2313-B-005-114,
Taiwan.
P113. Sperm washing: Lack of NHS funding is limiting access
to treatment.
C Gilling-Smith, B Tamberlin, AD Cox, G Rozis, JR Smith, S Barton
& PA Almeida. Chelsea and Westminster Hospital, London,UK.
Introduction: Sperm washing has been shown to reduce viral
transmission risk in HIV discordant couples wishing to conceive.
Only a few centres in the UK are able to provide this service.
Our programme, started in 1999, has received referrals from all
over the country. We review the outcome of the first 53 couples
treated in our centre to assess the safety, efficacy and
accessibility of our service.
Methods: 53 HIV-1 positive men with seronegative partners
entered the programme following pre-conceptual counselling
on risks of treatment and welfare of the child issues. Each partner
had a sexual health and fertility screen. Sperm washing was
performed with intrauterine insemination (IUI) if the fertility
screen was normal and IVF or ICSI after 3 failed IUI cycles or
when a tubal or male factor was diagnosed. HIV testing of the
female partner was carried out for one year post treatment.
Results and Discussion: 38 couples had 94 cycles of intrauterine
insemination and 30 couples had 22 cycles of IVF or 20 cycles of
ICSI. Semen was processed as previously described (Gilling-
Smith C, 2000) and verified HIV-1 negative by NASBA assay
before treatment. 4.2% (6/142) of cycles were cancelled due to
positive NASBA. Ongoing pregnancy/livebirth rates were
10.8% (11/94) for IUI and 23.8% (10/42) for IVF/ICSI resulting in
the birth of 15 children with no seroconversions in either female
partner or child. Satellite arrangements for investigations/
scanning were arranged for geographical reasons in 12 couples.
Only 9.6% (5/52) of couples received NHS funding for their
treatment (based on risk-reduction). A further 28 couples
referred were unable to proceed due to financial limitations. This
series confirms previous reports on the safety of sperm washing
as a risk reduction treatment but highlights lack of NHS funding
as a limiting factor in accessing treatment. This must be
addressed if HIV transmission in the heterosexual population is
to be minimised.
P114. Cholesterol oxidation is a common phenomenon in bovine
sperm cells.
PFN Silva, JFHM Brouwers, JB Helms, B Colenbrander &
BM Gadella. Department of Biochemistry and Cell Biology,
Faculty of Veterinary Medicine, Utrecht University,The
Netherlands; Department of Farm Animal Health, Faculty of
Veterinary Medicine, Utrecht University, The Netherlands.
Introduction: Lipid peroxidation of polyunsaturated fatty radyl
moieties and the associated functional damage to the sperm cell
membrane have been thoroughly investigated. However,
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nothing is known about the oxidative fate of sperm surface
cholesterol, despite its abundance. It is well established that
cholesterol is an important stabilizer of the membrane lipid bilayer
and reorientation, as well as lipoprotein mediated efflux of
cholesterol, that are key factors in successful sperm
cryopreservation and are required for sperm capacitation. We
report - for the first time - on oxidation of sperm sterols.
Methods: Ejaculates from 3 fertile bulls were split into two
portions. One was frozen in straws in liquid nitrogen whereas
the other was kept fresh and processed immediately. The samples
were washed over Percoll and incubated over night with Hepes
buffered Tyrodes medium either with or without 15 mM
bicarbonate (HBT+Bic - capacitation and HBT-Bic - control).
Lipids were extracted, cholesterol and its oxidized products
(COPs) were isolated by solid phase extraction and separated
by isocratic HPLC-MS analysis which led to the identification
of cholestane-3B,5a,6B-triol, 7-ketocholesterol, 5,6B-
epoxycholesterol, 5,6a-epoxycholesterol, 25-hydroxycholesterol
and 7B-hydroxycholesterol.
Results and Discussion: Initial experiments showed that COPs
formation was marginally altered in frozen sperm when compared
to fresh sperm. Addition of oxidants increased the levels of
COPs in fresh (1 to 12 times) and especially frozen sperm (7 to 40
times) indicating that the latter was more susceptible to oxidative
stress. Samples incubated in HBT+Bic showed approx. 48%
lower COPs formation when compared to HBT-Bic indicating
that capacitating sperm were less sensitive for oxidative stress.
The physiological role of COPs formation in bovine spermatozoa
is currently being investigated.
P115. Non-glycosylated peripheral proteins of the sow oviduct
are involved in the maintenance of boar sperm viability in vitro.
RMA Elliott1, PF Watson2, WV Holt1, R Hudson-Davies2 &
AR Fazeli3. 1Institute of Zoology, Zoological Society of London,
London, UK; 2Royal Veterinary College, Royal College Street,
London, UK; 3University of Sheffield, Sheffield, UK.
Introduction: We have previously shown that a soluble fraction
of porcine oviductal apical plasma membrane (sAPM) enhances
boar sperm longevity in vitro and that the viability enhancing
activity is likely to involve proteins. To identify sAPM proteins
binding to spermatozoa, that may include a candidate for the
bioactivity described, we labelled a sample of sAPM with biotin
prior to incubation with spermatozoa. Furthermore the
glycosylation status of sAPM proteins was examined.
Methods: Oviductal epithelium was scraped, homogenised and
purified to prepare APM vesicles. A soluble fraction was
extracted using salt treatment. A sample of the fraction was
incubated with EZ-Link Sulfo-NHS-LC-Biotin for 30 minutes at
room temperature and excess biotin removed. Washed swim-up
boar spermatozoa (50 x 106 sperm/ml) in Tyrode’s medium with
lactate and pyruvate were added to equal volumes of biotinylated
sAPM (final protein concentration 150 µg/ml). Spermatozoa and
sAPM were co-incubated for one hour at 39°C. Unbound sAPM
was removed and the spermatozoa solubilized. Sperm surface
proteins together with bound sAPM proteins were separated
by SDS-PAGE. Biotinylated proteins were detected by
NeutrAvidin/horse-radish peroxidase conjugate and visualized
by chemiluminescence. Proteins from a further sample of sAPM
were separated by SDS-PAGE and treated with glycoprotein
(Pro-Q Emerald) stain.
Results and Discussion: Biotinylated sAPM bands were seen
in the sperm profile most notably at approximately 18 and 19
kDa. Glycosylated sAPM protein bands were seen at
approximately 31 and 40 kDa. It seems the majority of sAPM
proteins bound to sperm were non-glycosylated.We suggest
that active factor(s) responsible for the maintenance of boar
sperm viability is/are of protein nature and peripherally bound
to the APM of porcine oviductal epithelial cells.
This study was funded by the Department for Environment,
Food and Rural Affairs, UK.
P116. Does the Arg-Gly-Asp (RGD) adhesion sequence play a
role in mediating sperm interaction with the human
endosalpinx?
L Reeve, WL Ledger & AA Pacey. Academic Unit of
Reproductive and Developmental Medicine, Sheffield, UK.
Introduction: Sperm from several species including the human
make direct contact with the endosalpinx. Although this is known
to be beneficial to sperm function, the specific mechanisms
mediating adhesion are poorly understood. Experiments were
designed to investigate the potential role of integrins and the
RGD adhesion sequence in sperm-epithelial binding.
Methods: Peptides containing the RGD sequence, RGDV and
GRGDTP, and a scrambled sequence, GRGES, were incorporated
into an established in vitro sperm binding assay to assess the
effect on sperm attachment to the endosalpinx. In addition, the
ability of beads coated with an RGD peptide to bind specifically
to sperm and/or epithelium was measured. Subsequently,
immunohistochemistry was used to evaluate the expression of
two integrin subunits beta 1 and alpha v in the endosalpinx. The
study was approved by the South Sheffield Research Ethics
Committee, and all patients gave their written consent.
Results and Discussion: Significantly fewer sperm associated
per field of isthmic epithelium in the presence of 250µM RGDV
(1.17 ± 0.29; mean ± SEM, p<0.01) and 62.5µM GRGDTP (1.18 ±
0.41; p<0.05) compared to the control incubation (3.34 ± 0.45).
There was no difference in sperm binding to ampullary
epithelium in the presence of any of the peptides tested.
Moreover, no beads were observed bound to sperm whereas
significantly more RGD-coupled beads bound to isthmic
epithelium compared to ampullary epithelium (1.47 ± 0.26 v 0.72
± 0.16; p<0.01). The integrin subunits beta 1 and alpha v were
expressed on the apical surface of isthmic and ampullary
epithelium with staining being the strongest for beta 1. These
findings indicate that the recognition between the RGD sequence
present as part of an unknown protein on sperm, and integrin
receptors present on the endosalpinx, may contribute to the
interaction between sperm and the human endosalpinx in the
isthmic region of the uterine tube.
P117. Relationship between cholesterol efflux, plasma
membrane organisation and capacitation in boar spermatozoa.
S Shadan, PS James & R Jones. Gamete Signalling Laboratory,
The Babraham Institute, Cambridge, UK.
Introduction: Cholesterol efflux from the plasma membrane of
spermatozoa is one of the early events that either triggers, or is
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closely associated with, capacitation. In this investigation we
have examined the effects of varying the levels of membrane
cholesterol on tyrosine phosphorylation, lipid diffusion and raft
organisation in boar spermatozoa.
Methods: Membrane cholesterol was removed using methyl-
beta-cyclodextrin (MBCD) and tyrosine phosphorylated proteins
detected by SDS-PAGE/immunoblotting. Lipid diffusion was
measured by photobleaching analysis (FRAP) and membrane
rafts isolated in cold Triton-X100/sucrose gradient
centrifugation. The distribution of gangliosides on whole
spermatozoa was observed using FITC-cholera toxin B subunit
(CTXB) and capacitation stages assessed from staining with
chlorotetracycline (CTC).
Results and Discussion: Our results showed that cholesterol
removal under conditions that resulted in capacitation (as
revealed by CTC staining) increased phosphorylation of 26 kDa
and 14 kDa proteins. However, there was no significant change
in lipid diffusion in any region of the sperm plasma membrane.
Low density Triton insoluble raft fractions isolated from whole
spermatozoa were enriched in cholesterol and specific classes
of proteins. Removal of cholesterol that induced capacitation
changes caused redistribution of some phosphorylated proteins
into the raft fraction. The distribution of membrane gangliosides,
as revealed by staining with CTXB, changed in a sequential
manner on the sperm head during cholesterol removal with
MBCD. The response tended to be heterogenous and varied
with the individual boar. These results suggest that as in many
other cellular systems, a proportion of plasma membrane
cholesterol in spermatozoa is raft associated and that removal
of cholesterol leads to raft re-organisation. Therefore, induction
of signalling events in boar spermatozoa that precede functional
capacitation may be regulated by raft-associated cholesterol at
the level of plasma membrane.
P118. Expression of vascular endothelial growth factor (VEGF)
family of peptides in the rat testis.
CL Au, JL Yeung & LF Chan. Department of Physiology, The
Chinese University of Hong Kong, Shatin, Hong Kong.
Introduction: VEGF family is a group of structurally related
peptides important in controlling vascular development and
functions. We have previously demonstrated the expression of
VEGF-A and its receptors (VEGFR-1 and VEGFR2) in the testis.
This study aims at determining whether other members of VEGF
family are also present, thus providing the basis for further
understanding their role in the vascular control of the testis.
Methods: Adult Sprague-Dawley rats were studied together with
the use of primary testicular cells and cell lines. The expression
of VEGF-B, -C, -D and placental growth factor (PlGF) were
examined using RT-PCR, Western immunoblotting and
immunostaining.
Results and Discussion: Using RT-PCR, mRNA of all VEGF
family members were shown to be expressed in rat testes, primary
Leydig and Sertoli cells, and testicular cell lines from rat (LC540,
R2C) and mouse (MLTC-1, TM3, TM4). These included PlGF-2
and the two spliced forms of VEGF-B. Western immunoblotting
of tissue and cell lysates revealed positive bands corresponding
to dimers (60 kD, 40 kD) and monomers (32 kD, 23 kD, 21 kD) of
VEGF-B186 and VEGF-B167. For VEGF-C, positive bands were
identified at 24 and 26 kD, VEGF-D at 64, 48, 35, 29 and 22 kD and
PlGF at 27 kD. Variations in signal intensity of protein bands
were observed in different samples and these could be related
to their relative abundance and levels of processing in different
cell types. Immunostaining showed strong immunoreactivity in
Leydig cells, and weak in Sertoli cells and vascular smooth
muscle. Both vascular and lymphatic endothelia were negative
in immunostaining. Following the destruction of Leydig cells
by ethane dimethanesulphonate treatment, most
immunoreactivity in the testicular interstitium disappeared and
immunoblotting showed decreased signal intensity of some
protein bands. In conclusion, VEGF family members are
expressed in the testis and besides Leydig cells, they occur in
other cell types.
P119. Developmental changes in cellular apoptosis,
proliferation and morphology throughout gestation in the sheep
fetal testis.
A Lindsay1, RG Lea2 & DW Miller1. 1School of Biology,
University of Aberdeen, Aberdeen, UK; 2Rowett Research
Institute, Aberdeen, UK.
Introduction: Appropriate fetal testicular development is
essential for adult fertility. However, little is known about the
key developmental changes that occur throughout gestation.
Fetal sheep testes were investigated for changes in cellular
markers of apoptosis, proliferation and morphology from day 30
to 140 (term = d145) of gestation.
Methods: Testes from ovine fetuses at day 30 (n = 6), 40 (n = 6),
50 (n = 4), 70 (n = 6) 100 (n = 7) and 140 (n = 7) of gestation were
fixed in Bouins solution. Tissue sections (5um) were mounted
on poly-L-lysine coated slides and immunohistochemically
stained for proliferating cell nuclear antigen (PCNA) and the
pro-apoptotis gene product, Bax. Staining was quantified over
six randomly selected fields using image analysis software. On
days 30, 40 and 50 of gestation, the total area of positively
stained cells was expressed as a percentage of the total area. On
days 70, 100 and 140 of gestation, the cords and the interstitial
area were analysed separately for staining. Data were statistically
analysed by regression analysis and Fishers unprotected
analysis of variance.
Results and Discussion: Testicular cords, Sertoli cells and germ
cells were first apparent in the fetal testes at day 40 of gestation.
Leydig cell differentiation followed between days 50 and 70 of
gestation. PCNA expression in the interstitium declined (p<0.001)
from day 30 to 140 of gestation, whereas cord levels remained
constant. Maximal Bax levels were found in the germ cells of the
cords at day 70 after which there was a significant decline
(p<0.001) to day 140. In contrast, interstitial levels remained
maximal from day 70 onwards. In conclusion, morphogenesis of
the sheep fetal testis throughout gestation is associated with
decreasing cellular proliferation and maximal levels of the pro-
apoptotis Bax protein from mid-gestation onwards.
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P120. Morphological investigation of adult human testicular
tissue cryopreserved by the different methods.
V Keros1,3, B Rosenlund1, L Levkov1, K Hultenby2,
V Grischenko3 & O Hovatta1. 1Department of Obstetrics &
Gynaecology, Fertility Unit, Karolinska Institute, Huddinge
University Hospital, Stockholm, Sweden; 2Clinical Research
Centre, Karolinska Institute, Stockholm, Sweden; 3Institute for
Problems of Cryobiology & Cryomedicine of the National
Academy of Sciences of the Ukraine, Kharkov, Ukraine.
Introduction: Cryopreservation of testicular tissue is important
for cancer patients especially for prepubertal boys, who are not
yet able to produce spermatozoa, and young adults who might
achieve sperm production and hence avoid the need for assisted
reproduction in later life. The aim of our investigation was to
select a method of adult human testicular tissue (AHTT)
cryopreservation for use in future infertility treatment.
Methods: AHTT samples were obtained by using needle biopsy
technique from infertile patients undergoing diagnostic
procedure and ICSI treatment. Samples have been cut into small
pieces (1-2 mm2) and then were frozen-thawed by three different
methods using dimethyl sulfoxide (DMSO), 1,2-propanediol
(PrOH) and glycerol in different concentrations, supplemented
with sucrose and patients serum. Two of these methods are
routinely used in the Fertility Unit, Huddinge University Hospital
for sperm and human ovarian tissue cryopreservation. They
were compared with human fetal testes tissue (HFTT) freezing
technique, worked out in the Institute for Problems of
Cryobiology and Cryomedicine of NAS of the Ukraine. We
analysed samples by the methods of light and transmission
electron microscopy (TEM) before and after freezing-thawing
procedure.
The study was approved by the Ethics Committee of the
Karolinska Institute.
Results and Discussion: The staining by hematoxylin-eosin
and light microscopy examination indicated that AHTT after
cryopreservation by program for HFTT with using DMSO in
majority of the cases had morphology close to normal, while the
tissue cryopreserved with PrOH looked partially destroyed. The
samples frozen by sperm cryopreservation method were devoid
of normal structure. Preliminary results from TEM investigation
support this.
Our data suggest that AHTT could be successfully
cryopreserved by the method for HFTT freezing. It could be
recommended for AHTT preservation with the aim of using for
assisted reproduction.
This study was supported by The Swedish Institute fellowship
for study and research.
P121. Mouse endometrial pinopodes expression during
implantation window after ovarian stimulation and progesterone
injection.
M Salehnia, SM Emadi & T Taki. Department of Anatomy, Tarbiat
Modarres University, Tehran, Iran.
Introduction: The aim of this study was evaluate the expression
of pinopodes as an implantation marker after ovarian
hyperstimulation and progesterone injection during implantation
period using scanning electron microscopic studies.
Methods: Adult N MRI mice were superovulated using human
menopausal gonadotropic hormone and human chorionic
gonadotropic hormones (hCG) and after that in one group of
superovulated mice daily injections of progesterone (1 mg/
mouse) were performed. Animals were sacrificed by cervical
dislocation 3.5 and 4.5 days after hCG injection. Tissues were
obtained from 1/3 middle part of uterine horns and processed
for scanning electron microscopic studies. The pseudopregnant
control samples were obtained on the 3.5 and 4.5 days of
pregnancy and studied as the same as experimental groups.
Results and Discussion: Our results showed that in control
groups on 3.5 days of pregnancy there were some pinopodes
and on the fourth day all apical cell surfaces expressed these
projections. In hyperstimulated groups without progesterone
injection the pinopodes were not seen 3.5 days after hCG
injection but one day later they were seen. In progesterone-
injected group well developed pinopodes were expressed 3.5
days after ovarian induction and they were transformed to small
projections on the day fourth of hCG injection.
Our results showed that the life span of pinopodes was limited
to a short time and this time changed during hyperstimulation
regimes and the progesterone cause premature expression of
pinopodes. Thus the implantation failure after ovarian induction
may be due to these timing changes.
P122. Localisation of vascular endothelial growth factor and
angiopoietins during the peri-implantation period and early
pregnancy in the marmoset.
AJ Rowe1, HM Fraser1 & C Wulff2. 1Medical Research Council,
Human Reproductive Sciences Unit, Centre for Reproductive
Biology, University of Edinburgh, Edinburgh, UK; 2Department
of Obstetrics and Gynaecology of the University of Ulm, Ulm,
Germany.
Introduction: Angiogenesis is likely to play a role in
implantation, but the molecular regulation of this process remains
to be elucidated. Vascular Endothelial Growth Factor (VEGF)
has been implicated in vascular remodelling and placentation
while angiopoietins (Ang-1 and Ang-2) have a role in regulation
of blood vessel growth, maturation and regression. The objective
of the current study was to localise these factors in marmoset
endometrium.
Methods: Experiments were carried out under the Animals
(Scientific Procedures) Act, (1986) and approved by the local
Ethical Review Committee. Marmoset uteri were studied at 2
(n=4), 3 (n=6) and 4 (n=6) weeks of pregnancy and compared to
late secretory non-pregnant endometrium (n=6). VEGF, VEGF
R1, VEGF R2, Ang-1, Ang-2 and Tie-2 mRNA’s were localised
and quantified by in situ hybridisation. Uteri were divided into
regions and scored according to grain density within each.
Scores were compared for each angiogenic factor across the
stages of pregnancy studied using a Kruskal-Wallis followed
by a Dunn’s multiple comparison test.
Results and Discussion: VEGF was present in all compartments
except endothelial cells, generally increasing throughout
pregnancy apart from in upper zone glandular epithelium and
luminal epithelium, where a decrease in expression was observed.
Receptors for VEGF were found in endothelial cells of the upper
zones immediately surrounding glandular epithelium. Ang-1 was
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localised to glandular epithelium of the upper and lower zones
increasing in stroma at 4 weeks. Ang-2 expression was localised
exclusively to endothelial cells of large luminal vessels and was
significantly higher in endometrium at 4 weeks than all other
stages. These data provide evidence that VEGF/R1R2 and Ang-
1/Ang-2/Tie-2 interactions may be involved in the preparation
of endometrium for implantation, remodelling of the maternal
vasculature and trophoblast invasion during the peri-
implantation period in the marmoset.
P123. Markers of endometrial function in women with
unexplained recurrent pregnancy loss: A comparison between
morphologically normal and retarded endometrium.
E Tuckerman1, SM Laird1,2, R Stewart3, M Wells3 & TC Li1.
1Biomedical Research Unit, Jessop Wing, Sheffield, UK; 2BRMC,
Sheffield Hallam University, Sheffield, UK; 3Academic Unit of
Pathology, University of Sheffield, UK.
Introduction: Endometrial defect, usually described as luteal
phase deficit (LPD), is associated with recurrent miscarriage
(RM). RM has also been associated with the abnormal expression
of various molecules by endometrial cells. In this study we
compare markers of endometrial function in women suffering
from RM with and without LPD.
Methods: Recurrent miscarriage was defined as three
consecutive losses in the first trimester and biopsies were
precisely timed from the LH surge. Morphological endometrial
delay in excess of two days (LPD) was present in 13 women.
Ethical consent was obtained for this study with informed
consent from the 36 women who participated.
Immunocytochemical analysis was used to detect CD45, CD56,
CD3, CD4, LIF, IL6, ER and PR in wax embedded sections. For
leukocyte populations the number of positive and negative cells
in 10 fields were counted. Immunostaining for LIF, IL6, ER and
PR was quantified by assigning an HSCORE. Serum estrogen
was measured on day LH+0 and serum progesterone on the day
of biopsy.
Results and Discussion: Chronological dating between days
LH+6 and LH+11 correlated positively with the number of cells
positive for CD45 (P<0.001) and CD56 (P<0.05) and negatively
with the amount of PR (P<0.001) and LIF (P<0.001) staining.
Comparison of markers within the peri-implantation period (LH+7-
9) showed significantly lower numbers of CD56+ (P<0.05) in
LPD compared to in-phase endometrium. Expression of other
markers was not significantly different. Although luteal phase
progesterone levels were similar in women with in-phase and
LPD, a lower mid-cycle estrogen level (P<0.05) was seen in women
with LPD.
The results suggest that there is a difference in the numbers of
CD56+ cells in LPD and in-phase endometrium from women with
recurrent miscarriage. They also confirm the importance of
follicular phase estrogen in LPD and the need for the precise
dating of the endometrium in RM.
P124. Clinical evaluation of postpartum vaginal mucus reflects
uterine bacterial infection.
EJ Williams1, D Fischer1, GW England1, H Dobson2 &
IM Sheldon1. 1Division of Veterinary Reproduction, Royal
Veterinary College, Hatfield, UK; 2Department of Veterinary
Clinical Science and Animal Husbandry, University of Liverpool,
Neston, UK.
Introduction: Bacterial contamination of the uterine lumen after
parturition is almost ubiquitous in cattle and infection persists
in 10 to 15% of animals, causing subfertility. However,
bacteriological evaluation of uterine infection is not readily
available in clinical practice. Thus, we tested the hypothesis
that clinical evaluation of postpartum vaginal mucus reflects
uterine bacterial infection.
Methods: The contents of the vagina of cattle (n = 70) were
examined 21 and 28 days postpartum, under Home Office
approval, and the mucus scored for character (colour, proportion
and volume of pus) and smell (foetid odour). In addition, swabs
were collected from the uterine lumen for aerobic and anaerobic
culture. Bacteria were identified and categorised as: (1) specific
uterine pathogens, (2) potential pathogens or (3) opportunist
contaminants. The number of colonies for each bacterial isolate
was estimated and the uterine bacterial load scored semi-
quantitatively.
Results and Discussion: The overall vaginal mucus score
(character + smell) was correlated with the score for all bacteria
(r = 0.40, P < 0.01), uterine pathogens (r = 0.48, P < 0.01) and
potential pathogens (r = 0.17, P < 0.05), but not with other bacterial
contaminants. The character of vaginal mucus was correlated
with the uterine pathogen score (r = 0.45, P < 0.01), and potential
pathogen score ( r = 0.17, P < 0.05) but not with other bacteria. In
particular, vaginal mucus character was correlated with
Arcanobacterium pyogenes (r = 0.43, P < 0.01), Fusobacterium
necrophorum (r = 0.26, P < 0.01) and Prevotella melaninogenicus
(r = 0.31, P < 0.01). These bacteria act synergistically to increase
the severity of endometritis. The presence of a vaginal mucus
foetid odour was correlated with the score for uterine pathogens
(r = 0.47, P < 0.01), but not other bacteria. Furthermore, the
abnormal smell was correlated with Arcanobacterium pyogenes
(r = 0.52, P < 0.01), Fusobacterium necrophorum (r = 0.32, P <
0.01) and Prevotella melaninogenicus (r = 0.24, P < 0.01). These
results indicate that clinical evaluation of vaginal mucus during
the postpartum period reflects the presence and number of
pathogenic bacteria within the infected uterus.
This study was supported by the Wellcome Trust.
P125. Clearance of charcoal following intra-uterine inoculation
in mares.
G Kolm1, M Gemeiner2, K Deichsel1, S Budik1 & C Aurich1.
1Centre for Artificial Insemination and Embryo Transfer, Clinic
for Obstetrics, Gynecology and Andrology, University of
Veterinary Science, Vienna, Austria; 2Institute of Medical
Chemistry, University of Veterinary Science, Vienna, Austria.
Introduction: In the mare, a transient, mating-induced
inflammatory reaction of the endometrium is physiological and
clears the uterus from bacteria, seminal plasma and excess
spermatozoa. Failure of these clearance mechanisms results in
persistent inflammation and is considered a major cause of
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subfertility in the horse. So far, no objective method for the
evaluation of uterine clearance exists.
Methods: We have studied whether retention of non-antigenic
charcoal from the uterus of oestrous (n=14) and ovariectomized
mares (n=4) can be used to assess uterine clearance. In a second
experiment, 4 mares with good clearance were treated with the
beta(2) adrenoceptor agonist clenbuterol to inhibit uterine
contractions. In all mares, charcoal (4-90 µm; 500 mg in 50 ml
PBS) was installed into the uterus. After 48 hours, uteri were
flushed with methylene blue (0.0012% in 50 ml PBS) for
determination of the diluting factor by photospectrometry. Flush
volume, colour, turbidity, pH, specific gravidity, extinction rate,
PMN number and size of the charcoal pellet were recorded.
Results and Discussion: Flush volume, pH, specific gravidity
and pellet size were correlated positively to each other and
negatively to extinction rate (p<0.05). A flush volume below 50
ml was associated with methylene blue dilution below 11%, a
charcoal pellet below 100 µl, pH of 7.0, specific gravidity of 1005
and PMN numbers from 8x105-5.5x106. Uterine clearance in these
mares was classified as normal. Delayed clearance was defined
as a flush volume exceeding 50 ml (69.5 ± 19.2 ml). Methylene
blue dilution was 33-76%, the charcoal pellet 0.5-5 ml (2.1 ± 2.0
ml), specific gravidity 1005-1010 (1007.3 ± 2.1), pH 7.0-8.25 and
PMN number between 6x107-1.5x108. Clearance parameters
neither in ovariectomized nor clenbuterol-treated mares differed
from oestrous mares with normal clearance. In conclusion,
charcoal inoculation allows assessing mechanical uterine
clearance in the horse. Neither the absence of ovarian steroids
nor clenbuterol treatment affects mechanical uterine clearance.
P126. Nutrient concentrations in oestrous mouse ovarian
follicles, oviduct and uterus.
SE Harris1, HJ Leese2, HM Picton1 & NM Orsi1. 1Department of
Obstetrics and Gynaecology, University of Leeds, Leeds, UK;
2Department of Biology, University of York, York, UK.
Introduction: The culture of murine oocytes and preimplantation
embryos in vitro results in cellular stress and reduced viability.
This phenomenon is likely to involve differences in nutrient
composition between culture media and maternal tract fluids.
We have therefore determined the concentrations of glucose,
pyruvate, lactate and 19 amino acids in murine preovulatory
follicles and oestrous oviductal and uterine fluids.
Methods: Fluid was aspirated from hyperstimulated preovulatory
follicles (n = 44; FF). Oviductal fluids (n = 27 and 9, with and
without oocyte-cumulus complexes, respectively; Ov+ and Ov)
and uterine (Ut; n = 62) fluids were collected from naturally
cycling animals at oestrus. Glucose, pyruvate and lactate
concentrations were analysed ultramicrofluorometrically; amino
acid profiles were determined by reverse phase HPLC.
Results and Discussion: Mean glucose concentrations in FF,
Ov+, Ov- and Ut were 0.46, 1.09, 1.65 and 0.61 mM, respectively.
Mean pyruvate concentrations were 0.38, 0.37, 0.17 and 0.25
mM, respectively, while mean concentrations of lactate were
17.34, 10.92, 11.68, 9.41 mM, respectively. Resumption of murine
oocyte maturation is known to be pH-sensitive and it is probable
that high follicular lactate lowers pH, potentially contributing to
maintenance of meiotic arrest. Oviduct pyruvate was significantly
higher and glucose significantly lower in the presence of cumulus
cells.
Taurine, glycine, alanine, glutamine and glutamate were the major
amino acids detected. Concentrations of amino acids differed
among tract fluids, with highest values reported in the oviduct.
Low levels of follicular amino acids may be due to granulosa cell
and oocyte metabolism. Oviduct amino acids tended to have
higher concentrations than plasma, suggesting some active
transport into the tract lumen and/or de novo synthesis in the
oviduct and uterine epithelia. The higher amino acid
concentrations in the oviduct may be related to their role as
osmolytes, nutrients, ROS scavengers and heavy metal ion
chelators.
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